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S U M M A R Y
Blood coagulation  has been in v e s tig a ted  in  lo b s te rs , fowl, 
c a t t l e ,  ho rses, and ra b b its .  Comparison has been made with the  
human blood coagulation  mechanism, on th e  basis  of cu rren t concepts 
of th a t  system.
Blood coagulation  in  the  lo b s te rs  was found to  occur in  one 
phase, namely th e  conversion of lo b s te r  fib rinogen  from the  s ta te  
of so l in to  th a t  of ge l by th e  ac tio n  of an ac tiv e  throm bin-like 
m a te ria l, in  the  presence of calcium ions. This m ateria l is  
re le ased  d ir e c t ly  from one p a r t ic u la r  kind of blood c e l l ,  the 
explosive c e l l ,  ch a ra c te rise d  by i t s  g rea t s e n s i t iv i ty  to  contact 
w ith fo re ig n  su rfaces which causes i t  to  d is in te g ra te  almost 
in stan tan eo u sly . The throm bin-like m ateria l had no hydro ly tic  
a c t iv i ty  on arg in ine  e s te r s ,  but i t s  property  of coagulating 
lo b s te r  plasma or p u r if ie d  lo b s te r  fib rinogen  was in h ib ite d  by 
la rg e  concen tra tions of heparin , which ac tio n  was reversed  by 
hexadim ethrine bromide. The lo b s te r  blood did  not contain  any of 
th e  o ther coagulation  fa c to rs  known to  occur in  man. The lo b s te r  
coagulation  reagen ts were ab so lu te ly  species sp ec if ic  and were not 
in terchangeable w ith human coagulation reagen ts .
Fowl blood lacked com pletely fa c to rs  IX, XI, and XII a c t iv i t i e s ,
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w hile fa c to rs  V, V II, V III, and X were p resen t but species sp e c if ic .  
Fowl thrombocytes possessed a weak throm boplastic a c t iv i ty  even in  
homologous throm boplastin  generation  m ixtures.
In  the  mammalian v e r te b ra te s , species s p e c if ic i ty  was only 
demonstrable in  the  case of fa c to rs  VII and X in  bovine and equine 
blood; a l l  the  o ther fa c to rs  were not species sp e c if ic  and mostly 
p resen t in  high co ncen tra tions, e sp e c ia lly  bovine fa c to rs  I ,  I I ,  and 
V III, equine fa c to rs  I I ,  V, and IX, and in  the  ra b b it  fa c to rs  V and 
X II. The exception was fa c to r  IX which was p a r t i a l l y  d e f ic ie n t in  
both c a t t l e  and ra b b it  se ra .
A ll v e r te b ra te  plasmas and the ex trac ted  fib rinogen  so lu tions 
were coagulated most ra p id ly  w ith the homologous thrombin so lu tio n , 
again rev ea lin g  the  species s p e c if ic i ty  of the  throm bin-fibrinogen 
re a c tio n .
Adsorbed plasmas from th e  fowl and horses had an in h ib ito ry  
e f fe c t  when added to  human throm boplastin  generation  m ixtures.
This in h ib ito ry  p roperty  can be removed by heating  th e  adsorbed 
plasma p r io r  to  i t s  ad d itio n , to  p re c ip ita te  the  fib rinogen  which 
i s  believed  to  be, or associa ted  w ith , the  responsib le  agent, s ince 
both fowl and horse se ra  had no such in h ib ito ry  a c t iv i ty  a t  a l l .
The presen ted  find ings revea l th a t  during th e  process of 
evo lu tion , severa l phenomena occur. F i r s t ly ,  functions which were 
the  so le  p roperty  of the  c e l ls  become a t tr ib u te d  to  fa c to rs  f re e ly
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so lub le  in  th e  e x tra -c e llu la r  plasma. Secondly, th e  coagulation  
mechanism becomes more complex due to  the  appearance of more 
coagu lation  fa c to rs ;  c lo tt in g  then occurs a f te r  severa l stages of 
in te ra c t io n s ,  w ith the  consequent d if f e re n t ia t io n  of two 
throm boplastin  systems, th e  more p rim itiv e  e x tr in s ic  or t is s u e  
throm boplastin  system, and the  more in t r ic a te  in t r in s ic  or plasma 
throm boplastin  system being acquired in  h igher anim als. T hird ly , 
the  mammals which are  regarded as the  most h igh ly  evolved spec ies, 
have an increased  concen tra tion  of the  coagulation  fa c to rs , thereby 
probably ensuring the e ff ic ie n c y  of the  coagulation  mechanism.
F in a lly , fa c to rs  which in  lower animals were com pletely species 
sp e c if ic  g radually  lo se  th e i r  s p e c if ic i ty ,  even tually  becoming 
f u l ly  in terchangeable w ith human blood coagulation fa c to rs .
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I N T R O D U C T I O N
The o b je c t of th i s  work is  to  study  the  blood coagu la tion  
mechanisms of d if f e re n t  animal species as compared to  th a t  of man.
A g re a t  dea l has been done in  th e  p a s t by various workers on th e  
same s u b je c t ,  when knowledge of th e  human blood coagu la tion  
mechanism was lack ing . Except in  few cases, u su a lly  each 
in v e s t ig a to r  has looked in to  one or two aspects of th e  coagu la tion  
mechanism, again  only of a p a r t ic u la r  species of anim als. Though 
th e re  i s  f a i r  agreement in  the  r e s u l t s  of the  d if f e r e n t  rep o rted  
in v e s t ig a t io n s ,  s t i l l  on reviewing the voluminous l i t e r a t u r e  on 
t h i s  su b jec t one can d isce rn  many co n trad ic tio n s  and wide v a r ia tio n s  
among them.
T herefo re , i t  was thought worthwhile to  undertake such an 
in v e s t ig a t io n , covering th e  whole coagulation  mechanism of sev e ra l 
sp e c ie s , using  th e  same methods and th e  same re fe ren ce  standard  
plasm a or serum so as to  be ab le to  compare and c o n tra s t th e  r e s u l t s  
w ith  a  c e r ta in  degree of accuracy and conform ity.
The main in t e r e s t  was to  see i f  th e  r e s u l t s  would suggest th e  
p resence of any r e la t io n  between the  p a tte rn  of th e  blood coagu lation  
mechanism o f a c e r ta in  c la ss  of animals and i t s  p o s itio n  in  the
-  2 -
ev o lu tiv e  zoo lo g ica l c l a s s i f i c a t io n ,  or w ith  sp e c ia l p h y sio lo g ica l 
p e c u l ia r i t i e s  o f th e  sp e c ie s . This i s  by no means a simple question  
to  answer adequate ly , and I  make no p re tence  to  have done so.
A lso, i t  was hoped th a t  such an in v e s tig a tio n  would help  in  
th e  f u l l e r  understand ing  of th e  ev o lu tio n  of the  human coagu la tion  
mechanism, as w ell as throw ing some l ig h t  on th e  use of animal 
coagu la tio n  reag en ts  in  human coagu la tion  s tu d ie s .
Endeavour in  th e  choice of anim als was made to  re p re se n t as 
w idely v a r ie d  sp ec ie s  as fe a s ib le ,  su b jec t to  a v a i la b i l i ty ,  ease 
o f hand ling , and th e  p o s s ib i l i ty  of o b ta in ing  reasonable amounts 
of blood from them.
I  w ish to  p o in t out th a t  r e fe r r in g  to  chicken blood or plasma, 
ra b b i t  b lood, e t c . . ,  i s  only  tru e  w ith  reg ard  to  th e  p a r t ic u la r  
genus or s t r a i n  in v e s tig a te d , namely chicken o f th e  L ight Sussex 
s t r a in ,  ra b b its  of th e  C a lifo rn ian  s t r a in ,  and so on.
S ince th e  coagu la tio n  mechanism as i t  occurs in  th e  human 
blood forms th e  b a s is  fo r  comparison between th e  sp ec ie s , a 
d e ta i le d  review  and d iscu ss io n  of th e  p rocesses and fa c to rs  
involved  in  i t  a re  p resen ted  in  P a r t  1. In  th e  subsequent p a r ts  
d isc u ss io n  of th e  r e s u l t s  of experim ents made on th e  various 
sp ec ies  i s  p resen ted . D e ta ils  of th e  methods used and of th e  
r e s u l t s  ob ta ined , as w ell as th e  i l l u s t r a t i o n s  a re  a l l  contained 
in  volume two.
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GLOSSARY OF ABBREVIATIONS 
Recourse has o f te n  been made to  th e  use of the  fo llow ing 
ab b rev ia tio n s  fo r  th e  sake o f b re v ity ,  e s p e c ia lly  in  th e  co n s tru c tio n  
o f th e  ta b le s  and in  th e  g rap h s ' fo o tn o te s .
Chemicals were d esignated  t h e i r  agreed formulae and a re  not 
inc luded  in  th i s  l i s t .
A.H.G. = A ntihaem ophilic g lo b u lin .
A d s.p l. = Adsorbed plasm a. U nless o therw ise s ta te d , th i s
u s u a lly  means plasma adsorbed w ith  alumina.
Alumina = Aluminium hydroxide g e l .
A.R. = A n a ly tica l reag e n t.
B.D.H. = B r i t i s h  Drug Houses L td .
Bov. = Bovine.
Br. = B rain .
B.W. & Co. = Burroughs Wellcome and Company.
Ceph. ss C ephalin .
Ck. a  Chicken.
Cone. ss C oncen tra tion .
Def. ss D e f ic ie n t.
D il.  = D ilu ted , d i lu t io n .
D is t.  =s D is t i l le d .
E xpt. = Experim ent.
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F = F a c to r .
g = A cce le ra tio n  of g ra v ity .
Hse. = Horse.
Hum. ss Human.
H .S .p l. = H igh-spun plasm a, i . e .  p la te le t-p o o r  plasm a.
I .C . I .  Im peria l Chemical In d u s tr ie s .
Lob. ss L o b ste r.
M = Molar s o lu tio n , moles,
mp. = Mil li -m i cron
jjM = M icromoles,
p. ss Io n ic  s tre n g th .
M.S.E. ss Measuring and S c ie n t if ic  Equipment L im ited.
N = Normal s o lu tio n .
P.C.V. = Packed c e l l  volume.
P.D. & Co. ss Parke Davis and Company.
P h en in d .p l. = Phenindione plasm a, i . e .  plasma from p a t ie n ts  
under phenindione th e rap y .
P I . s= Plasma.
P la t .  = P l a t e l e t s .
P .T.A . ss Plasma th rom bop lastin  an teceden t.
P .T .C . ss Plasma th rom boplastin  component.
P p t. ss P r e c ip i ta te .
Rab. ss R ab b it.
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r.p.m * = re v o lu tio n  per m inute.
R.V.V. = R u s s e ll’s v ip e r  venom.
S er. = Serum.
Sp.G. = S p e c ific  g ra v ity .
S.V.G. = S tandard  w ire gauge.
TAMe = p-Tosyl-L-A rginine Methyl e s te r .
T .C.A .a. = T ric h lo ra c e tic  ac id .
Temp. = Tem perature.
W.B.Cs. = White blood co rp u sc le s .
Wt. = W eight.
X-mas P. _ Christm as fa c to r .
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SYNONYMS OF BLOOD COAGULATION FACTORS 
The Roman numerals used are  in  accordance w ith  th e  recommendations 
of th e  In te rn a tio n a l  Committee on Nomenclature of Blood C lo ttin g  F ac to rs .
Use was made o f th e se  Roman numerals whenever p o ss ib le , except 
in  few in s ta n c e s  when th e  more fa m ilia r  synonym was used, e .g .  t i s s u e  
th rom bop lastin , f ib rin o g en , prothrom bin, e t c . .
F ac to r Synonyms
I  : F ib rinogen .
I I  Thrombogen, (Morawitz, 1905).
-  Thrombozyme, (N olf, 1908).
-  Prothrom bin.
I l l  Throrabokinase,(Morawitz, 1903).
-  T issue th rom boplastin ,(H ow ell, 1935).
IV s Calcium.
V L ab ile  fac to r ,(Q u ic k , 1943, 1951).
-  Thrombogen,(Nolf, 1945).
-  Prothrom bin a c c e le ra to r ,(F a n t l  and Nance, 1946).
-  F acto r V, (Owren, 1947).
-  Plasma a c c e le ra to r  g lo b u lin , (Ware and Seegers, 1948a and b ) .
-  P roaccelerin ,(O w ren , 1950).
VI : A ccelerin ,(O w ren, 1951).
F acto r
VII
V III
-  7 -
Synonyms
: -  In a c tiv e  prothrom bin,(Q uick, 1943; Quick and 
S te f a n in i , 1949).
-  S tab le  facto r,(O w ren , 1947; Owen, Magath, and 
Bollman, 1951).
-  C o-throm boplastin , (Mann e t  a l ,  1947, 1950, 1951, 
and 1952; Hum, B arker, and Mann, 1947; Hum and 
Mann, 1947).
-  Prothrom bin conversion factor,(O w en and Bollman, 1948).
-  Serum f a c to r  of Jacox, (Jacox, 1949; Jacox and Bays,
1949 and 1950).
-  Serum prothrom bin conversion a c c e le ra to r  (SPCA),
(Alexander e t  a l ,  1949, 1949a, 1949b, 1950, and 1951).
-  P roconvertin  and Convertin,(O wren, 1947 and 1951;
Owren and B jerkelund, 1949; Owren and Aas, 1951).
-  F acto r V II ,(R o lle r , L o e lig e r, and D uckert, 1951).
-  Autoprothrombin I ,(S e e g e rs , A lk ja e rs ig , and Johnson, 1955).
: -  Antihaem ophilic g lo b u lin  (AHG), (Patek  and T aylor, 1937).
-A n tih em o p h ilic  fa c to r  (AHF), (Brinkhous, 1947, and 1954; 
Brinkhous and Wagner, 1958).
-  Throm boplastinogen,(Q uick, 1947, and 1951).
-  F acteu r antihem ophilique A ,(S o u lie r e t  L a rrieu , 1953a, 
and 1953b).
F acto r
IX
X
XI
XII
X III
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Synonyms
-  Plasma th rom boplastic  fa c to r  A.
-  P ro throm boplastin .
-  A ntihaem ophilic g lo b u lin  A, (Cramer e t a l ,  1953).
-  P la t e l e t  c o -fa c to r  I ,(S e e g e rs , 1954).
-  F ac to r V II I ,(R o lle r ,  1954).
: -  Ghristmas fa c to r ,(B ig g s , Douglas, M acfarlane, Dacie, 
P itn e y , Merskey, and O 'B rien , 1952).
-  Plasma th rom bop lastin  component (PTC), (Aggeler e t  a l ,
1952 a and b; White e t  a l ,  1952, and 1953).
-  Plasma th rom boplastic  fa c to r  B,(Cramer e t  a l ,  1953).
-  F acteu r antihem ophilique B ,(S o u lie r e t  L a rr ieu , 1953a, 
and 1953b).
-  P la t e le t  c o -fa c to r  I I ,(S e e g e rs ,  1954).
-  Autoprothrombin I I ,(S e e g e rs ,  1954).
-  F acto r IX, (R o lle r, 1954).
: -  F acto r X, (R o lle r, 1955).
-  S tu a r t  fac to r,(H o u g ie  e t  a l ,  1957).
-  S tuart-P row er factor,(Bachm ann, D uckert, G eiger, Baer, 
and R o lle r , 1957).
: Plasma th rom boplastin  an tecedent (PTA), (Rosenthal e t
a l ,  1953, and 1955).
-  Hageman fa c to r ,(R a tn o ff ,  1954; R atnoff and Colopy, 1955).
-  C ontact fa c to r ,(M a rg o lis , 1958a).
F ib r in  s ta b i l iz in g  fa c to r  (FSF), (Lorand, 1950b).
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P A R T  I
HOMAN BLOOD COAGULATION MECHANISM
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HUMAN BLOOD COAGULATION MECHANISM 
H I S T O R I C A L
Man must have been m y s tif ied  s in ce  tim e began by th e  simple 
a c t  o f th e  spontaneous change of shed blood from th e  f lu id  s ta t e  
to  th a t  o f s o l id  c lo t .  Though many hypotheses may have been 
p o s tu la te d , and p o ss ib ly  some experim ents c a r r ie d  out e a r l i e r ,  
th e  f i r s t  comprehensive recorded account was th a t  compiled by 
George G u lliv e r , F .R .S .(1846) in  the  in tro d u c tio n  to  h is  book 
"The Works of W illiam Hewson".
A r is to t le  (1605) perhaps was th e  f i r s t  to  recogn ise  th e  ro le  
p layed by f ib r i n  in  th e  coagu la tion  o f th e  blood. He re a l is e d  
th a t  th e  removal of th e  f ib ro u s  m atte r from th e  blood rendered i t  
in co ag u lab le . However, i t  i s  no t c e r ta in  whether he considered 
th i s  f ib ro u s  m atte r e x is te d  as such in  th e  c i rc u la t io n ,  or as 
l iq u id ,  being formed in  th e  blood a f te r  i t s  ex tra v asa tio n .
The d iscovery  o f th e  c i rc u la t io n  of blood in  1616 by Harvey, 
and h is  monograph "Motion of th e  H eart and Blood" pub lished  in  
1628 were major fa c to rs  in  a t t r a c t in g  many workers to  th i s  
fa s c in a tin g  f ie ld  o f study . Harvey (1628, 1651) supposed th a t  
th e  l iv in g  blood does no t con ta in  th e  p a r ts  found in  i t  a f te r  death .
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He d escribed  blood a f t e r  death  as a cruor of red  and w hite p o rtio n s , 
one dense and f ib ro u s , th e  o th e r w atery and serous, w ith  f ib re s  
connecting th e  whole. W illis  in  1659 described  th e  filam en ts  of 
th e  crassamentum ( s o l id  c lo t)  as jo in ed  to g e th e r or connected in to  
a parenchyma. He sep a ra ted  th e  "serum", id e n t if ie d  i t  as th e  
l i g h te s t  p a r t  o f th e  blood, coagulable by h ea t and by some a c id s . 
M alpighi (1666) washed away th e  co louring  m atter of th e  c lo t ,  and 
examined th e  w h itish  f ib ro u s  p a r t  under th e  m icroscope, which he 
found to  be made up of a f ib ro u s  network. B o re lli  (1681) from 
m icroscop ical o bservations on th e  f ib r e s ,  was th e  f i r s t  worker to  
conclude th a t  what he d escribed  as w hite g lu tin o u s and spontaneously 
coagulable m a tte r of th e  blood, i s  l iq u id  in  th e  l iv in g  body.
C o llin s  (1685), and Bidloo (1685) both regarded  th e  c lo t  as made 
up of minute w hite t e n s i le  filam en ts  enclosing  th e  red  p a r t i c le s .
The in c re a s in g  p ra c t ic e  of blood le t t i n g  in  th e  seven teen th  
and e ig h teen th  c e n tu r ie s  prompted more experiments as to  the  n a tu re  
o f th e  f i b r i n  c lo t .  I t  i s  in te r e s t in g  to  note th a t  Ruysch (1707) 
made th e  f i r s t  attem pt to  sep a ra te  th e  f ib ro u s  m atte r from f lu id  
blood by a g i ta t in g  i t  w ith  a tw ig .
Hewson's experim ents and observations were perhaps th e  most 
p re c ise  ones performed up to  th a t  tim e. He separa ted  a coagulable 
plasma from cooled blood by allow ing th e  c e l ls  to  s e t t l e ,  and 
dem onstrated th a t  th i s  plasma contained a substance which could be
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p re c ip i ta te d  a t  tem peratu res above 50°C. He a lso  a sc rib ed  th e  
coagu la tion  o f the  blood to  th e  form ation  of th i s  in so lu b le  
substance from a so lu b le  p recu rso r in  th e  plasma, which he c a lle d  
"coagulable lymph", (Hewson, 1771).
Amidst th e  p revious worthwhile re p o r ts ,  th e re  were many o thers  
m ain tain ing  the  im portance of th e  red  corpuscles as a fa c to r  in  th e  
co ag u la tio n  of th e  b lood. However, i t  was Davies (1760) who 
f in a l ly  re fu te d  th i s  assum ption. Furtherm ore, he dec la red  th e  
a b i l i t y  of th e  f ib ro u s  m a tte r "g lu ten"  to  p ress  out th e  serum from 
th e  c lo t ,  by i t s  concre ting  fo rc e . A lso, th a t  th e  denser th e  
s t ru c tu re  o f the  "g lu ten" i s ,  th e  more serum i t  p re sse s  ou t, 
a t t r ib u t in g  a ten d er coagulum to  th e  weakened c o n tra c tio n  of th e  
g lu tin o u s  p a r ts .
Fordyce (1770) was ab le  to  p reven t blood coagu la tion  by 
s a tu ra t in g  whole blood w ith  common s a l t .  He c le a r ly  d is tin g u ish e d  
between th e  coagulable lymph, th e  red  co rpusc les, and th e  serum.
His observations th a t  blood coagu la tion  was not due to  change of 
tem peratu re, c e s sa tio n  of movement, or exposure to  a i r ,  and th a t  
blood remains f lu id  fo r  more than  th re e  hours when re ta in e d  in  the  
blood v e s s e ls ,  are  in  p e r fe c t agreement w ith  those  of Hewson (1771) 
who in  f a c t  sa id  th a t  th e se  fin d in g s  were mentioned in  h is  le c tu re s  
in  1767. Thackrah (1819) suggested th a t  c lo t t in g  of blood depends 
on th e  tone of th e  en d o th e lia l l in in g  of th e  blood v e s s e ls .
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Rudolph Virchow in  1821 coined th e  term  ''fibrinogen '* , s ta t in g  
th a t  th e re  was only one type of f ib r in ,  which could not be d e tec ted  
in  th e  blood stream  or t i s s u e s ,  bu t only  by th e  a c t o f coagu la tion ; 
and th a t  most of th e  f i b r i n  was fib rin o g en  which was formed in  the  
lym phatic and connective t i s s u e ,  (M acfarlane and Robb-Smith, 1961).
P ro fe sso r Andrew Buchanan (1879), p ro fe sso r of physiology a t  
Glasgow U n iv e rs ity , made very  o r ig in a l co n trib u tio n s  which 
u n fo rtu n a te ly  were n o t recognised  t i l l  much l a t e r .  In  1831 he 
dem onstrated th a t  c lo t  washings can c lo t  hydrocele f lu id  w ith in  
few m inutes (norm ally in c o ag u lab le ), comparing th i s  p ro p e rty  to  
th e  enzyme a c tio n  of ren n in  on m ilk. He c a rr ie d  out m icroscopical 
s tu d ie s  o f f ib r i n ,  red  c e l l s ,  and of th e  c o lo u rle ss  co rp u sc les, th e  
p l a t e l e t s .  Several experim ents le d  him to  conclude th a t  th e  
p la t e l e t s  were th e  c lo t t in g  agen t. His most im portan t d iscovery  
was th a t  emulsions of c e r ta in  body t is s u e s  (sk in  and muscles) 
promoted c lo t t in g  when added to  cooled blood.
Briicke (1857) produced experim ental evidence th a t  blood v e sse ls  
e x e rt an a c tiv e  in flu en ce  on th e  blood to  m ain tain  i t s  f lu id  s ta t e .  
He t r a n s fe r re d  p a r t  of th e  t u r t l e ' s  f r e s h  blood in to  th e  h e a r t of 
a re c e n tly  k i l l e d  t u r t l e ,  and p a r t  in to  an open d ish , and observed 
th a t  th e  form er took  much longer tim e to  c lo t .  He supposed th a t  
in t a c t  e n d o th e lia l c e l l s  must possess th e  power of p reven ting  
c lo t t in g .
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Richardson in  1856 pu t forw ard the''Ammonia Theory of Blood 
C oagulation” , propounding th a t  th e  f l u i d i ty  of the  c irc u la t in g  
blood i s  due to  sm all amounts of f re e  ammonia in  th e  blood which 
kep t th e  f ib r i n  in  so lu tio n , and th a t  in  shed blood th e  ammonia 
i s  g iven o f f ,  th e reb y  d im in ish ing  th e  a lk a l in i ty  of th e  blood, 
causing th e  s o l id i f i c a t io n  of th e  f ib r in .  This th eo ry  was 
d is c re d i te d  by Joseph L is te r  (1863) who showed con c lu siv e ly  th a t  
blood in  an open v e sse l kep t in  an ammoniacal atmosphere c lo tte d  
as q u ick ly  as blood exposed to  a i r .  L is te r  was a lso  th e  f i r s t  
to  draw a t te n t io n  to  th e  in flu en ce  of fo re ig n  su rfaces  in  
h as ten in g  blood c lo t t in g .
Hammarsten (1879) in  1875 succeeded in  is o la t in g  a f a i r l y  pure 
f ib rin o g e n  p re p a ra tio n  from horse plasma by repea ted  p re c ip ita t io n s  
w ith  25 per cen t s a tu ra t io n  w ith  sodium c h lo rid e . This f ib rin o g en  
p re p a ra tio n  was used by Schmidt in  fu r th e r  experim ents.
Schmidt (1892) confirm ed Buchanan's prev ious f in d in g s  and 
observed th a t  th e  a c tiv e  coagu lan t, th e  f ib r in  ferm ent, l a t e r  named 
throm bin by him, could be e x tra c te d  by a lcohol p re c ip i ta t io n  from 
serum, bu t no t from f re s h ly  shed u n c lo tte d  blood. He thus in fe r re d  
th a t  an a c t iv e  coagulant substance was produced in  th e  blood during 
th e  p rocess o f c lo t t in g .  In  1895 he p o s tu la te d  th e  main fe a tu re s  
of th e  c la s s ic a l  th e o ry  of blood coagu la tion  as occuring in  two 
phases. The f i r s t  i s  th e  union between fib rin o g en  and a p a rag lo b u lin ,
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a h y p o th e tica l substance derived  from th e  co lo u rless  co rpuscles. 
The second phase being th e  a c tio n  of th e  f ib r in  ferm ent "thrombin" 
on th e  product of th e  f i r s t  union, producing f ib r in .  He be lieved  
throm bin to  be derived  a lso  from th e  co lo u rle ss  co rpusc les, and 
th a t  i t  was p re se n t in  a l l  types o f l iv in g  c e l l s ;  m ain tain ing  
th a t  c lo t t in g  would no t occur so long as th e  co lo u rle ss  corpuscles 
c i r c u la te  u n in ju red . A schem atic p re se n ta tio n  of h is  th eo ry  
could be expressed as fo llo w ss-
F ib r in  ferm ent .F ibrinogen  + P arag lo b u lm  -------------------------  ^ F ib r in
(Thrombin)
He a lso  assumed th e  n e c e s s ity  of calcium  fo r  th e  throm bin- 
f ib rin o g en  re a c tio n , which was dem onstrated experim en tally  by 
Arthus and Pages (1890) who have shown th a t  calcium  p re c ip ita n ts  
prevented  c lo t t in g ,  th e i r  e f f e c t  being reversed  by th e  ad d itio n  
of calcium . These w orkers, however, were more c o rre c t in  
in fe r r in g  th e  n e c e s s ity  o f calcium  fo r  th e  form ation of throm bin 
from i t s  p recu rso r. L a te r experim ents confirmed t h i s ,  bu t only 
when throm bin form ation  occurs in  a normal p h y sio lo g ica l system, 
i . e .  plasm a. In  1899, Hammarsten proved th a t  calcium  i s  no t 
necessary  fo r  th e  th rom bin -fib rinogen  re a c tio n .
Conradi (1901) showed th a t  from a l l  types of organs i t  was 
p o ss ib le  to  e x tra c t substances which enhanced blood c lo t t in g ,  and
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a lso  those which opposed i t .  The l a t t e r  he found to  be h ea t 
s ta b le ,  and can be p re c ip i ta te d  by a lco h o l. Now i t  i s  known th a t  
heparin  can be e x tra c te d  from d if f e r e n t  t i s s u e s .
Morawitz (1905) using  Buchanan's washed t i s s u e  e x tra c ts ,  found 
th a t  th e y  had no e f f e c t  on a s o lu tio n  of fib rin o g en , though Schm idt's 
throm bin from serum produced immediate c lo t t in g .  Thus i t  seemed 
im probable th a t  throm bin o r ig in a te d  in  th e  t i s s u e s .  He th e re fo re  
suspected  th e  presence of an in a c tiv e  p recu rso r of throm bin in  the  
plasm a, and th a t  th i s  p recu rso r was a c tiv a te d  by t i s s u e  e x tra c ts  or 
throm bokinase. His hypothesis could be rep resen ted  as follow s
t> ,, , . T issue e x tra c t  mi_ , .Pro-throm bin ----------------------------> Thrombin
Calcium
tut. • Thrombin .F ibrinogen  -------------— ^  F ib r in
Morawitz be liev ed  th a t  th e  thrombokinase in  th e  t i s s u e  e x tra c t 
was th e  same substance as was l ib e ra te d  from th e  p l a te l e t s .  He 
a lso  f u r th e r  e lab o ra ted  L i s t e r 's  fo re ig n  su rface  th eo ry , m ain tain ing  
th a t  shed p la te l e t s  coming in to  co n tac t w ith  a w ater-w ettab le  
su rface  d is in te g ra te  re le a s in g  throm bokinase, and rep o rted  th a t  
th e  en d o th e lia l l in in g  of th e  blood v esse ls  i s  non -w ater-w ettab le .
He was a lso  aware th a t  calcium  i s  e s s e n tia l  in  th e  i n i t i a l  phase 
of c lo t t in g .
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M oraw itz's th e o ry  deserved ly  stood unchallenged fo r  n e a rly  
f o r ty  y e a rs , t i l l  th e  a p p lic a tio n  of Q uick's one-stage prothrom bin 
tim e t e s t  posed some q uestions  no t adequately  explained by the  
c la s s ic a l  th e o ry , which though s t i l l  holds in  i t s  main fe a tu re s , 
has been expanded to  encompass th e  newly recognized f a c to r s .
In  view of th e  growing com plexity of the  blood coagu lation  
mechanism, and th e  huge amount of in fo rm ation  pub lished  on th e  
su b je c t th e r e a f te r ,  i t  i s  proposed to  d iscuss  th e  modern th eo ry  
o f th e  human blood co ag u la tio n  mechanism in  th e  nex t chap ters in  
terras o f th e  d i f f e r e n t  fa c to rs  concerned, a llu d in g  to  in te r e s t in g  
h i s to r i c a l  background when a p p ro p ria te .
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MODERN THEORY OF HUMAN BLOOD COAGULATION MECHANISM
The mechanism of human blood coagu la tion  is  a very  complex 
chain  o f re a c tio n s ,  which i s  as y e t very  c o n tro v e rs ia l and not 
u n iv e rs a l ly  agreed upon. However, th e re  i s  f a i r  agreement on th e  
more s a l i e n t  fe a tu re s ,  and i t  i s  th e se  th a t  a re  now to  be d iscussed .
The appearance o f f i b r i n  in  any c lo t t in g  m ixture i s  u su a lly  th e  
l a s t  s tag e  in  th e  coagu la tio n  mechanism, but being th e  only 
phenomenon th a t  can be observed v is u a l ly  w ith  a c e r ta in  degree of 
accuracy , i t  i s  perhaps more in s tru c t iv e  to  d escribe  f i r s t  th e  
fa c to r s  and v a r ia b le s  a f fe c t in g  the  th rom bin-fib rinogen  re a c tio n .
F I B R I N O G E N  (F acto r I )
F ib rinogen , a so lu b le  p ro te in  p re se n t in  normal blood, i s  
re sp o n s ib le  fo r  th e  change of blood on coagu la tion  from th e  so l 
s t a t e  to  th a t  of a g e l ,  due to  th e  a c tio n  of throm bin on i t ,  
transfo rm ing  i t  in to  f ib r i n ,  an in so lu b le  p ro te in  p re c ip i ta te d  as 
a network of f ib r e s .
P ro p e rtie s  of f ib rin o g en
I t  i s  a g lo b u lin , w ith  a m olecular w eight o f about 340,000, 
p re se n t in  Cohn's f r a c t io n  1-2 . I t s  i s o e le c t r ic  p o in t i s  a t
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pH 5.5 (Seegers, N ie f t,  and Yandenbelt, 1945). I t  i s  p re c ip ita te d  
from plasma by 25 per cen t s a tu ra t io n  w ith  ammonium su lp h a te , or 
50 per cen t s a tu ra t io n  w ith  sodium ch lo rid e  (Biggs and M acfarlane,
1957), by 10 p e r cen t (v /v) ethanol a t  pH 7 (B ailey  and B ettelheim , 
1955), and by 11 per cen t (v /v) e th e r  (Kekwick, Mackay, Nance, and 
Record, 1955). F ibrinogen  i s  destroyed  by hea ting  to  47°C., and 
p r e c ip i ta te s  i r r e v e r s ib ly  a t  56°C. The te rm inal amino ac id  groups 
of bovine f ib rin o g en  were shown by Lorand and Middlebrook (1952a) 
to  be two ty ro s in e  groups and one glutam ic ac id  m olecule; w hile 
human fib rin o g en  contained  one N -alanine molecule in s te a d  of th e  
g lutam ic ac id , (Lorand and M iddlebrook, 1953).
Role of f ib rin o g en
F ibrinogen i s  th e  n a tu ra l s u b s tra te  of throm bin which converts 
i t  in to  f ib r in .  Laki and Mommaerts (1945) suggested th a t  f ib rin o g en  
i s  transform ed in to  f i b r i n  by a tw o-step  re a c tio n . F i r s t ,  the  
fib rin o g en  i s  transform ed under th e  in flu en ce  of throm bin to  pro­
f ib r in ,  which then  polym erizes to  the  f ib r in  p roper. At ac id  
re a c tio n  (pH 5 .1) only  th e  f i r s t  s te p  occurs, bu t th e  substance 
formed produces a c lo t  when th e  m ixture i s  n e u tra liz e d  (Laki and 
M ihalyi, 1949). The a c t  o f po lym eriza tion  i s  in h ib ite d  by th e  
a d d itio n  of n e u tra l s a l t s ,  (Mommaerts, 1946).
Lorand (1952, 1954) dem onstrated the  re le a se  of a so lub le  
f ib r in o -p e p tid e  and th e  appearance of a f ib r in  monomer during th e
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c lo t t in g  of f ib rin o g en  by throm bin. He shoved that at optimum pH 
and io n ic  s tre n g th , po lym eriza tion  of th e  monomer occurs independent 
of th e  presence of throm bin. He suggested th a t  th e  linkage of the 
f i b r i n  m olecules forming th e  s o lid  c lo t  may be due to  th e  e f f e c t  of 
e l e c t r o s ta t i c  fo rces  fo llow ing  th e  removal of the  h ig h ly  charged 
p e p tid e s . Laki and Folk  (1958) suggested th a t  th e  re le a se  of 
p ep tid e  A allow s end-to -end  a s so c ia t io n  (in te rm ed ia te  polym er), 
w hile re le a se  of p ep tid e  B allow s s id e - to -s id e  a sso c ia tio n .
Van Zandt e t  a l  (1947) and P o r te r  e t  a l  (1949) s tu d ied  th e  
form ation  o f f i b r i n  from fib rin o g en  and thrombin w ith  th e  a id  of 
th e  e le c tro n  m icroscope. They noted end-to-end linkages between 
p a r t i c le s  of about th e  same s iz e  as th e  fib rin o g en  m olecules.
L a te r , th e se  aggregates form bundles which have re g u la r  c ro s s -  
- s t r i a t i o n s  of d i f f e r e n t  d e n s i t ie s .  H a ll and S la y te r  (1959) 
exp lained  th i s  appearance as due to  th e  alignm ent of th e  f ib r in  
m olecules, the  darker bands corresponding to  th e  te rm in a l nodules 
ly in g  end to  end, and th e  in te rm ed ia te  bands corresponding to  th e  
c e n tra l  nodules ly in g  s id e  by s id e . The sequence of events 
could th u s  be rep resen ted  as fo llow s s -
. Thrombin . _ . . .F ibrinogen---------------------------- > F ib r in  monomer + P ep tides
F ib r in  monomers — Optimum pH ^ F ib r in  polymer
F ib r in  polymers_________________> F ib r in  c lo t  (u rea  so lu b le ) .
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P re p a ra tio n  of fib rin o g en
Many methods fo r  th e  p re p a ra tio n  of fib rin o g en  were devised by 
v ario u s  au th o rs , u sing  d i f f e r e n t  p re c ip i ta t in g  p rocedures. A strup 
and D arling  (1942c) were th e  f i r s t  to  remove the  prothrom bin from 
th e  plasma by adsorbing agents ( tr ic a lc iu m  phosphate) before 
p r e c ip i ta t in g  the  f ib rin o g en , the reb y  ob ta in ing  a more pure 
p re p a ra tio n . Jaq u es1 method (1943) of fib rin o g en  p rep a ra tio n  by 
phosphate p r e c ip i ta t io n  was m odified by Biggs and M acfarlane (1957) 
who adsorbed th e  c i t r a te d  bank plasma w ith  alumina before fib rin o g en  
p r e c ip i ta t io n .  This i s  perhaps th e  most p r a c t ic a l  method, and i t  
y ie ld s  a f a i r l y  pure fib rin o g en  p re p a ra tio n , s u ita b le  fo r  use as 
s u b s tra te  in  th e  various assay  systems of blood coagu la tion  fa c to r s .  
I t  was th i s  method th a t  was used in  th i s  work fo r  th e  p rep a ra tio n  
of f ib rin o g en , and i s  described  in  d e ta i l  in  appendix I I I ,  6, A.
I t  should be noted , however, th a t  fib rin o g en  prepared  by any 
of th e  known methods i s  l ik e ly  to  co n ta in  an tihaem ophilic  g lo b u lin  
and plasminogen as im p u r itie s .
Measurement of f ib rin o g en
S ince fib rin o g en  i s  converted q u a n t i ta t iv e ly  in to  f i b r i n  by 
throm bin, es tim atio n  of th e  f ib r in  in  a c lo t  i s  in d ic a tiv e  of th e  
fib rin o g en  con ten t o f th e  o r ig in a l plasma which formed th a t  c lo t .
Two methods were used fo r  th e  e s tim a tio n  of f ib r i n  p rev io u s ly  
c lo t te d  w ith  throm bin and thoroughly  washed to  g e t r i d  of any
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contam inant p ro te in s  entrapped in  th e  f ib r in  network.
1. micro--K.ieldahl method
The f ib r i n  i s  d ig e s ted  w ith  concen trated  su lphu ric  ac id  in to  
p ro te in  n itro g e n  in  th e  form of ammonia. The ammonia i s  d riven  
o f f  from so lu tio n  by excess sodium hydroxide, and c o lle c te d  
v o lu m e tric a lly  in  s tandard ized  su lphu ric  ac id  s o lu tio n . By a 
s e r ie s  of t i t r a t i o n s  th e  amount of p ro te in  p resen t i s  ca lc u la te d  
on th e  assum ption th a t  16 per cen t of th e  dry  w eight of p ro te in  i s  
n itro g e n . The r e s u l t  i s  then  m u ltip lie d  by th e  f a c to r  6.25 to  
convert n itro g e n  in to  fib rin o g en . This method i s  f u l ly  described  
in  appendix XV, 2, I .
2. M odified Greenberg method
A fte r th e  fib rin o g en  i s  c lo t te d  w ith  throm bin, i t s  ty ro s in e  
con ten t i s  re le a se d  by hyd ro ly sis  w ith  sodium hydroxide, and a 
co lour re a c tio n  made w ith  P o lin -C io c a lte u 's  phenol reag e n t. The 
depth of colour produced i s  measured p h o to m etrica lly  and i s  
in d ic a tiv e  of th e  o r ig in a l fib rin o g en  con ten t, as read  from a 
s tan d ard  ty ro s in e  c a l ib ra t io n  curve. I t  i s  assumed th a t  each 
m illig ram  ty ro s in e  i s  equ iva len t to  11.7 m illig ram s of fib rin o g en . 
D e ta iled  procedure i s  described  in  appendix IV, 2, I I .
A th i r d  tu rb id im e tr ic  method fo r  th e  determ ination  of 
f ib rin o g en  was o cca sio n a lly  used (appendix IV, 2, I I I ) .  I t  
depends on p r e c ip i ta t in g  th e  plasma fib rin o g en  in  a so lu tio n  of
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one p er cen t sodium c h lo rid e , and measuring the  degree of tu r b id i ty  
sp ec tro p h o to m etrica lly . On comparison of the  r e s u l t s  of animal 
plasma samples (ch icken), estim ated  sim ultaneously  by th e  previous 
c la s s ic a l  methods, however, a g re a t d iffe re n c e  was observed which 
may be due to  th e  d i f f e r e n t  p re c ip i ta t io n  c h a ra c te r is t ic s  of th e  
fib rin o g en s  of d i f f e r e n t  sp ec ie s . This method was th e re fo re  
abandoned in  l a t e r  in v e s t ig a t io n s .
Normal plasma fib rin o g en  con ten t
Normal human plasma con tains 300-500 mg of f ib rin o g en  per 
100 m is. o f plasma (Biggs and M acfarlane, 1962). The minimal 
f ib rin o g en  co n cen tra tio n  necessary  fo r  e f fe c t iv e  haem ostasis i s  
u n c e rta in . Biggs (1955) rep o rted  th a t  a fib rin o g en  co n cen tra tio n  
of 25 to  40 p er cent o f th e  normal le v e l ( i . e .  60 to  100 mg per cen t) 
produced e f fe c t iv e  haem ostasis.
F ibrinogen d e fic ien cy
F ibrinogen  i s  in fre q u e n tly  reduced below th e  minimum haem ostatic 
le v e l req u ire d , but when i t  does so i t  r e s u l t s  in  a severe 
haemorrhagic co n d itio n . D eficiency  may occur as a congen ita l 
d e fe c t due to  a simple re c e ss iv e  c h a ra c te r , o r as an acquired  
co n d itio n . Acquired fib rin o g en  d e fic ien cy  may be acu te  due to  
ra p id  u t i l i z a t i o n  and /or d e s tru c tio n  as occurs in  th e  acute 
d e f ib r in a tio n  syndrome encountered as a com plication of pregnancy, 
p a r tu r i t io n ,  and s u rg ic a l operations w ith  massive t i s s u e  d e s tru c tio n
-  24 -
or invo lv ing  th e  use of ex traco rp o rea l c i rc u la t io n . This may be 
due to  th e  sudden re le a s e  in  th e  c i rc u la t io n  of excess throm boplastic 
substances, and a lso  to  the  a c t iv a t io n  of th e  f ib r in o ly t ic  mechanism.
Chronic f ib rin o g en  d e fic ien cy  due to  d e fec tiv e  production  occurs 
in  p a t ie n ts  su ffe r in g  from severe l iv e r  damage.
Species s p e c i f i c i ty  of fib rin o g en
D is s im ila r i ty  between fib rin o g en s from d if f e re n t  species  was 
shown to  occur, as regards i t s  various p ro p e r tie s . Hektoen and 
Welker (1927) have shown th a t  f ib rin o g en s from a s e r ie s  of mammals 
had a n tig e n ic  p ro p e r tie s  more or le s s  in  common, and th a t  those 
from a s e r ie s  of b ird s ,  w hile having p re c ip itin o g e n ic  p ro p e r tie s  
common to  them selves, were s l ig h t ly  d i f f e re n t  from mammalian 
f ib rin o g e n s . Kenton (1933) employing th e  s p e c i f ic i ty  of th e  in  
vivo s e n s i t iz a t io n  of anim als to  d if f e r e n t  f ib rin o g en s, obtained 
by m u ltip le  p re c ip ita t io n s  w ith  sodium c h lo rid e , dem onstrated 
th a t  an tib o d ies  produced to  sheep fib rin o g en  do no t r e a c t w ith  
h o rse , fow l, or ra b b it  f ib rin o g en s . A lso, th a t  an tib o d ies  fo r 
bovine f ib rin o g en  do no t re a c t  w ith  ra b b it  fib rin o g en . His 
f in d in g s  were co rroborated  by d e s e n s it iz a t io n  experim ents w ith  the  
homologous fib rin o g en .
Davide (1925) using  s a lt in g -o u t experim ents w ith  sodium ch lo rid e  
so lu tio n s  found th e  fo llow ing  concen tra tions necessary  to  produce 
optimum fib rin o g en  p re c ip i ta t io n  s-
Species
25 -
Percentage of
G uinea-pig 30 -  40
Dog 30 -  40
R abbit 35 -  45
Man 40 -  50
Horse 45 -  60
Sheep 60 -  65
Wdhlisch (1929) a lso  used th e  same method of d i f f e r e n t ia t io n .  
A strup and D arling (1942c) rep o rte d  th a t  h o rse , ox, and chicken 
fib rin o g en s  were op tim ally  p re c ip ita te d  by 25, 30, and 35-40 per 
cen t s a tu ra t io n  of ammonium su lp h a te , re sp e c tiv e ly . They also  
found d if f e r e n t  pH optima fo r  th e  a c tio n  of th e  same throm bin 
so lu tio n  on p u r if ie d  fib rin o g en s o f man, ho rse , ox, and chicken, 
s ta t in g  th a t  th e  s p e c i f i c i ty  i s  due to  th e  fib rin o g en  s in ce  they  
found th e  same pH optima on using  throm bins from d if f e r e n t  species 
fo r  th e  same fib rin o g en  s o lu tio n  (A strup and D arling , 1942b).
D ifferences in  s o lu b i l i ty  s tu d ie s  in  e thano l-w ater m ixtures 
were observed by M orrison e t  a l  (1951) fo r  fib rin o g en s of d i f f e re n t  
s p e c ie s .
The te rm inal amino groups o f bovine fib rin o g en  were found to  
co n ta in  one glutam ic ac id  molecule in s te a d  o f th e  N -alanine molecule 
p re se n t in  human fib rin o g en  (Lorand and Middlebrook, 1952a, and 1953).
Species s p e c i f i c i ty  of fib rin o g en s was a lso  dem onstrated
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b io lo g ic a l ly  by observing th e  d iffe re n c e s  in  th e  c lo t t in g  tim es 
o f d i f f e r e n t  f ib rin o g en s or plasmas c lo tte d  w ith  th e  same thrombin 
so lu tio n  (Seegers and Smith, 1942; F an tl and Ebbels, 1953; 
B u rs te in  and Guinand, 1954). This b io lo g ic a l method was th e  one 
adopted in  th i s  study  to  in v e s tig a te  the  species s p e c i f i c i ty  of 
f ib r in o g e n s .
T H R O M B I N
Thrombin i s  th e  n a tu ra l enzyme which converts f ib rin o g en  in to  
f i b r i n .  I t  i s  derived  from prothrom bin by various mechanisms 
which s h a l l  be described  l a t e r .
P ro p e r tie s  o f throm bin (Biggs and M acfarlane, 1957, and 1962) 
Thrombin i s  a carbohydrate-con ta in ing  p ro te in  which belongs 
to  th e  albumin group, and whose m olecular weight v a r ie s  from 
31,000 to  62,000. P rep ara tio n s  of 15,000 to  20,000 m olecular 
w eight have a lso  been d escrib ed . Various throm bin p rep a ra tio n s  
had i s o - e l e c t r i c  p o in ts  of 3 .6 , 4 .1 , and 4 .7 . Thrombin i s  h ig h ly  
so lu b le  both  in  w ater and in  s a l in e .  In  s a lin e  s o lu tio n  i t  i s  
perm anently in a c tiv a te d  by ac id  a t  pH 3 .5 , and re v e rs ib ly  
in a c tiv a te d  in  th e  zone pH 3.5  -  4 .1 . A lk a li in a c tiv a tio n  begins 
a t  pH 10 and i s  marked above pH 11 (Seegers, 1940). In  aqueous 
so lu tio n s  throm bin shows p a r t i a l  in a c tiv a tio n  a f te r  h ea tin g  fo r
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t h i r t y  minutes a t  40 C. I t  i s  com pletely destroyed a t  60°C.
D ilu te  throm bin so lu tio n s  lo se  th e i r  a c t iv i ty  ra p id ly  in  o rd inary  
g lassw are, bu t not i f  th e  su rface  i s  lin e d  w ith p a ra f f in  or s i l ic o n e , 
(Waugh and L iv ingstone, 1951). T his, however, i s  no t n o ticed  w ith  
concen tra ted  s o lu tio n s , because th e  r e la t iv e  amount removed from 
s o lu tio n  i s  sm all (Seegers e t a l ,  1952).
A ction  of thrombin
Thrombin i s  a p ro te o ly tic  enzyme which a c ts  on th e  a rg in y l-  
g ly c in e  bonds in  the  fib rin o g en  molecule (G ladner, Folk, and Laki, 
1958), w ith  th e  s p l i t t in g  o ff  of f ib r in o p e p tid e  groups (Lorand, 1952; 
and B ettelheim  and B ailey , 1952). The lo ss  of th e se  n eg a tiv e ly  
charged p ep tid es  r e s u l t s  in  a change in  the  e l e c t r o s ta t ic  fo rces 
which allow s th e  polym erization  of th e  newly formed f ib r i n  monomers 
(Lorand, 1954), provided th e  pH i s  optimum.
Thrombin p rep a ra tio n s  a lso  a t ta c k  a rg in in e  e s te r s  (su b s tra te s  
which co n ta in  a rg in in e  as th e  s p e c if ic  amino ac id  re s id u e ) , but 
have no a c t iv i t y  on ly s in e  e s te r s  (Sherry  and T ro l l ,  1954). The 
l a t t e r  au thors fu r th e r  m ain tain  th a t  th e  e s t e r - s p l i t t i n g  a c tio n  
of throm bin i s  q u a n t i ta t iv e ly  re la te d  to  i t s  c lo t t in g  a c t iv i ty .  
Landaburu and Seegers (1959), however, b e liev e  th a t  th e  e s te ra se  
and c lo t t in g  a c t iv i t i e s  of throm bin may vary  independently , and 
consider th e  c lo t t in g  a c t iv i t y  r e la te d  to  th e  form ation of 
d is so c ia b le  conqplexes of su b -u n its  w ith  e s te ra se  a c t iv i ty .
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Ronwin (1960) regards th e  e s te ra se  a c t iv i ty  of throm bin as 
e s s e n t ia l ly  p ep tid ase  a c t iv i ty ,  and considers i t  in sep arab le  from 
th e  o v e ra l l c lo t t in g  a c t iv i ty .
P re p a ra tio n  o f throm bin
The e a r l i e s t  p re p a ra tio n  of throm bin i s  th a t  of Schmidt (1892) 
who p re c ip i ta te d  i t  from fre s h  serum by a lco h o l. Mellanby (1933) 
sep a ra ted  th e  g lo b u lin  f r a c t io n  from d ilu te d  plasma by a c id i f ic a t io n  
to  pH 5 .3 , d isso lv ed  i t  in  s a lin e  and allowed throm bin to  form 
spontaneously  on r e c a lc i f ic a t io n  of th e  so lu tio n . This method was 
m odified by Biggs and M acfarlane (1957) by fu r th e r  p u r if ic a t io n  of 
th e  throm bin by acetone p r e c ip i ta t io n .  This method i s  described  
in  d e ta i l  in  appendix I I I ,  7, B, and was used throughout th i s  work.
The p u r is t  p re p a ra tio n  of thrombin as y e t known i s  th a t  p repared  
by Seegers (1962) and known as C itra te  Thrombin. I t  was ob ta ined  
as an e le c tro p h o re t ic a l ly  and chrom atographically  homogeneous 
m a te r ia l ,  p repared  by a u to -a c tiv a tio n  of prothrom bin in  25 per cent 
c i t r a t e  so lu tio n , p u rify in g  th e  re -d is so lv e d  p r e c ip i ta te  by acetone 
p r e c ip i ta t io n s ,  and f in a l ly  f ra c t io n a t in g  th e  product over IRC-50 
columns, e lu tin g  th e  throm bin w ith  0 .3  M sodium phosphate b u ffe r  
a t  pH 8. The s p e c if ic  a c t iv i t y  of th i s  p re p a ra tio n  was 3,600 Iowa 
u n its  per mg d ry  w eight. One Iowa u n i t  i s  th e  amount of thrombin 
re q u ire d  to  c lo t  1 ml. of s tandard ized  fib rin o g en  s o lu tio n  in  15 
seconds a t  28°C. (Seegers and Smith, 1942). Thrombin prepared
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in  t h i s  manner i s  r e fe r r e d  to  as " C itra te  re s in  throm bin". 
Measurement of throm bin
Thrombin i s  measured by th e  speed of c lo t t in g  fib rin o g en  in  
seconds, and expressed as u n i t s .  S everal sp e c if ic a t io n s  fo r  th ese  
u n i ts  have been proposed. The fo llow ing two are  those  g e n e ra lly  
used .
O w ren*m ritj^  i s  defined  by him as th e  amount of throm bin which 
in  a  volume of 1 ml. con ta in ing  0 .1  per cent f re s h  p ro - f ib r in - f r e e  
human f ib rin o g e n , a t  a tem perature of 37°C. and pH 7 .3  and sodium 
ch lo rid e  co n ce n tra tio n  o f 0.154 M, causes coagu la tion  in  15 seconds, 
(Owren, 1947).
Naibional_InsM^ute_of^ H e ji l th _ (N .H . unit^_ i s  th a t  amount of 
throm bin which w il l  c lo t  1 ml. of a s tandard  s o lu tio n  of fib rin o g en  
a t  28°C. in  15 seconds. I t  i s  rep o rte d  th a t  1 N .I.H . u n it  i s  
eq u iv a len t to  1.25 Iowa u n its  (Seegers, 1962).
I t  should be noted th a t  any r e s u l t s  hereby expressed in  terras 
of throm bin u n i ts  a re  of no ab so lu te  va lue , bu t were adopted to  
allow  a r e l i a b le  comparison of a l l  th e  experim ents on th e  same 
fo o tin g . The o r ig in a l  s to ck  throm bin so lu tio n  used fo r  
c a l ib ra t io n  was Thrombin to p ic a l  (Parke Davis and Company) taken 
a t  i t s  face  value of 5000 N .I.H . u n its  p er v ia l ,  and d isso lv ed  in  
g ly c e ro l s a lin e  so lu tio n  to  co n ta in  1000 u n its  per ml. Prom th i s  
s to ck  so lu tio n  th e  n ecessary  d ilu tio n s  were made in  s a lin e  and a
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th rom bin -fib rinogen  d i lu t io n  curve constru c ted  as described  in  
appendix IV, 7, and i l l u s t r a t e d  in  f ig u re  1 (Volume 2, page 55). 
Prom th i s  d i lu t io n  curve th e  r e s u l t s  of a l l  re le v a n t experim ents 
were read  in  term s o f throm bin u n its  as equ iva len t to  th e  c lo t t in g  
tim es ob ta ined  in  seconds.
New batches of f ib rin o g en  p rep a ra tio n s  or throm bin so lu tio n  
were te s te d  befo re  use a g a in s t a re fe ren c e  s tock  so lu tio n , and 
only  those  complying w ith  th e  o r ig in a l  th rom bin-fib rinogen  d i lu t io n  
curve ( f ig u re  1) were re le a se d  fo r  u se , so as to  m ain tain  a f a i r l y  
s tan d ard  u n i t  of a c t iv i ty .
Species s p e c i f i c i ty  of thrombin
The presence of spec ies  s p e c i f i c i ty  in  th e  c lo t t in g  a c tio n  of 
throm bin on fib rin o g en  or plasma was f i r s t  shown by Quick (1938a, 
and 1941) who noted th a t  thrombin from d if f e r e n t  mammals i s  th e  
same bu t d i f f e r s  from th a t  o f b ird s  or to ad s. Varner e t  a l  (1939a, 
and 1939b) assumed th a t  throm bin from a l l  v e r te b ra te  bloods to  be 
th e  same, and dem onstrated th a t  dog fish  throm bin i s  spec ies  
s p e c if ic .  Bryce (1954) found th a t  sheep thrombin had th e  same 
a c t iv i t y  on sheep and bovine plasma, w hile bovine throm bin had 
more a c t i v i t y  on bovine plasma th an  sheep throm bin. He was aware 
of th e  p o s s ib i l i ty  o f s p e c i f i c i ty  in  th e  in a c tiv a tin g  mechanisms 
p re se n t in  th e  plasma which cannot be ignored u n t i l  i t  can be 
shown no t to  e x is t .  L y ttle to n  (1954), however, thought i t  i s
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im probable th a t  an tith rom bin  should be the  cause fo r  d iffe re n c e s  
in  plasma r e a c t iv i ty  to  throm bin, s in ce  he found antith rom bin  to  
be w ithou t e f f e c t  on c lo t t in g  tim es sh o rte r  th an  100 seconds.
N our-Eldin (1962b) dem onstrated d iffe re n c e s  in  th e  adso rp tion  
c h a r a c te r i s t ic s  of human and bovine throm bins, th e  l a t t e r  being 
adsorbed w ith  calcium  phosphate, w hile th e  human throm bin was no t 
a f fe c te d . He noted th a t  both throm bins g en e ra lly  had th e  same 
tre n d  in  re sp e c t of various adsorbing agen ts, though bovine throm bin 
was u s u a lly  more a f fe c te d .
THROMBIN-FIBRINOGEN REACTION 
When th e  th rom bin-fib rinogen  re a c tio n  i s  performed using  
p u r if ie d  so lu tio n s  of throm bin and fib rin o g en , i t s  speed i s  
in flu en ced  by the  fo llow ing f a c to r s :  (Biggs and M acfarlane, 1957)
-  C oncen tration  of f ib rin o g en : the  optimum being about 0 .1  mg per 
c en t.
-  F ib rinogen  con ten t of p ro - f ib r in ,  a product of in te rm ed ia te  
s o lu b i l i ty  between fib rin o g en  and f ib r i n  (A pitz, 1937) which 
r e a c ts  more ra p id ly  to  throm bin (Owren, 1947). P ro - f ib r in  i s  
e a s i ly  removed from fib rin o g en  so lu tio n s  by c e n tr ifu g a tio n  in  
th e  co ld , when i t  i s  deposited  a t  th e  bottom.
-  Optimum pH w ith in  th e  range 6 .5  to  7 .5 .
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-  Optimum tem perature i s  a t  37°C.
-  P resence of o th e r p ro te in s .
-  Ion ic  s tre n g th : excess o f n e u tra l  s a l t s  leads to  delayed c lo t t in g .
-  Species of both f ib rin o g en  and throm bin.
The in flu en ce  of th e se  fa c to rs  i s  la rg e ly  e lim inated  when using  
plasma in s te a d  of p u r if ie d  fib rin o g en  so lu tio n , as th ey  a re  more or 
le s s  co n stan t in  normal plasm a. However, th e  use o f plasma i s  
com plicated by th e  presence of o th e r known and p o ss ib ly  unknown 
f a c to r s ,  such as prothrom bin, p la t e l e t s ,  and l ip id s j  and a lso  by 
th e  v a r ia t io n  in  plasma c o n s titu e n ts  from one sample to  ano ther.
Though calcium  i s  no t needed fo r  th e  th rom bin-fib rinogen  
r e a c tio n , y e t i t s  presence shortens th e  c lo t t in g  tim e, th i s  e f f e c t  
being more apparent in  plasmas w ith  r e la t iv e ly  long throm bin 
c lo t t in g  tim es.
Thrombin converts many tim es i t s  w eight of f ib rin o g en  in to  
f ib r i n ,  s in ce  i t  a c ts  enzym atically .
The c lo t t in g  time o f f ib rin o g en  i s  in v e rse ly  p ro p o rtio n a l to  
th e  throm bin co n cen tra tio n , when observed in  pure so lu tio n s .
This r e la t io n  i s  somewhat more com plicated when plasma i s  used, 
(A strup, 1944).
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FIBRIN STABILIZING FACTOR (Factor X III)
C lo ts ob ta ined  by mixing f ib rin o g en  and throm bin were found 
to  be so lu b le  in  weak ac id s  (0.03 per cent HCl) and in  weak 
a lk a l ie s  (0 .5  per cen t Na2C0^) (Robbins, 1944), and in  a 5 molar 
so lu tio n  of u rea  (Laki and Lorand, 1948); w hile c lo ts  formed in  
plasma a re  no t so lu b le , s ig n ify in g  th a t  in  th e  l a t t e r  th e  p a r t ic le s  
a re  bound by s tro n g er cro ss  linkages (Lorand, 1950a; and F erry  
e t  a l ,  1951). Lorand (1954) suggested th i s  may be due to  
re in fo rc e d  linkages of d isu lp h id e  bonds, a s tep  which invo lves the  
f i b r i n  s ta b i l iz in g  f a c to r .
Calcium was found to  be necessary  fo r  th e  form ation of u re a -  
- in s o lu b le  c lo ts  (E d sa ll, 1951).
Lorand and Jacobsen (1958) prepared  a p u r if ie d  p re p a ra tio n  of 
th e  f i b r i n  s ta b i l iz in g  f a c to r  from human plasma, which was found 
to  be a g lo b u lin , th e rm o lab ile , and n o n -d ia ly sab le  (Lorand e t  a l ,
1958). I t  i s  s ta b le  in  fro zen  plasm a, and i s  p re sen t only in  
t r a c e s  in  serum, as i t  i s  used up in  th e  c lo t t in g  process by being 
in co rp o ra ted  in to  th e  c lo t .
I t  i s  in te r e s t in g  to  no te  th a t  Murray (1959) found antemortem 
c lo ts  to  be so lu b le  in  u rea  so lu tio n s  which f a i l  to  d isso lv e  blood 
c lo ts  formed in  g la ss  tu b es .
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The s te p s  involved  in  th e  th rom bin-fib rinogen  re a c tio n  can 
th e re fo re  be sch em a tica lly  p resen ted  as follow s
F ib rinogen  . — )  F ib r in  monomer + F ib rin o p ep tid es
F ib r in - i  
(u rea  in so lu b le )
FSF
Calcium
a t optimum pH
>K
F ib r in  polymer
F ib r in -s  
(u rea  so lu b le )
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A N T I T H R O M B I N  
Thrombin i s  in h ib ite d  or n e u tra liz e d  by various an tith rom bins. 
Schmidt (1892) hypothesized  th a t  blood contained a throm bin 
in a c t iv a t in g  substance which Morawitz (1904) named an tith rom bin . 
Morawitz (1905) and M ellanby (1909) showed th a t  weak so lu tio n s  of 
throm bin c lo t te d  f ib rin o g en  more re a d i ly  than  oxala ted  plasma, 
s ta t in g  th a t  th e  amount o f an tith rom bin  p resen t in  plasma could 
in a c t iv a te  many tim es th e  amount of throm bin formed from th e  same 
amount of plasm a. This was confirmed by Gasser (1917), and l a t e r  
by Quick (1938b) and by K lein  and Seegers (1950).
N ature of an tith rom bin
The an tith rom bin  a c t iv i t y  of plasma seems to  be due to  the  
presence o f se v e ra l an tith rom bins which have been designated  in  
Roman numerals as fo llow s
A ntithrom bin I  : i s  th e  a c t iv i t y  removed by th e  adso rp tion  of
throm bin onto f i b r i n  (K lein and Seegers, 1950). 
A ntithrom bin I I  : i s  th e  h ep arin  c o -fa c to r  which s h a l l  be d iscussed
l a t e r  (Brinkhous, Smith, V arner, and Seegers, 1939). 
A ntithrom bin I I I :  i s  th e  main in h ib ito ry  a c t iv i ty  p re sen t in
plasm a, and i s  described  below.
A ntithrom bin IV : i s  th e  an tith rom bin  a c t iv i ty  which appears during
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coagu la tion  (Seegers, Johnson, and F e l l ,  1954). 
A ntithrom bin V : i s  an an tith rom bin  which appeared in  th e  blood
of a p a t ie n t  w ith rheumatoid a r t h r i t i s  (L oeliger 
and H erts , 1957).
A ntithrom bin VI : i s  a substance derived  from fib rin o g en  ly sed  by
plasm in (Kowalski, 1959).
P ro p e r tie s  o f an tith rom bin  I I I
A ntithrom bin I I I  i s  separa ted  in  th e  a -g lo b u lin  f r a c t io n  which 
contam inates th e  crude albumin f r a c t io n  p re c ip ita te d  by ammonium 
su lp h a te  or by a c id i f ic a t io n  (Biggs and M acfarlane, 1957).
I t  i s  destroyed  by e th e r  f ra c t io n a t io n , chloroform , and acetone 
(A strup and D arling , 1942d), by h ea tin g  to  56°C., and a t  pH values 
above 9-5 or below 6. I t  i s  no t adsorbed by calcium  phosphate, 
(A strup and D arling , 1942d).
A ction  of an tith rom bin
Mellanby (1909) found th a t  th e  n e u tra l iz a tio n  of an tith rom bin  
in  chicken plasma i s  a slow p ro cess , and i s  complete a f te r  30 
m inutes a t  30°C. This was confirmed by Collingwood and MacMahon 
(1914) who s tre s s e d  th e  n e c e ss ity  of in cubation  a t  37°C. to  speed 
up th e  p ro cess . A strup and D arling  (I942d) s ta t e  th a t  th e  
n e u tra l iz a t io n  i s  complete a f te r  15 minutes a t  37°C. They a lso  
b e liev ed  th e  re a c tio n  to  be of th e  f i r s t  o rd er. Biggs and 
M acfarlane (1957) a lso  agree th a t  thrombin and an tith rom bin  re a c t
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to g e th e r  s to ic h o m e tric a lly , and suggest th a t  the  process of
prothrom bin a c t iv a t io n  a lso  a c t iv a te s  the  an tith rom bin  system in
plasma as w e ll.
Measurement of an tith rom bin
The an tith rom bin  i s  measured by d e te rmining th e  re s id u a l throm bin
a c t iv i t y  a f t e r  n e u tra l iz a t io n  w ith  a known concen tra tio n  of throm bin.
In  th e  f i r s t  method used (Astrup and D arling , 1942d) a
s u f f ic ie n t ly  h igh  throm bin co n cen tra tio n  i s  achieved by using  sm all
amounts of d i lu te d  plasma, allow ing complete n e u tra l iz a t io n  to  occur 
om  15 minutes a t  37 C ., then  subsampling equal a liq u o ts  onto p u r if ie d  
f ib rin o g e n  to  determ ine th e  re s id u a l thrombin a c t iv i ty .  The 
accuracy of th i s  t e s t  i s  enhanced by varying th e  amount o f plasma 
(o r th e  an tith rom bin  contained in  i t )  w hile th e  amount of throm bin 
was k ep t co n stan t; by allow ing fo r  throm bin decay in  th e  s a lin e  
co n tro l tub e ; by measuring th e  various samples in  t r i p l i c a t e ;  and 
by read ing  co rrec ted  fib rin o g en  c lo t t in g  values from a s p e c ia l ly  
drawn graph. In  i t s  au th o rs ' hands, th e  accuracy of th e  t e s t  was 
d: 5 per cen t. Under th e  cond itions of th e  t e s t  th ey  found d ir e c t  
p ro p o r tio n a li ty  between th e  amount of an tithrom bin  added (i.e .p la sm a ) 
and th e  amount o f throm bin in a c tiv a te d .
O rig in a lly , th e  plasma under t e s t  was f i r s t  d e f ib r in a te d , but 
in  my assays whole u n tre a te d  plasma was used, thus measuring m ainly 
th e  an tith rom bin  I I I  and to  a le s s e r  degree th e  an tith rom bin  I
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co n ten t o f th e  plasm a. The t e s t  i s  described  in  d e ta i l  in  
appendix IV, 11, B.
The second method used was th a t  of Douglas and Biggs (1953) in  
which a  known amount of thrombin i s  added to  whole plasma and the  
re s id u a l  throm bin estim ated  a t  one minute in te rv a ls  by subsampling 
onto p u r if ie d  fib rin o g en  so lu tio n . A curve i s  drawn r e la t in g  th e  
re s id u a l  throm bin in  u n its  to  th e  incubation  tim e in  m inutes (on 
sem ilogarithm ic graph p ap er), and th e  d is ta n ce  in  m inutes a t  which 
throm bin a c t iv i t y  i s  zero i s  compared w ith  th a t  o f th e  co n tro l 
normal plasma tr e a te d  id e n t ic a l ly .  This method a lso  measures th e  
t o t a l  c ap a c ity  of plasma antithrom bin  a c t iv i t i e s .  I t  i s  described  
f u l l y  in  appendix IV, 11, A.
C A L C I U M  (Factor IV)
The removal of calcium  from blood by th e  ad d itio n  of sodium 
o x a la te  was found to  in h ib i t  blood coagu la tion  (Arthus and Pages, 
1890). Morawitz (1905) a lso  r e a l is e d  the  n e c e s s ity  of calcium  
fo r  th e  i n i t i a l  phase of c lo t t in g  when using  t i s s u e  e x tra c ts .
I t  i s  now g e n e ra lly  accepted th a t  calcium i s  e s s e n tia l  fo r  both 
e x t r in s ic  and in t r in s ic  systems of prothrom bin a c t iv a t io n  (Biggs 
and M acfarlane, 1957), though Cekada (1926) showed th a t  in  h ig h ly  
p u r if ie d  p rep a ra tio n s  of prothrom bin th e  form ation of throm bin can
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occur in  th e  absence o f calcium . Seegers (1962) a lso  was ab le  to  
o b ta in  throm bin from p u r if ie d  prothrom bin in  a ca lc ium -free  system.
As was mentioned p rev io u s ly , calcium i s  no t e s s e n tia l  fo r  the  
th rom bin -fib rinogen  re a c tio n  to  occur, though i t  sho rtens i t  when 
p re s e n t.
M ellanby (1930) and Loomis and Seegers (1944) found th a t  calcium  
can be rep laced  by stron tium , magnesium, and barium, which however 
were much le s s  a c t iv e  than  calcium  (Seegers e t  a l ,  1945).
Large co n cen tra tio n s  o f calcium  are  in h ib ito ry  on coagu la tion , 
s im ila r  to  th e  e f f e c t  o f n e u tra l  s a l t s  a t  a comparable high 
co n ce n tra tio n  (Loomis and Seegers, 1944).
P R O T H R O M B I N  (Factor I I )
H is to r ic a l
In  1909 Mellanby prepared  a  substance from b ird  plasma which 
was no t coagulant bu t could be converted in to  one which caused th e  
form ation  of f ib r in  from f ib rin o g en . He prepared  th i s  substance 
by d i lu t io n  of th e  plasma w ith  w ater and p re c ip i ta t in g  i t  by 
a c id i f ic a t io n  to  pH 5 .3 .
Bordet and Delange (1914) observed th a t  adsorbed plasma would 
no t c lo t  on th e  a d d itio n  of t i s s u e  fa c to r  and calcium . They were 
ab le  to  e lu te  a substance from th e  tr ic a lc iu m  phosphate p r e c ip i ta te ,
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which when added to  th e  supernatan t adsorbed plasma rendered the  
l a t t e r  coagulable on th e  a d d itio n  of t i s s u e  e x tra c t and calcium .
Howell (1914b) p re c ip i ta te d  a pro throm bin-containing f r a c t io n  
from c a t plasma w ith  an equal volume of acetone. Cekada (1926) 
m odified Howell’s method by p reh ea tin g  th e  plasma to  56°C. to  
remove th e  fib rin o g en  before p r e c ip i ta t in g  w ith  acetone.
These f in d in g s  e s ta b lish e d  th e  presence of prothrom bin as a 
d e f in i te  e n t i ty ,  and was co rroborated  l a t e r  by various workers, 
n o tab ly  Owren (1947).
P ro p e r tie s  o f prothrom bin (Biggs and M acfarlane, 1957, and 1962) 
Prothrom bin i s  a p ro te in  p resen t in  Cohn’s f r a c t io n  I I I - 2 ,  
having an e le c tro p h o re tic  m o b ility  of a ^ -g lo b u lin s , an i s o e le c t r ic  
p o in t o f pH 4 .2 , and a m olecular weight of 68,000. I t  i s  w ater 
so lu b le , bu t p re c ip i ta te s  out a t  pH 3 .9  to  5 .6 . The optimum pH 
fo r  i t s  a c tiv a t io n  i s  7 .2 . I t  i s  adsorbed from plasma by alumina, 
barium su lp h a te , barium carbonate , tr ic a lc iu m  phosphate, e t c . . . ,  
and can be e lu te d  from th e  p r e c ip i ta te  by c i t r a t e  or phosphate 
b u f fe rs ,  or carbon dioxide under p ressu re  in  th e  case o f magnesium 
hydroxide p r e c ip i ta te s  only . Prothrom bin w ithstands h ea tin g  in  
aqueous so lu tio n  a t  56°C. fo r  2 hours, and th e  p re p a ra tio n  obta ined  
from e lu tio n  of alumina w ithstands even b o il in g . I t  i s  destroyed  
a t  pH values beyond 4 .5  or 11 (Seegers e t  a l ,  1945), and by 
p ro te o ly tic  enzymes (Eagle and H a rris , 1937). Prothrombin is
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s y n th e tis e d  in  th e  l i v e r ,  only  i f  s u f f ic ie n t  v itam in  K i s  p re se n t, 
(Seegers e t  a l ,  1945).
Role o f prothrom bin
Prothrom bin, as i t s  name im p lie s , i s  th e  in a c tiv e  p recu rso r of 
throm bin, which i s  p re sen t as such in  the  c irc u la t in g  blood.
Under th e  in flu en ce  o f d if f e r e n t  substances i t  i s  converted 
q u a n t i ta t iv e ly  in to  throm bin. Prothrom bin a c t iv a t io n  may be 
e f fe c te d  enzym atically  by try p s in , in  which case th e  conversion i s  
incom plete and does no t re q u ire  th e  presence of calcium  or o the r 
accesso ry  c lo t t in g  fa c to rs  (K le in fe ld  and H abif, 1953). Or i t  
can be brought about in  p u r if ie d  so lu tio n s , spontaneously, in  25 
per cen t sodium c i t r a t e  so lu tio n , w ithout th e  ad d itio n  of o ther 
plasma coagu la tion  fa c to rs  or calcium , th e  so c a l le d  c i t r a t e  
a c t iv a t io n  or a u to -a c tiv a tio n  p rocess of Seegers e t  a l  (1950).
The p h y sio lo g ica l a c t iv a t io n  of prothrom bin i s  e i th e r  by the  
e x t r in s ic  t i s s u e  th rom boplastin  which to g e th e r  w ith  fa c to rs  V, "VTI,
X, and calcium  forms th e  e x tr in s ic  a c tiv e  th rom boplastin  (e x tr in s ic  
pro throm binase), or by th e  in t r in s ic  or plasma a c tiv e  th rom boplastin  
( in t r in s ic  prothrom binase) formed by th e  in te ra c t io n  o f th e  blood 
p la te l e t s  w ith  fa c to rs  V III, IX, X, V, and calcium , th e  whole 
mechanism being tr ig g e re d  by co n tac t a c t iv a t io n  of fa c to rs  XII and
XI. These two mechanisms s h a ll  be described  in  g re a te r  d e ta i l  in  
th e  fo llow ing  ch ap te rs .
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P re p a ra tio n  of prothrom bin
S everal methods a re  used fo r  th e  p rep a ra tio n  of p u r if ie d  
prothrom bin from plasm a. Seegers e t a l (1945) have prepared  the  
most pure prothrom bin as y e t known, by a method e n ta i l in g  i t s  
i s o e le c t r i c  p r e c ip i ta t io n ,  ad so rp tio n  w ith  magnesium hydroxide, 
and e lu tio n  of th e  prothrom bin w ith  carbon d ioxide under p re ssu re , 
fo llow ed by fu r th e r  f r a c t io n a t io n  by ammonium su lphate  p r e c ip i ta t io n  
in  th e  co ld , and f in a l ly  i t s  sep a ra tio n  by i s o e le c t r ic  p r e c ip i ta t io n .  
T heir p re p a ra tio n  was homogeneous in  th e  u ltra c e n tr ifu g e  and as 
judged from s o lu b i l i ty  s tu d ie s .
Surgenor e t  a l  (1951) adsorbed prothrom bin from plasma onto 
barium su lp h a te , and e lu ted  i t  w ith  phosphate b u ffe r ; w hile Quick 
(1951) adsorbed i t  w ith  tr ic a lc iu m  phosphate and e lu te d  w ith  sodium 
c i t r a t e  so lu tio n . Biggs and M acfarlane (1957) used alumina as th e  
adsorbing agen t, and e lu ted  th e  prothrom bin w ith  phosphate b u f fe r .  
This method i s  described  in  appendix I I I ,  8; and was used whenever 
a p u r if ie d  prothrom bin p re p a ra tio n  was req u ired  fo r  t h i s  study . 
Measurement of prothrom bin
S ince th e  amount of throm bin formed i s  d i r e c t ly  p ro p o rtio n a l to  
th e  amount of p recu rso r substance (Eagle, 1935; H erbert, 1940; 
and Owren, 1947), th e  c lo t t in g  tim e of s u b s tra te  plasma or p u r if ie d  
fib rin o g en  i s  in d ic a tiv e  of th e  prothrom bin co n cen tra tio n , which i s  
u su a lly  expressed in  term s of throm bin u n i t s .
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A u n i t  o f prothrom bin i s  defined  as th a t  amount capable of 
forming one u n i t  of throm bin (Owren, 1947; and Ware and Seegers, 
1948c).
In  one-stage methods fo r  prothrom bin es tim atio n , th e  c lo t t in g  
tim es a re  a measure o f th e  prothrom bin conversion r a te s ,  and 
th e re fo re  a re  very  s e n s it iv e  to  vary ing  concen tra tions of blood 
c lo t t in g  a c c e le ra to rs .  When, however, th ese  are  p re sen t in  th e i r  
optimum amounts, th e  c lo t t in g  tim e of th e  m ixture becomes a f a i r  
measure of th e  prothrom bin co n cen tra tio n . On p lo t t in g  th e  c lo t t in g  
tim es ob ta ined  w ith  various d i lu tio n s  ag a in s t th e  re c ip ro c a l of th e  
prothrom bin co n cen tra tio n  a s t r a ig h t  l in e  i s  ob ta ined , which does 
no t pass through th e  o r ig in  due to  the  i n i t i a l  d e lay  in  thrombin 
fo rm ation , and depending on th e  a c t iv i t y  of th e  t i s s u e  e x tra c t  and 
th e  r e a c t iv i ty  of f ib rin o g en . The one-stage method of R o lle r e t 
a l  (1951) employed in  th i s  study, e n ta i ls  th e  use of adsorbed bovine 
plasma as su b s tra te  to  provide f a c to r  V and fib rin o g en , w ith  the  
a d d itio n  of pro throm bin-free oxala ted  human serum to  supply fa c to rs  
VII and X. A fter th e  a d d itio n  of th e  d ilu te d  t e s t  plasma and th e  
b ra in  e x tra c t ,  the  c lo t t in g  tim e i s  measured on r e c a lc i f i c a t io n .
This method ensures th e  uniform  ample concen tra tio n  of a l l  o the r 
n ecessary  c lo t t in g  f a c to r s ,  bu t fo r  th e  purpose of th i s  study  su ffe rs  
from th e  in te r fe re n c e  of species  s p e c i f ic i ty  between b ra in  e x tra c ts  
and plasma com binations. I t  i s  described  in  appendix IV, 12, A.
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In  tw o-stage methods, throm bin i s  evolved in  a m ixture of 
prothrom bin (p u r if ie d  or plasm a), b ra in  e x tra c t,  and calcium . At 
in te rv a ls  a liq u o ts  from th i s  m ixture are  removed and added to  
f ib rin o g e n  s o lu tio n  whose c lo t t in g  tim e i s  recorded . The fib rin o g en  
c lo t t in g  tim e i s  a measure of th e  amount of thrombin evolved. I t  
was shown by Biggs (1951) th a t  when prothrom bin i s  converted in to  
throm bin in  th e  tw o-stage techn ique, th e  amount of throm bin formed, 
as rep resen ted  by th e  minimum c lo t t in g  time of fib rin o g en , i s  
d i r e c t ly  p ro p o rtio n a l to  th e  amount of prothrom bin. And sin ce  the  
f ib rin o g e n  c lo t t in g  tim e i s  in v e rse ly  p ro p o rtio n a l to  th e  throm bin 
co n cen tra tio n , i t s  r e la t io n  to  prothrom bin co n cen tra tio n  may thus 
by expressed as fo llo w s :-
C lo ttin g  time = --------------------------------------------
Prothrom bin co n cen tra tio n
In  o th e r words, th e  fib rin o g en  c lo t t in g  tim e i s  p ro p o rtio n a l to  the
re c ip ro c a l o f th e  prothrom bin co n cen tra tio n , d ep ic tin g  a s t r a ig h t
l in e  when p lo t te d  on graph paper. This l in e  passes very  n e a r ly
through th e  o r ig in .
Two-stage methods are  independent of t i s s u e  e x tra c t  a c t iv i ty ,  
as w ell as of f ib rin o g en  r e a c t iv i ty ,  provided th e  l a t t e r  conforms 
to  th e  re fe ren c e  th rom bin -fib rinogen  d i lu t io n  curve.
Douglas and B iggs' method (1953) comprises th e  incu b a tio n  of 
th e  eug lobu lin  p r e c ip i ta te  (con ta in ing  the  prothrom bin) w ith  b ra in
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e x tra c t  and calcium  fo r  30 m inutes, a f te r  which tim e an a liq u o t i s  
d e liv e re d  onto f ib rin o g en  so lu tio n  and th e  c lo t t in g  tim e recorded . 
This i s  compared w ith  the  r e s u l t  of the  con tro l plasma. This 
system has th e  advantage of being f re e  from a n t i  throm bin. Also, 
th e  long in cu b a tio n  tim e p recludes th e  need fo r  optimum amounts of 
th e  a c c e le ra tin g  f a c to r s ,  and allow s fo r  th e  complete conversion 
of th e  prothrom bin p re se n t in  th e  m ixture to  occur. The method 
i s  d escrib ed  in  appendix IV, 12, B.
The tw o-stage a rea  method of Biggs and Douglas (1953a) i s  
perhaps th e  most s u ita b le  method fo r  th e  in v e s t ig a tio n  of prothrom bin 
le v e ls  in  plasmas of d if f e r e n t  sp ec ie s . The c i t r a te d  plasma i s  
incubated  w ith  th e  b ra in  e x tra c t and th e  m ixture r e c a lc i f ie d ,  
th e re a f te r  subsampling a t  in te rv a ls  onto fib rin o g en  so lu tio n .
When th e  c lo t t in g  tim es a re  converted in to  throm bin u n its  and a 
curve drawn r e la t in g  th e  throm bin u n i ts  to  th e  in cu b a tio n  tim e, 
th e  a re a  enclosed by th e  curve i s  a measure of th e  prothrom bin 
co n cen tra tio n  in  th e  plasma, and i s  compared to  th a t  of th e  co n tro l 
plasma s im ila r ly  te s te d .  As th e  c lo t t in g  tim es are  th e  n e t r e s u l t  
of throm bin gen era tio n  and throm bin n e u tra l iz a t io n  by an tith rom bin , 
th e  l a t t e r * s  co n cen tra tio n  in  both  co n tro l and t e s t  plasmas has to  
be a ssessed  in  o rder to  exclude i t s  v a r ia t io n  from v i t i a t in g  th e  
in te r p r e ta t io n  of the  t e s t  r e s u l t s ,  or to  take  i t  in to  co n sid e ra tio n  
i f  p re s e n t. The au thors  have shown th a t  v a r ia t io n  in  th e  potency
-  46 -
of th e  b ra in  e x tra c t  does no t a f f e c t  th e  r e s u l t s .  The lim ita tio n s  
when u sing  species  sp e c if ic  b ra in  e x tra c ts  s h a ll  be d iscussed  when 
re le v a n t .  This method i s  described  in  f u l l  in  appendix IV, 12, C. 
Prothrom bin d e fic ien cy
Normal plasma w il l  genera te  about 300 u n its  of throm bin per ml. 
(Seegers e t  a l ,  1945). Biggs and Douglas (1953a) have in v e s tig a te d  
a p a t ie n t  w ith  acqu ired  prothrom bin d e fic ien cy  who had 10 per cent 
o f th e  normal prothrom bin co n cen tra tio n  as estim ated  by th e i r  two- 
s tag e  a rea  method, bu t whose one-stage prothrom bin time was only 
s l ig h t ly  lengthened . Biggs (1955) rep o rte d  th a t  th e  minimum le v e l 
of prothrom bin req u ired  fo r  e f fe c t iv e  haem ostasis i s  about 10 per 
cen t of th e  normal. U sually , however, h igher le v e ls  a re  necessary  
to  achieve normal haem ostasis. Prothrom bin d e fic ien cy  occurs 
r a r e ly  as a congen ita l d e fe c t, bu t u su a lly  as an acqu ired  cond itio n  
in  p a t ie n ts  under dicoum arin the rapy , in  cases of v itam in  K 
d e fic ie n c y , and in  p a t ie n ts  w ith  severe l i v e r  d ise a se .
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P R O T H R O M B I N  A C T I V A T I O N  
The a c t iv a t io n  of prothrom bin in to  throm bin can be brought 
about by sev e ra l mechanisms, namely
1. E x tr in s ic  th rom boplastin  system.
2 . I n t r i n s i c  th rom boplastin  system.
3. C it r a te  a c t iv a t io n , or a u to -a c tiv a tio n .
4 . T rypsin  a c t iv a t io n .
The f i r s t  two systems a re  th o se  p h y s io lo g ic a lly  o p e ra tiv e  in  
th e  human body, and s h a l l  now be d escribed  in  tu rn .
THE EXTRINSIC THROMBOPLASTIN SYSTEM 
(T issue th rom boplastin  system)
As i t s  name im p lie s , a c t iv a t io n  of prothrom bin by the  e x tr in s ic  
th rom bop lastin  system can only  be e f fe c te d  by th e  presence of the  
e x tr in s ic  or t i s s u e  th rom bop lastin , a fa c to r  no t norm ally p resen t 
in  th e  c i rc u la t in g  b lood . Blood coagu la tion  fa c to rs  involved in  
th i s  re a c tio n  a re  s T issue th rom boplastin  ( fa c to r  I I I ) ,
Calcium ( fa c to r  IV),
F ac to r V,
F acto r V II,
F ac to r X.
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I t  should be noted th a t  fib rin o g en  was no t inc luded , as i t  is  
no t re q u ire d  fo r  prothrom bin a c t iv a t io n , but i t s  c lo t t in g  tim e i s  
used as an in d ic a to r  of th e  r a te  and y ie ld  of throm bin form ation, 
whether o r ig in a l ly  p re se n t in  th e  a c t iv a t io n  system as in  one-stage 
procedures, or samples from th e  a c tiv a t io n  m ixture d e liv e red  l a t e r  
onto i t  as in  tw o-stage p rocedures.
F A C T O R  V
D iscovery and h i s to r i c a l
Nolf (1908, 1928, and 1945) claimed th a t  prothrom bin (thrombozyme) 
is o la te d  from plasma by adso rp tion  onto calcium  phosphate would no t 
form throm bin on th e  ad d itio n  of t i s s u e  th rom boplastin  a lone, bu t 
th a t  a substance from th e  adsorbed plasma was necessary , namely 
"thrombogen". He thought thrombozyme, thrombogen, and fib rin o g en  
combined to  form f ib r in .  This th eo ry  i s  now known to  be in c o rre c t ,  
bu t h is  experim ents were th e  f i r s t  to  dem onstrate th e  n e c e ss ity  of 
f a c to r  V in  th e  process of prothrom bin a c t iv a t io n .
Quick (1943) observed th a t  s to rag e  of oxala ted  plasma lengthened 
i t s  one-stage prothrom bin tim e, th i s  d e fec t was co rrec ted  by th e  
a d d itio n  of sm all amounts of normal f re sh  plasma. Thus he suggested 
th e  presence of a " la b i le  fa c to r"  th a t  i s  req u ired  fo r  normal 
prothrom bin a c t iv a t io n .
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In  1947 Owren d iscovered  a p a t ie n t  in  whose blood a prolonged 
one-stage prothrom bin time was re s to re d  to  normal by th e  a d d itio n  
of p ro th rom bin -free  plasma, thus e s ta b lish in g  beyond doubt the  
m issing f a c t o r ’s d i f f e r e n t  id e n t i ty  from prothrom bin, and c a lle d  
i t  " fa c to r  V". A lso, Ware and Seegers (1948a) were ab le to  
id e n t i f y  a substance e s s e n t ia l  fo r  th e  ra p id  a c tiv a t io n  of p u r if ie d  
prothrom bin, in  th e  presence of t i s s u e  th rom boplastin . They c a lle d  
i t  ’’a c c e le ra to r  g lo b u lin ” .
P ro p e r tie s  of f a c to r  V
F ac to r V i s  a w ater so lu b le  g lo b u lin  p resen t in  Cohn's f r a c t io n  
I I I .  I t  i s  destroyed  by h ea tin g  to  50°C. fo r  30 m inutes, or 
im m ediately i f  heated  a t  58°C. F actor V d e te r io ra te s  on s to rag e  
in  o x a la ted  plasma, w hile i t  i s  s ta b le  in  c i t r a te d  plasma (Fahey, 
Ware, and Seegers, 1948; and Quick, 1943, and 1960). F actor V i s
la b i le  a t  a l l  pH v a lu es, bu t most s ta b le  a t  pH 5 to  9. I t  i s
adsorbed f irm ly  on blood p la te le t s  and cannot be washed o ff  them, 
(Ware, Fahey, and Seegers, 1948; and H jo rt, Rapaport, and Owren, 
1955). F acto r V can be p re c ip i ta te d  from plasma by 33 -  50 per 
cen t s a tu ra t io n  w ith ammonium su lp h a te , a f te r  th e  prim ary removal 
of th e  plasma prothrom bin by ad so rp tio n . F actor V cannot be 
adsorbed by any of th e  adsorbing ag en ts, and i s  th e re fo re  p re sen t 
in  th e  supernatan t adsorbed plasm a. A lso, i t  i s  no t re ta in e d  by 
S e itz  f i l t e r s  con ta in ing  50 per cen t a sb es to s . F actor V i s  used
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up during  "the coagu la tion  of th e  blood, and th e re fo re  i s  no t p re sen t 
in  normal human serum (S te fa n in i and Crosby, 1950).
A ction  of fa c to r  V
The presence o f fa c to r  V i s  e s s e n tia l  fo r  prothrom bin a c t iv a t io n  
w hether by th e  e x tr in s ic  throm boplastin  system or th e  in t r in s ic  
th rom bop lastin  system.
I t  was found to  behave as a su b s tra te  whose fu r th e r  ad d itio n  
in c re a se s  th e  y ie ld  of throm bin in  v i t r o  (S traub and Duckert, 1961).
I t  i s  supposed th a t  f a c to r  V (p ro acce le rin ) i s  converted by 
tra c e s  of throm bin in to  a more a c t iv e  form, a c c e le r in , (Ware, Murphy, 
and S eegers, 1947; H jo rt, 1957; T h e rr ia u lt e t  a l ,  1957; Rapaport, 
Ames, and Duval, 1960; and Rapaport e t  a l ,  1963). S trong thrombin 
s o lu tio n s , however, a re  known to  in a c tiv a te  a c c e le r in  (H jo rt, 1957). 
P re p a ra tio n  of fa c to r  V
The most pure p rep a ra tio n  known i s  th a t  prepared  by Ware and 
Seegers (1948b) which s t i l l  was sa id  to  con ta in  about 50 per cent 
of substances o th e r than  a c c e le ra to r  g lo b u lin .
In  th i s  work, fa c to r  V p re p a ra tio n  was made by ammonium su lphate  
p r e c ip i ta t io n  as d escribed  by Douglas and Biggs (1953), a method 
th a t  e n ta i ls  adsorbing th e  plasma to  ge t r id  of th e  prothrom bin, 
th en  th e  fib rin o g en  i s  removed by 33 per cen t s a tu ra t io n  w ith  
ammonium su lp h a te , and th e  fa c to r  V i s  obtained  by r a is in g  th e  
ammonium su lphate  co n cen tra tio n  to  50 per cen t. F acto r V is
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f i n a l ly  recovered  from th e  p r e c ip i ta te  by d is so lv in g  i t  in  s a l in e ,  
and th e  so lu tio n  d ia ly sed  ag a in s t s a lin e  to  f re e  i t  from th e  ammonium 
su lp h a te  io n s . S o lu tions prepared  as such were used in  th e  re le v a n t 
experim ents im m ediately a f te r  p rep a ra tio n  w ithout any s to rag e .
D e ta ils  of th e  method a re  described  in  appendix I I I ,  9.
Measurement of f a c to r  V
F acto r V a c t iv i ty  can be measured e i th e r  in  one-stage or in  
tw o-stage methods.
In  one-stage methods, th e  su b s tra te  plasma i s  e i th e r  from a 
p a t ie n t  w ith  congen ita l d e fic ien cy  of fa c to r  V, a ra re  d e fe c t, or 
plasma made a r t i f i c i a l l y  d e f ic ie n t  in  fa c to r  V by s to ra g e . The 
degree of c o rre c tio n  of th i s  su b s tra te  plasma by th e  t e s t  m a te ria l 
i s  compared w ith  th a t  of a co n tro l normal plasma, in  a one-stage 
procedure u t i l i s i n g  b ra in  th rom boplastin ; as described  in  d e ta i l  
in  appendix IV, 14.
In  th e  tw o-stage method of Ware and Seegers (1948a) th e  r a te  
a t  which th e  thrombin t i t r e  develops from p u r if ie d  prothrom bin 
under s tan d ard ized  cond itions i s  p ro p o rtio n a l to  th e  amount of the  
fa c to r  V p re se n t.
F ac to r V d e fic ien cy
F acto r V d e fic ien cy  occurs in  th e  fo llow ing cond itions
1. As a congen ita l abnorm ality , g iv ing  r i s e  to  a  haemorrhagic 
d ia th e s is .
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2. In  d ise a se s  invo lv ing  th e  l i v e r ,  e .g .  c i r rh o s is ,  leukaem ias, 
and advanced carcinoma.
3. As an a sso c ia te d  f in d in g  in  d e f ib r in a tio n  syndromes.
F ac to r V i s  n o t s ig n if ic a n t ly  reduced by dicoumarin th erapy . 
Quick (i960) has shown th a t  fa c to r  V has to  be reduced a t  l e a s t  by 
50 p e r cen t befo re  th e  one-stage prothrom bin time i s  prolonged.
He a lso  no ted  th a t  th e  co n cen tra tio n  of fa c to r  V in  human serum i s  
a p p a re n tly  h ig h e r than  in  th e  corresponding plasma, th i s  observed 
h y p e ra c tiv i ty  i s  l o s t  when th e  serum i s  adsorbed w ith  calcium  
phosphate, and f a c to r  V then  found to  be a c tu a lly  v ery  low.
F A C T O R  VII
H is to r ic a l
The p o s s ib i l i ty  o f another f a c to r  p re sen t in  th e  serum was f i r s t  
recognized  by Mann e t  a l  (1947). Owen and Bollman (1948) a lso  
found th a t  serum sho rtens th e  prothrom bin time of dicoum arin plasma, 
in d ic a tin g  th a t  th e  f a c to r  supp lied  could th e re fo re  be n e ith e r  
prothrom bin nor f a c to r  V, Alexander and de V ries (1949 a and b) 
found t h a t  serum of a  d icou m arin -trea ted  p a t ie n t  lacked  th e  a b i l i t y  
to  sh o rten  th e  one-stage t e s t  in  a  system using  plasma d i lu te d  w ith  
barium su lp h a te  adsorbed plasma as su b s tra te . Owren (1950, 1951, 
and 1952) observed th a t  S e i t z - f i l t e r e d  bovine plasma con tains both
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fa c to r  V and some prothrom bin, and th a t  the  l a t t e r  i s  no t readily- 
converted to  throm bin u n le ss  some serum was added. He c a lle d  the  
serum a c c e le ra to r  "p roconvertin '1. K oller e t  a l  (1951) confirmed 
Owren1s f in d in g s , and c a lle d  th e  new fa c to r  " fa c to r  V II", the  term  
now in te rn a t io n a l ly  adopted.
P ro p e r tie s  of fa c to r  VII
F ac to r VII i s  a p ro te in  p re sen t in  th e  j3-globulin f r a c t io n  of 
normal plasma and serum (Owen and McKenzie, 1954). I t  i s  adsorbed 
from plasma or serum by alumina, barium su lp h a te , tr ic a lc iu m  
phosphate, e t c . . . ;  and i s  a lso  removed from the  plasma by S e itz  
f i l t r a t i o n  through pads con ta in ing  50 per cent a sb es to s . I t  i s  
s ta b le  fo r  long tim es when s to red  a t  -20°C ., and s ta b le  fo r  fou r 
days a t  25-37°C. in  serum; bu t i t  i s  h ea t la b i le ,  and i s  destroyed  
a t  pH 3. F acto r VII i s  no t consumed during c lo t t in g ,  and th e re fo re  
i s  p re sen t in  normal serum. I t s  a c t iv i t y  i s  id e n t ic a l  in  s i l ic o n e -  
-co a ted  or uncoated g la ss  su rfa c e s , as judged by th e  c lo t t in g  of 
whole blood w ith b ra in  throm boplastins (F an tl and Osborn, 1962). 
A ction o f fa c to r  VII
F ac to r VII i s  an enzyme (not consumed) th a t  a c c e le ra te s  the  
conversion  o f prothrom bin in to  throm bin in  th e  presence of t i s s u e  
th ro m bop lastin s. The r a te  o f product form ation was found to  be 
d i r e c t ly  p ro p o rtio n a l to  th e  enzyme concen tra tion  (S traub and 
B uckert, 1961). Owren (1951 and 1955) suggests th a t  f a c to r  VII
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r e a c ts  w ith  b ra in  e x tra c ts  to  form a sp e c if ic  in term ed ia te  product 
which he c a l le d  "convertin '* .
Though f a c to r  VII i s  e s s e n tia l  fo r  th e  e x tr in s ic  a c tiv a t io n  of 
prothrom bin, s a t i s f a c to r y  in t r in s ic  throm boplastin  g en era tio n  and 
a c t iv a t io n  of prothrom bin in  th e  absence of fa c to r  VTI was rep o rted  
to  occur by R o lle r (1955).
P re p a ra tio n  of fa c to r  VII (Biggs and M acfarlane, 1957)
Normal serum i s  adsorbed w ith  barium su lp h a te , th e  p r e c ip i ta te  
washed w ith  d i s t i l l e d  w ater, then  e lu ted  w ith  5 per cen t sodium 
c i t r a t e  in  s a l in e .  The e lu a te  i s  d ia ly sed  ag a in s t c i t r a t e  s a lin e  
s o lu tio n , and kep t a t  -20°C. This method i s  described  in  appendix 
I I I ,  10. I t  should be noted th a t  such a p rep a ra tio n  a lso  con tains 
f a c to r s  IX and X.
Measurement of fa c to r  VTI
The id e a l method i s  n a tu ra l ly  to  measure th e  degree of c o rre c tio n  
of plasma from a p a t ie n t  w ith  congen ita l d e fic ien cy  of f a c to r  V II, 
caused by the  ad d itio n  o f various amounts of th e  t e s t  m a te r ia l,  as 
compared w ith  a normal co n tro l plasm a. Since th i s  d e fe c t i s  r a re ,  
th e  scarce  a v a i la b i l i ty  of such plasma does no t allow  fo r  continued 
use of th i s  method.
Biggs and M acfarlane (1957) noted th a t  f a c to r  VII i s  g re a t ly  
reduced in  th e  plasma o f p a t ie n ts  given dicoum arin drugs, e s p e c ia lly  
in  th e  f i r s t  few days, w hile o th e r fa c to rs  a re  le s s  ra p id ly  reduced
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(Douglas, 1962). They made use of th i s  f a c t  by observing th e  
degree of c o rre c tio n  o f dicoum arin plasma on th e  ad d itio n  of the  
t e s t  plasma or serum as compared to  a  normal co n tro l plasm a, in  
th e  presence o f t i s s u e  th rom boplastin  and calcium c h lo rid e  so lu tio n . 
This method i s  d escribed  in  appendix IV, 15, A.
K o lle r e t  a l  (1951) dev ised  a method based on the  c o rre c tio n  
o f S e i t z - f i l t e r e d  bovine plasma, as described  in  d e ta i l  in  appendix 
IV, 15, B. This method, however, i s  a lso  s e n s it iv e  to  changes in  
f a c to r  X co n cen tra tio n , th e  s u b s tra te  plasma being t o t a l l y  d e f ic ie n t  
in  f a c to r  X. The observed values a re  th e re fo re  in d ic a tiv e  of the  
combined f a c to r  VII and X a c t i v i t i e s .
Serum was rep o rte d  to  have a  g re a te r  fa c to r  VII a c t iv i t y  than  
th e  o r ig in a l  plasma (H jo rt, 1957; Johnston e t  a l ,  1959; and 
Johnston and H jo rt, 1961). This may be explained  by th e  presence 
o f r e s id u a l  th rom bop lastin  a c t iv i t y  in  th e  serum* A lso, th e re  
a re  observa tions which in d ic a te  no d iffe re n c e  between plasm a and 
serum f a c to r  VII a c t i v i t i e s  (K o ller e t  a l ,  1951; Hougie, 1959a and 
1959b; and F an tl and Osborn, 1962). In  view o f th e se  c o n f lic tin g  
r e p o r ts ,  a l l  measurements o f  f a c to r  VII of th e  d i f f e r e n t  spec ies  
were made on plasm a sam ples, which r e f l e c t s  th e  f a c to r fs  t r u e  le v e l 
as i f  occurs in  th e  c i rc u la t in g  blood.
F ac to r VII d e fic ien cy
F ac to r VII d e fic ie n c y  occurs in  th e  fo llow ing  e o n d itio n ss -
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1. C ongenital d e fe c t (Alexander e t  a l ,  1951; and D ische, 1958).
2 . During dicoum arin drug therapy .
3. Vitamin K d e fic ie n c y .
4 . D iseases o f th e  l i v e r .
5. In  th e  newborn.
F A C T O R  X 
The term  " fa c to r  X" was f i r s t  used by D uckert, F lu ck ig er, and 
K o lle r (1954) who d escribed  a d e fic ien cy  o f a f a c to r  in  p a t ie n ts  
t r e a te d  w ith  dicoumarol which was d if f e r e n t  from fa c to r  VII or 
f a c to r  IX, th a t  produced an abnormal r e s u l t  in  th e  throm boplastin  
g en era tio n  t e s t  of Biggs and Douglas (1953b).
However, conclusive evidence of th e  presence of y e t another 
serum fa c to r  was p resen ted  by Hougie, Barrow, and Graham (1957) 
who describ ed  a case of congen ita l S tu a r t  fa c to r  d e fic ien cy , which 
o r ig in a l ly  was diagnosed as fa c to r  VII d e fic ien cy  by Lewis, F resh, 
and Ferguson (1953). The p a t i e n t 's  plasma had a prolonged R.V.V. 
c lo t t in g  tim e, w hile h is  serum was d e fec tiv e  when te s te d  in  the  
th rom bop lastin  gen era tio n  t e s t .  Both th ese  t e s t s  do no t re q u ire  
th e  presence o f fa c to r  V II. They found th a t  th e  d e fe c t was 
co rrec ted  by plasma or serum from a p a t ie n t  w ith  a known congen ita l 
f a c to r  VII d e fic ien cy . They named th e  m issing f a c to r  "S tu a rt fa c to r"
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a f t e r  th e  p a t i e n t ’s surname.
P ro p e r tie s  of f a c to r  X
F ac to r X i s  a p ro te in  th a t  sep a ra te s  w ith  th e  a -g lo b u lin ,
(Denson, 1958), having a m olecular weight of 86,000 (Esnouf and 
W illiam s, 1962). I t  i s  s ta b le  a t  pH 5 to  9, and w ithstands 
s to rag e  a t  4°C. fo r  two months. I t  i s  destroyed  by h ea tin g  to  
56°C, in  30 minutes (Bachmann e t  a l ,  1957). F actor X can be 
adsorbed from th e  plasma by alum ina, barium su lp h a te , or calcium 
phosphate, and can be e lu ted  by 0.14 molar sodium c i t r a t e  so lu tio n . 
A lso, i t  can be removed from th e  plasma by S e itz  f i l t r a t i o n  (Bachmann 
e t  a l ,  1957). I t  i s  no t a f fe c te d  by g la ss  su rfaces  (Bachmann e t 
a l ,  1958).
A ction of f a c to r  X
The presence of fa c to r  X i s  e s s e n t ia l  fo r  th e  e x tr in s ic  
a c t iv a t io n  of prothrom bin w ith  t i s s u e  th rom boplastin  or w ith  
R u s s e l l 's  v ip e r  venom, and a lso  fo r  th e  normal in t r in s ic  gen era tio n  
of th rom bop lastin  (D uckert, F lu ck ig er, M atter, and K o lle r, 1955; 
and R abiner and Spaet, 1959).
In  th e  re a c tio n  w ith  b ra in  th rom bop lastins, a q u a n t i ta t iv e  
r e a c tio n  occurs between th e  b ra in  throm boplastin  and f a c to r  X, both  
being consumed during  th e  process of c lo t t in g  (S traub and D uckert, 
1961). Also in  i t s  re a c tio n  w ith  R.V.V. i t  was s p l i t  as seen in  
th e  u l t r a c e n tr i fu g e ,  on e le c tro p h o re s is , and by th e  appearance of
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a new te rm in a l amino ac id  (Esnouf and W illiam s, 1962).
I t  i s  in te r e s t in g  to  note th a t  during normal blood coagulation  
by the  in t r in s ic  th rom boplastin  system, fa c to r  X i s  no t consumed, 
and th e re fo re  i s  p re sen t in  normal serum. In  th i s  re a c tio n  i t  
a c ts  as an enzyme a c c e le ra tin g  the  form ation of th e  in t r in s ic  
a c tiv e  th rom boplastin  (F isch and Duckert, 1959).
P rep a ra tio n  of fa c to r  X
F acto r X was prepared by Esnouf and Williams (1962) from barium 
su lphate  e lu a te s  of bovine plasma, passed through a chromatography 
column of DEAE re s in ,  and a f te r  fu r th e r  p u r if ic a tio n  step s  was 
obta ined  as a homogeneous p ro te in  f r a c t io n  as judged by i t s  uniform 
behaviour in  th e  u lt ra -c e n tr i fu g e .
For th i s  in v e s tig a tio n , th e  p rep a ra tio n  of fa c to r  VII as was 
described  before was a lso  used as a source of p u r if ie d  fa c to r  X, 
(appendix I I I ,  10).
Measurement of fa c to r  X
The method described  by Bachmann, Duckert, and K oller (1958) 
was used. I t  measures th e  a b i l i t y  of th e  t e s t  or normal plasma 
to  c o rre c t bovine plasma made a r t i f i c i a l l y  fa c to r  X d e f ic ie n t by 
S e itz  f i l t r a t i o n ,  using  R ussell*s v ip e r venom -  cephalin  reagent 
as th e  throm boplastic agen t. The bovine plasma contained a l l  
o the r necessary  fa c to rs  in  optimum concen tra tions, namely fa c to r  
V, prothrom bin, and f ib rin o g en . Using various d ilu tio n s  of the
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t e s t  plasma rendered fa c to r  X th e  only v a r ia b le . This method is  
described  in  appendix IV, 18.
I t  should be noted th a t  u n t i l  th e  reco g n itio n  of fa c to r  X, 
r e s u l t s  a t t r ib u te d  to  f a c to r  VII by th e  then  av a ilab le  methods may 
have been p a r t ly  due to  th e  presence in  the  serum of fa c to r  X. 
F acto r X d e fic ien cy
D eficiency  of fa c to r  X may occur as a congenital abnorm ality 
(T e lfe r e t  a l ,  1956; and Hougie e t  a l ,  1957), or as an acquired 
d e fic ien cy  in  l iv e r  d isea se , dicoumarin therapy , or vitam in K 
d e fic ien cy  (Bachmann e t  a l ,  1957).
T I S S U E  T H R O M B O P L A S T I N  (Factor I I I )
H is to r ic a l
Buchanan (1879) observed th a t  emulsions of c e r ta in  body tis s u e s  
promoted c lo t t in g  when added to  cooled blood. Schmidt (1892) 
prepared  a lco h o lic  e x tra c ts  of t i s s u e s  which acce le ra ted  blood 
c lo t t in g ,  and he noted th a t  th e i r  a c t iv i ty  was r e s is te n t  to  hea tin g . 
Morawitz (1905) named th i s  substance "thrombokinase", and was the  
f i r s t  to  suggest i t s  a c tio n  on a p recu rso r p resen t in  th e  plasma, 
namely "pro-throm bin", converting  i t  in to  thrombin in  th e  presence 
of calcium . He noted th a t  aqueous e x tra c ts  of t i s s u e s  had g re a te r  
a c t iv i t y  than  a lco h o lic  e x tra c ts .  Howell in  1912 coined the  term
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"th rom boplastin” , and emphasised th a t  a lco h o lic  e x tra c ts  r e s i s t  
b o il in g , w hile aqueous e x tra c ts  lo se  th e i r  a c t iv i ty  on h ea tin g . 
P ro p e rtie s  of t i s s u e  throm boplastin
T issue or e x tr in s ic  throm boplastin  i s  an in t r a c e l lu la r  substance 
p re sen t in  m uscles, lungs, b ra in , and most o ther t i s s u e s  of the  body.
Bordet and Delange (1913) thought the  ac tiv e  p r in c ip le  to  be a 
l ip o id  of th e  le c i th in  group, w hile Howell (1912) believed  i t  to  be 
a l ip o id  component of cephalin  ch a rac te r asso c ia ted  w ith a p ro te in , 
which was a lso  the  view held  by G ra tia  and Levene (1922), Tocantins 
(1944 a and b ) , and Chargaff e t  a l  (1944).
P u r if ic a t io n  of aqueous p repara tions  was repo rted  by various 
workers by physico-chem ical methods. I t  i s  the opinion of F ischer 
and Hecht (1934), Wohlisch (1940), and Astrup and D arling (1942a) 
th a t  a l l  attem pts to  p u r ify  t is s u e  throm boplastin  by such methods 
r e s u l t  in  decreased a c t iv i ty .  The molecule of th e  ac tiv e  component 
o f t i s s u e  throm boplastin  i s  be lieved  to  be la rg e , because a l l  i t s  
a c t iv i t y  could be removed by c e n tr ifu g a tio n  a t  10,000 r.p .m . (Biggs 
and M acfarlane, 1957). The a c t iv i ty  of b ra in  e x tra c ts  on plasma 
i s  u n a ffec ted  by changes in  plasma l ip id s ,  i t  a lso  r e s i s t s  b o ilin g , 
and w ill  no t c lo t  p ro throm bin-free fib rinogen  (Biggs and M acfarlane, 
1957). A powerful t i s s u e  throm boplastin  could be prepared from the  
t i s s u e s  of a haem ophilic p a t ie n t  who died of haemorrhage (Brown,
1952, c i te d  by Biggs and M acfarlane, 1957).
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A ction of t i s s u e  throm boplastin
The a c t iv i t y  of t i s s u e  throm boplastin  i s  preformed. Tagnon 
e t  a l  (1942) b e liev e  i t  to  a c t as a p ro te o ly tic  enzyme which 
a c c e le ra te s  thrombin form ation, and i s  not consumed during the 
re a c tio n . I t  was shown by M acfarlane and P i l l in g  (1946) and by 
M acfarlane (1947) th a t  soya-bean try p s in  in h ib ito r ,  an a n t i -  
- p ro te o ly tic  substance, in h ib i ts  the  ac tio n  of t i s s u e  e x tra c ts . 
R ecently , S traub and Duckert (1961) using  p u r if ie d  reagen ts , found 
th a t  th e  t i s s u e  fa c to r  behaves l ik e  a su b s tra te  whose fu r th e r  
a d d itio n  to  th e  re a c tio n  m ixture a f te r  maximal a c t iv i ty  has been 
a t ta in e d  in c re ases  th e  y ie ld  of th e  f in a l  a c tiv a to r  product.
They a lso  found i t  was consumed during the  process of coagulation .
The most a c tiv e  t i s s u e  e x tra c ts  are  those prepared from the 
b ra in , lungs, or p la cen ta . T issue throm boplastin  was found to  ac t 
most s tro n g ly  when in  optimal concen tra tion , u nd ilu ted  p repara tions  
g iv ing  r e la t iv e ly  long c lo tt in g  tim es, w hile d i lu te d  ones caused 
s h o r te r  c lo t t in g  tim es (Quick, 1935; Larsen and Plum, 1941; and 
Owren, 1949).
Biggs and M acfarlane (1951) and Biggs and Nossel (1961) have 
drawn a t te n t io n  to  th e  f a c t  th a t  in  wounds, even those  w ith severe 
damage, th e  concen tra tion  of t i s s u e  throm boplastin  re le a se d  i s  
u n lik e ly  to  equal th e  concen tra tio n  used in  la b o ra to ry  t e s t s .
They concluded th a t  in  p h y sio lo g ica l haem ostasis th e  a c t iv i ty  of
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of th e  e x tr in s ic  throm boplastin  system must th e re fo re  be brought 
about by much more d i lu te  concen trations of t i s s u e  throm boplastin . 
They fu r th e r  noted th a t  blood from p a tie n ts  w ith fa c to rs  V III or 
IX d e f ic ie n c ie s , though re a c ts  norm ally to  strong  t is s u e  e x tra c ts ,  
i t s  re a c tio n  to  weak p rep ara tio n s  i s  poor.
P rep a ra tio n  of t i s s u e  throm boplastin
A fte r th e  chosen t i s s u e  i s  cleaned from blood v esse ls  and 
membranes, i t  i s  em ulsified  in  s a lin e  in  a homogeniser, or ground 
w ith  sand in  a m ortar. The supernatan t i s  separated  a f te r  
c e n tr ifu g a tio n , and i t s  optimum d ilu tio n  assessed  on fre sh  normal 
plasm a. F in a lly  th e  whole p rep a ra tio n  i s  thus ad justed  and kept 
a t  -20°C. in  sm all b o t t le s .
B rain  i s  u su a lly  th e  b es t organ fo r  th e  p rep ara tio n  of t is s u e  
throm boplastin  as i t  can be very  e a s i ly  freed  from blood vesse ls  
and membranes v i r tu a l ly  com pletely. This ensures th e  le a s t  
p o s s ib i l i ty  of contam ination w ith  th e  o ther blood c lo tt in g  fa c to rs .  
Two methods fo r  th e  p rep a ra tio n  of various t i s s u e  throm boplastins 
a re  d escribed  in  appendix I I I ,  13.
Species s p e c i f i c i ty  of t i s s u e  throm boplastin
Muraschew (1904) observed th a t  t i s s u e  throm boplastin  from lower 
v e r te b ra te s  was incapable of in a c tiv a tin g  mammalian prothrom bin. 
Quick (1935) found d iffe re n c e s  in  the  throm boplastic a c t iv i t i e s  of 
t i s s u e  e x tra c ts  prepared from various common lab o ra to ry  anim als,
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namely G uinea-pig, c a t ,  dog, r a b b i t ,  and. manj as w ell as d iffe ren ces  
in  th e  response of th e  blood of th ese  animals to  throm boplastin .
Trevan and M acfarlane (1936) dem onstrated th a t  lung p rep ara tio n s  
from d if f e r e n t  animal species gave v aried  one-stage c lo t t in g  times 
w ith  th e  same plasma samples from th e  d if fe re n t  animal spec ies.
Warner e t  a l  (1939a) were unable to  a c t iv a te  chicken prothrombin 
w ith  mammalian t i s s u e  throm boplastin . Mann and Hurn (1952) observed 
th a t  p re -in c u b a tio n  of th e  t i s s u e  e x tra c t w ith th e  homologous serum 
removed i t s  species s p e c if ic i ty ,  in fe r r in g  th a t  the  s p e c if ic i ty  of 
a  serum c o -fa c to r  may be th e  cause of th e  species s p e c if ic i ty ,  ra th e r  
th an  th e  s p e c i f i c i ty  of th e  t i s s u e  e x tra c t i t s e l f .  This serum 
c o -fa c to r  i s  now known to  comprise fa c to rs  VII and X, and from the 
a v a ila b le  d a ta  i t  i s  very  d i f f i c u l t  indeed to  asc rib e  the  s p e c if ic i ty  
to  one or th e  o the r of th e  components involved in  th e  re a c tio n .
I t  i s  perhaps s a fe r  to  say th a t  th e  re a c tio n  between the  serum 
fa c to rs  and th e  t i s s u e  throm boplastin  i s  species sp e c if ic .
Stormorken (I957d) a lso  confirmed the  species s p e c if ic i ty  of 
t i s s u e  thromboplastins and of p roconvertin  (fa c to r  V II), in  th e  ox, 
h o rse , dog, and man.
S h irakura  e t  a l  (1959) dem onstrated th a t  serum contain ing  
an tib o d ie s  ag a in s t human b ra in  throm boplastin  d id  no t n e u tra liz e  
r a b b i t  b ra in  throm boplastin  a c t iv i ty ,  concluding th a t  human and 
ra b b it  b ra in  throm boplastins a re  a n t ig e n ic a lly  d if f e r e n t .
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F an tl and Osborn (1962), however, found th a t  " the combination 
of fa c to rs  VII and X w ith  th e  b ra in  p recurso r showed no abso lu te  
sp ec ies  s p e c if ic i ty ,  although a markedly higher a c t iv i ty  in  the  
homologous system was apparen t" . They used p u r if ie d  human and 
ra b b it  reag e n ts . They concluded th a t  a h igher concen tra tion  of 
th e se  fa c to rs  i s  req u ired  fo r  prothrom bin conversion in  a 
hetero logous re a c tio n  m ixture.
FORMATION OF ACTIVE EXTRINSIC THROMBOPLASTIN 
The ac tiv e  e x tr in s ic  th rom boplastin  (e x tr in s ic  prothrombin 
a c t iv a to r ,  or e x tr in s ic  prothrom binase) i s  the  end r e s u l t  of the 
in te ra c t io n  of t i s s u e  throm boplastin , fa c to rs  V, VII, and X, 
to g e th e r w ith  calcium . Since a simultaneous in te ra c t io n  of a l l  
f a c to rs  concerned i s  h ig h ly  improbable, i t  was suggested by Jaques 
(1954) th a t  such a re a c tio n  i s  a m u lti-s ta g e  one, w ith fa c to rs  
re a c tin g  in  p a ir s  and subsequent s im ila r  in te ra c tio n  of th e i r  
p ro d u c ts . Mann e t  a l  (1950, 1951, and 1952) believed  th a t  fa c to r  
VII (co-throm boplastin) re a c ts  w ith t i s s u e  throm boplastin  before 
prothrom bin en te rs  th e  re a c tio n . L a te r, Biggs, Douglas, and 
M acfarlane (1953a) dem onstrated th a t  p re-incubation  of th e  b ra in  
e x tra c t  w ith  normal serum and fa c to r  V re su lte d  in  th e  form ation 
of a powerful prothrom bin converting substance. S traub and
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Duckert (1961) using  p u r if ie d  reagen ts  proved conclu sive ly  th a t  
t i s s u e  th rom boplastin  re a c ts  f i r s t  w ith  fa c to rs  X and VII in  the  
presence of calcium  forming an in term ed ia te  product which then  
r e a c ts  w ith  f a c to r  V forming th e  a c tiv e  e x tr in s ic  prothrom binase. 
They showed th a t  f a c to rs  V, X, and the  t i s s u e  fa c to r  behave l ik e  
s u b s tra te s ,  and are  consumed during th e  re a c tio n , w hile fa c to r  VII 
ac ted  as an enzyme a c c e le ra tin g  th e  re a c tio n  w ithout being consumed. 
This confirmed th e  p rev ious observations of R o lle r e t  a l  (1951) 
th a t  f a c to r  VII only  a f f e c ts  th e  speed of th e  re a c tio n , and of 
H ard is ty  (1955) th a t  serum e lu a te  (con ta in ing  fa c to rs  VII and X) 
a f f e c ts  th e  speed of th e  form ation of th e  coagulant, w hile fa c to r  
V a ffe c te d  i t s  y ie ld .  Hougie (1959a) using  se ra  from p a t ie n ts  
w ith  congen ita l fa c to r  VII and fa c to r  X d e f ic ie n c ie s  a lso  has 
dem onstrated th a t  f a c to r  VII a f fe c ts  th e  speed, w hile fa c to r  X 
a f f e c ts  th e  amount of prothrom bin converting  substance formed.
The sequence of events can th e re fo re  be rep resen ted  as follow s
T issue throm boplastin  „    vtt
+ ----- P^ ° r  ^ ----> In term ed ia te  product, Calcium 'F acto r X +
F actor V
Prothrombin
< -
Thrombin
Calcium
Calcium
A ctive e x tr in s ic  th rom boplastin
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RUSSELL'S VIPER VENOM
The venom of th e  v ip e r  snake has a powerful coagulant a c t iv i t y  
on normal plasma. I t  i s  a s o r t  of e x tr in s ic  prothrom bin a c tiv a to r  
which, however, d i f f e r s  from t i s s u e  throm boplastin  in  two re sp e c ts .
F i r s t ly ,  i t s  a c t iv i t y  was found to  depend on th e  presence of 
l ip id s  (Leathes and Mellanby, 1939), a fin d in g  which was confirmed 
by M acfarlane, Trevan, and Attwood (1941) who dem onstrated th a t  i f  
th e  plasma i s  freed  from th e  l i p id  c o -fa c to r , the  a c t iv i t y  of the  
R.V.V. d isap p ea rs. F u lle r to n  and A nastasopoulos (1949) noted 
th a t  in c re a se  of th e  plasma l i p id  con ten t caused shorten ing  of th e  
c lo t t in g  tim es obta ined  when using  R.V.Y. as th e  e x tr in s ic  
th rom bop lastin . Lee e t  a l  (1955) a lso  found th a t  R.V.V. does no t 
a c t iv a te  p u r if ie d  prothrom bin in  th e  presence of fa c to r  V and 
calcium , w hile i f  p la te le ts  or p la t e l e t  e x tra c ts  were added, 
prothrom bin a c t iv a t io n  was ra p id . However, the  p la te l e t  e x tra c t 
th ey  used was p u r if ie d  from bovine p la te le t s  and i s  rep o rted  to  be 
r ic h  in  carbohydrates and p ro te in , bu t presumably l i t t l e  i f  any 
phospholip id . I t  i s  now g en e ra lly  accepted th a t  phospholip ids 
a re  e s s e n tia l  fo r  th e  f u l l  a c t iv i ty  of R.V.V. Poole and Robinson 
(1956) and O 'B rien (1957) id e n t i f ie d  th ese  phospholip ids as 
phosphatidyl ethanolam ine, phosphatidyl s e r in e , phosphatidyl
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in o s i t id e ,  and d ip h o sp h o in o sitid e .
The second p ro p erty  by which R.V.V. d i f f e r s  from t is s u e  
throm boplastin  i s  th a t  i t  a c ts  independently  of the  p roconvertin  
( fa c to r  VII) content of th e  plasma (Rapaport, Aas, and Owren, 1954). 
F ac to r V, however, was found by them to  be necessary .
M acfarlane (1961) incubated  various combinations of R.V.V., 
f a c to r  V, fa c to r  X, phospholip id , and calcium , and n e u tra liz e d  the  
re s id u a l venom a c t iv i ty  w ith a s p e c if ic  antibody fo r  R.V.V. He 
dem onstrated th a t  th e  i n i t i a l  concen tra tio n  of fa c to r  X a ffe c te d  
g re a t ly  th e  amount of a c tiv e  venom product formed, w hile changes 
in  th e  R.V.V. concen tra tion  a ffe c te d  m ainly th e  speed of the  re a c tio n .
This evidence suggests th a t  th e  venom a c ts  enzym atically  on 
fa c to r  X to  form th e  a c tiv e  p roduct, in  the  presence of fa c to r  V, 
phospholip id , and calcium . This was confirmed by W illiams and 
Esnouf (1962) who fu r th e r  is o la te d  th e  venom coagulant p ro te in  as 
a p h y s ic a lly  homogeneous component by chromatography of th e  crude 
venom on HEAE-cellulose (d ie th y lam in o e th y l-ce llu lo se ) columns.
Esnouf and W illiams (1962) rep o rted  the  p u r if ie d  coagulant p ro te in  
to  have a  m olecular weight of about 150,000, and a lso  noted i t  had 
an am ino-acid e s te ra se  a c t iv i t y  when TAMe was used as s u b s tra te ,  
resem bling o th e r p ro te o ly tic  enzymes, e sp e c ia lly  throm bin, though 
i t  had no coagulant a c tio n  on fib rin o g en . R.V.V. does no t seem 
to  possess any species  s p e c i f ic i ty  as regards i t s  coagulant ac tio n .
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THE INTRINSIC THROMBOPLASTIN SYSTEM 
(Plasma throm boplastin  system)
Blood plasma con tains a l l  th e  necessary  fa c to rs  fo r  prothrom bin 
a c t iv a t io n  in to  throm bin, w ithout th e  ad d itio n  of any e x tr in s ic  
reag e n ts . The a c tiv e  in t r in s ic  throm boplastin  or in t r in s ic  
prothrom binase i s  formed by th e  in te ra c t io n  of sev e ra l f a c to rs ,  
nam ely:- F actor IV (Calcium ),
F acto r V (P ro a c c e le r in ) ,
F actor V IIl(A ntihaem ophilic g lo b u lin ) ,
F actor IX (Christmas f a c to r ) ,
F actor X (S tuart-Prow er f a c to r ) ,
F acto r XI (Plasma throm boplastin  an teced en t),
Factor XII (Hageman fa c to r ) ,
P la te le t s ,  or phospholip id .
Gross d efic ien cy  of any of th ese  fa c to rs  h a l ts  th e  sequence of 
events a t  th e  stage  where th e  m issing fa c to r  i s  o p e ra tiv e , p reven ting  
th e  form ation of a c tiv e  in t r in s ic  th rom boplastin . This can be 
co rrec ted  only by supplying th e  m issing fa c to r ,  whether in  v i t r o  
or in  v ivo .
F ac to rs  not described  p rev iously  s h a ll  now be d iscussed  in  the  
l i g h t  of p resen t day knowledge.
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^_A__C_T_0_^__ (Hageman fa c to r)
H is to r ic a l
L is te r  in  1863 drew a t te n t io n  to  th e  in flu en ce  of fo re ig n  
su rfaces  on blood c lo t t in g ,  which have an ac c e le ra tin g  e f f e c t .  
Morawitz (1905) suggested th a t  shed p la te le t s  coming in to  co n tac t 
w ith  a  v a te r-w e tta b le  su rface  d is in te g ra te  re le a s in g  throm bokinase. 
He in tim a ted  th a t  th e  e n d o th e lia l l in in g  of th e  blood v esse ls  i s  
non-w ater-w ettab le . Bordet and Gengou in  1901 observed th a t  th e  
c lo t  promoting e f fe c t  of g la ss  was exerted  p a r t ly  upon c e ll-p o o r 
plasma (c ite d  by R atnoff, 1961). Lozner, Taylor, and McDonald 
(1942) suggested th a t  con tac t w ith  g la ss  su rfaces  a c t iv a te s  a 
p recu rso r of blood throm bokinase. This was subsequently  confirmed 
by Hartmann, Conley, and L a lley  (1949), Conley e t  a l  (1949),
R atnoff and Conley (1951), and by Quick and E p s te in  (1952).
Rose and Broida (1954) found th a t  nylon which i s  non-w ater- 
-w ettab le  s tim u la tes  c lo t t in g ;  a lso , Hirschboeck (1940) found 
th a t  co llod ion  (w ater-w ettab le) does no t s tim u la te  c lo t t in g .  
However, normal v ascu la r endothelium which i s  presumably th e  le a s t  
c lo t  promoting su rface  i s  w ater-w ettab le .
I t  was a lso  observed th a t  su rfaces  which a re  n eg a tiv e ly  charged 
in  r e la t io n  to  the  blood appear to  in h ib i t  c lo t t in g  (Lovelock and 
P o r te r f ie ld ,  1951) w hile the  c re a tio n  of a p o s itiv e  charge w ill
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provoke c lo t t in g ,  even in  vivo (Sawyer and P a te , 1953; and Sawyer, 
P a te , and Weldon, 1953). L a te r, Sawyer e t a l (i960 and 1961) 
dem onstrated th a t  thrombus form ation i s  enhanced in  vivo by a 
p o s it iv e  charge, and prevented by th e  presence of a negative  charge, 
even when th e  v esse l w all has p rev io u s ly  been damaged.
The presence in  blood of a co n tac t fa c to r  resp o n sib le  fo r  the  
a c t iv a t io n  of blood c lo t t in g  was e s ta b lish e d  by R atnoff (1954), and 
R atnoff and Colopy (1955) who described  a p a t ie n t  whose blood showed 
g ro s s ly  abnormal la b o ra to ry  r e s u l t s ,  and whose anomaly was co rrec ted  
by th e  ad d itio n  of normal plasma or plasma from p a t ie n ts  su ffe r in g  
from congen ita l d e f ic ie n c ie s  of o th e r known coagu la tion  f a c to rs .  
P ro p e r tie s  of Hageman fa c to r
I t  i s  a p ro te in  of th e  f^ -g lo b u lin  group (P rick  and Hagen, 1956), 
though i t  i s  be lieved  to  be a sso c ia ted  w ith  (3 and /or Y -g lobulin  
f r a c t io n s  (Lewis e t  a l ,  1958; and Haanen e t  a l ,  1960).
Hageman fa c to r  p re c ip i ta te s  p a r t ly  w ith  a l l  concen tra tions of 
ammonium su lphate  s a tu ra t io n  (P rick  and Hagen, 1956), bu t th e  maximal 
a c t iv i t y  i s  obta ined  in  th e  f r a c t io n  p re c ip ita te d  between 50 and 75 
per cen t s a tu ra tio n  (Haanen e t  a l ,  1960). I t  i s  no t adsorbed by 
ino rgan ic  p re c ip ita n ts  bu t i s  adsorbed onto g la ss  from which i t  can 
be e lu te d  a t  pH 9 -  11. I t  r e s i s t s  h ea tin g  to  56°C. fo r  30 minutes 
(P rick  and Hagen, 1956), and i s  a c tiv a te d  by sto rag e  a t  -20°C.
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Role of Hageman fa c to r
The exact ro le  of Hageman fa c to r  i s  as y e t no t conclusive ly  
rev ea led . P rick  and Hagen (1956) p o s tu la te d  the  presence of an 
in h ib i to r  opposing th e  a c t iv a t io n  of Hageman fa c to r  in  p a t ie n ts  
thought to  have Hageman fa c to r  d e fic ien cy . This was shown no t to  
be th e  case by H ard is ty  and M argolis (1959), E g li e t  a l  (1959), 
and Haanen e t  a l  ( i9 6 0 ).
R atnoff (1961) b e liev es  th a t  Hageman fa c to r  i s  a c tiv a te d  by 
g la ss  co n tac t through m olecular re-arrangem ent, and enzym atically  
a c t iv a te s  fa c to r  XI (P .T .A .) .  R atnoff e t a l  (1961) found th a t  
v a r ia t io n  in  th e  co n cen tra tio n  of Hageman fa c to r  a ffe c te d  th e  speed 
of form ation of th e  a c tiv e  product formed to g e th e r w ith  fa c to r  XI, 
w hile v a r ia t io n  in  th e  concen tra tio n  of f a c to r  XI a ffe c te d  th e  
amount formed, confirm ing th e  enzymic n a tu re  o f Hageman fa c to r ,  and 
th e  s u b s tra te  fu n c tio n  of fa c to r  XI (P .T .A .).
A ctiv a ted  Hageman fa c to r  i s  rep o rte d  to  be extrem ely la b i le ,  
being ra p id ly  destroyed  by another enzymic p r in c ip le  p resen t in  
normal d e c a lc if ie d  plasma, d e lip id iz e d  plasma, as w ell as in  plasma 
of p a t ie n ts  w ith  th e  Hageman t r a i t  (M argolis, 1957, 1958a, and 1958c; 
and M argolius and R atnoff, 1956). Again, an in h ib ito ry  a c t iv i ty  
has been found in  Hageman t r a i t  plasma, bu t no t in  u n tre a te d  normal 
plasma; in h ib ito r s  which may have th i s  p ro p erty  have a lso  been 
observed in  h o rse , bovine, and fowl plasma (R atnoff, 1961).
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Niewiarowski e t  a l  (1962) found th a t  p u r if ie d  Hageman fa c to r  
e lu a te s  prepared  from normal in ta c t  plasma ex h ib ited  s ig n if ic a n t  
a rg in in e  e s te ra se  a c t iv i ty ,  an a c t iv i t y  th a t  could be in h ib ite d  by 
soya-bean try p s in  in h ib i to r  or p an c re a tic  try p s in  in h ib i to r .
S im ila r e lu a te s  prepared  from Hageman d e f ic ie n t  plasma lacked any 
c lo t t in g  or a rg in in e  e s te ra se  a c t i v i t i e s .
F u rth e r a d d itio n  of Hageman fa c to r  to  normal plasma a c c e le ra te s  
i t s  c lo t t in g  (R atnoff, 1961).
M argolis (1957, 1958 a and b) dem onstrated th a t  w hile normal 
blood possessed a con tac t fa c to r  which on a c tiv a tio n  by g la ss  co n tac t 
a c c e le ra te s  c lo t t in g ,  i t  a lso  t r ig g e r s  a mechanism invo lv ing  pa in  
and p e rm eab ility  f a c to r s .
In  c o n tra s t to  the  usual e f f e c t  of th e  d e fic ien cy  of a blood 
coagu la tion  f a c to r ,  d e fic ien cy  of Hageman fa c to r  does no t give r i s e  
to  a haemorrhagic d ia th e s is  in  p a t ie n ts  su ffe rin g  from th i s  d e fec t 
(Ramot e t  a l ,  1956} and M argolius and R atnoff, 1956), th e  only 
dem onstrable change in  th e se  p a t ie n ts  i s  a l te re d  t i s s u e  p e rm eab ility  
(M argolis, 1959 a and b ) .
The a c tio n  of Hageman fa c to r  may be convenien tly  rep resen ted  
as fo llo w s: -
Hageman fa c to r  
(proenzyme)
Glass su rface ^  A ctive Hageman fa c to r  
(enzyme)
Factor IX A ctive H.F. ^  A ctive P.T.A.
(P .T .A .)
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Measurement of Hageman fa c to r
The a c t iv i t y  of Hageman fa c to r  in  plasma or plasma p rep a ra tio n s  
i s  measured by th e  degree of shorten ing  in  th e  r e c a lc i f ic a t io n  
c lo t t in g  tim e of e i th e r  normal in ta c t  plasma, or of plasma from a 
p a t ie n t  w ith  congen ita l Hageman fa c to r  d efic ien cy , on th e  ad d itio n  
of th e  maximally a c t iv a te d  t e s t  sample. Two such methods are  
d escribed  in  appendix IV, 24, I  and I I .  The second method i s  
n a tu ra l ly  the  id e a l one, but due to  th e  s c a rc i ty  of the  Hageman 
d e f ic ie n t  plasma recourse  was made to  the  f i r s t  method devised by 
R atnoff and Rosenblum (1958). I t  should be noted th a t ,  now, i t  
i s  ap p rec ia ted  th a t  th i s  l a t t e r  method i s  m ainly r e f le c t iv e  of the  
P.T.A . a c t iv i ty  in  th e  t e s t  m a te ria l (R atnoff, 1962), and s l ig h t ly  
in d ic a tiv e  of Hageman fa c to r  a c t iv i ty .
PLASMA THROMBOPLASTIN ANTECEDENT (Factor XI) 
R osenthal, D reskin, and Rosenthal (1953) f i r s t  described  P.T.A. 
as a th i r d  throm boplastic  fa c to r ,  through th e i r  fin d in g  a p a t ie n t  
w ith  haemorrhagic d ia th e s is  whose plasma was found to  co n ta in  a l l  
o th e r known coagu la tion  f a c to r s ,  by c ro s s -c o rre c tio n  experim ents. 
P ro p e rtie s  of P.T.A.
Rosenthal (1955) described  P.T.A. as a ^ - g lo b u l in  occuring in  
Cohn’s f r a c t io n  V II-I  and f ra c t io n  I I I ,  p re c ip ita te d  by 25 -  33
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per cen t s a tu ra t io n  w ith  ammonium su lp h a te , p a r t i a l l y  and 
i r r e g u la r ly  adsorbed by barium su lp h a te , no t re ta in e d  or removed 
by S e itz  f i l t r a t i o n ,  and s ta b le  on s to rage  a t  -20°C. Hyndman e t  
a l  (1961) found i t  to  be p re sen t in  barium su lphate  adsorbed serum 
which has been heated  a t  56°C. fo r  30 m inutes, a procedure which 
e lim in a tes  or in a c tiv a te s  a l l  o the r known coagu la tion  f a c to r s .
Role of P.T.A.
Plasma th rom boplastin  an tecedent i s  req u ired  fo r  th e  form ation 
of th e  co n tac t a c tiv e  product necessary  fo r  th e  proper development 
of th e  a c tiv e  in t r in s i c  th rom boplastin .
I t s  d e fic ien cy  r e s u l t s  in  a d e fe c t c l in ic a l ly  le s s  severe than  
th a t  due to  A.H.G. or Christmas fa c to r  d e f ic ie n c ie s . The only 
o v e rt in d ic a tio n  of th e  d e fec t may be excessive b leed ing  fo llow ing 
to o th  e x tra c tio n . L aboratory t e s t s  are  a lso  le s s  s e r io u s ly  
a f fe c te d , abno rm alities  are  d e tec ted  in  whole blood c lo t t in g  tim e, 
prothrom bin consumption, and in  the  throm boplastin  gen era tio n  t e s t  
when both th e  p a t i e n t ’s adsorbed plasma and serum are  incubated 
to g e th e r . In  a th rom boplastin  g enera tion  m ixture th e  d e fec t in  
P.T.A . d e f ic ie n t  serum i s  poorly  co rrec ted  by Christm as d isease  
serum (Biggs e t  a l ,  1958), though f u l ly  co rrec ted  by normal serum. 
This i s  due to  the  f a c t  th a t  th e  la g  fo r  th e  a c t iv a t io n  of th e  
Christmas fa c to r  in  th e  former case i s  measured a t  th e  same time 
to g e th e r w ith  th e  time necessary  fo r  th e  gen era tio n  of th e  ac tiv e
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th rom boplastin , w hile norm ally th e  d ilu te d  t e s t  se ra  a re  allowed 
to  s tand  fo r  a w hile b efo re  use , during which tim e th e  form ation 
of th e  co n tac t a c tiv e  product has taken  p lace  in  a normal serum 
co n ta in ing  both  Hageman fa c to r  and P.T.A. and a lread y  a c tiv a te d  
th e  Christm as fa c to r  p re se n t. In  o the r words, in  case of 
immediate c o rre c tio n  of P .T .A .-d e f ic ie n t serum w ith  Christmas 
d isea se  serum, we a re  measuring th e  t o t a l  speed of th e  Christmas 
fa c to r  a c t iv a t io n  process to g e th e r  w ith fu r th e r  s tep s  in  a c tiv e  
th rom bop lastin  g en era tio n . But i f  th e  m ixture of the  d e f ic ie n t  
se ra  i s  incubated  fo r  a period  befo re  te s t in g  i t ,  we g e t f u l l  
c o rre c tio n  w ith  th e  normal genera tion  of a c tiv e  th rom boplastin .
R atnoff e t  a l  (1961) and Biggs and M acfarlane (1962) agree 
th a t  a c tiv a te d  P.T.A. a c ts  as a p ro te o ly tic  enzyme which a c tiv a te s  
th e  p recu rso r of fa c to r  IX in to  a c tiv e  fa c to r  IX, expressing  th e  
re a c tio n  as fo llo w s: -
—. _ _ , Contact a c t iv a t io n  product . . .  „ , TVP recu rso r of f a c to r  IX ______________ I----------—----------^ A ctive fa c to r  IX
(A ctive P .T .A .)
Measurement of P.T.A.
Due to  th e  u n a v a i la b l i ty  o f P.T.A. co n g en ita lly  d e f ic ie n t  
plasm a, measurement of th i s  f a c to r  was no t performed on plasmas 
of th e  spec ies  s tu d ie d  in  th i s  in v e s tig a tio n .
G a llic k  e t  a l (i960) devised a t e s t  system to  assay  P.T.A. in
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v i t r o ,  which d id  no t re q u ire  th e  use of P.T.A. d e f ic ie n t  plasma 
or serum, u sing  h ig h ly  p u r if ie d  reag e n ts . However, they  s t i l l  
acknowledged th a t  i t  i s  unknown whether Hageman fa c to r  c o n trib u te s  
any a c t iv i t y  to  t h i s  system which might be m istaken fo r  P.T.A. 
a c t iv i ty .
CHRISTMAS FACTOR (Factor IX)
Christm as fa c to r  was d iscovered  by Biggs e t  a l  (1952) who
observed mutual c o rre c tio n  between blood samples from p a t ie n ts  
p rev io u s ly  thought to  be a l l  haem ophiliacs. The d e fic ien cy  was 
tra c e d  to  a  serum fa c to r  whose absence in  th ese  p a t ie n ts  re s u lte d  
in  th e  haemorrhagic tendency c h a ra c te r is t ic  of the  cond ition , and
in  th e  im paired th rom boplastin  g enera tion  observed when th e i r  se ra
were used in s te a d  of th e  normal serum. These p a t ie n ts  were found 
to  have normal le v e ls  of A.H.G., th e  m issing fa c to r  in  c la s s ic a l  
haem ophilia. The same fin d in g s  were a lso  rep o rted  by Aggeler e t  
a l  (1952a and 1952b) who named th e  m issing fa c to r  th e  "plasma 
th rom boplastin  component".
P ro p e rtie s  of Christm as fa c to r
F acto r IX i s  a p ro te in  p resen t in  Cohn's f ra c t io n s  VII and I I I ,  
which has th e  m o b ility  of a ^ -g lo b u l in  (R osenthal, 1955). I t s  
m olecular w eight i s  rep o rted  to  be 110,000 as estim ated  by i t s
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s e n s i t i v i ty  to  in a c tiv a tio n  by 7 k i lo v o l t  e lec tro n s  (Aronson e t a l ,  
1962). I t  i s  not consumed during coagu lation , and th e re fo re  is  
p re sen t in  normal human serum. I t  i s  adsorbed by barium su lphate , 
alumina, and tr ic a lc iu m  phosphate (Biggs and M acfarlane, 1957).
I t  can be p re c ip ita te d  by 33 -  50 per cent s a tu ra tio n  w ith  ammonium 
su lp h a te , and i s  com pletely re ta in e d  by S e itz  f i l t e r s  (Rosenthal, 
1955). I t  i s  s ta b le  on s to rag e , and r e s i s t s  a c id i ty  of pH 3 (Biggs 
and M acfarlane, 1957). I t  w ithstands hea ting  a t  56°C. fo r  t h i r t y  
minutes (S te fa n in i and Dameshek, 1955). D ecalcify ing  agents 
in a c tiv a te  i t ,  w hile i t s  re a c tio n  w ith  calcium i s  acc e le ra ted  by 
A.H.G-. (B ergsagel, 1955). O’B rien (1958) showed th a t  i t  can be 
in a c tiv a te d  by heparin  and re a c tiv a te d  by to lu id in e  blue or by 
protam ine su lp h a te . Biggs and M acfarlane (1962) doubt O 'B rien ’s 
view, s ince  Biggs e t a l  (1961) were ab le  to  prepare an a c tiv e  
concen tra te  of fa c to r  IX con ta in ing  h eparin .
Role of Christmas fa c to r
The presence of Christmas fa c to r  i s  e s s e n tia l  fo r  th e  e f f ic ie n t  
gen e ra tio n  of a c tiv e  in t r in s ic  th rom boplastin  necessary  fo r  normal 
haem ostasis. I t s  d e fic ien cy  r e s u l t s  in  a haemorrhagic s ta te  very  
s im ila r  to  haem ophilia, though le s s  freq u en t. P a tie n ts  w ith  th i s  
d e fec t show abnorm alities  in  th e  whole blood c lo t t in g  tim e, 
prothrom bin consumption t e s t ,  and throm boplastin  g enera tion  t e s t .  
Normal serum c o rre c ts  a l l  th ese  d e fec ts  when added to  th e i r  blood.
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R atnoff e t  a l (1961) and Biggs and M acfarlane (1962) b e liev e  
th a t  f a c to r  IX i s  p re sen t in  th e  c i rc u la t io n  in  a p recu rso r form 
which i s  a c tiv a te d  by th e  co n tac t a c t iv a t io n  product in to  an ac tiv e  
fa c to r  IX, which to g e th e r w ith  A.H.G. and calcium forms a complex 
th a t  s e ts  in  motion fu r th e r  s tag es  o f in t r in s ic  throm boplastin  
form ation .
P rep a ra tio n  of Christmas fa c to r
F acto r IX can be prepared  e i th e r  from plasma or from serum; 
th e  l a t t e r  i s  p re fe rre d  as th e  p rep a ra tio n  i s  then  f re e  from 
prothrom bin. For use in  th i s  study , fa c to r  IX was prepared  from 
serum by adso rp tion  onto barium su lphate  and e lu tio n  by trisod ium  
c i t r a t e  so lu tio n , as described  in  f u l l  in  appendix I I I ,  12.
Most of the  serum conten t of f a c to rs  VII and X i s  destroyed  by the  
p re lim in ary  s tep  of a c id if ic a t io n  to  pH 2.9  p r io r  to  ad so rp tion . 
Measurement of Christmas fa c to r
Measurement of f a c to r  IX in  serum depends on th e  a b i l i t y  of 
th i s  serum to  c o rre c t the  d e fec t of a co n g en ita lly  fa c to r  IX 
d e f ic ie n t  serum, in  a th rom boplastin  g enera tion  techn ique, as 
compared to  th e  c o rre c tiv e  a b i l i t y  of d i f f e re n t  d ilu tio n s  o f normal 
serum. D e ta ils  of a method based on P itn e y ’s method fo r  A.H.G. 
assay  (1956) a re  d escribed  in  appendix IV, 22.
Haemostatic le v e l of Christmas fa c to r
Biggs (1955) found th a t  th e  minimum le v e l of fa c to r  IX requ ired
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fo r  e f fe c t iv e  haem ostasis to  be 50 per cen t of normal fa c to r  IX 
a c t iv i ty .  Johnson e t  a l  (1957) observed th a t  the  concen tra tion  
of f a c to r  IX in  serum and plasma of many h ea lth y  in d iv id u a ls  was 
o f te n  extrem ely low. Seegers (1962) s ta te s  th a t  in  some h ea lth y  
persons fa c to r  IX co n cen tra tio n  was even lower than  in  p a tie n ts  
diagnosed as having haem ophilia B (Christm as d ise a se ) .
ANTIHAEMOPHILIC GLOBULIN (Factor V III)
The d e fe c t caused by th e  absence of fa c to r  VIII was the  
e a r l i e s t  haemorrhagic cond ition  described  (Hopff, 1828; and 
Bulloch and F ild e s , 1911; c i te d  by Biggs and M acfarlane, 1962).
Yet, i t  was in  1937 th a t  Patek  and Taylor dem onstrated th a t  
haem ophilic blood lacks a fa c to r  p resen t in  normal plasma, which 
th ey  c a lle d  "an tihaem ophilic  g lo b u lin ” . The presence of th i s  
f a c to r  as a s in g le  e n t i ty  was l a t e r  v e r if ie d  by sev era l au thors , 
(Brinkhous, 1947; Quick, 1947; S o u lie r and L arrieu , 1953 a and b; 
Biggs and Douglas, 1953b; Biggs, Douglas, and M acfarlane, 1953 a 
and b; Cramer e t  a l ,  1953; Seegers, 1954; and R o lle r , 1954). 
P ro p e r tie s  of f a c to r  V III
F acto r V III i s  a p ro te in  w ith  th e  m ob ility  of a ^ -g lo b u l in  
(Creveld e t  a l ,  1956), p resen t in  Cohn’s f ra c t io n  I .  The m olecular 
w eight of p u r if ie d  A.H.G. was found by Shulman e t  a l  (i960) to  be
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196,000; a lso  Aronson e t  a l (1962) estim ated  i t  as 180,000 as 
measured by i t s  s e n s i t iv i ty  to  in a c tiv a tio n  by 7 k i lo v o lt  e le c tro n s , 
assuming th a t  th e  s e n s i t i v i ty  of th e  macromolecules bombarded by 
th e  io n iz in g  ra d ia t io n  i s  p rim a rily  a function  of th e i r  m olecular 
w eight. F acto r V III i s  no t adsorbed by inorganic  p re c ip ita n ts  as 
barium su lphate  (Biggs and Douglas, 1953b) and th e re fo re  fa c to r  
V III a c t iv i t y  i s  p resen t in  adsorbed plasma. F acto r V III can be 
p re c ip ita te d  from plasma by 25 per cen t s a tu ra tio n  w ith ammonium 
su lp h a te . I t  i s  p a r t i a l l y  removed by S e itz  f i l t r a t i o n  (Rosenthal,
1955). In  plasma, fa c to r  V III a c t iv i ty  i s  g re a tly  dim inished on 
s to rag e  a t  -4°C. fo r  24 hours (Biggs and M acfarlane, 1962). Spaet 
and Garner (1955) s ta te  th a t  human fa c to r  V III i s  considerably  more 
s to ra g e -s ta b le  in  c i t r a te d  plasma than  in  oxalated  plasma.
F reeze -d ried  p u r if ie d  p rep ara tio n s  were found to  lo se  h a lf  
th e i r  a c t iv i t y  i f  kep t a t  room tem perature fo r two months, while 
in  humid atmosphere h a lf  th e  a c t iv i ty  was lo s t  in  two weeks (Nour- 
E ld in , 1961). This author a lso  dem onstrated th a t  in  sealed  
ampoules th i s  p rep a ra tio n  re ta in e d  i t s  a c t iv i ty  over a period  of 
fou r months a t  room tem perature, and of s ix  months i f  kep t a t  4°C., 
w hile a t  37°C. d e te r io ra t io n  of h a l f  the a c t iv i ty  occured in  5 to  
8 days.
Factor V III is stable at pH 6.2  -  7 (Biggs and Macfarlane, 1957) 
and withstands heating to 49°C. for 5 minutes (Bidwell, 1955).
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S te fa n in i and Dameshek (1955) found i t  was s ta b le  a t  56°C. fo r 
30 m inutes, though th i s  i s  not g en e ra lly  accepted.
P a r t i a l l y  p u r if ie d  fa c to r  V III i s  destroyed by f ib r in o ly s in ,
70 per cen t of th e  a c t iv i ty  d issappears  a f te r  i t s  incubation  fo r  
one minute w ith  0 o8 Loomis u n it  per ml. (Vagner, P a te , and Brinkhous, 
1954). S trong thrombin so lu tio n s  cause complete in a c tiv a tio n  of 
fa c to r  V III w ith in  f iv e  minutes (Penick, 1957; and F a n tl, 1958) j 
th i s  exp lains the  apparent increased  s t a b i l i t y  of fa c to r  V III in  
adsorbed plasma in  which th e re  i s  no in c ip ie n t thrombin form ation, 
th e  mechanism th a t  may w ell be resp o n sib le  fo r  the  sto rage  l a b i l i t y  
o f f a c to r  V III in  plasma.
Role of f a c to r  V III
The presence of fa c to r  V III in  s u f f ic ie n t  amounts i s  necessary  
fo r  normal haem ostasis to  occur through the  development of the  
in t r in s ic  a c tiv e  throm boplastin . The f a c t  th a t  fa c to r  V III i s  
consumed during coagu lation  suggests i t s  behaviour as a su b s tra te  
during  th e  process of in t r in s ic  throm boplastin  form ation, which 
in  f a c t  was dem onstrated by F isch  and Duckert (1959).
T h e r r ia u lt  e t  a l  (1957) working w ith m ixtures of p a r t i a l l y  
p u r if ie d  p recu rso rs  of th e  in t r in s ic  throm boplastin  p resen ted  
evidence th a t  tra c e s  of throm bin a c tiv a te  fa c to r  V III as w ell as 
fa c to r  V. Rapaport e t  a l  (1963) a lso  dem onstrated th a t  minute 
tra c e s  of throm bin (0.1 ml of 0.01 u n its /m l so lu tio n ) markedly
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augmented fa c to r  V III a c t iv i ty  by 5 to  40 tim es, w hile in c reasin g  
fa c to r  V a c t iv i ty  by tw ofolds. They suggest th a t  A.H.G. and 
p ro a c c e le r in  must be ac tiv a ted  by tra c e s  of thrombin before they  
can p a r t ic ip a te  e f fe c t iv e ly  in  the  genera tion  of a c tiv e  in t r in s ic  
th rom bop lastin .
F acto r V III to g e th e r w ith  ac tiv a te d  fa c to r  IX and calcium form 
a calcium  complex which then  in te ra c ts  w ith fa c to r  X and p la te le ts  
or phospholip id  g iving r i s e  to  an ac tiv e  product. This a c tiv e  
product to g e th e r w ith fa c to r  V, in  th e  presence of calcium, forms 
th e  a c tiv e  in t r in s ic  throm boplastin  or prothrombin a c tiv a to r  (Biggs 
and M acfarlane, 1962).
P re p a ra tio n  of fa c to r  V III
Various methods were devised fo r  the  p rep ara tio n  of fa c to r  V III 
from plasma, th e  s im plest p rep ara tio n  su ita b le  fo r  th e  purposes of 
th i s  s tudy  i s  th a t  described  by Biggs and M acfarlane (1957). The 
fa c to r  V III p resen t in  alumina-adsorbed plasma i s  p re c ip ita te d  by 
33 per cen t s a tu ra tio n  w ith ammonium su lphate , d isso lved  in  s a lin e , 
and d ia ly sed  ag a in st c i t r a te - s a l in e  so lu tio n  overn ight. This 
method i s  c i te d  f u l ly  in  appendix I I I ,  11.
More e lab o ra te  methods fo r  th e  p rep ara tio n  of h ig h ly  p u r if ie d  
f a c to r  V III were described  by Kekwick and Wolf (1957) and by 
Blomback e t  a l  (1958).
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Measurement of fa c to r  VIII
S everal d if f e re n t  methods are  av a ilab le  fo r  fa c to r  V III assay, 
m ostly  depending on the  a b i l i t y  of the  t e s t  plasma to  c o rre c t th e  
d e fe c t o f a co n g en ita lly  fa c to r  V III d e f ic ie n t plasma.
Merskey (1950) and S ou lie r and L arrieu  (1953 a and b) used 
plasma re c a lc i f ie d  c lo t t in g  tim es as in d ic a tiv e  of the  degree of 
c o rre c tio n  of the  various mixture prepared in  haemophilic plasma. 
This method, however, seldom gives reproducib le r e s u l t s  due to  the  
g re a t in flu en ce  of g la ss  con tact and p la te le t  concen tra tion  on the  
c lo t t in g  tim e of re c a lc if ie d  plasma. T ests based on changes in  
th e  c lo t t in g  time of whole blood or r e c a lc if ie d  plasma appear to  
be le s s  s p e c if ic  (Brinkhous and Wagner, 1958).
The improvement in  prothrom bin consumption of haemophilic plasma 
on th e  ad d itio n  of d if f e re n t  d ilu tio n s  of t e s t  or normal plasma 
was used as a measure of th e  A.H.G. content by Graham e t a l (1951) 
and by Quick (1951). This method, however, gives normal r e s u lts  
a t  a s tag e  when the  coagulation  mechanism i s  s t i l l  im paired.
So f a r  th e  most accurate  method i s  th a t  described  by Biggs, 
E veling , and Richards (1955) which i s  e s s e n tia l ly  a throm boplastin  
g en era tio n  technique and req u ire s  th e  a v a i la b i l i ty  of p u r if ie d  
reag en ts  and of a s tandard ized  p rep a ra tio n  of bovine fa c to r  V III
ag a in s t which th e  t e s t  plasma i s  compared.
The method used in  th i s  study i s  a lso  based on the  throm boplastin
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g en era tio n  t e s t  of Biggs and Douglas (1953b), measuring th e  a b i l i t y  
of th e  t e s t  adsorbed plasma to  c o rre c t the  d e fec t of adsorbed 
haem ophilic plasma in  a throm boplastin  g enera tion  m ixture con tain ing  
optimum amounts of a l l  o th e r necessary  coagulation  fa c to rs  (P itney ,
1956). I t  i s  described  in  d e ta i l  in  appendix IV, 21.
Haem ostatic le v e l of f a c to r  V III
The le v e l of fa c to r  V III in  normal plasma samples v a rie s  
between 50 and 200 per cen t of th e  average (P itney , Biggs, and 
M acfarlane, 1957). The minimum le v e l req u ired  fo r  e f fe c t iv e  
haem ostasis i s  35 per cen t (Biggs, 1955).
F A C T O R  X 
F acto r X has been d iscussed  in  d e ta i l  e a r l ie r  as regards i t s  
ro le  in  th e  e x tr in s ic  prothrombin a c tiv a tio n  system.
F actor X i s  y e t another fa c to r  necessary  fo r  the  f u l l  a c tiv a tio n  
of th e  in t r in s ic  system. While in  th e  e x tr in s ic  system i t  behaves 
l ik e  a s u b s tra te , in  th e  in t r in s ic  system i t  seems to  a c t as an 
enzyme, being no t consumed, and th e re fo re  p resen t in  serum obtained 
from th e  c lo t t in g  of -whole blood or r e c a lc if ie d  plasma (F isch and 
D uckert, 1959). I t  appears to  be a c tiv a te d  by th e  product formed 
from th e  in te ra c t io n  of fa c to rs  IX, V III, and calcium (Biggs and 
M acfarlane, 1962).
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B L O O D  P L A T E L E T S  
Though the  blood p la te le t s  were recognized e a r ly  in  the  
n in e te e n th  cen tury , th e i r  im p lica tio n  in  the  blood coagulation  
mechanism was f i r s t  suggested some t h i r t y  years l a t e r  by Hayem in  
1878 who be liev ed  th a t  th e  p la te le ts  s e t  f re e  a substance in to  the  
plasma w ithou t which the  l a t t e r  could no t s o l id i fy .  Bizzozero in  
1882 d escribed  p la te le t s  in  thrombi in  th e  m esenteric v esse ls  of 
ra b b its  and G uinea-pigs. Biirker (1904) observed th a t  when blood 
coagu la tio n  was prevented by any means p la te le t  d is in te g ra tio n  was 
a lso  preven ted , and th a t  when coagulation  was allowed to  occur 
p l a t e l e t  d is in te g ra t io n  a lso  took p lace . Bordet and Delange (1912) 
recognized  th a t  p la te le t s  have throm boplastic a c t iv i ty ,  and in  fa c t  
used p la t e l e t  e x tra c ts  which th ey  c a lle d  "cytozyme" as a source of 
th rom bop lastin .
P ro p e r tie s  of blood p la te le ts
Human blood p la te le t s  a re  non-nucleated , co lo u rle ss , round or 
oval c e l l s ,  and about 2 to  3 p. in  s iz e  but o ccasio n a lly  la rg e r  
forms a re  seen. In  s ta in ed  blood film s th ey  appear blue or purp le 
(w ith  Leishm an's s ta in )  w ith  a hy alin e  cytoplasm, th e  hyalomere, 
and some granu les towards th e  cen tre , th e  granulomere.
The normal number of p la te le ts  in  th e  c irc u la t io n  i s  250,000 
to  500,000 per c.mm. whole blood. The li f e - s p a n  of p la te le ts
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v a r ie s  from four to  nine days (M ollison, 1956).
When p la te le ts  come in  con tact w ith a fo re ig n  su rface , damaged 
endothelium , or a w ater-w ettable su rface , they  e x h ib it a s trong  
adhesive p ro p erty  and undergo d is in te g ra tio n  a f te r  passing  through 
a s tag e  of viscous metamorphosis.
Role o f blood p la te le ts
That blood p la te le ts  are e s s e n tia l  fo r  normal blood coagu la tion  
i s  ev iden t from various observations. A s ig n if ic a n t  decrease in  
t h e i r  number r e s u l t s  in  a prolonged bleeding tim e, and in  im paired 
prothrom bin consumption, two fa c ts  th a t  denote d e fec tiv e  haem ostasis. 
This could a lso  be shown by the  ad m in is tra tio n  of h eparin , or by 
th e  use of s ilic o n e d  glassw are, procedures which prevent p la te le t  
d is in te g ra tio n  (Biggs and M acfarlane, 1962). P la te le t  viscous 
metamorphosis i s  a lso  in h ib ite d  by th e  absence of calcium (Sharp, 
1958), and delayed in  cases of P.T.A. defic ien cy  or Hageman fa c to r  
d e fic ie n c y  (Biggs e t a l ,  1958). Otherwise, i t  appears to  be 
la rg e ly  independent of o ther known coagulation  fa c to rs .
Schmid e t a l  (1962) dem onstrated th a t  thrombin in  concen tra tions 
which w il l  no t cause macroscopic conversion of f ib rin o g en , w il l  
cause p la te le t s  to  clump; w hile p la te le ts  from which su rface  
p ro te in s  have been d igested  o ff  w ith try p s in  do no t clunrp in  th e  
presence of thrombin. I t  seems th e re fo re  th a t  an e a r ly  change in  
th e  plasma involv ing  th e  con tact a c t iv a tio n  product of fa c to rs  XI
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and X II, and calcium i s  responsib le  fo r  th e i r  viscous metamorphosis 
and d is in te g ra tio n .
On d is in te g ra tio n , p la te le ts  re le a se  among o ther fa c to rs  a 
th rom bop lastic  m a te r ia l, " p la te le t  fa c to r  3", which p a r t ic ip a te s  
in  th e  form ation of the  ac tiv e  in t r in s ic  throm boplastin . This 
m a te r ia l i s  now known to  be mainly composed of phospholip ids, 
namely phosphatidyl ethanolam ine, phosphatidyl s e r in e , le c i th in ,  
and o th e r le s s  im portant f ra c tio n s  (Biggs and M acfarlane, 1962). 
This p l a t e l e t  fa c to r  3 re a c ts  w ith  th e  ac tiv e  product formed from 
fa c to r s  IX, V III, X, and calcium to  form another ac tiv e  product 
which again  re a c ts  w ith fa c to r  V in  the  presence of calcium giving 
r i s e  to  th e  a c tiv e  in t r in s ic  throm boplastin  or in t r in s ic  
prothrom binas e .
The blood p la te le ts  a lso  con tain  o ther fa c to rs  concerned w ith 
blood coagu la tion , fo r  example p la te le t  fa c to r  1 (resembles fa c to r  
V a c t iv i t y ) ,  p l a t e l e t  fa c to r  2 (a c c e le ra te s  the throm bin-fibrinogen 
r e a c t io n ) ,  p l a t e l e t  f a c to r  4 (an a n ti-h e p a rin ) , a lso  a fib rin o g en - 
- l i k e  substance, a f ib r in  s ta b i l iz in g  fa c to r ,  a co-throraboplastin , 
and an a n t i f ib r in o ly s in .  Of th e se , the  p la te le t  fa c to r  1, the 
f ib r in o g e n - lik e  substance, and th e  a n t i f ib r in o ly s in  are  believed  
to  be adsorbed by th e  p la te le ts  from th e  surrounding plasma, and 
are  no t a c tu a l components of th e  p la te le ts  themselves (H jo rt, 
Rapaport, and Owren, 1955; Salmon e t a l ,  1957; and S te fa n in i and
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Murphy, 1956). The exact id e n t i ty  and ro le  of "the remainder 
c o n s ti tu e n ts  a sc rib ed  "to th e  p la te le t s  i s  as y e t a co n tro v e rs ia l 
su b je c t beyond th e  scope of th i s  work.
Blood p la te le t s  a lso  a f f e c t  c lo t  r e t r a c t io n .  I n ta c t  v ia b le  
p la te l e t s  in  s u f f ic ie n t  number are  necessary  fo r  normal c lo t  
r e t r a c t io n  (Biggs and M acfarlane, 1962). This has been shown to  
depend on th e  in ta c t  g ly c o ly tic  system of the  p la te le t s  involv ing  
adenosine tr ip h o sp h a te  (Bettex-G-alland and Liischer, 1959).
Born and G ilson (1959) have found th a t  p la te le ts  a ss im ila te  
se ro to n in  ( 5-hydroxytryptam ine) from the  plasma through a sp ec ia l 
tr a n s p o r t  system invo lv ing  adenosine tr ip h o sp h a te . This i s  a 
v a so c o n s tr ic to r  substance whose exact ro le  in  haem ostasis i s  s t i l l  
d isp u ted .
The most im portant functions of th e  blood p la te le ts  may 
th e re fo re  be a sc rib ed  to  p la te l e t  aggregation  forming p la te le t  
p lugs (w hite throm bi) which se a l any d is c o n tin u ity  of the  vascu la r 
t r e e ,  r e le a s e  of p la t e l e t  f a c to r  3 allow ing e f f ic ie n t  genera tion  
o f a c tiv e  in t r in s ic  th rom boplastin , and l a s t l y  th e i r  a b i l i t y  to  
cause c lo t  r e t r a c t io n  which i f  occurs in  a p la te le t  plug fu r th e r  
s e a ls  th e  wound, w hile i f  in  an in tra v a sc u la r  or in tra -lu m in a l 
blood c lo t  w il l  he lp  r e p a ir  through re c a n a liz a tio n .
Preparation of platelet suspensions
Platelets are separated from the plasma by high speed
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c e n tr ifu g a tio n , then  washed in  s a lin e  two or th re e  tim es, a.nrl 
f in a l ly  resuspended in  s a lin e  so lu tio n  h a lf  th e  o r ig in a l volume 
of th e  plasm a. Methods fo r  th e  p rep a ra tio n  of th e  various p la te le t  
suspensions from th e  d i f f e r e n t  species a re  described  in  appendix 
I I I ,  15, A, B, and C.
O ccasionally  cepha lin  suspension was used as th e  phospholip id  
fa c to r  in s te a d  of th e  p la t e l e t s ,  as described  by B ell and A lton 
(1954). I t  was prepared  from human b ra in  t i s s u e  as described  in  
appendix I I I ,  14.
P l a t e l e t  counts
Whole blood was d ilu te d  im mediately a f te r  withdrawal in  formol 
c i t r a t e  so lu tio n  in  th e  p rop o rtio n  of 1 in  100 re sp e c tiv e ly , and 
th e  p la te le t s  counted in  a haemocytometer chamber under the  
m icroscope. For th e  nucleated  thrombocytes of the  fowl, to t a l  and 
d i f f e r e n t i a l  w hite blood c e l l s ' counts were made, from which the 
thrombocyte counts were derived . Counts of the  lo b s te r  explosive 
c e l l s  were derived  from to t a l  lo b s te r  blood c e l l s 1 counts performed 
as o rd in ary  t o t a l  w hite blood c o rp u sc le s1 counts, and from the  
d i f f e r e n t i a l  counts of lo b s te r  blood c e l ls  made w ith  th e  a id  of 
phase c o n tra s t  microscopy. Such methods fo r  p la t e l e t ,  thrombocyte, 
o r exp losive  c e l l  counts a re  described  in  d e ta i l  in  appendix IY, 1,
A, B, and C, re sp e c tiv e ly .
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ACTIVE INTRINSIC THROMBOPLASTIN 
( in t r in s ic  prothrom bin a c tiv a to r )
N olf (1908 and 1909b) always m aintained th a t  plasma contains 
a l l  t h a t  i s  n ecessary  fo r  i t s  own coagu la tion . This was confirmed 
by v ario u s w orkers, as d iscussed  e a r l i e r .  However, plasma a lso  
con ta in s  fa c to r  VII which i s  no t req u ired  fo r  th e  in t r in s ic  system, 
as s a t i s f a c to r y  th rom boplastin  g enera tion  was shown to  occur in  i t s  
absence (Hicks, 1955; K o lle r, 1955; and Bergsagel and Hougie, 1956).
N our-Eldin and W ilkinson (1956) were able to  i s o la te  an ac tiv e  
p re p a ra tio n  of plasma throm boplastin  by an e th er p re c ip ita t io n  
techn ique . Spaet and C intron (1959) a lso  prepared p u r if ie d  ac tiv e  
plasma th rom boplastin  by phosphatide sedim entation a t  20,000 r.p .m .
That plasma or in t r in s ic  a c tiv e  throm boplastin  i s  d if fe re n t  
from t i s s u e  or e x tr in s ic  throm boplastin  was shown by Shirakura e t 
a l  (1959) who found th a t  a n t i - s e r a  n e u tra liz e d  th e  a c t iv i ty  of the 
a p p ro p ria te  th rom boplastin  w ith  no c ro ss - re a c tio n . This was also  
confirm ed by Spaet and C in tron  (1960a) who found th a t  th e  
a n t i  th rom boplastin  a c t iv i t y  induced in  ra b b its  by th e  in je c t io n  of 
sedim ented human in t r in s ic  throm boplastin  f a i le d  to  a f f e c t  in t r in s ic  
th rom boplastin  p recu rso rs , and had no a c t iv i ty  on t i s s u e  
th rom bop lastin , e s ta b lish in g  th e i r  an tig en ic  d is s im i la r i ty .
S ince a l l  necessary  fa c to rs  are  p re sen t in  optimum amounts in
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th e  c i rc u la t in g  blood, i t  i s  d i f f i c u l t  to  exp la in  th e  blood f lu i d i ty  
on ly  by th e  e f f e c t  of in h ib i to r s .  Spaet and K ropatkin (1958) 
proposed th e  hypothesis th a t  blood f lu i d i ty  i s  preserved  in  vivo 
la rg e ly  by c e l lu la r  c learance  of c lo t t in g  in te rm ed ia te s . Spaet 
and C in tron  (1960b) p resen ted  evidence th a t  coagu la tion  in term ed ia te  
p roduct I  d issappeared  from th e  blood of in ta c t  ra b b its  more ra p id ly  
th an  could be explained  by th e  ac tio n  of c irc u la t in g  an ticoagu lan ts  
a lo n e .
Species s p e c i f i c i ty  of th e  in t r in s i c  throm boplastin
Nour-Eldin and W ilkinson (1957) observed the  s p e c if ic i ty  of the  
i n t r i n s i c  throm boplastin  in  homologous systems -when using p la te le ts  
as th e  th rom boplastic  agent, and found th i s  s p e c if ic i ty  dependent 
on th e  homologous f a c to r  V. While on using b ra in  phospholipid as 
th e  th rom boplastic  agent, they  found th a t  the  serum then becomes 
th e  determ ining f a c to r .  Spaet and C intron (1960a) found th a t  the 
an tith ro m b o p lastic  a c t iv i t y  induced in  ra b b its  by the  in je c tio n  of 
sedim ented human th rom boplastin  was in h ib ito ry  only in  a human 
th rom boplastin  g enera tion  m ixture, bu t no t e f fe c t iv e  in  a ra b b it  
th rom boplastin  g enera tion  m ixture. Though th i s  r e f le c ts  an 
an tig e n ic  d iffe re n c e  between th e  throm boplastins of d if f e re n t  
sp ec ie s , i t  does no t n e c e ss a r i ly  p reclude th e  p o s s ib i l i ty  of th e i r  
fu n c tio n a l in te r - r e a c t io n  in  a throm boplastin  g enera tion  m ixture.
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A N T I T H R O M B O P L A S T I N  
The presence of an tith ro m b o p lastin  was f i r s t  p o s tu la te d  by 
Coliingwood and MacMahon in  1912. L a te r, Tocantins (1943 a and b; 
1944 a and b ; and 1945) and Tocantins and C a rro ll (1949) gave 
evidence supporting  th e  ex isten ce  of an tith ro m b o p lastin  in  the  
normal blood, and th a t  i t  i s  p resen t in  excess in  haem ophiliacs. 
They have is o la te d  th i s  in h ib ito ry  substance from th e  plasma. 
V arious substances were found to  be in h ib ito ry  in  a throm boplastin  
g en era tio n  m ixture. Robinson and Poole (1956) found th a t  the  
in h ib i to ry  a c t iv i t y  was asso c ia ted  w ith  th e  content of phosphatidyl 
ethanolam ine; w hile Barkhan and S ilv e r  (i960) have shown th a t  
p u r if ie d  phosphatidyl se rin e  from normal human p la te le ts  had an 
an tith ro m b o p las tin  a c t iv i t y  in  the  throm boplastin  genera tion  t e s t  
and in h ib ite d  th e  throm boplastic a c t iv i ty  of suspensions of both 
p la t e l e t s  and phosphatidyl ethanolam ine.
Niewiarowski e t  a l  (1959) m ain tain  th a t  h ea tin g  the  plasma to  
60°C. fo r  20 minutes destroys the  an tithrom bin a c t iv i ty  while 
leav in g  th e  an tith ro m b o p lastin  a c t iv i ty  unim paired.
A r t i f i c i a l  an tith ro m b o p lastin  a c t iv i t y  has been induced in  
ra b b its  by th e  in je c t io n  of sedimented human throm boplastin  (Spaet 
and C in tron , 1960a). S h irakura  e t a l  (1959) induced d if f e re n t  
an tith ro m b o p las tin  a c t iv i t i e s  by th e  in tram uscu lar in je c tio n  of
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t i s s u e  or plasma throm boplastins prepared by e th e r p re c ip i ta t io n ,  
and observed th a t  th e  an tith rom bop lastin  a c t iv i t i e s  a re  spec ies 
s p e c if ic  w ith  no c ro s s - re a c tio n  between t is s u e  and plasma 
an tith ro m b o p las tin s , or between human and ra b b it  reag en ts .
Biggs and M acfarlane (1962) regard  an tith rom bop lastin  as a 
"h y p o th e tica l substance u n t i l  fu r th e r  inform ation  i s  a v a ila b le '1. 
T heir method fo r  th e  dem onstration of th e  presence of in h ib ito r s  
of human in t r in s ic  th rom boplastin  in  plasma or serum samples in  
a  th rom boplastin  gen era tio n  m ixture was u t i l i s e d  in  th i s  study as 
d escrib ed  in  appendix IV, 23.
H E P A R I N
H eparin, a su lp h a te -co n ta in in g  mucopolysaccharide, i s  an 
an tico ag u lan t fre q u e n tly  used as a th e ra p e u tic  agent in  throrabo- 
-em bolic d ise a se . I t  i s  no t n a tu ra lly  p resen t in  th e  c irc u la t io n  
in  m easurable amounts (Biggs and M acfarlane, 1962).
I t s  a c tio n  i s  dependent on a f ra c t io n  of plasma p ro te in s  
p re c ip i ta te d  between one th i r d  and one h a lf  s a tu ra t io n  w ith  
ammonium su lp h a te , which i s  now known to  be id e n tic a l  to  an tith rom bin  
I I ,  th e  heparin  c o -fa c to r  (B urste in  and Loeb, 1956). Howell and 
H olt (1918) considered heparin  as an in h ib i to r  of thrombin form ation. 
Mellanby (1935) and Quick (1938b) showed th a t  heparin  i s  m ainly an
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in h ib i to r  of th e  th rom bin -fib rinogen  re a c tio n  of th e  plasma. 
Brinkhous e t  a l (1939) found th a t  heparin  in  combination w ith  the 
c o -fa c to r  in  plasma impedes prothrom bin conversion in to  throm bin.
The process by which heparin  delays th e  throm bin-fibrinogen 
re a c tio n  i s  rev ersed  by to lu id in e  blue (L y ttle to n , 1950, c i te d  by 
Biggs and M acfarlane, 1962), or by hexadim ethrine bromide (Douglas, 
1962).
H eparin a lso  promotes the  adso rp tion  of thrombin by f ib r in  
(Biggs and M acfarlane, 1962). B iggs, Douglas, and Macfarlane 
(1953b) dem onstrated th a t  heparin  p reven ts the form ation of the  
in t r i n s i c  th rom bop lastin . Solandt and Best (1940) observed th a t  
h ep a rin  s ta b i l iz e s  th e  blood p la te le t s  and in h ib i ts  th e i r  
a g g lu tin a tio n  when adm inistered  in  doses g re a t ly  in  excess of 
those  needed to  p reven t blood coagu la tion . Murphy e t  a l (1961) 
found th a t  h ep arin  in  la rg e  doses depresses or suppresses p la te le t  
d ep o s itio n , no tin g  th a t  heparin  c a r r ie s  a negative charge.
H eparin was found to  be adsorbed by alumina (MacMillan and 
Brown, 1954; and Douglas, 1957) and th e re fo re  absent in  the  
su p ern a tan t adsorbed plasma used in  th e  throm boplastin  genera tion  
t e s t .
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V I T A M I N  K 
Dam in  1929 (quoted from Seegers, 1962) noted a haemorrhagic 
co n d itio n  in  chicks fed  on a sy n th e tic  d ie t  w hile studying 
c h o le s te ro l m etabolism, and from l a t e r  experiments concluded th a t  
some u n - id e n t if ie d  substance was m issing from th e  d ie t ,  which he 
c a l le d  "K oagulation v itam in".
Halbrook in  1935 (c ite d  by Biggs and M acfarlane, 1962) showed 
th a t  5 p e r cen t a l f a l f a  added to  th e  d ie t  prevented th e  haemorrhages. 
In  1936, Dam e t a l .  e s ta b lish e d  the  r e la t io n  between v itam in K and 
prothrom bin fo rm ation . This was confirmed by Quick (1937) who 
found th a t  th e  prothrom bin concen tra tio n  f a l l s  ra p id ly  in  chicks 
g iven v itam in  K d e f ic ie n t  d ie t ,  and th a t  b leeding  occurs when the 
prothrom bin co n cen tra tio n  drops to  10 per cen t, w hile i t  stops on 
adm in is te rin g  a l f a l f a .  Smith e t a l  (1938) rep o rted  th a t  prothrombin 
sy n th es is  was stopped through m alabsorption of v itam in K in  cases 
w ith  b i l i a r y  f i s tu l a e  or o b s tru c tiv e  jaund ice , due to  th e  lack  of 
th e  b i l e  ac id s  necessary  fo r  v itam in  K absorp tion  from th e  gu t.
Douglas (1958) suggested th a t  v itam in  K p lays a lso  a p a r t  in  
th e  sy n th es is  of f a c to r  VII and p o ss ib ly  fa c to r  IX.
S ince th i s  work dea ls  w ith h ea lth y  animals of d if f e r e n t  sp ec ie s , 
i t  i s  assumed th a t  th e y  d id  no t su f fe r  any d e fic ien cy  of v itam in  K.
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C L O T  R E T R A C T I O N  
C lo t r e t r a c t io n  i s  th e  phenomenon of co n tra c tio n  of c lo tte d  
b lood. I t s  ro le  in  haem ostasis i s  no t y e t c le a r ,  and sev era l 
fu n c tio n s  have been asc rib ed  to  i t  none of which are  convincing.
Barkhan and S ilv e r  (1962) have drawn a t te n tio n  to  the  f a c t  
th a t  s in ce  r e t r a c t io n  i s  m ainly a fu n c tio n  of v ia b le  p la te le t s ,  
i t  may w ell be th a t  c o n tra c tio n  of in tra v a sc u la r  p la t e l e t  thrombi 
i s  th e  b io lo g ic a l ly  im portant fu n c tio n  in  haem ostasis, w hile the  
r e t r a c t io n  of th e  f ib r in  web may be a secondary and perhaps an 
in c id e n ta l  phenomenon.
S everal f a c to r s ,  p hysica l and b io lo g ic a l ,  a f f e c t  the  degree 
of c lo t  r e t r a c t io n .  Apart from the  shape and na tu re  of the 
su rface  of th e  v e sse l con ta in ing  th e  c lo t ,  th e  most im portant 
determ inant fa c to rs  a re  th e  p la t e l e t  number and th e  fib rinogen  
co n cen tra tio n . Budtz-Olsen (1951) has shown th a t  c lo t  r e tr a c t io n  
v a r ie s  d i r e c t ly  w ith th e  p l a te l e t  count, and in v e rse ly  to  the  
fib rin o g en  co n cen tra tio n . The p la te le t s  should be in  a v iab le  
co n d itio n , and more th an  100,000 per c.mm,, o therw ise r e t r a c t io n  
i s  p ro p o rtio n a te ly  d e f ic ie n t  (M acfarlane, 1938). The optimum 
co n cen tra tio n  of f ib rin o g en  i s  100 mg per 100 mis of plasma; 
h igher f ib rin o g en  con ten t causes decreased values of r e t r a c t io n .  
The packed c e l l  volume a lso  a f fe c ts  c lo t  r e t r a c t io n  in v e rse ly .
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M acfarlane (1939) has shown th a t  plasma c lo ts  con ta in ing  no red  
c e l l s  w il l  sh rin k  u n t i l  they  are  only about 10 per cent th e i r  
o r ig in a l  volume. U n fo rtunate ly , th e re  i s  no simple method fo r  
c o rre c tin g  such r e t r a c t io n  values fo r  th e  v a r ia t io n  in  th e  packed 
c e l l  volume (Biggs and M acfarlane, 1962).
The optimum pH of plasma fo r  c lo t  r e t r a c t io n  ranges between 
6 and 8 .2  (E l l ic o t  and Conley, 1951, c i te d  by Biggs and M acfarlane, 
1962).
Measurement o f c lo t  r e t r a c t io n
M acfarlane (1938) estim ated  th e  degree of c lo t  r e tr a c t io n  in  
term s o f th e  amount of serum squeezed from the  c lo t  in  one hour, 
expressed as a percentage of th e  t o t a l  c lo t  volume. This i s  done 
sim ply by c a re fu l ly  removing th e  con trac ted  c lo t  from a graduated 
c e n tr ifu g e  tube , d ra in in g  i t  com pletely, and reading  th e  volume 
of expressed serum and red  c e l ls  from th e  sca le  on th e  tube , then 
c a lc u la tin g  th e  percentage value . This method was used in  th i s  
study , as m odified by Aggeler e t a l (1942) who used a wire s p ira l  
around which th e  c lo t  i s  allowed to  co n tra c t in s te a d  of the  
o r ig in a l ly  devised g la ss  rod w ith p ro je c tio n s . A d e ta ile d  
d e s c r ip t io n  of th i s  method i s  p resen ted  in  appendix IV, 4.
Normal values obta ined  w ith  th i s  method are  from 48 to  64 per 
cen t serum expressed in  one hour (Biggs and M acfarlane, 1962).
CONTROL HUMAN BLOOD SAMPLES
In  a l l  the  fo llow ing in v e s tig a tio n s  t e s t  blood samples from 
th e  v a rio u s  animal spec ies  were compared to  human blood samples. 
For q u a l i ta t iv e  t e s t s ,  pooled t e s t  plasma or serum samples were 
compared w ith  human plasma or serum samples pooled from a t  le a s t  
th re e  in d iv id u a ls . For q u a n t ita t iv e  t e s t s ,  the t e s t  plasma or 
serum samples were compared to  plasma or serum obtained  from th e  
same in d iv id u a l -  th e  author -  which were a r b i t r a r i l y  designated  
th e  value of 100 per cen t to  allow  v a lid  comparison between the  
v arious spec ies  on a uniform  b a s is .
I t  should be mentioned th a t  though th i s  comparison gives a 
f a i r  id e a  about th e  v a r ia tio n s  p re sen t in  the  d if f e re n t  species 
examined, th e  r e s u l t s  obtained cannot be compared w ith  those 
p rev io u s ly  rep o rted  by o the r workers except in  a genera l way, due 
to  th e  d if f e r e n t  co n tro l samples used. However, in  order to  
compare such r e s u l t s  s l ig h t ly  more c r i t i c a l l y ,  the  le v e l of th e  
blood coagu la tion  fa c to rs  in  th e  co n tro l plasma and serum used in  
th i s  work has been assayed ag a in s t s a m p le s  pooled from te n  normal 
human in d iv id u a ls . The r e s u l t s  a re  ta b u la te d  in  appendix V, pages 
97 and 98. From th ese  r e s u l t s  th e  t r u e r  le v e ls  of th e  coagu lation  
fa c to r s  in  t e s t  samples can perhaps be c a lc u la te d . S t i l l ,  due to  
th e  wide range in  le v e ls  of normal samples as regards coagulation
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f a c to r s ,  a lso  th e  b io lo g ic a l methods of assay  used by th e i r  very  
n a tu re  having a ra th e r  wide la t i tu d e  of accuracy, one can only 
r e ly  on gross v a r ia tio n s  as s ig n if ic a n t .  No attem pt th e re fo re  
has been made to  c o rre c t th e  f in a l  r e s u l t s  as to  th e  v a r ia t io n  in  
th e  c o n tro l sample i t s e l f .
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P A R T  I I
FOWL BLOOD COAGULATION MECHANISM
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FOWL BLOOD COAGULATION MECHANISM 
The fo llow ing  in v e s tig a tio n s  were made on blood samples ob ta ined  
from young a d u lt domestic fowl of th e  L ight Sussex s t r a in ,  which 
were k ep t in  pens and fed  on o rd inary  p e l le t  d ie t .
A ll th e  animals were h ea lth y , none su ffe red  from any bleeding  
nor showed undue haematomata form ation a f te r  v en ipunctu res .
The fin d in g s  s h a l l  be p resen ted  in  th e  same order as was used 
in  review ing th e  human blood coagu la tion  system s.
F I B R I N O G r E N  
F ibrinogen  in  chicken plasma was estim ated  by th e  m icro-K jeldahl 
method (appendix IV, 2, I ) .  The average of fou r experim ents on 
pooled samples was 264.2 mg fib rin o g en  per 100 mis plasma, w ith  a 
range from 246 mg to  298.5 mg per 100 mis plasma (Table 1 ). This
i s  eq u iv a len t to  low normal human v a lu es, and i s  reasonably  
s u f f ic ie n t  to  e f f e c t  normal haem ostasis.
E stim ations of chicken fib rin o g en  using  S t i r l a n d ’s tu rb id im e tr ic  
method (1956) y ie ld ed  very  low f ig u re s , and in  one in s tan ce  
(Experiment 3, Table 2) gave th e  value of 25 mg as compared w ith 
172 mg when estim ated  by th e  m icro-K jeldahl method. I t  seems 
th e re fo re  th a t  chicken fib rin o g en  i s  d if f e r e n t  from th e  human
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f ib rin o g e n  in  a t  l e a s t  i t s  p r e c ip i ta t io n  c h a ra c te r i s t ic s .  A strup 
and D arling  (1942c) dem onstrated th a t  chicken fib rin o g en  i s  
o p tim ally  p re c ip i ta te d  from plasma by 35 -  40 per cent s a tu ra tio n  
w ith  ammonium su lp h a te , a co n cen tra tio n  th a t  i s  h igher than  th a t  
re q u ire d  to  p r e c ip i ta te  human fib rin o g en , suggesting  a chemical 
d if fe re n c e  between chicken and human fib rin o g en s.
Hektoen and Welker (1927) and Kyes and P o rte r  (1931) found 
th a t  mammalian f ib rin o g en  i s  a lso  a n tig e n ic a lly  d if f e r e n t  from 
b irds*  f ib rin o g en .
C onclusions
The fib rin o g en  concen tra tio n  in  chicken plasma i s  about 264 mg 
p e r 100 mis, which compares w ith  a low normal human fib rinogen  
c o n ce n tra tio n . I t  i s  s u f f ic ie n t  fo r  e f fe c tiv e  haem ostasis.
I t  seems to  be chem ically  d if f e re n t  from human fib rin o g en .
THROMBIN-FIBRINOGEN REACTION OF CHICKEN PLASMA
When chicken c i t r a te d  plasma was c lo tte d  w ith various 
co n cen tra tio n s  of bovine throm bin (Parke Davis and Company) i t  was 
observed to  take a much longer time than  th e  co n tro l human plasma. 
The d iffe re n c e  was m aintained w ith a l l  the  thrombin concen tra tions. 
C oncentrations of 25 throm bin u n its  per ml or lower d id  not c lo t 
chicken plasma in  th re e  m inutes, w hile human plasma was c lo tte d  in
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s ix  seconds (Table 3, and F igure 3 ).
The a d d itio n  of an a liq u o t of M /40  calcium ch lo rid e  so lu tio n  
to  th e  chicken plasma shortened  i t s  throm bin c lo t t in g  tim es 
ap p rec iab ly  (F igure 3, curve b ^  though the  l a t t e r  were s t i l l  
longer th an  th e  human plasma c lo t t in g  tim es.
T olu id ine b lu e , a h eparin  n e u tra l iz e r ,  d id  no t have any 
sho rten in g  e f f e c t ,  in  f a c t  i t  s l ig h t ly  prolonged th e  c lo t t in g  tim es, 
as seen from curve b as compared to  curve b in  F igure 3.
c*  X
Pyrocatechol to g e th e r  w ith calcium  ch lo rid e  had th e  maximum 
e f f e c t  in  shorten ing  th e  thrombin c lo t t in g  tim es of chicken plasma 
(F igure 3, curve b^) and was more obvious w ith  th e  stro n g er thrombin 
co n ce n tra tio n s , though on th e  whole th e  c lo t t in g  tim es were s t i l l  
longer th an  tho se  of s im ila r ly  tr e a te d  human co n tro l plasma.
S ince th e  normal body tem perature of chicken i s  41°C ., the  t e s t  
was a lso  c a rr ie d  out a t  th i s  tem perature in s te a d  of the  usual 37°G.; 
th e  r e s u l t  was id e n t ic a l  in  th e  two cases (Table 3 ).
D iscussion
The f a c t  th a t  chicken plasma thrombin c lo tt in g  time i s  longer 
th an  th a t  o f th e  human plasma was shown as e a r ly  as 1942 by Seegers 
and Smith who found th a t  1 ml of human oxalated  plasma requ ired  
2 u n i ts  of throm bin to  c lo t  in  15 seconds a t  28°C., while chicken 
plasma req u ired  more than  10 u n its  to  c lo t  in  the  same tim e . They 
b e liev ed  th i s  to  be due to  an in h ib ito ry  re a c tio n  ra th e r  than to
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th e  sp ec ies  s p e c i f i c i ty  of fib rin o g en . B u rste in  (1950) s im ila r ly  
found th a t  human throm bin c lo ts  human plasma in  4 -  7 seconds, w hile 
i t  c lo ts  chicken plasma in  50 -  90 seconds, a t  20°C. Hawkey (i960) 
a lso  observed th e  same phenomenon, and she showed th a t  th e  a d d itio n  
of calcium  ch lo rid e  to  chicken plasma shortens i t s  throm bin c lo t t in g  
tim e. W arte lle  (1957a), however, has p resen ted  evidence th a t  the  
le v e l of io n ise d  calcium  in  a d u lt chicken serum i s  equal to  th a t  in  
man, th u s  ru lin g  out th e  p o s s ib i l i ty  th a t  calcium d e fic ien cy  may 
be th e  re sp o n sib le  f a c to r .
F an tl and Ebbels (1953) suggest th a t  th i s  delay  may be due to  
th e  sp e c ia l co n fig u ra tio n  of th e  n a tiv e  fib rin o g en , which can be 
a l te r e d  by chemical trea tm en t w ith  phenolic substances such as 
py rocatecho l, or by p u r if ic a t io n  of the  fib rinogen  by s a l t in g  out 
methods. L a te r in  1954, F an tl showed th a t  phenols depress a n t i­
throm bin a c t iv i t y  in  serum or plasma, th a t  pyrocatechol had g re a te r  
an tith rom bin  depressing  a c t iv i t y  than  gum acac ia , and th a t  i t  d id  
no t in te r f e r e  w ith c lo t t in g  re a c tio n s  i f  used in  concen tra tions 
between 0.03 and 0.04 m o larity . Though th i s  mode of ac tio n  of 
pyrocatecho l seems very  a t t r a c t iv e ,  y e t i t  does no t hold in  some 
o th e r experim ental co n d itio n s . For example, chicken plasma 
an tith rom bin  a c t iv i t y  was found to  be n ea rly  the  same as th e  human 
as w il l  be shown l a t e r ,  y e t th e  e f f e c t  of pyrocatechol on chicken 
plasma was s ig n if ic a n t ly  s tro n g er than  on human plasma. Secondly,
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in  a system of p u r if ie d  reagen ts f re e  from antithrom bin , pyrocatechol 
s t i l l  shortened th e  fib rin o g en  c lo t t in g  tim es when d if f e re n t  thrombin 
so lu tio n s  were used (Table 7 ) . I t  seems more probable th e re fo re  
th a t  pyrocatecho l a c ts  d i r e c t ly  on the  fib rin o g en .
The d e lay  in  chicken plasma thrombin c lo t t in g  time i s  no t due 
to  excess h eparin  in  chicken plasma, since  th e  ad d itio n  of to lu id in e  
b lue  so lu tio n  to  th e  plasma p r io r  to  the  thrombin so lu tio n  d id  not 
a l t e r  th e  c lo t t in g  tim es.
Species s p e c i f i c i ty  of chicken throm bin-fibrinogen  re a c tio n
Chicken th rom bin-fib rinogen  re a c tio n  was in v e s tig a te d  in  a 
p u r if ie d  system using  fib rin o g en  and thrombin reagen ts prepared 
f re e  from an tith rom bin  as described  in  appendix I I I ,  6, A, and 
appendix I I I ,  7, A and B, re sp e c tiv e ly . In  th i s  system, 0 .4  ml 
amounts of chicken or human fib rin o g en  so lu tio n s  were c lo tte d  with 
0 .1  ml amounts of human, chicken, or bovine thrombin so lu tio n s .
All throm bins were found to  c lo t  the human fib rin o g en  in  about the  
same tim e, w hile they  c lo tte d  th e  p u r if ie d  chicken fib rinogen  in  
much longer tim es (Table 7 ) . A ll thrombins had n e a rly  th e  same 
a c t iv i t y ,  except th a t  chicken thrombin was s l ig h t ly  weaker in  
c lo t t in g  human fib rin o g en , p o ss ib ly  because of th e  lower chicken 
plasma prothrom bin con ten t, as s h a ll  be d iscussed  l a t e r ,  thus 
g iv ing  a lower y ie ld  of throm bin. The ad d itio n  o f 0 .1  ml of a 
1 p er cen t so lu tio n  of pyrocatechol to  th e  chicken fib rin o g en
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n e a r ly  halved i t s  c lo t t in g  time w ith  th e  th re e  throm bin so lu tio n s  
used . Again, the  a c t i v i t i e s  of a l l  th e  thrombins were s im ila r  on 
chicken fib rin o g en  whose c lo t t in g  time was s t i l l  longer than  th a t  
of th e  human p re p a ra tio n . These fin d in g s  suggest th a t  th e  delay  
in  chicken fib rin o g en  c lo t t in g  time i s  an in h e re n t c h a ra c te r is t ic  
of th e  fib rin o g en  i t s e l f ,  which can be a f fe c te d  favourably  by the  
ad d itio n  o f pyrocatecho l so lu tio n . No species s p e c if ic i ty  was 
observed, s in ce  both  fib rin o g en s were approxim ately equally  a ffe c te d  
by th e  th re e  throm bin so lu tio n s . I t  should be mentioned th a t  these  
throm bin so lu tio n s  were prepared  from equal volumes of the  re sp ec tiv e  
plasmas which, however, d i f f e r  in  th e i r  o r ig in a l content of 
prothrom bin. The f in a l  thrombin y ie ld  in  terms of u n its  per ml of 
so lu tio n  i s  th e re fo re  no t id e n t ic a l  by any means in  th e  th ree  
p re p a ra tio n s . The only  v a l id  comparison i s  th a t  between the  e f fe c t  
o f one throm bin so lu tio n  on th e  d i f f e re n t  fib rin o g en s which 
dem onstrates s ig n if ic a n t ly  the  delay  in  chicken fib rin o g en  c lo tt in g  
tim e.
Since chicken throm bin c lo t te d  human fib rin o g en  in  8 seconds, 
i t  can be assumed to  con ta in  th e  equ iva len t of 22 thrombin u n its  
p e r ml, as read  from th e  th rom bin-fib rinogen  d i lu t io n  curve (F igure 1, 
page 55 in  volume 2 ); w hile th e  human thrombin contained about 
58 u n i ts  per ml. This agrees w ith  th e  find ing  th a t  chicken plasma 
prothrom bin i s  about 13 -  24 per cent of human plasma prothrom bin.
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These fin d in g s  d isag ree  w ith  those  of Didisheim e t  a l  (1959) 
who found chicken fib rin o g en  to  be c lo tte d  only w ith  chicken 
throm bin, though th ey  agree th a t  chicken thrombin c lo ts  a l l  o ther 
f ib r in o g e n s . Warner e t  a l  (1939a) a lso  have found th a t  chicken 
throm bin was a c tiv e  on mammalian fib rin o g en .
Conclusions
There i s  a  long de lay  in  th e  throm bin-fibrinogen re a c tio n  of 
chicken plasm a, as compared to  th e  human, which can be shortened 
by th e  a d d itio n  of calcium  ch lo rid e  and pyrocatechol so lu tio n s .
The d e lay  i s  a lso  m anifest w ith p u r if ie d  thrombin and fib rin o g en  
p re p a ra tio n s . This phenomenon i s  most probably due to  an inhe ren t 
c h a r a c te r i s t ic  of chicken fib rin o g en .
Chicken throm bin i s  a c tiv e  on human fib rin o g en . Chicken 
f ib rin o g en  i s  c lo t ta b le  by human, chicken, and bovine thrombins 
eq u a lly  w e ll, and i s  th e re fo re  no t species s p e c if ic .
CHICKEN PLASMA. ANTITHROMBIN ACTIVITY
A ntithrom bin was measured in  chicken plasma by th e  m odified 
method of A strup and D arling  (I942d) as described  in  appendix IV,
11, B. This method measures both plasma antithrom bin  I  and 
an tith rom bin  I I I  a c t i v i t i e s .  The r e s u l t s  a re  p resen ted  in  Tables 
4 , 5, and 6, and F igure 4. The average of th e  th re e  experiments
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shows th a t  chicken plasma has an a n t i  thrombin a c t iv i t y  about equal 
to  th a t  of th e  human co n tro l plasma, w ith  a range of 90 -  116 per 
cen t o f th e  human plasma an tith rom bin  a c t iv i ty .
No measurement of an tith rom bin  a c t iv i t y  in  chicken plasma 
could be found in  th e  l i t e r a t u r e .
Chicken plasma when added to  human plasma was found to  prolong 
th e  la t t e r * s  throm bin c lo t t in g  tim e from 4 seconds to  37 seconds 
(Table 8 ) . H eating th e  chicken plasma a t  56°C. fo r  15 minutes 
p r io r  to  i t s  a d d itio n  to  th e  human plasma prolonged th e  la t te r * s  
c lo t t in g  tim e only  to  19 seconds. Such h ea tin g  p re c ip ita te s  most 
of th e  plasma*s fib rin o g en  con ten t, and probably destroys a l l  the 
an tith rom bin  a c t iv i ty  p re se n t. Since the  chicken plasma antithrom bin 
a c t iv i t y  i s  s im ila r  to  th a t  o f th e  human plasma, such an in h ib ito ry  
e f f e c t  i s  probably  due to  the  chicken fib rin o g en  or f ib r in .
B u rs te in  and Guinand (1956) dem onstrated th i s  e f fe c t  using  p u r if ie d  
chicken fib rin o g en , an e f f e c t  which was com pletely n u l l i f ie d  on 
h ea tin g  th e  fib rin o g en  so lu tio n  p r io r  to  i t s  ad d itio n . They 
concluded th a t  chicken plasma owed th i s  in h ib ito ry  e f fe c t  to  i t s  
f ib rin o g en  con ten t.
Conclusion
Chicken plasma an tith rom bin  a c t iv i ty  as measured by th e  modified 
method of Astrup and D arling  (I942d) i s  about equal to  th a t  of human 
plasm a. Chicken an tith rom bin  cannot th e re fo re  be blamed fo r the
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delayed th rom bin -fib rinogen  re a c tio n  observed in  chicken plasm a.
FOWL EXTRINSIC THROMBOPLASTIN SYSTEM
The e x tr in s ic  throm boplastin  system of prothrom bin a c t iv a t io n  
i s  b e s t exem plified  by Quick’s one-stage prothrom bin time t e s t  
which r e f l e c t s  th e  combined e f fe c ts  o f a l l  fa c to rs  concerned, namely 
f a c to rs  V, V II, X, t i s s u e  throm boplastin , prothrom bin, fib rin o g en , 
and calcium .
Using th i s  t e s t ,  chicken b ra in  throm boplastin  was found to  
cause c lo t t in g  of chicken c i t r a te d  plasma in  the  presence of calcium 
ch lo rid e  in  14 seconds, th e  same time as req u ired  fo r  normal human 
plasma to  c lo t  on th e  ad d itio n  of human b ra in  throm boplastin  and 
calcium  c h lo rid e . This means th a t  chicken plasma contains a l l  the  
necessary  fa c to rs  involved in  th i s  re a c tio n  in  a concen tra tion  th a t  
i s  s u f f ic ie n t  to  m ain tain  e f fe c t iv e  haem ostasis, i f  i t  i s  assumed 
th a t  chicken plasma c lo ts  in  the  same manner as human plasma.
But chicken b ra in  throm boplastin  had very  weak a c t iv i ty  on human 
plasm a, a lso  human b ra in  th rom boplastin  was h ard ly  a c tiv e  on chicken 
plasm a. Various combinations of plasmas were te s te d  by both types 
o f t i s s u e  th rom boplastin  as p resen ted  in  Table 9 from which i t  can 
be seen th a t  th e  m ixture of human and chicken plasma was c lo tte d  
in  a longer tim e than  when each plasma was equally  mixed w ith  s a lin e ,
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and c lo tte d  w ith  th e  homologous b ra in  p rep a ra tio n . In  o th e r words, 
each plasma was s l ig h t ly  in h ib ito ry  on th e  o the r homologous system, 
and th i s  i s  b e lieved  to  be due to  th e  added e f fe c t  of d i lu t io n , 
s in ce  th e  hetero logous plasma co n trib u te s  t o t a l l y  in a c tiv e  f a c to r s ,  
to g e th e r  w ith th a t  of an tithrom bin  supplied  by the  heterologous 
plasma which i s  p o te n t ia l ly  a c tiv e  ag a in s t the  thrombin produced.
The l a t t e r ' s  e f f e c t  i s  s l ig h t  because throm bin p roduction  a t  a 
c e r ta in  s tag e  a t ta in s  such a high co n cen tra tio n  as to  momentarily 
overpower th e  an tith rom bin  p re sen t, and produce c lo t t in g  of the  
f ib rin o g en .
D iscussion
The species  s p e c i f ic i ty  of th e  re a c tio n  between t is s u e  
th rom boplastin  and plasma has been observed as e a r ly  as 1902 by 
Fuld who found th a t  b ird  muscle e x tra c t d id  not c lo t  horse blood. 
Loeb (1904c) a lso  s tre s s e d  the  s p e c if ic i ty  of mammalian and avian 
muscle e x tra c ts  when ac tin g  on blood from these  two c la sse s  of 
an im als. This was l a t e r  confirmed w ith o the r types of t i s s u e  
e x tra c ts  (embryo, b ra in , and lung) by sev era l au thors (Mendeleef, 
1934; Quick, 1935; Trevan and M acfarlane, 1936; Dam and Glavind, 
1938; Warner e t  a l ,  1939a; Copley, 1942; W arte lle , 1957 a and b; 
Didisheim  e t  a l ,  1959; and Hawkey, 1960).
Quick (1941) suggested th a t  th e re  i s  no abso lu te  species 
s p e c i f i c i ty  though a considerab le  r e la t iv e  s p e c if ic i ty  i s  found
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and i s  g re a te s t  between substances from chicken and mammalian 
b loods, on the  assumption th a t  h igher concen tra tions of the  fa c to rs  
involved  could b ring  about c lo t t in g  of th e  hetero logous blood in  a 
r e la t iv e ly  sh o rte r  tim e.
Mann and Hurn (1952) have dem onstrated th a t  th e  species 
s p e c i f i c i ty  can la rg e ly  be e lim inated  by th e  b r ie f  trea tm en t of the  
t i s s u e  th rom boplastin  w ith  the  d ilu te d  homologous serum, suggesting  
a co-th rom boplastic  re a c tio n  to  occur. The serum fa c to rs  
re sp o n s ib le  fo r  such a re a c tio n  are  now known to  be fa c to rs  VII and 
X. Thus th e re  i s  no doubt th a t  t i s s u e  throm boplastins are  
p o te n t ia l ly  most a c tiv e  on the  homologous plasma, bu t as y e t i t  i s  
no t e s ta b lish e d  which fa c to r  i s  m ostly  resp o n sib le  fo r  th i s  
phenomenon. An attem pt i s  made in  th e  follow ing sec tio n  to  
in v e s t ig a te  th i s  f u r th e r .
Conclusions
Chicken and human t i s s u e  throm boplastins a re  only  a c tiv e  on 
chicken and human plasmas re sp e c tiv e ly , in  one—stage  t e s t s ,  while 
th e y  a re  very  weak in  heterologous system s. T issue throm boplastin  
has a marked degree of spec ies  s p e c i f ic i ty  towards th e  homologous 
plasm a.
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SPECIES SPECIFICITY OF FACTOR V 
The ro le  of fa c to r  V in  "the e x tr in s ic  throm boplastin  system 
as f a r  as species s p e c i f ic i ty  i s  concerned was in v e s tig a te d  by 
u sing  a tw o-stage technique in  which b ra in  throm boplastin  s u ita b ly  
d ilu te d  was incubated w ith d ilu te d  adsorbed plasma and a t  in te rv a ls  
a l iq u o ts  were removed and d e liv ered  onto normal su b s tra te  plasma, 
and on plasma rendered fa c to r  V d e f ic ie n t .  The c lo tt in g  tim es of 
th e se  su b s tra te  plasmas were recorded. In  such an incubation  
m ixture th e  t i s s u e  throm boplastin  i s  allowed to  re a c t w ith the 
f a c to r  V p re sen t in  th e  adsorbed plasma, th e  degree of in te ra c tio n  
i s  r e f le c te d  in  the  c lo t t in g  tim es of the  su b s tra te  plasmas which 
should become sh o rte r  ra p id ly  i f  th e re  has been any such re a c tio n . 
The p a r t ly  preformed a c tiv e  t i s s u e  throm boplastin  in  a sense sh o r t-  
—c i r c u i t s  one stage  which otherw ise would have taken p lace  in  the 
s u b s tra te  plasma i t s e l f .  This method i s  described  in  d e ta i l  in  
appendix IY, 16. The reagen ts  were so d ilu te d  as to  ob ta in  a 
somewhat long c lo t t in g  time a f te r  the  f i r s t  minute of incubation , 
in  o rder th a t  fu r th e r  shorten ing  in  the  c lo tt in g  tim es would be 
e a s i ly  dem onstrable. A lso, th e  use of fa c to r  V d e f ic ie n t  plasma 
as s u b s tra te  fu r th e r  exaggerates any tendency, and e lim inates the  
in te r fe re n c e  of fa c to r  V p resen t in  th e  su b s tra te  plasma from 
com plicating the  is su e .
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The r e s u l t s  p resen ted  in  Table 10 show th a t  w hile human b ra in  
incubated  w ith human adsorbed plasma c lo tte d  th e  s u b s tra te  plasmas 
very  ra p id ly , namely in  13^ and 15 seconds a f te r  s ix  m inutes' 
in c u b a tio n , when incubated  w ith chicken adsorbed plasma th e  human 
b ra in  had very  weak throm boplastic a c t iv i ty  (34 and 65 seconds), 
and was s im ila r  to  th e  sa lin e  co n tro l (34 and 65 seconds). Thus, 
we can in f e r  th a t  human b ra in  throm boplastin  and chicken fa c to r  Y 
d id  n o t r e a c t  to g e th e r under th e  cond itions of th i s  t e s t .
A lso, chicken b ra in  incubated w ith chicken adsorbed plasma 
c lo t te d  th e  s u b s tra te  chicken, human, and fa c to r  V d e f ic ie n t human 
plasmas in  th e  s h o r te s t  tim es which were 12, 24, and 80 seconds 
re s p e c tiv e ly , fo r  th e  s ix  minute read ing ; while i t s  incubation  
w ith  human adsorbed plasma gave s im ila r  c lo tt in g  tim es as th e  s a lin e  
c o n tro l,  namely 24, 135, and more than  180 seconds re sp e c tiv e ly .
This means th a t  chicken b ra in  throm boplastin  a lso  d id  not re a c t 
w ith  th e  human fa c to r  V under th e  conditions of th e  t e s t .
But th e  com bination o f chicken b ra in  and chicken adsorbed plasma 
d id  have an apprec iab le  throm boplastic a c t iv i ty  on th e  human 
su b s tra te  plasma which c lo tte d  in  22 seconds. Such trea tm ent of 
th e  b ra in  e x tra c t w ith  th e  homologous adsorbed plasma has th e re fo re  
suppressed i t s  spec ies s p e c i f ic i ty  towards th e  heterologous 
s u b s tra te  plasma. Because fa c to r  VII i s  a lso  species s p e c if ic  as 
s h a ll  be shown l a t e r ,  i t  i s  my b e l ie f  th a t  such p o ten t c lo tt in g
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a c t iv i t y  of th e  b ra in  e x tra c t — adsorbed plasma combination is  
p a r t ly  due to  th e  presence of tra c e s  of th e  homologous fa c to r  VII 
which may have been incom pletely  adsorbed from the  chicken plasma. 
Conclusions
Human b ra in  and chicken b ra in  e x tra c ts  a re  each species sp e c if ic  
towards th e  homologous fa c to r  V. P re incuba tion  of th e  homologous 
reag en ts  p o ss ib ly  p a r t ly  suppresses th e i r  species s p e c if ic i ty  
towards th e  heterologous su b s tra te  plasma.
ASSAY OP CHICKEN PLASMA FACTOR Y 
Chicken plasma fa c to r  V was measured by th e  a b i l i t y  of f re sh  
chicken plasma to  c o rre c t th e  d e fec t of plasma made fa c to r  V 
d e f ic ie n t  by sto rag e  as described  in  appendix IV, 14. Since 
chicken fa c to r  V cannot be estim ated in  a human system because of 
i t s  spec ies  s p e c if ic i ty ,  i t  was measured in  f re sh  chicken plasma 
by th e  a b i l i t y  of th i s  plasma to  c o rre c t chicken plasma made fa c to r  
V d e f ic ie n t  by s to rag e , using chicken b ra in  as th e  throm boplastic 
agen t. Various d i lu tio n s  were made ranging from 100 to  0 per cent 
to  enable th e  drawing of a d ilu t io n  curve (Figure 5, curve B ).
I f  i t  i s  f e a s ib le  to  compare th i s  curve w ith a  human homologous 
f a c to r  V d ilu tio n  curve s im ila r ly  constru c ted  (F igure 5, curve A) 
we f in d  th a t  th e  slope o f both curves very  s im ila r . I t  may
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th e re fo re  be assumed th a t  chicken plasma contains fa c to r  V a c t iv i ty  
in  a co n cen tra tio n  s im ila r  to  th a t  of th e  human co n tro l plasma.
I f  i t s  co n cen tra tio n  was i n i t i a l l y  low, one would expect i t s  
a c t i v i t y  to  wane ra p id ly  w ith  d i lu t io n ,  w ith  le v e lin g  of th e  curve 
s lo p e , which in  f a c t  d id  no t occur in  any of th e  th re e  experiments 
p resen ted  in  Table 11.
D iscussion
From th e  p rev ious r e s u l t s  chicken fre sh  plasma was found to  
have f a c to r  Y a c t iv i t y  th a t  c o rre c ts  the  d e fic ien cy  produced 
a r t i f i c i a l l y  in  plasma by s to rag e , in  a concen tra tion  s u f f ic ie n t  
to  m ain ta in  e f f ic ie n t  haem ostasis. Murphy and Seegers (1948) 
estim ated  chicken fa c to r  V (A c-globulin) in  plasma by a tw o-stage 
techn ique , u t i l i s i n g  p u r if ie d  prothrom bin. They found fa c to r  V 
a c t iv i t y  in  chicken plasma to  be about one q u a rte r  th a t  p resen t 
in  human plasm a. This ra th e r  low value could be a t t r ib u te d  to  
th e  sp ec ie s  s p e c i f i c i ty  of th e  reagen ts  used. The b ra in  e x tra c t 
used in  th e i r  experiments i s  presumed to  be human, as no mention 
of i t s  spec ies  was no ted . W artelle  (1957b) a lso  dem onstrated 
th e  presence of a la b i le  fa c to r  in  chicken plasma, which 
d e te r io ra te d  on sto rag e  fo r  f iv e  hours a t  room tem perature, w hile 
i f  kep t in  s ilic o n e d  tubes a t  0 C. i t  was s ta b le  fo r  10 hours, 
w ith  p a r t i a l  d e te r io ra t io n  a f te r  24 hours and complete d e s tru c tio n  
a f t e r  72 hours. The long c lo tt in g  time of such s to red  plasma was
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com pletely co rrec ted  by th e  ad d itio n  of f re sh  chicken plasma.
She a lso  observed th a t  such s to red  plasma was not co rrec ted  by the  
ad d itio n  o f adsorbed bovine serum (which should con tain  fa c to r  V 
in  ample amount), s t r e s s in g  th e  spec ies s p e c if ic i ty  of th e  fa c to r
V — b ra in  th rom boplastin  re a c tio n . Since th i s  species s p e c i f ic i ty  
in te r f e r e s  w ith  th e  proper comparison w ith  a human co n tro l, and in  
view o f th e  normal values of prothrom bin time of chicken plasma and 
i t s  sh o rt stypven c lo t t in g  tim e, W artelle  assumed th a t  chicken plasma 
fa c to r  Y a c t iv i t y  i s  equal to  th a t  of human plasma. Hawkey (i960) 
in v e s t ig a te d  White Leghorn chicken, and rep o rted  th a t  th e i r  plasma 
and serum co n ta in  3 to  4 per cen t of th e  human co n tro l plasma fa c to r
V a c t iv i ty .  However, in  her t e s t  system, she used human b ra in  
throm boplastin  and human fa c to r  V d e f ic ie n t  plasma, reagen ts  th a t  
do n o t re a c t  w ith chicken fa c to r  V, a f a c t  th a t  explains her low 
r e s u l t s .
Conclusions
Due to  th e  species  s p e c if ic i ty  of chicken fa c to r  V -  b ra in  
th rom boplastin  re a c tio n , i t  i s  inqpossible to  compare chicken fa c to r
V a c t iv i t y  in  plasma w ith  th a t  of the  human w ith any degree of 
p re c is io n . However, in  view of th e  s im ila r fa c to r  V homologous 
d i lu t io n  curves of chicken and human plasmas, to g e th er w ith the 
normal prothrom bin time of chicken plasma, i t  i s  believed  th a t  
chicken plasma con ta ins fa c to r  V in  a concen tra tion  s im ila r  to
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th a t  p re se n t in  human plasm a. Chicken fa c to r  V i s  p resen t in  
an amount s u f f ic ie n t  to  m ain tain  e f f ic ie n t  haem ostasis in  chicken 
blood.
SIECIES SPECIFICITY OF CHICKEN FACTORS VII AND X 
The species  s p e c i f ic i ty  of chicken fa c to rs  VII and X -  b ra in  
th rom boplastin  re a c tio n  was in v e s tig a te d  by a tw o-stage technique 
s im ila r  to  th a t  used fo r  the  in v e s t ig a tio n  of fa c to r  s p e c if ic i ty .  
This method e n ta i ls  th e  incubation  of th e  d ilu te d  b ra in  e x tra c t 
w ith  th e  d ilu te d  serum in  th e  presence of calcium ch lo ride  so lu tio n . 
A liquo ts  from th e  incubation  m ixture are  removed a t  minute in te rv a ls  
and d e liv e re d  to g e th e r w ith  calcium ch lo ride  so lu tio n  onto 
p rev io u s ly  d is tr ib u te d  a liq u o ts  of normal su b s tra te  plasma, both 
human and chicken, and of phenindione human plasma. The c lo tt in g  
tim es a re  then  recorded. Various combinations of serum and b ra in  
e x tra c ts  were thus te s te d .  The method i s  described  in  d e ta i l  in  
appendix IV, 17. The r e s u l t s  a re  ta b u la te d  in  Table 12.
The fa c to rs  concerned in  th i s  e x tr in s ic  throm boplastin  system 
and supp lied  by th e  t e s t  serum are  fa c to rs  VII and X whose combined 
a c tio n  i s  r e f le c te d  in  th e  r e s u l t s .  This was in e v ita b le , since 
even in  p u r if ie d  f ra c t io n s  from serum, both  fa c to rs  separa te  
to g e th e r , un less each i s  prepared from serum or plasma from a
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p a t ie n t  w ith congen ita l d e fic ien cy  of th e  o the r fa c to r ,  which 
being a r a re  cond itio n  was u n av a ilab le . Moreover, chicken plasma 
or serum presumably contained  both f a c to r s .
While human b ra in  incubated w ith human serum c lo tte d  normal 
and phenindione human plasmas in  a sh o rt time (18 and 17 seconds), 
th e  m ixture of human b ra in  w ith  chicken serum behaved as th e  sa lin e  
c o n tro l, c lo t t in g  th e  su b s tra te  plasmas in  app rec iab ly  longer tim es 
(38 and 60 seconds).
S im ila r ly , chicken b ra in  e x tra c t incubated w ith chicken serum 
was h ig h ly  a c tiv e  on chicken plasma (13 seconds), w hile w ith human 
serum i t  was much weaker, in  f a c t  id e n tic a l  to  the  s a lin e  con tro l 
(23 seconds). The same d iffe re n ce  was observed on using human 
normal and phenindione plasmas as s u b s tra te , except th a t  the 
c lo t t in g  tim es were much longer due to  the  species s p e c if ic i ty  of 
f a c to r  V as d iscussed  befo re . The combined chicken b ra in  and 
chicken serum m ixture had very  feeb le  a c t iv i ty  on human su b stra te  
plasma, though s t i l l  dem onstrable, c lo t t in g  i t  in  34-57 seconds, 
an a c t iv i t y  equ iva len t to  th a t  of chicken b ra in  throm boplastin  
d i lu te d  1 in  40 in  s a l in e .
D iscussion
Mann and Hurn in  1952 suggested th a t  the  species s p e c if ic i ty  
of b ra in  e x tra c ts  re s id e s  in  i t s  in te ra c t io n  w ith  a serum 
co-th rom boplastin  ( fa c to r  VII) and have shown th a t  b r ie f  trea tm ent
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of the  b ra in  e x tra c t  w ith th e  d ilu te d  homologous serum la rg e ly  
e lim in a tes  th i s  s p e c if ic i ty .
That serum and plasma con ta in  fa c to rs  which a re  species s p e c if ic  
towards th e  homologous b ra in  e x tra c t has a lso  been confirmed by 
W artelle  (1957b) in  one-stage t e s t s .
This work again  confirms such f in d in g s , and by th e  tw o-stage 
technique tra c e s  the  s p e c i f ic i ty  to  fa c to rs  p resen t in  the serum, 
which presumably a re  fa c to rs  VII and X since they  are  the  only 
f a c to rs  th a t  take  p a r t  in  such an e x tr in s ic  system and supp lied  
by th e  serum.
Conclusion
The in te ra c t io n  of chicken b ra in  e x tra c t w ith chicken serum 
f a c to r s ,  most probably  fa c to rs  VII and X, i s  species s p e c if ic .
ASSAY OF CHICKEN PLASMA FACTOR VII
Due to  th e  p rev io u s ly  dem onstrated species s p e c if ic i ty  of fa c to r  
VII towards th e  homologous b ra in  e x tra c t ,  i t  was im possible to  assay  
f a c to r  VII w ith  any c e r ta in ty  using  th e  degree of co rre c tio n  of 
human phenindione plasma as a guide, since  the  use of human b ra in  
would be in s e n s it iv e  to  chicken fa c to r  V II, w hile chicken b ra in  
would be in s e n s it iv e  to  the  human fa c to r  VII in  th e  co n tro l plasma.
The p rep a ra tio n  of chicken phenindione plasma has been t r i e d  by
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feed ing  th e  chicken phenindione ta b le ts .  U nfo rtunate ly  I  was 
unable to  ob ta in  chicken phenindione plasma of s u f f ic ie n t ly  long 
one-stage prothrom bin time su ita b le  fo r  such a q u a n tita t iv e  assay, 
although huge doses of phenindione were adm inistered o r a l ly  in  the  
o rder of 50 mg tw ice d a i ly  per b ird  (equ iva len t to  66 mg/Kgm/day) 
over a perio d  of f o r ty  days. Such therapy  only prolonged th e  
one-stage t e s t  from the  normal 17 seconds to  25 seconds which does 
no t g ive  enough spread s u ita b le  fo r  th e  co n stru c tio n  of a d i lu t io n  
curve. This i s  now thought to  have been due to  th e  presence of 
v itam in  K in  th e  p e l le t  d ie t  on which th e  chicken were kep t. 
D iscussion
S ince chicken plasma c lo ts  in  a very  sh o rt time on th e  ad d itio n  
o f chicken b ra in  e x tra c t and calcium ch lo rid e  so lu tio n , i t  i s  safe  
to  assume th a t  chicken plasma contains s u f f ic ie n t  concen tra tion  of 
f a c to r  VII to  m ain tain  adequate haem ostasis. The d i f f i c u l ty  of 
f a c to r  VII assay  was a lso  encountered by sev era l workers. I t s  
sp ec ies  s p e c i f ic i ty  accounts fo r  th e  low values rep o rted  by 
Didisheim e t  a l  (1959), and fo r  th e  absence of co rre c tio n  of human 
c o n g e n ita lly  fa c to r  VII d e f ic ie n t  plasma repo rted  by Hawkey (i960) 
who moreover has used human b ra in  e x tra c t .  W artelle  (1957b) was 
a lso  unable to  c o rre c t th e  d e fec t in  bovine S e i t z - f i l t e r e d  plasma, 
and a t t r ib u te d  th i s  to  th e  species  s p e c if ic i ty  of th i s  re a c tio n .
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Conclusion
As y e t th e re  i s  no s a t i s f a c to ry  method fo r  comparing chicken 
f a c to r  VII a c t iv i ty  q u a n t i ta t iv e ly  w ith  human fa c to r  VII a c t iv i ty ,  
due to  th e  species s p e c if ic i ty  between fa c to r  V II, su b s tra te  plasma, 
and b ra in  e x tra c t  used.
ASSAY OF CHICKEN FACTOR X
Chicken fa c to r  X was measured by th e  method of Bachmann e t  a l 
(1958) as described  in  appendix IV, 18. This method measures the  
degree of c o rre c tio n  of S e i t z - f i l t e r e d  bovine plasma on th e  ad d itio n  
of R ussell*s v ip e r  venom -  cephalin  reagent and calcium ch loride 
so lu tio n , caused by th e  various d ilu tio n s  of t e s t  plasma or serum. 
The s u b s tra te  plasma i s  v i r t u a l ly  f re e  from fa c to rs  VII and X which 
a re  re ta in e d  com pletely re ta in e d  by th e  S e itz  asbestos pads.
S ince th e  ac tio n  of R.V.V. i s  independent of fa c to r  VII, th e  only 
v a r ia n t in  th i s  system i s  the  concen tra tion  of fa c to r  X.
Table 13 shows th e  r e s u l t s  of two experiments on chicken plasma 
fl.nfi one experiment on chicken serum. A ll chicken samples were 
found to  have very  feeb le  fa c to r  X a c t iv i ty  as compared to  the 
human co n tro l plasma or serum, in v a ria b ly  le s s  than  1 per cen t. 
D iscussion
Hawkey (i960) using  th e  same method obtained s im ila r  r e s u l t s ,
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namely 3 per cent fo r  chicken plasma and 1 per cen t fo r  chicken 
serum fa c to r  X a c t iv i t i e s .
Judging from th e  previous r e s u l ts  th e re  are  th re e  p o s s ib i l i t i e s  
th a t  can exp la in  the  apparent n e g lig ib le  fa c to r  X a c t iv i ty  in  both 
chicken plasma or serum.
F i r s t l y ,  th a t  fa c to r  X i s  a lto g e th e r  absent from chicken plasma 
or serum, a suppo sitio n  d i f f i c u l t  to  accept w ithout fu r th e r  evidence. 
Also ag a in s t i t  i s  th e  sh o rt one-stage prothrombin time of chicken 
plasma which must be p a r t ly  con trib u ted  to  by the  presence of a 
normal le v e l of chicken fa c to r  X in  th e  plasma, th a t  i s  i f  we assume 
th a t  chicken blood c lo ts  by the  same mechanism as human blood.
The second p o s s ib i l i ty  i s  th a t  chicken fa c to r  X i s  species 
s p e c if ic  and does no t re a c t  w ith R.V.V. Again, th i s  i s  re fu te d  
by th e  f a c t  th a t  chicken c i t r a te d  plasma i s  c lo tte d  by R.V.V., 
though in  a longer time than human plasma, which i s  mainly due to  
th e  lower concen tra tio n  of chicken plasma prothrombin as s h a ll be 
d iscu ssed  l a t e r .  The r e s u l t s  of R .V .V .-cephalin  c lo tt in g  tim es 
of chicken plasma are  p resen ted  in  Table 14.
The th i r d  p o s s ib i l i ty  i s  th a t  th e  in term ed ia te  product formed 
by th e  in te ra c t io n  of R.V.V. and chicken fa c to r  X i s  i t s e l f  d if f e re n t  
and does no t re a c t  w ith  bovine fa c to r  V or prothrom bin. This i s  
perhaps th e  most p la u s ib le  theo ry . Indeed, i t  i s  hard to  v is u a l is e  
th a t  such a t e s t  system con tain ing  reagen ts  from th re e  w idely
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d i f f e r in g  species  (mammalian, avian, and r e p t i le )  would y ie ld  
r e s u l t s  th a t  can be in te rp re te d  in  the  usual manner as when using 
a homologous system.
U n til fa c to r  X can be prepared and id e n t if ie d  as a chem ically  
pure substance th a t  can be estim ated  by some biochem ical method, 
th e  q u estio n  of th e  presence and concen tra tion  of chicken fa c to r  
X cannot be s e t t le d  w ith  any degree of c e r ta in ty .
Conclusion
As y e t ,  th e re  i s  no s a t i s f a c to ry  method fo r  th e  q u a n tita tiv e  
assay  o f chicken fa c to r  X a c t iv i ty ,  due to  i t s  species s p e c if ic i ty .
ASSAY OF CHICKEN PLASMA PROTHROMBIN
Chicken plasma prothrom bin was estim ated  q u a n ti ta t iv e ly  by two 
methods, th e  tw o-stage a rea  method of Biggs and Douglas (1953a), 
and th e  g lo b u lin  f r a c t io n  method of Douglas and Biggs (1953).
The use of th e  f i r s t  method as described  in  appendix IV, 12, C, 
was com plicated by th e  species s p e c if ic i ty  of th e  b ra in  e x tra c t 
in  r e la t io n  to  th e  plasma assayed. Therefore, each of the  con tro l 
and t e s t  plasmas was te s te d  using the  homologous b ra in  e x tra c t.  
Apart from th i s ,  th e  t e s t  systems were id e n t ic a l .  By comparison 
of th e  amounts of throm bin produced, chicken plasma was found to  
have about 13 per cen t of the  human plasma prothrom bin con ten t.
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D e ta ils  o f th e  r e s u l t s  a re  p resen ted  in  Table 15 and i l lu s t r a t e d  
in  F igure  6.
The g lo b u lin  f r a c t io n  method of Douglas and Biggs (1953) is  
a lso  a tw o-stage techn ique measuring th e  thrombin produced from 
a p u r i f ie d  eug lobu lin  f r a c t io n  which con tains th e  prothrom bin.
Both c o n tro l and t e s t  plasmas were te s te d  w ith  human b ra in  e x tra c t,  
as d esc rib ed  in  appendix IV, 12, B. By th is  method, chicken 
plasm a prothrom bin amounted to  about 23 per cent of the  human 
c o n tro l plasm a prothrom bin con ten t (Table 16).
D iscussion
The choice o f tw o-stage techniques was made as they  are  f a i r l y  
a c c u ra te  in  r e f le c t in g  the  amount of prothrombin in  the  plasma 
in v e s t ig a te d . They are  minim ally a f fe c te d  by v a r ia t io n  in  the 
co n ce n tra tio n  of o th e r a c c e le ra tin g  f a c to rs ,  or by v a r ia tio n  in  
th e  th rom bop lastin  e x tra c t a c t iv i ty ;  w hile one-stage methods are  
g r e a t ly  a f fe c te d  by th e  amount of a c c e le ra to rs  p re sen t, and a t  
th e  same tim e measure only the  amount of thrombin formed in  the 
i n i t i a l  exp lo sive  s tag e  of prothrom bin conversion.
Though th e  a rea  method i s  a ffe c te d  by th e  amount of an tithrom bin 
p re se n t in  th e  m ixture, here th i s  fa c to r  can be ignored since  i t  
was shown th a t  chicken plasma a n ti  thrombin a c t iv i ty  i s  about the 
same as th a t  of th e  human con tro l plasma. Such a low prothrom bin 
co n ten t as found in  chicken plasma i s  by no means paradox ical to
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th e  f in d in g  of very  sh o rt c lo tt in g  tim es in  th e  one-stage 
prothrom bin time t e s t  which depends on th e  i n i t i a l  concen tra tion  
o f throm bin only . A lso, Biggs and Douglas (1953a) have described  
a p a t ie n t  w ith  acqu ired  prothrom bin d e fic ien cy  whose prothrom bin 
was 10 p e r  cen t, y e t h is  prothrom bin c lo t t in g  tim e was only very  
s l i g h t ly  prolonged (18 seconds in s te a d  of th e  normal 15 seconds).
In  th e  g lo b u lin  f r a c t io n  method th e  incubation  mixture i s  f re e  
from an tith ro m b in . Also the  long in cubation  time of 30 minutes 
ren d ers  th e  e f f e c t  of v a r ia t io n  in  a c c e le ra to r  fa c to rs  very  
n e g l ig ib le .  S t i l l  i t  shows th a t  chicken plasma prothrombin i s  very  
low compared to  th a t  of human plasma. I t  i s  assumed th a t  the acid  
p r e c ip i ta t io n  c h a ra c te r i s t ic s  of both human and chicken prothrombins 
a re  s im ila r ,  though th ey  may w ell be d if f e r e n t .
Warner e t  a l  (1939a) measured th e  prothrom bin conten t of White 
Leghorn chicken by a tw o-stage method and re p o rt i t  to  be 50 per 
cen t as compared to  84 per cent fo r  th e  human plasma which was 
compared to  dog plasma th a t  was designated  the  100 per cent value. 
Murphy and Seegers (1948) a lso  u t i l i s i n g  a two—stage  method found 
th a t  chicken plasma contained 93-110 u n its  of prothrom bin per m l., 
w hile  human plasma prothrom bin was 290 u n its  per ml. ( i* e . chicken 
plasm a prothrom bin n e a r ly  one th i rd  th e  concen tra tion  of human 
plasma p ro throm bin). The d iffe re n c e s  in  th ese  rep o rted  values 
of chicken prothrom bin are  to  be expected since  th e  t e s t  systems
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were n o t id e n t ic a l ,  a lso  th e  co n tro l plasmas may have had d if f e r in g  
prothrom bin co n ce n tra tio n s , and f in a l ly  each group of workers 
te s te d  plasmas of d if f e r e n t  s t r a in s  of chicken. But th e re  i s  
gen era l agreement th a t  chicken plasma prothrom bin i s  much lower 
th an  human plasma prothrom bin. This low concen tra tion  of chicken 
prothrom bin exp la in s th e  long R.V.V. c lo tt in g  tim es of chicken 
plasm a p re v io u s ly  d iscu ssed .
Conclusion
Chicken plasma contained  le s s  than  one th i r d  th e  prothrombin 
co n ten t of human plasm a.
EFFICIENCY OF CHICKEN EXTRINSIC THROMBOPLASTIN SYSTEM
The p rev ious in  v i t r o  observations dem onstrate th a t  chicken 
have an e f f ic ie n t  e x tr in s ic  system fo r  prothrom bin a c tiv a tio n , which 
i s  b e s t exem plified  in  th e  one-stage prothrom bin tim e. A ll the 
f a c to r s  concerned in  th i s  re a c tio n  seem to  be p resen t in  s u f f ic ie n t  
amounts as dem onstrated by the  in d iv id u a l assays, except in  the 
case o f prothrom bin which i s  p re sen t in  ra th e r  a b o rd e rlin e  
co n c e n tra tio n  in  chicken plasma, and i s  only r e f le c te d  in  the  
R u sse ll* s  v ip e r  venom c lo t t in g  time of chicken plasma.
In  vivo observations a lso  support th e  f a c t  th a t  the  chicken 
e x t r in s ic  th rom boplastin  system i s  e f f ic ie n t .  During a s p ira t io n
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of blood samples from th e  wing v e in s , th e  s l ig h te s t  trau m a tiza tio n  
to  th e  v e in  w alls  by th e  needle re s u lte d  in  the  c lo t t in g  of the  
f r e s h ly  withdrawn blood in s id e  th e  syringe w ith in  few seconds, 
in s p i t e  o f th e  use of s ilic o n e d  ware. Also any haematomata th a t  
were caused were found to  c lo t  qu ick ly .
CHICKEN INTRINSIC THROMBOPLASTIN SYSTEM 
The a c t iv e  in t r i n s i c  th rom boplastin  i s  formed by the  in te ra c t io n  
of f a c to r s  derived  w holly from the  plasma, w ithout th e  ad d itio n  of 
any ex traneous re a g e n ts . The fa c to rs  concerned in  th e  in t r in s ic  
system  s h a l l  now be described  in  tu rn .
CHICKEN THROMBOCYTES 
Chicken throm bocytes a re  th e  formed elements in  blood analogous 
to  th e  human blood p la te l e t s .  They adhere to g e th e r , as w ell as to  
fo re ig n  s u rfa c e s . Their removal from chicken plasma g re a tly  
re ta rd s  th e  l a t t e r ' s  c o a g u la b ility , as th ey  possess throm boplastic 
p ro p e r tie s  as s h a l l  be d iscussed  l a t e r .  They d i f f e r  from human 
p l a t e l e t s  in  being nuclea ted  c e l ls  very  s im ila r  to  the  lymphocytes. 
They a re  u su a lly  oval c e l l s ,  th e  s iz e  of a sm all or in te rm ed ia te  
lymphocyte, the  nucleus i s  oval or rounded, w ith  a heavy chrom atin
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network, w hile th e  cytoplasm  i s  pale  v io le t  and appears vacuo la ted . 
The throm bocytes occur in  th e  o rd inary  blood film s e i th e r  s in g ly  or 
in  clumps of two, th re e , or four c e l l s .
Being n u c lea ted  i t  i s  very  d i f f i c u l t  to  d is tin g u ish  them in  
u n s ta in ed  p re p a ra tio n s  from th e  o th e r blood c e l ls  of chicken blood. 
T here fo re , an o rd in a ry  t o t a l  w hite blood c e l l s 1 count was f i r s t  
made, th e n  a  d i f f e r e n t i a l  count c a rr ie d  out on a blood film  s ta in e d  
w ith  Leishman’s s ta in .  From th ese  d a ta  the  to t a l  thrombocyte count 
was c a lc u la te d . The average of f iv e  es tim ations was 19,650 per c.mm. 
o f whole blood (Table 17), w ith  a range of 16,800 to  21,060 per c.mm. 
The throm bocytes c o n s ti tu te d  n ea rly  50 per cent of the  to t a l  w hite 
blood c e l l s ’ count.
Thrombocyte counts rep o rted  in  th e  l i t e r a t u r e  v a ried  widely. 
A lb e rto n i and Mazzoni (1891) c i te d  by Forkner (1929) repo rted  
45,566 throm bocytes per c.mm. blood, w hile K lieneberger and Carl 
in  1912 found them to  vary  from 22,900 to  130,000 per c.mm. (c ite d  
by Forkner, 1929). Forkner (1929) s tu d ied  White Leghorn, Plymouth 
Rock, and Black Je rse y  G iant R ooster s t r a in s .  From 29 estim ations 
on 11 anim als he found th e  average thrombocyte count of 34,990 w ith 
a range from 5,408 to  142,048 per c.mm. of whole blood. In  1937, 
Olson has made th e  most comprehensive survey on the  su b jec t. From 
408 observ a tio n s  on 89 domestic fowl, he found a v a r ia t io n  from 
5,400 to  120,000 thrombocyte per c.mm. His average fo r  ad u lt fowl
-  129 -
was 25,700 ± 400 w ith  a s tandard  d ev ia tio n  of 125. He found no 
d a i ly ,  weekly, or seasonal v a r ia t io n  in  the  thrombocyte number, 
nor d if fe re n c e s  between the  sexes, or between b ird s  kept indoors 
and tho se  kep t ou tdoors.
The th rom bop lastic  ch a ra c te rs  of chicken thrombocytes w il l  be 
d iscu ssed  l a t e r  in  th e  se c tio n  on throm boplastin  genera tion .
CHICKEN WHOLE BLOOD CLOTTING TIME
The whole blood c lo t t in g  time i s  a measure of th e  o v e ra ll 
e f f ic ie n c y  o f th e  i n t r in s ic  throm boplastin  system of prothrombin 
a c t iv a t io n .  Decrease of any of th e  fa c to rs  concerned r e s u l t s  in  
th e  p ro lo n g a tio n  of th e  c lo t t in g  tim e. I t  was measured by th e  
method of Lee and White (1913) as described  in  appendix IV, 3, 
bo th  in  o rd in ary  g la ss  tubes and in  s ilic o n e d  g la ss  tubes under 
id e n t ic a l  c o n d itio n s . The average c lo t t in g  time in  ord inary  g la ss  
was about 24 m inutes, w hile in  s ilic o n e d  g la ss  i t  was about 28 
m inutes (Table 18). This d if fe re n c e  i s  not s ig n if ic a n t .  These 
r e s u l t s  suggest th a t  chicken blood lacks th e  coagulation  fa c to rs  
concerned in  th e  i n i t i a l  phases of su rface  con tac t a c tiv a tio n , 
namely P.T .A . and Hageman fa c to r s .
D iscussion
Whole blood c lo t t in g  tim es obtained  ranged from 11 minutes to
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45 m inutes. This wide d iffe re n c e  is  be lieved  to  be due to  th e  
contam ination  of th e  f a s t  c lo t t in g  samples w ith tra c e s  of t i s s u e  
th rom bop lastin  re le a se d  from the  s i t e  of in je c tio n . With more 
experience in  o b ta in in g  the  sample from the  wing v e in s, which are  
very  th in  and narrow, w ith  the  le a s t  p o ssib le  trau m atiza tio n , the 
c lo t t in g  tim es were in v a ria b ly  very  long. This confirms Bigland 
and T riantQ phyllopoulos (i960) fin d in g s  th a t  even th e  f lu t te r in g  
o f th e  v e in  w all a g a in s t the  needle caused damage to  the  endothelium 
and consequently  th e  re le a se  of t i s s u e  throm boplastin . This can 
be obv ia ted  by th e  very  slow w ithdrawal of the  blood sample.
These workers a lso  found th a t  whole blood c lo tt in g  tim es varied  
from wing to  wing, and from tube to  tube . Their r e s u l t s  ranged 
from 13 to  180 m inutes, w ith  an average of 69.2 ± 36.6 minutes.
W arte lle  (1957b) rep o rted  c lo t t in g  tim es of 15 to  20 minutes, 
w ith  no d iffe re n c e  when c lo tte d  in  g la ss  or s ilic o n e d  v e sse ls , which 
was a lso  confirm ed by Didisheim e t a l (1959).
A part from th e  la c k  of con tac t fa c to rs  which w ill  be d iscussed 
s h o r t ly ,  such long whole blood c lo t t in g  tim es may w ell be due to  
th e  l e s s e r  number of throm bocytes p re se n t, as w ell as to  th e i r  
g re a te r  s t a b i l i t y  s in ce  s in g le  thrombocytes were o ften  encountered 
in  b lood film s in d ic a tin g  an adhesive or clumping tendency much 
le s s  th a n  th a t  of human p la te l e t s .
-  131 -
C onclusions
Chicken whole blood c lo t t in g  tim e i s  much longer than  th a t  of 
human whole b lood, and i s  s im ila r  in  o rd inary  g la ss  or s ilic o n e d  
tu b e s .
CHICKEN PLASMA RECALCIFICATION TIME
S im ila r  to  th e  whole blood c lo t t in g  tim e, th e  r e c a lc i f ic a t io n  
tim e o f c i t r a t e d  plasma a lso  r e f le c t s  th e  o v e ra ll e f f ic ie n c y  or 
potency  o f th e  i n t r in s ic  th rom boplastin  system of prothrombin 
conversion . I t  i s  prolonged i f  any of the  concerned fa c to rs  i s  
d e f ic ie n t .
Chicken plasma r e c a lc i f ic a t io n  tim es v aried  from 480 to  1157 
seconds (Table 19), as compared w ith  160 seconds fo r  th e  human 
plasm a. I t  should be noted , however, th a t  w hile both plasmas 
were t r e a te d  id e n t ic a l ly ,  chicken plasma was v i r tu a l ly  rendered 
f r e e  from th e  throm bocytes as th ese  sediment e a s ily , w hile the 
human plasm a was p la t e l e t - r i c h .  This lack  of thrombocytes 
n a tu r a l ly  accen tuated  th e  d e fec t in  chicken in t r in s ic  throm boplastin  
g en e ra tio n , r e s u l t in g  in  a more prolonged c lo tt in g  time as compared 
to  human plasma r e c a lc i f ic a t io n  tim e.
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CHICKEN PLASMA CONTACT FACTORS
In v e s tig a tio n  of chicken plasma con tac t a c t iv a t io n  fa c to rs  
concerned in  th e  i n i t i a l  s tag es  o f in t r in s ic  throm boplastin  
g e n e ra tio n  was c a r r ie d  out u t i l i s i n g  the  method of R atnoff and 
Rosenblum (1958) as d escribed  in  appendix IV, 24, I .
The a d d itio n  of chicken in ta c t  or g la ss  a c t iv a te d  plasma to  
th e  in t a c t  p la te le t-p o o r  c i t r a te d  plasma gave the  same r e s u l t  of 
more th a n  120 m inutes c lo t t in g  time a f te r  th e  ad d itio n  of the  
calcium  c h lo rid e  so lu tio n , ir re s p e c tiv e  of th e  species of th e  
s u b s t r a te  plasm a, whether human or av ian . In  o th e r words, chicken 
g la s s  a c t iv a te d  plasma d id  no t have any throm boplastic a c t iv i ty ,  
n e i th e r  in  a  homologous system, nor in  a hetero logous one.
But human a c tiv a te d  plasma shortened th e  c lo tt in g  tim e of in ta c t  
human plasma from 66 minutes to  13 m inutes, and th a t  of chicken 
in t a c t  plasma from 120+ minutes to  38 minutes (Table 20).
D iscussion
I t  i s  obvious from th e  above r e s u l t s  th a t  chicken plasma lacks 
com pletely  th e  fa c to rs  concerned in  th e  con tac t a c tiv a tio n  phase, 
namely Hageman fa c to r  and th e  plasma throm boplastin  an tecedent (PTA), 
to  which th i s  t e s t  system i s  s e n s i t iv e ,  though la t e ly  i t  has been 
acknowledged th a t  th i s  method i s  m ainly a measure of th e  P .T .A ., 
th e  Hageman fa c to r  p lay ing  a minor ro le  in  i t  (R atnoff, 1962).
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However, th e  ab so lu te  la ck  of any a c t iv i ty ,  to g e th e r w ith  th e  f a c t  
th a t  whole blood c lo t t in g  tim es are  s im ila r  in  o rd inary  g la ss  and 
in  s il ic o n e d  g la s s ,  s tro n g ly  suggest th a t  both fa c to rs  a re  absent 
from chicken plasm a. I t  i s  u n fo rtu n a te  th a t  Hageman fa c to r  
d e f ic ie n t  plasma or P.T.A . d e f ic ie n t  plasma were unava ilab le  so 
th a t  th e  p o s it io n  could be fu r th e r  c l a r i f i e d .  I t  i s  h ig h ly  
im probable th a t  th e se  fa c to rs  a re  p re sen t but species  s p e c if ic ,  
f i r s t l y  because of th e  la c k  of any d iffe re n c e  between c lo tt in g  
tim es in  g la ss  and s ilic o n e d  tu b es , and secondly because g la ss  
a c t iv a te d  human plasma d id  a c tu a lly  sho rten  th e  r e c a lc i f ic a t io n  
tim e o f in t a c t  chicken plasma ap p rec iab ly .
The a d d itio n  of in ta c t  or g la ss  a c tiv a te d  chicken plasma had 
some in h ib i to ry  e f f e c t  on the  in ta c t  human su b s tra te  plasma, 
when compared to  human plasma (Table 20). Though th i s  may be due 
to  d i lu t io n  e f f e c ts ,  i t  i s  more probable th a t  i t  i s  due to  an 
in h ib i to r  in  chicken plasm a. The presence of such an in h ib ito r  
in  chicken plasma was observed by R atnoff (1961) s im ila r  to  the  
in h ib i to ry  a c t iv i t y  p re sen t in  plasma of p a t ie n ts  w ith the  Hageman 
t r a i t .  T a i t  and Green (1926) observed th a t  b i r d s 1 blood or plasma 
has le s s  tendency to  undergo spontaneous coagulation  on con tact 
w ith  g la s s .  The absence of Hageman fa c to r  in  duck plasma was 
dem onstrated by R atnoff and M argolius (1957), and in  chicken plasma 
by Wart e l l  e (1957 a and b ) ,  Thompson e t  a l  (1960), and F an tl (1961).
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T heir experim ents were based on the  c o rre c tio n  of th e  d e fe c t of 
plasma from p a t ie n ts  w ith  congen ita l Hageman fa c to r  d e fic ien cy . 
W arte lle  (1957b) a lso  dem onstrated th a t  chicken plasma cannot 
c o r re c t  th e  d e fe c t o f plasma from a p a t ie n t  w ith  congen ita l P.T.A. 
d e f ic ie n c y , in  a r e c a lc i f i c a t io n  t e s t  system.
Conclusion
Chicken plasma lacks both  Hageman fa c to r  and plasma throm boplastin  
an teceden t (PTA) a c t i v i t i e s .
CHICKEN PLASMA ANTIHAEMOPHILIC GLOBULIN ACTIVITY 
A ntihaem ophilic g lo b u lin  a c t iv i t y  was te s te d  fo r  in  chicken 
adsorbed plasma in  th e  throm boplastin  genera tion  t e s t  of Biggs and 
Douglas (1953b) as described  in  appendix IV, 20. The incubation  
m ixture contained  human serum d ilu te d  1 in  10 in  s a lin e , human 
p l a t e l e t s ' suspension, and M/40 calcium ch lo rid e  so lu tio n , w ith 
th e  adsorbed plasma d ilu te d  1 in  5 in  s a lin e  as th e  v a r ia b le .
The s u b s tra te  was human high-spun plasm a. Curve a in  Figure 8, I ,  
shows 100 per cen t th rom boplastin  g enera tion  from th e  normal human 
adsorbed plasm a. This a c t iv i t y  i s  due to  th e  A.H.G. con ten t of 
th e  adsorbed plasma, as w ell as i t s  fa c to r  V con ten t. Curve b 
was produced when chicken adsorbed plasma was used in s te a d  of th e  
human adsorbed plasma, hard ly  any a c tiv e  throm boplastin  was formed.
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In  f a c t  th e  a c t iv i t y  of chicken plasma was very  s im ila r  to  th a t  of 
th e  s a l in e  c o n tro l (curve c ) , and to  th a t  of the  human haem ophilic 
plasma (curve d ) . D e ta ils  of the  experim ental r e s u l t s  are  
p re sen te d  in  Tables 21 and 22.
The t e s t  was m odified to  see th e  degree of c o rre c tio n  of human 
adsorbed haem ophilic plasma by th e  adsorbed chicken plasma. Apart 
from th e  vary ing  d ilu tio n s  of the  chicken plasma in  the  haemophilic 
plasm a, a l l  th e  o the r reagen ts  were kept co nstan t. In  Figure 8, I I ,  
curves a^, a£, a^ , and a^ rep re sen t the  throm boplastin  genera tion  of 
m ix tures con ta in ing  human adsorbed plasma d ilu te d  l / 2 ,  l / 4 ,  l / 8 ,  and 
1/20 in  adsorbed haem ophilic plasma, re sp e c tiv e ly . Curve b^ was 
ob ta ined  fo r  chicken adsorbed plasma d ilu te d  1/2 in  haemophilic 
adsorbed plasm a. I t  has le s s  than  5 per cen to f the a c t iv i ty  of 
th e  human co n tro l plasma, and very  s l ig h t ly  h igher a c t iv i ty  than 
th e  s a l in e  c o n tro l. The ac tu a l c lo t t in g  tim es in  seconds as obtained 
a re  p resen ted  in  Table 21.
These fin d in g s  suggest th a t  e i th e r  the  chicken plasma does not 
co n ta in  an tihaem ophilic  g lo b u lin , or i f  i t  does, i t s  a c t iv i ty  i s  
sp ec ie s  s p e c if ic .  The same b a t te ry  of t e s t s  were th e re fo re  repea ted  
u sin g  human cepha lin  as the  throm boplastic agent in s te a d  of the  human 
p l a t e l e t s .  The r e s u l t s  when using cephalin  are  g ra p h ic a lly  
i l l u s t r a t e d  in  F igure 9 (a c tu a l fin d in g s  in  Table 23) whose general 
p a t te rn  i s  n e a r ly  a r e p l ic a  of F igure 8, thus confirm ing the  previous
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r e s u l t s .  Again, the  whole procedure was repea ted  using  chicken 
throm bocyte suspension in s te a d  of th e  human p la te le t s  or cephalin , 
and F igure 10 was compiled from th e  d a ta  obtained and p resen ted  in  
Table 24. I t  should be noted, however, th a t  fo r  the  conversion 
of c lo t t in g  tim es as measured in  seconds in to  percentage values of 
a c t iv e  th rom boplastin , a sp ec ia l th rom boplastin  d ilu t io n  curve was 
made in  which th e  incubation  m ixture fo r  the  production of the 
a c t iv e  th rom bop lastin  co n sis ted  of equal amounts of chicken adsorbed 
plasm a d ilu te d  1/5 in  s a l in e , human normal serum d ilu te d  1/10 in  
s a l in e ,  chicken thrombocyte suspension, and M/40 calcium ch lo ride  
s o lu tio n . Subsampling was onto human high-spun normal plasma.
Thus F igure 7 was co n stru c ted , and was used to  convert the  measured 
c lo t t in g  tim es from seconds in to  percentage of chicken ac tiv e  
th rom bop lastin . Though th i s  curve was made in  a s im ila r  manner 
to  th e  human throm boplastin  d i lu t io n  curve, in  the  l a t t e r  th e  10 
seconds c lo t t in g  tim e was a r b i t r a r i l y  designated  th e  100 per cent 
value s in ce  i t  was th e  s h o r te s t  tim e obtained . In  the  chicken 
in cu b a tio n  m ixture th e  sh o r te s t  c lo t t in g  time obtained was 20 seconds 
and th i s  was th e re fo re  a r b i t r a r i l y  designated  th e  100 per cent value 
fo r  chicken a c tiv e  in t r in s ic  th rom boplastin . Therefore, no d ir e c t  
comparison can be made between th e  curves in  F igure 10 and those
in  F igures 8 and 9.
A nalysis of th e  d a ta  p resen ted  in  Figure 10 shows th a t  chicken
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adsorbed plasma when incubated  w ith human serum and chicken 
throm bocytes produced the  g re a te s t  amount of ac tiv e  throm boplastin  
(curve b ) , w hile human adsorbed plasma had le ss  than  h a lf  the  
a c t i v i t y  of th e  chicken adsorbed plasma (curve a ) .  This means 
th a t  sp ec ie s  s p e c i f i c i ty  occurs in  th e  re a c tio n  between the  adsorbed 
plasm a and th e  p l a t e l e t  or thrombocyte suspension. Homologous 
m ix tures genera te  a c tiv e  th rom boplastin  op tim ally , w hile heterologous 
m ix tures h a rd ly  genera te  any a c tiv e  throm boplastin  a t  a l l .
F igure  10, I I ,  re p re se n ts  th e  values obtained by c o rre c tio n  of 
human haem ophilic plasma w ith  adsorbed chicken plasma or w ith 
adsorbed human plasm a, using  chicken thrombocytes as the  l ip id  
th rom bop lastic  agen t. Though th i s  f ig u re  i s  d i f f i c u l t  to  in te r p r e t  
y e t i t  i s  seen th a t  curve b^ which rep re sen ts  chicken adsorbed 
plasm a d ilu te d  l / 2  in  haem ophilic adsorbed plasma, shows b e t te r  
a c t i v i t y  th an  curve a^ obtained  w ith human normal adsorbed plasma 
d i lu te d  s im ila r ly  in  haem ophilic plasma. Both curves show a c t iv i ty  
much le s s  th an  would be expected because fa c to r  V which i s  supplied  
in  th e  adsorbed plasma was a lso  found to  be species sp e c if ic  in  
th e  th rom bop lastin  g en era tio n  m ixture, as s h a ll  be d iscussed  l a t e r .  
Thus m ixtures con ta in ing  both chicken and human haemophilic plasma 
s u f fe r  from decrease of th e  p o te n t ia l ly  a c tiv e  fa c to r  V by h a lf  in  
th e  l / 2  d i lu t io n ,  and by one q u a rte r  in  th e  l / 4  d ilu t io n  (curve ^ 2} '  
This f a c t  accounts fo r  the  ra p id  d ec lin e  in  a c t iv i ty  observed when
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chicken plasma i s  d ilu te d  in  human haem ophilic plasm a. Also,
curve a, cannot be favourab ly  compared w ith curve b. because the  
J- 1
fa c to r  V con ten t of th e  human m ixture used i s  a l l  human and 
v i r t u a l l y  in a c tiv e  w ith  chicken throm bocytes, thus impeding the  
p roper g en e ra tio n  of a c tiv e  throm boplastin , ap a rt from th e  species 
s p e c i f i c i t y  in te rv en in g  between th e  chicken thrombocytes and the  
human A.H.G. a c t iv i t y  in  th e  adsorbed plasma.
Assay of th e  A.H.G. con ten t of chicken adsorbed plasma by the  
method of P itn e y  (1956) using  human p la t e l e t s ,  and measuring the 
a b i l i t y  of chicken adsorbed plasma to  c o rre c t the  d e fec t of human 
haem ophilic adsorbed plasma, showed th a t  chicken plasma had no 
A.H.G. a c t iv i t y  as compared to  th e  human co n tro l plasma (Table 28). 
This aga in  r e f le c t s  th e  species s p e c if ic i ty  of th e  chicken A.H.G. 
towards th e  human p l a t e l e t s .  Since antihaem ophilic g lobu lin  
a c t i v i t y  i s  defined  as th a t  a c t iv i ty  in  adsorbed plasma th a t  co rrec ts  
th e  d e fe c t in  human haem ophilic plasma in  a throm boplastin  genera tion  
m ixture u sing  human p la te l e t s ,  i t  i s  concluded th a t  chicken adsorbed 
plasm a has no such a c t iv i ty .  But in  a throm boplastin  genera tion  
m ixture using  chicken throm bocytes, chicken adsorbed plasma showed 
an ap p rec iab le  a c t iv i t y  which can only be presumed to  be due to  i t s  
co n ten t o f a fa c to r  analogous to  human antihaem ophilic g lo b u lin .
The sp ec ies  s p e c i f i c i ty  of chicken A.H.G. a c t iv i ty  was 
in v e s tig a te d  in  a p u r if ie d  throm boplastin  g enera tion  mixture
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c o n s is tin g  of equal amounts of human cephalin  d ilu te d  l/lOO in  
s a l in e ,  human serum d ilu te d  1/10 in  s a l in e , p u r if ie d  human fa c to r  
V p repared  by ammonium su lphate  p re c ip i ta t io n  (appendix I I I ,  9) in  
a  co n c e n tra tio n  eq u iv a len t to  th a t  p resen t in  adsorbed plasma 
d i lu te d  1/5 in  s a l in e ,  p u r if ie d  human or chicken A.H.G. prepared 
by ammonium su lp h a te  p r e c ip i ta t io n  (appendix I I I ,  11) in  a 
co n ce n tra tio n  eq u iv a len t to  adsorbed plasma d ilu te d  1/5 in  s a l in e , 
and M/40 calcium  ch lo rid e  so lu tio n . The r e s u l ts  in  Table 29 show 
th a t  in  m ixture number 71 con ta in ing  human A.H.G. po ten t ac tiv e  
th rom bop lastin  was produced, w hile in  m ixture 71b contain ing  
chicken p u r if ie d  A.H.G. no a c tiv e  throm boplastin  was produced, 
s ig n ify in g  th a t  chicken A.H.G. i s  species  sp e c if ic  towards human 
cep h a lin , as rev ea led  p rev io u sly  using  adsorbed chicken plasma 
w ith  human p la te le t s  o r human cepha lin  (Table 21, m ixture 1, Table 
23, m ixture 17, and curves b in  F igures 8 and 9 re sp e c tiv e ly ) .
This la c k  of th rom boplastin  gen era tio n  cannot be blamed on the 
h e te ro g e n e ity  of A.H.G. -  fa c to r  V, since  a lso  the  combination of 
chicken p u r if ie d  A.H.G. w ith  chicken p u r if ie d  fa c to r  V d id  not 
y ie ld  any a c tiv e  throm boplastin  in  th e  presence of human cephalin  
(Table 29, m ixture 71c).
D iscussion
V a r te l le  (1957b) rep o rted  100 per cent fo r  chicken plasma 
A.H.G. a c t iv i t y  when measuring th e  degree of c o rre c tio n  of human
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haem ophilic plasma in  a r e c a lc i f ic a t io n  time t e s t  using human 
cep h a lin  as th e  th rom boplastic  l i p id .  The c lo tt in g  time of the  
m ixture co n ta in in g  chicken plasma d ilu te d  1 in  20 was 3* 50", 
s im ila r  to  th a t  ob ta ined  fo r  the  m ixture con ta in ing  human plasma 
s im i la r ly  d i lu te d . I  was unable to  reproduce h er fin d in g s on 
u sin g  th e  same techn ique , namely th e  method of S o u lie r and L arrieu  
(1953 a and b ) . The r e c a lc i f ic a t io n  time of th e  m ixture which 
con ta ined  chicken plasma d ilu te d  1 in  20 was 4 1 34", w hile the  
m ixture co n ta in in g  human plasma d ilu te d  1 in  160 c lo tte d  in  4 1 3", 
which g ives a value of le s s  than  12 per cent of A.H.G. a c t iv i ty  
fo r  th e  chicken plasma A.H.G. a c t iv i ty .  I  b e liev e  th i s  t e s t  i s  
no t s u i ta b le  fo r  the  measurement of chicken plasma A.H.G. a c t iv i ty  
as th e  use o f human cepha lin , as w ell as th e  human fa c to r  V content 
of th e  haem ophilic plasma in te r f e r e  w ith  th e  proper form ation of 
a c t iv e  th rom bop lastin  due to  th e i r  spec ies  s p e c if ic i ty ,  as 
p re v io u s ly  dem onstrated.
Didisheim  e t  a l  (1959) a lso  observed th a t  chicken antihaem ophilic 
f a c to r  (A .H .F .) does no t sho rten  th e  r e c a lc i f ic a t io n  time of human 
haem ophilic plasm a. Hawkey (I960) m aintains complete co rrec tio n  
of haem ophilic plasma by 1 in  10 d i lu t io n  of chicken adsorbed plasma 
in  a th rom bop lastin  g en era tio n  t e s t  using  human cepha lin , while she 
re p o rte d  in  another s e c tio n  of her th e s is  th a t  chicken plasma 
th rom bop lastin  g en era tio n  was very  poor whether human or chicken
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cep h a lin  were used, th e  a c tu a l c lo t t in g  tim es varying from 90 to  
more th an  180 seconds. Her fin d in g s  are  co n tra d ic to ry  and 
d i f f i c u l t  to  analy se , more so because she used chicken high-spun 
plasm a as th e  s u b s tra te  which as s h a ll  be shown l a t e r  imposes y e t 
ano ther in te r f e r in g  f a c to r ,  namely th a t  of delayed chicken su b s tra te  
r e a c t iv i ty .
C onclusions
In  a homologous human th rom boplastin  genera tion  m ixture, chicken 
adsorbed plasma does no t have any A.H.G. a c t iv i ty ,  nor does i t  c o rre c t 
th e  d e fe c t o f haem ophilic plasma. But on using  chicken thrombocyte 
suspension  in s te a d  of human p la te l e t s ,  th e  chicken adsorbed plasma 
to g e th e r  w ith  human serum produced an apprec iab le  amount of ac tiv e  
i n t r i n s i c  th rom bop lastin , suggesting  th a t  chicken plasma contains a 
f a c to r  or f a c to r s  analogous to  human A.H.G. and fa c to r  V, which 
s p e c i f ic a l ly  re a c t  w ith  chicken throm bocytes. Chicken p u r if ie d  
A.H.G. i s  spec ies  s p e c if ic  and does not re a c t w ith human cephalin .
SPECIFICITY OF CHICKEN FACTOR V IN THE T.G.T.
The s p e c i f i c i ty  of th e  re a c tio n  of chicken p u r if ie d  fa c to r  Y  
w ith  human reagen ts  in  a m odified throm boplastin  genera tion  mixture 
was in v e s t ig a te d  by incubating  equal amounts of p u r if ie d  human 
A.H.G., human serum d ilu te d  l/ lO  in  s a lin e ,  human cephalin  d ilu te d
-  142 -
l/lOO in  s a l in e ,  M/40 calcium  ch lo rid e  so lu tio n , and p u r if ie d  
chicken o r human fa c to r  V as th e  v a r ia b le . Table 30 and F igure 11 
show th a t  w hile human fa c to r  V y ie ld ed  80 per cen t a c tiv e  in t r in s ic  
th rom bop lastin  (curve a ) ,  chicken fa c to r  V y ie ld ed  14 per cent 
a c t i v i t y  (curve b ) , and th e  s a lin e  co n tro l y ie ld ed  7 per cent 
a c t i v i t y  ( curve c ) .
Conclusion
Chicken p u r if ie d  fa c to r  Y i s  species s p e c if ic  and does not 
r e a c t  w ith  th e  a c tiv e  product formed from human fa c to rs  IX, V III,
X, and cep h a lin , in  th e  presence of calcium  ch lo rid e  so lu tio n .
CHRISTMAS FACTOR ACTIVITIY OF CHICKEN SERUM
Chicken Christm as fa c to r  a c t iv i ty  in  serum was te s te d  by 
s u b s t i tu t in g  chicken serum d ilu te d  l / lO  fo r  th e  human serum, in  a 
th rom bop lastin  g en era tio n  m ixture con tain ing  a l l  th e  o ther necessary  
f a c to r s .  S ince fa c to r  VII does no t co n trib u te  any a c t iv i ty  in  the  
i n t r i n s i c  system, and fa c to rs  XII and XI are  supplied  by the  
adsorbed plasma as w e ll, the  only  v a ria b le s  in troduced  would be
fa c to r s  X and IX.
In  F igure  12, curve a rep re sen ts  human serum a c t iv i ty  when 
incubated  w ith  human adsorbed plasma, human p la te le ts  or cephalin  
(F igures 12, I  and I I  re s p e c t iv e ly ) ,  and M /40 calcium ch lo rid e .
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The chicken serum a c t iv i t y  was n e a r ly  n i l ,  s im ila r  to  th e  s a lin e  
c o n tro l ,  and to  Christm as d isease  serum (curves b, c , and d ) .
This was confirm ed by c o rre c tio n  experiments of human Christmas 
d ise a se  serum, u sing  a method based on th a t  of P itn e y  (1956) as 
d e sc rib ed  in  appendix IV, 22. Chicken serum was found to  have 
no a b i l i t y  a t  a l l  to  c o rre c t th e  d e fec t of Christmas d isease  serum 
(Table 31). Again we can deduce th a t  chicken serum has no a c t iv i t y  
e i th e r  because of th e  absence of f a c to r  IX, or to  i t s  species 
s p e c i f i c i ty .  In  view of the  prev ious species s p e c if ic i ty  observed 
w ith  human l i p id  reag e n ts , fu r th e r  in v e s tig a tio n  fo r  Christmas 
f a c to r  was c a r r ie d  out in  a m odified throm boplastin  genera tion  
m ixture in  which th e  incubation  m ixture co n sis ted  of equal p a r ts  
o f chicken adsorbed plasma d ilu te d  1/5 in  s a l in e , chicken thrombocyte 
suspension , chicken or human serum d ilu te d  1/10 in  s a l in e , and M/40 
calcium  c h lo rid e  so lu tio n . In  F igure 13, I ,  curve a shows th a t  
human serum re a c te d  w ith  chicken adsorbed plasma and chicken 
throm bocytes y ie ld in g  a f a i r l y  a c tiv e  throm boplastin , and suggesting  
th a t  human Christm as fa c to r  and human fa c to r  X are no t species 
s p e c if ic  in  such a system. Curve b fo r  chicken serum s t i l l  had 
very  l i t t l e  a c t iv i ty ,  though s l ig h t ly  h igher than  th e  sa lin e  con tro l 
or th e  Christm as d isease  serum (curves c and d ) . In  a s im ila r 
system , d ilu t io n s  of human serum in  Christmas serum ranging from 
1/2 to  1/20 y ie ld ed  100 per cent a c t iv i ty  (F igure 13, I I ,  curves ax ,
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a2 , a y  and a ^ ) . Chicken serum d ilu te d  1/2 in  Christmas serum 
(curve b^) y ie ld ed  about h a l f  th e  a c t iv i ty  of the  human serum 
d i lu te d  1/20, proving th a t  chicken serum lacks com pletely Christmas 
f a c to r  a c t iv i t y .  I t s  spec ies  s p e c if ic i ty  cannot be blamed since  
th e  system con ta in s  chicken throm boplastic reag en ts . The fa c to r  
X co n ten t o f th e  chicken serum i s  of no importance since  the  human 
Christm as d ise a se  serum a lread y  con tains optimal concen tra tio n  of 
f a c to r  X. The exact co n cen tra tio n  and/or s p e c i f ic i ty  of chicken 
f a c to r  X in  th e  serum could not be estim ated  in  such a system due 
to  th e  u n a v a i la b i l i ty  of human serum c o n g en ita lly  d e f ic ie n t  in  
f a c to r  X.
D iscussion
W arte lle  (1957b) found th a t  chicken serum lacks Christmas 
f a c to r  which she estim ated  as 1 per cent of the  human Christmas 
f a c to r  co n ce n tra tio n , using  th e  r e c a lc i f i c a t io n  time technique of 
S o u lie r  and L a rrie u  (1953 a and b) by co rre c tio n  of Christmas 
d ise a se  plasm a. D idisheim e t  a l (1959) a lso  rep o rted  s im ila r 
f in d in g s . Hawkey (i960) found th a t  chicken serum d ilu te d  1 in  
10 had some c o rre c tiv e  a c t iv i t y  on Christmas serum in  a throm boplastin  
g en e ra tio n  m ixture using  human cepha lin . Her s ix  minute c lo ttin g  
tim e fo r  chicken serum was 16 seconds as compared to  10 seconds 
fo r  th e  human serum; thus chicken serum possessed about one th i rd  
th e  a c t i v i t y  o f th e  human serum when converted in  term s of percentage
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a c t iv e  th rom boplastin .
Conclusions
Chicken serum has no Christmas fa c to r  a c t iv i ty .  Human serum 
fa c to r s  a re  no t spec ies  s p e c if ic  and re a c t w ith  chicken adsorbed 
plasma and chicken thrombocytes to  produce an in t r in s ic  th rom boplastin  
o f moderate a c t iv i t y  when compared to  human ac tiv e  throm boplastin .
THROMBOPLASTIC ACTIVITY OF CHICKEN THROMBOCYTES 
The haem ostatic fu n c tio n  of chicken thrombocytes seems to  be 
much le s s  th an  th a t  of human p la te l e t s .  F i r s t ly ,  th i s  i s  re f le c te d  
in  th e  very  long whole blood c lo t t in g  tim e, though th i s  i s  a ffec ted  
g re a t ly  by th e  absence of o the r c lo t t in g  f a c to rs ,  namely Hageman 
f a c to r ,  P .T .A ., and f a c to r  IX. Secondly, i t  i s  evident from the 
in e f f i c ie n t  c lo t  r e t r a c t io n  of chicken whole blood as estim ated by 
th e  method of M acfarlane (1938) described  in  appendix IV, 4. The 
average o f f iv e  estim atio n s  on chicken blood was 19.8 per cent of 
serum expressed in  one hour (Table 34), as compared to  48-64 per 
cen t fo r  human normal blood. The chicken blood c lo ts  were s o f t  
and f r i a b l e .  This d e fic ien cy  may a lso  be due to  the  much lower 
number of chicken thrombocytes per u n it  volume of blood, though on 
th e  o th e r hand th i s  i s  counteracted  by th e  low haem atocrit value 
of chicken blood which was u su a lly  about 30 per cen t; since
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Mac f a r  lane  (1939) has shown th a t  th e  packed c e l l  volume a f fe c ts  
th e  c lo t  r e t r a c t io n  in v e rse ly . T h ird ly , the  weak throm boplastic 
a c t i v i t y  of chicken throm bocytes i s  m anifest in  the  throm boplastin  
g en e ra tio n  t e s t  when s u b s t i tu t in g  them fo r  the  human p l a t e l e t s .
The s h o r te s t  c lo t t in g  tim es of th e  s u b s tra te  were about 20 seconds 
as compared to  10 seconds when using  human p la te le ts  or cepha lin .
F in a l ly  i t  should be re c o lle c te d  th a t  th e i r  adhesive power is  
le s s  th an  th a t  of human p la te l e t s ,  s ince chicken thrombocytes were 
f re q u e n tly  observed in  blood film s to  occur s in g ly .
Bracco e t  a l  (1956) separated  from e x tra c ts  of chicken thrombocytes 
a  m a te r ia l which corresponded p e r fe c t ly  to  5-hydroxytryptamine in  i t s  
chem ical, spectropho tom etric , and b io lo g ic a l p ro p e r tie s . They 
concluded th a t  as f a r  as th e  v aso c o n s tr ic to r  fa c to r  i s  concerned, 
b ird  throm bocytes a re  p h y s io lo g ic a lly  id e n t if ia b le  w ith  mammalian 
p l a t e l e t s .
HOMOLOGOUS CHICKEN INTRINSIC THROMBOPLASTIN GENERATION 
Because of th e  spec ies  s p e c i f ic i ty  between human p la te le ts  or 
cep h a lin  and chicken adsorbed plasma fa c to rs ,  to g e th e r w ith  the 
la c k  of fa c to rs  X II, XI, and IX in  chicken adsorbed plasma and 
serum, i t  was expected to  f in d  no genera tion  of ac tiv e  throm boplastin  
in  m ixtures of chicken adsorbed plasma and serum alone. F igure 14
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d e p ic ts  v i r t u a l ly  no a c t iv i ty  fo r  th e  mixture of chicken adsorbed 
plasma and serum, whether w ith human p la te le ts  (curve A) or w ith 
human cepha lin  (curve B ). On using  a com pletely homologous system 
co n ta in in g  chicken throm bocytes, chicken adsorbed plasma, and 
chicken serum, no a c t iv i t y  a t  a l l  was produced when subsampling 
onto chicken high-spun plasma (F igure 16, IV, curve b ) , w hile a 
n e g l ig ib le  amount of a c tiv e  throm boplastin  was produced when 
subsampling onto human high-spun plasma (Figure 16, IV, curve a ) , 
th e  minimum c lo t t in g  tim es were 30 seconds fo r  th e  homologous 
chicken m ixture (Table 24, m ixture 34), compared to  10 seconds fo r  
a homologous human m ixture (Table 21, mixture 4)
D iscussion
The poor throm boplastin  gen era tio n  obtained w ith  chicken blood 
i s  g e n e ra lly  agreed on by th e  various workers who in v e s tig a te d  the  
s u b je c t .  W artelle  (1957b) rep o rted  th a t  chicken throm boplastin  
g en era tio n  was weak compared to  th a t  of th e  human, bu t she concluded 
th a t  i t  was more a c tiv e  on f re sh  chicken su b s tra te  plasma than on 
human h igh—spun plasma, co n tra ry  to  my f in d in g s. But i f  we examine
her a c tu a l c lo t t in g  tim es we f in d  th a t  the  homologous chicken 
m ixture c lo tte d  th e  human su b s tra te  plasma in  about 80 seconds, and 
c lo t te d  th e  chicken f re sh  su b s tra te  plasma in  about 45 seconds, 
a f t e r  11 minutes incubation  w ith human cephalin  cepha lin . From 
th e  a c t iv e  th rom boplastin  d i lu t io n  curves i t  can be seen th a t  such
-  148 -
long c lo t t in g  tim es a c tu a lly  denote an ac tiv e  th rom boplastin  in  
th e  reg io n  of 0.75 -  3 per cent of the  human a c tiv e  throm boplastin , 
which i s  very  poor indeed. Didisheim e t a l (1959) and Hawkey (i960) 
a lso  observed th a t  chicken throm boplastin  genera tion  was very  poor, 
even in  homologous systems and not improved by using  chicken cepha lin  
(Hawkey, I960).
The in e f f i c ie n t  form ation of chicken in t r in s ic  a c tiv e  
th rom bop lastin  due to  the  various d e f ic ie n c ie s  or species  s p e c i f ic i ty  
p re v io u s ly  dem onstrated, i s  resp o n sib le  fo r  th e  long chicken whole 
blood c lo t t in g  tim es obta ined , a lso  fo r  th e  long r e c a lc i f ic a t io n  
tim es of chicken plasma.
Conclusion
The g en era tio n  of in t r in s ic  throm boplastin  from homologous 
chicken reag en ts  i s  very  poor and v i r t u a l ly  n i l  when compared to  
human th rom boplastin  g en era tion .
CHICKEN PLASMA. SUBSTRATE REACTIVITY IN THE T.Cr.T.
The use o f chicken high-spun plasma as th e  su b s tra te  in  the 
th rom bop lastin  g enera tion  t e s t  in s te a d  of th e  human high—spun plasma 
was found to  give much longer c lo t t in g  tim es than  p rev iously  
ob ta ined  w ith  the  human plasma s u b s tra te . For example, th e  human 
in cu b a tio n  m ixture which had 100 per cent throm boplastin  a c t iv i ty
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on th e  human su b s tra te  plasma y ie ld ed  only 10 per cent throm boplastin  
a c t i v i t y  on chicken s u b s tra te  plasma (Figure 15, I ,  curves a and b 
r e s p e c t iv e ly ) .  The same fin d in g s  were found on using  human cepha lin  
in s te a d  of th e  human p la te le t s  (F igure 15, I I ,  curves a and b ) .
Again, in cu b a tio n  of chicken adsorbed plasma w ith  human serum in  th e  
presence o f chicken thrombocytes had an a c t iv i ty  of 100 per cent on 
th e  human s u b s tra te ,  bu t only 38 per cent on the  chicken su b s tra te  
plasma (F igure 16, I I I ,  curves a and b re s p e c tiv e ly ) . This 
o b serv a tio n  i s  exaggerated in  a com pletely homologous chicken 
th rom bop lastin  g en era tio n  m ixture (F igure 16, IV, curves a and b ) . 
D iscussion
Though th e  delayed r e a c t iv i ty  of the  chicken su b s tra te  plasma 
may be a t t r ib u te d  to  th e  low prothrom bin content of chicken plasma, 
i t  i s  my b e l ie f  th a t  th e  main fa c to r  resp o n sib le  fo r  th i s  delay  i s  
th e  p ro p e r ty  of chicken fib rin o g en  whose r e a c t iv i ty  even to  
preform ed throm bin i s  delayed, as observed in  th e  throm bin- 
- f ib r in o g e n  re a c tio n  (Table 3 and F igure 3 ) .
Conclusion
The r e a c t iv i ty  of chicken s u b s tra te  plasma to  a throm boplastin  
g e n e ra tio n  m ixture i s  delayed and i s  due to  i t s  conten t of chicken 
fib rin o g e n .
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INHIBITORS AGAINST HUMAN THROMBOPLASTIN IN CHICKEN BLOOD
The presence of inhibitors in chicken plasma «-nd serum against 
human intrinsic thromboplastin formation was investigated by the 
method, of Biggs and. Macfarlane (1957) described in appendix IV, 23.
Chicken adsorbed plasma when added to human adsorbed plasma did 
not have any immediate inhibitory effect and gave clotting times 
similar to those obtained with the saline control (Table 32, A, 
mixtures 75 and 74; illustrated in Figure 17, A, curves b and a^ ). 
But after incubation of the same mixture for two hours at 37°C. the 
chicken plasma was definitely inhibitory when compared to the saline 
control (Table 32, B, mixtures 78 and 77; Figure 17, B, curves b 
and a^), or when compared to the activity of the same mixture before 
incubation (Figure 17, A, curve b). When the chicken adsorbed 
plasma was heated at 56°C. for 15 minutes before mixing it with the 
human adsorbed plasma its inhibitory activity was found to be much 
less than the unheated chicken adsorbed plasma, being very similar 
to the saline control (Figure 17, B, curve c).
On the other hand, testing chicken serum in the same manner for 
inhibitors against human intrinsic thromboplastin did not reveal 
any such activity. The serum gave values very much the same as 
the saline control (Table 33, A and B; Figure 18, A and B).
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Discussion
The inhibitory effect of chicken adsorbed plasma on hnnwn 
intrinsic thromboplastin formation cannot be ascribed to its content 
of chicken thrombocytes or extracts therefrom, as these are removed 
completely by adsorption. The removal of the observed inhibitory 
activity by heating the adsorbed plasma at 56°C. for 15 minutes 
suggests that the main factor responsible for such activity is the 
fibrinogen, since it is the only factor present in a great amount 
and removable by heat precipitation. Though not much is known 
about anti thromboplastin, according to Niewiarovski et al (1959) 
antithremboplastin withstands heating to 60°C. for 20 minutes, a 
procedure which inactivates the anti thrombin. So, if it were an 
antithromboplastin activity, the heated adsorbed plasma would have 
had the same inhibitory effect as the unheated plasma. It is 
unlikely to be due to chicken anti thrombin, because the latter was 
found to bo present in nearly the same concentration as the human 
plasma antithrombin. Vartelle (1957b) has observed that defibrination 
of the chicken adsorbed plasma by heating at 64 C. for 3 minutes 
before its addition to the human thromboplastin generation mixture 
gave a better yield of thromboplastin and concluded that chicken 
fibrinogen in the substrate or adsorbed plasma inhibits thromboplastin 
formation.
It may well be that chicken plasma thromboplastic factors react
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with human reagents (cephalin) as it were by competetive interference, 
rendering it unavailable for the human plasma factors, thus producing 
an inactive thromboplastin. This is suggested by the fact that such 
plasma factors are also destroyed by heating and may have therefore 
been the responsible agents. This is unlikely, because if chicken 
plasma factors other than fibrinogen did react with human cephalin 
their inhibitory effect would have also been obvious in mixtures of 
human and chicken plasmas without incubation, since such a reaction 
occurs in a short time and does not require prolonged incubation. 
Conclusions
Chicken adsorbed plasma has an inhibitory effect when added to 
a human thromboplastin generation mixture for a sufficiently long 
time, and can be removed by heating the adsorbed plasma to precipitate 
the fibrinogen, which is believed to be the main factor responsible 
for such anti—human thromboplastin activity.
Chicken serum does not possess any inhibitory activity against 
intrinsic thromboplastin.
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EFFICIENCY OF THE CHICKEN COAGULATION MBRHANTSM
In view of the demonstrated deficiency of various coagulation 
factors in chicken blood, namely Hageman factor, plasma thromboplastin 
factor, Christmas factor, and the low prothrombin content, together 
with the delayed reaction of chicken fibrinogen, it may seem that 
chicken are severely handicapped by a haemorrhagic diathesis. This 
in fact is not the case. Firstly, it is quite obvious that chicken 
survive the stresses they are subjected to quite admirably and 
flourish extremely well without showing any sign of a haemorrhagic 
condition. Secondly, the adequacy of the chicken intrinsic 
thromboplastin system is partly reflected in the complete prothrombin 
utilisation as assessed from the very low prothrombin consumption 
index obtained for chicken blood, whose average was 7.3 per cent 
(Table 35), a value that is perfectly normal when compared to human 
prothrombin consumption index values, though it may be argued that 
chicken prothrombin consumption —and hence thrombin generation- does 
not necessarily occur at the same rapid rate as in human blood.
Indeed, this may well be the case, judging from the prolonged 
clotting times observed for chicken whole blood and recalcified plasma.
Though chicken have an efficient extrinsic thromboplastin system, 
by itself it is not sufficient for a normal clotting defence mechanism 
since both the intrinsic and extrinsic thromboplastin systems are
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known to complement each other in the intact individual; deficiency 
in one or the other might lead to a life handicapped with haemorrhages 
or haematomata from the least of injuries.
It should be remembered, however, that the anatomy and physiology 
of chicken is different from those of the human. A system known to 
be required for the well-being of human individuals need not be 
necessary at all for chicken. Furthermore, chicken may well have 
their own particular, as yet unknown, clotting defence mechanism.
The striking anatomical differences from the human are the anatomy 
of their legs which have very tight and strong integument in the 
exposed parts, a feature that perhaps prevents the formation of 
haematomata as well as shields the underlying structures from external 
stresses. Also, such a wealth of feathers as they possess again 
seems to protect their bodies from external injuries. To my mind, 
it seems fair to expect that any injury in chicken would be detrimental 
mainly because of the interference with the proper functioning of 
vital organs, rather than to the ensuing haemorrhage.
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SUMMARY OF CHICKEN BLOOD COAGULATION MECHANISM
Chicken blood contains many coagulation factors in concentrations 
sufficient for effective haemostasis, namely fibrinogen, prothrombin, 
factor V, and probably factors VII, VIII, and X.
It completely lacks the riageman factor (factor XII), the Plasma 
Thromboplastin Antecedent (factor XI), and the Christmas factor (IX).
Chicken platelets are nucleated cells with a weak thromboplastic 
activity. Chicken fibrinogen has a characteristic delayed reactivity 
to thrombin, whether homologous or heterologous. Chicken adsorbed 
plasma possesses an inhibitory activity against human intrinsic 
thromboplastin, possibly due to its content of fibrinogen. The 
antithrombin activity of chicken plasma is similar to that of human 
plasma.
Several coagulation factors show absolute species specificity, 
namely tissue extracts, factor V, factor VII, factor VIII, the 
thrombocyte factor, and possibly factor X.
They possess an efficient extrinsic thromboplastin system, 
while their intrinsic system suffers from multiple deficiencies 
that render it very inefficient to sustain normal haemostasis, 
judging by the accepted normal human standards.
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P A R T III
BOVINE BLOOD COAGULATION MECHANISM
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BOVINE BLOOD COAGULATION MECHANISM 
Data presented in this section are based on the results of 
experiments conducted on blood samples obtained from domesticated 
cattle at the slaughter-house, which were of several breeds.
All the animals were healthy and were killed for human consumption 
purposes only. None of them suffered any disease detectable by 
the medical authorities of the slaughter-house.
BOVINE PLASMA FIBRINOGEN 
Estimation of bovine plasma fibrinogen by the micro-Kj eldahl 
method of Cullen and van Slyke (1920) and by Stirland's method 
(1956) gave similar results ranging from 620 to 750 mg fibrinogen 
per 100 mis plasma, with an average of 697 mg per cent, (Table 36).
This suggests that bovine fibrinogen has the same heat 
precipitation characteristics as the human fibrinogen.
Discussion
Fibrinogen is present in bovine plasma in a much higher 
concentration than human plasma fibrinogen, nearly twice the latter. 
Stormorken (1957b) also using Kjeldahl’s method obtained values of 
450 - 750 mg with an average of 560 mg per 100 mis of plasma.
The observed similarity in heat precipitation characteristics
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of bovine and human fibrinogens agrees with the fact that both have 
a molecular weight of about 340,000 (Caspary and Kekwick, 1954). 
Conclusion
Bovine plasma fibrinogen concentration is higher than the human, 
with an average of about 700 mg per 100 mis of plasma.
THROMBIN - FIBRINOGEN REACTION OF BOVINE PLASMA
Bovine citrated plasma gave slightly prolonged clotting times 
when clotted with various concentrations of bovine thrombin, as
compared to human citrated plasma similarly treated (Table 37 and
Figure 19). This prolongation was more obvious with the lower 
thrombin concentrations as expected, since the longer clotting 
times exaggerate the difference. The addition of a 1 per cent 
solution of pyrocatechol (final concentration in the clotting 
mixture is 0.3 per cent) shortens both the bovine and human plasma 
clotting times similarly, though the former was still slightly 
longer (Figure 19, curves b^ and a^ respectively).
Discussion
The longer clotting times observed with bovine plasma is 
believed to be mainly due to its higher content of fibrinogen, 
since the clotting time is directly proportional to the fibrinogen 
concentration provided the thrombin concentration is constant.
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There can be no question of species specificity of the thrombin 
fibrinogen reaction since bovine thrombin was used in clotting both 
plasmas; if any such specificity existed the bovine plasma clotting 
times should have been the shorter.
The delay is also not due to anti thrombin which was found to be 
present in the same concentration in bovine plasma as in the human 
plasma as shall be demonstrated later.
Seegers and Smith (1942) observed that 1 ml of human oxalated 
plasma required 2 units of bovine thrombin to clot in 15 seconds at 
28°C., while bovine oxalated plasma required 2.2 - 2.5 units, again 
reflecting the delayed reactivity of bovine plasma when clotted 
with the homologous thrombin solution. Astrup (1950) found that 
the optimum pH for bovine thrombin in phosphate buffer of 0.2 ionic 
strength to be 7.5 for human fibrinogen and 7 for bovine fibrinogen 
suggesting their species specificity. Stormorken (1957b), however, 
found that the pH optima of purified fibrinogens were less distinct 
than those of the respective plasmas and were nearly the same between 
pH 7.05 and 7.8, but that the lower limits varied, that for human 
fibrinogen was 7 while that for bovine fibrinogen was 6.9 which is 
a very slight difference. He also observed that ox plasma was less 
reactive than human plasma to bovine thrombin, being 93 per cent 
and 100 per cent respectively.
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Conclusion
Bovine plasma thrombin-fibrinogen reaction is slightly more 
delayed than that of human plasma when clotted with bovine thrombin.
This is thought to be due to its higher fibrinogen content, and 
not to species specificity or antithrombin interference.
BOVINE PLASMA ANTITHROMBIN ASSAY
Antithrombin was estimated in bovine plasma by the modified 
method of Astrup and Darling (l942d). The average of two such 
experiments was 100.7 per cent of the human plasma antithrombin 
content (Table 38, and Figure 20). However, using the method of 
Douglas and Biggs (1953)the average of three experiments was 130 
per cent of the human plasma anti thrombin activity (Table 39, and 
Figure 21). This discrepancy can perhaps be explained by the 
assumption that the latter method is more sensitive to the fibrinogen 
content of the plasma tested as it is present in an appreciable 
amount in the incubation mixture and therefore its adsorptive effect 
on thrombin would be more likely to affect the amount of residual 
thrombin. While in the method of Astrup and Darling (I942d) the 
highest plasma volume present in the last incubation mixture is 
0.06 ml mixed with 1 ml of thrombin solution, thus rendering the 
adsorptive effect of fibrinogen very negligible due to the minute
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amount of fibrinogen present.
Conclusion
Antithrombin III concentration in bovine plasma is equal to 
that present in human plasma. The total antithrombin activity of 
bovine plasma is about 130 per cent that of human plasma, most 
probably due to its higher content of fibrinogen.
BOVINE EXTRINSIC THROMBOPLASTIN SYSTEM 
Using Quick*s one-stage prothrombin time test, the bovine brain 
extract was found to clot bovine plasma in as short a time as the 
human brain and human plasma mixture, namely 14.8 and 15.8 seconds 
respectively (Table 40). The use of the heterologous brain resulted 
in a prolonged clotting time in either case, 31 and 36 seconds 
respectively. A mixture of human and bovine plasma was clotted 
with bovine brain in a slightly longer time than when bovine plasma 
was mixed with saline, which means that human plasma had an 
inhibitory effect on the bovine extrinsic system. No such 
inhibitory activity was observed for bovine plasma w h e n  added to 
a human system, in fact the bovine plasma shortened the clotting 
time slightly presumably due to its much higher factor V content 
as shall be seen later.
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Discussion
The previous findings suggest a certain degree of species 
specificity in the reaction between bovine brain extracts »T>d 
bovine plasma. Similar findings have been reported by Stormorken 
(I957d), Goldstein (1958), and Quick et al (1961).
Conclusion
Bovine brain extract is species specific towards bovine plasma.
A homologous bovine extrinsic system clots in as short a time as a 
homologous human extrinsic system. The bovine extrinsic system 
is therefore assumed to be haemostatically as efficient as the 
human system.
SPECIES SPECIFICITY OF BOVINE FACTOR V
The species specificity of purified human or bovine factor V 
was investigated in a two-stage extrinsic thromboplastin system by 
incubating the purified factor V with the diluted human or bovine 
brain extract and testing the formed thromboplastin activity of 
the mixture by subsampling onto human substrate fresh plasma and 
observing the latter*s clotting time on simultaneous recalcification 
as described in appendix IV, 16.
Table 41 shows that human brain extract produced more activity 
when incubated with the bovine factor V than with the human factor V.
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It seems therefore that bovine factor V does not exhibit any 
species specificity, or if any this is masked by the higher 
concentration of the bovine factor V. The species specificity 
of the bovine brain extract towards the human substrate plasma was 
counteracted by the previous inclusion of human serum diluted 1 in 
10 in saline to the incubation mixture allowing the serum factors 
to react with the bovine brain, as they seem to be the main factors 
responsible for such species specificity. Prolonged incubation 
was not necessary since the complete reaction seemed to occur 
within one minute of incubation.
Prom the way Stormorken (1957c) used bovine and human purified 
factor V preparations interchangeably in his two-stage methods for 
prothrombin estimations it seems that he believed bovine factor V 
not to be species specific towards human brain thromboplastin. 
Conclusions
Bovine factor V is not species specific towards human brain 
extracts. Similarly, human factor V is not species specific 
towards bovine brain extracts.
BOVINE PLASMA FACTOR V ASSAY 
Bovine plasma factor V content was estimated by the degree of 
correction of human stored plasma, utilising human brain extract.
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The average of three estimations was 268 per cent of the human 
plasma factor V activity (Table 42 and Figure 22).
Owren (1947) first observed the high bovine plasma factor V 
content. Murphy and Seegers (1948) using a two-stage technique 
reported about a tenfold concentration of bovine factor V as 
compared to the human factor V concentration in plasma (120-140 
units per ml and 12-17 units per ml of plasma respectively).
Using one-stage techniques Wartelle (1957b) found it to be four 
times the human, Stormorken (1957a) reported it to be five times 
the human, Nour-Eldin and Wilkinson (1957) found it three to four 
times the human, while Quick et al (1961) reported it as eight 
times the human factor V concentration. Stormorken (1957a) also 
demonstrated the increased stability of bovine factor V, a fact 
confirmed by Wartelle (1957b). This stability accounts for the 
presence of factor V in the bovine serum as observed by Alexander, 
Goldstein and Landwehr (1951). Bergna (I960) reported a value 
of 200 per cent for the factor V activity in bovine serum as 
compared to human plasma factor V content.
Conclusion
Factor V concentration in bovine plasma is much higher than 
its concentration in human plasma, at least by threefolds.
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SPECIES SPECIFICITY OF BOVINE SERUM FACTORS 
A purified preparation containing factors VII and X (appendix 
III, 10) was incubated with the brain extract and calcium chloride 
solution, and at minute intervals samples were removed and pipetted 
onto fresh human plasma or onto phenindione plasma together with an 
aliquot of calcium enloride solution. The clotting time of the 
substrate is indicative of the thromboplastic activity produced in 
the incubation mixture, this being dependent on the proper interaction 
of the reagents concerned.
The incubation of human brain extract and human purified factor 
VII and X preparation resulted in clotting of the substrate normal 
plasma and phenindione plasma after one half minute of incubation 
in 11 and 15 seconds respectively (Table 43), while if incubated 
with the bovine serum factors preparation the clotting times were 
20 and 27 seconds respectively. The six minute clotting times 
were similar. Thus there was a certain degree of species specificity 
between the bovine serum factors and the human brain extract which 
was only demonstrable within the first minute of incubation, being 
surmounted with prolonged incubation.
Similarly, incubation of the human serum factors with bovine 
brain extract resulted in longer clotting times within the first 
minute of incubation than those obtained with the homologous bovine
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mixture. Again, further incubation eliminated this delay. 
Furthermore, the bovine brain extract activated with the bovine 
serum factors clotted the human substrate plasma in a shorter time 
than that obtained with the human homologous mixture. This is 
difficult to explain satisfactorily, but it should be remembered 
that both the brain preparations were not necessarily of identical 
concentration in terms of active material per unit volume.
Discussion
Stormorken (I957d) has emphasised the species specificity of 
the bovine factor VII in one-stage assay systems. This is confirmed 
by the findings reported here in the two-stage system. The delay 
observed in the half and one minute readings is that measured in 
a one-stage test which is the sum total of the time required for 
the brain extract activation (incubation time in the above system) 
and that required for prothrombin activation and fibrin formation.
The dissappearance of this delay on further incubation of the 
heterologous reagents suggests that the species specificity observed 
is not absolute as for instance in the case of chicken—human mixtures.
As yet no information has been published regarding the species 
specificity of bovine factor X. Since the purified preparation of 
factor VII also contained factor X, it is assumed that partial 
species specificity of both these factors is responsible for the 
observed delay. Until methods are devised for the preparation of
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factors VII and X in pure form free from each other, the exact 
specificity of each factor cannot be known with certainty.
Conclusions
Human and bovine serum factors are partly species specific 
towards the homologous brain extract. Prolonged incubation of 
heterologous mixtures eliminates their species specificity.
BOVINE PLASMA FACTOR VII ASSAY 
Utilising the one-stage methods of Biggs and Macfarlane (1957) 
and Koller et al (1951) it was found that the concentration of factor 
VII in the test plasma was dependent on the type (species) of the 
brain extract used. The use of human brain in the first method 
showed that bovine plasma contained about one fifth of the human 
plasma factor VII content (Table 44, experiments 1 and 2; and 
Figure 23, curve A). Its use in the second method gave a value 
of 13 per cent of the human factor VII concentration (Table 44, 
method B with human brain; and Figure 23, curve B). Assay of the 
same plasma pools with bovine brain extract instead showed that the 
factor VII content of bovine plasma was about four times that of 
human plasma. In other words, the human plasma factor VII content 
was calculated as 23 per cent of the bovine plasma factor VII 
activity (Table 44, method B with bovine brain; and Figure 23, curve C).
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Discussion
Firstly it should be noted that the factor VII deficient plasmas 
used in both the above assay systems were also deficient in factor 
X to a certain extent in the phenindione plasma and completely in 
the Seitz-filtered bovine plasma. Therefore the measured corrective 
activity of the test or control plasmas was actually due to both 
factors VII and X. However, in view of the presence of factor X 
in bovine plasma in a similar concentration to human plasma as shall 
be shown shortly, the differences observed in these assay systems 
may be assumed to be largely due to changes in factor VII content. 
Still, the issue is further complicated by whatever effect the species 
specificity of factor X may have towards the type of brain extract 
used.
Judging from the short one-stage prothrombin time of bovine 
plasma, together with the reciprocal findings observed in the factor 
VII assays according to the species of brain used, it can be safely 
presumed that bovine plasma contains factor VII in a concentration 
sufficient to effect normal haemostasis.
The low values of bovine plasma factor VII content reported by 
Koller et al (1951), Wartelle (1957b), and Didisheim et al (1959) 
can be ascribed to the use of human brain extracts in their assay 
systems. Stormorken (1957d) tried measuring the factor VII content 
by correction of human plasma congenitally deficient in factor VII,
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supplying excess factor V of bovine origin, and clotting the mixture 
with the homologous brain thromboplastin. He stressed that the 
quantitative comparison between the species cannot be done with 
present day methods. Quick et al (1961) also realised this difficulty 
while investigating variations in the prothrombin complex in various 
species, and did not attempt to study the quantitative differences 
of factors VII and X in the species surveyed. Strangely enough,
Hawkey (i960) reported a value of 86 per cent for bovine plasma 
factor VII activity, and 90 per cent for bovine serum factor VII 
activity, though she measured the degree of correction of human 
factor VII deficient plasma of congenital origin, using human brain 
extract as the lipid thromboplastin agent.
Conclusion
No valid quantitative measurement of bovine factor VII as compared 
to human factor VII in plasma could be made with present day methods 
with any degree of precision. Bovine plasma, however, contains 
sufficient factor VII to give a normal one—stage prothrombin time in 
a homologous system.
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BOVINE PLASMA FACTOR X ASSAY
Bovine plasma factor X content was estimated by the method of 
Bachmann, Duckert, and Koller (1958) which measures the degree of 
correction of Seitz-filtered bovine plasma when clotted with Russell's 
viper venom and cephalin in the presence of calcium chloride solution. 
The action of R.V.V. is independent of factor VII and therefore the 
only variant in the test mixture will be the factor X concentration, 
all the other necessary factors being present in optimum amounts.
Bovine plasma was found to contain 101 per cent of the human 
plasma factor X content, while bovine serum contained 90 per cent 
of the human serum factor X activity (Table 45). No species 
specificity towards the R.V.V. was observed.
Hawkey (1960) using the same method reported that bovine reagents 
contained comparable amounts of factor X as in human serum.
Conclusion
Bovine plasma and serum contain about the same concentration 
of factor X activity as present in the human control reagents.
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MSAgjR@@jT_OF BOVINE PLASMA. PROTHROMBIN
The bovine plasma prothrombin content was estimated by three 
different methods. Firstly, by the one-stage technique of Koller 
et al (1951) which measures the degree of correction of bovine 
plasma rendered prothrombin-free by adsorption, adding prothrombin- 
free human serum to supply the serum factors necessary for the 
extrinsic prothrombin activation, and clotting the mixture with 
brain extract in the presence of calcium chloride solution. Using 
human brain extract, the bovine plasma prothrombin was estimated as 
45 per cent of the human plasma prothrombin (Table 46, experiment 1; 
and Figure 24, curve A). When bovine brain extract was used, the 
bovine plasma prothrombin content was found to be about twice the 
amount present in the human plasma (Table 46, experiments 2 and 3; 
and Figure 24, curve B).
The second method used was the two-stage area method of Biggs 
and Douglas (1953a). Bovine plasma prothrombin values when 
estimated using human brain were 116 per cent and on another 
occassion 233 per cent of the human plasma prothrombin (Table 47, 
experiments 8 and 7 respectively). The use of bovine brain extract, 
however, gave higher results for the same plasmas, namely 162 and 
299 per cent respectively (Table 47, experiments 5 and 6). A third 
bovine plasma pool had 101 per cent of human plasma prothrombin,
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even when estimated with bovine brain extract.
The third method employed was the globulin fraction technique 
of Douglas and Biggs (1953) which is also a two—stage system. In 
spite of the use of human brain extract only, the bovine plasma 
prothrombin content was about the same as that of human plasma, 
namely 96 and 89 per cent of the human prothrombin activity (Table 
48, experiments 1 and 2).
Discussion
The low results obtained by the one-stage method when using 
human brain were expected in view of the previous experiences of 
Koller et al (1951) who reported bovine prothrombin as 40 per cent 
of the human prothrombin. Didisheim et al (1959) also reported 
low bovine plasma prothrombin content. Quick et al (1961) found 
that in one-stage methods the results varied greatly according to 
the type of brain extract used. This is only natural since in 
such methods the delayed reaction between the heterologous brain- 
plasma mixture causes an initial lag until enough active extrinsic 
thromboplastin is formed, then this converts the prothrombin into 
thrombin thereby clotting the fibrinogen in the mixture. All 
these steps contribute to the final reading which is therefore very 
misleading as far as the concentration of the prothrombin is concerned. 
For quantitative comparative purposes, the presence of a heterologous 
brain—plasma mixture is unavoidable in any one—stage test system,
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which is therefore rendered inadequate for such estimations.
Two-stage procedures are less amenable to the interfering effect 
of heterologous mixtures since incubation is over longer periods 
which though largely eliminates the species specificity does not 
completely nullify it, since the use of the homologous brain (Figure 
25, curve B) gave a final higher value of prothrombin than when the 
same plasma was assayed with a heterologous brain extract (Figure 25, 
curve C). The latter curve illustrates the slow prothrombin 
conversion due to the delay in active thromboplastin formation 
caused by the use of a heterologous brain-plasma mixture.
However, if it is feasible to compare the values obtained for 
bovine and human plasmas when each was assayed with the use of the 
homologous brain extract, on the assumption that we are measuring 
the maximum amount of prothrombin that could be converted optimally 
into thrombin, we find that bovine prothrombin concentration in the 
plasma varied from 101 to 299 per cent of the human control plasma 
prothrombin content. Plasma antithrombin levels were about the 
same a.pd therefore without effect on these results.
Murphy and Seeger (1948) using a two-stage method reported 
250^ *285 prothrombin units per ml of bovine plasma as compared to 
290 units per ml of human plasma. Quick et al (1961) obtained 
similar findings for both the bovine and the human plasmas.
Stormorken (1957c) stressed the need for homologous factor VII -
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brain combinations in one— and two—stage methods for prothrombin 
assays. He further used a modified two—stage method which is in 
fact a three-stage method. In the first stage the activated 
extrinsic thromboplastin is formed by the incubation of the brain 
extract with the homologous purified factor VII preparation (which 
also contains factor X), bovine factor V, and calcium chloride 
solution for five minutes at 37°C. An aliquot from this mixture 
added to equal aliquots of the test plasma and calcium chloride 
solution constitutes the second stage. The third stage comprises 
subsampling from the latter solution onto purified fibrinogen 
solution. He had to use a combination of brain - factor VII - 
plasma that was homologous. With this method he found bovine 
prothrombin in plasma to be 86 per cent that in human plasma.
Perhaps the most suitable method for the comparative estimation 
of bovine prothrombin is the globulin fraction method of Douglas 
and Biggs (1953). Firstly, this system is free from anti thrombin. 
Secondly, the prolonged incubation over a thirty minutes' period 
with the brain extract largely eliminates the effect of species 
specificities and allows for the maximal formation of thrombin, 
which is proportional to the prothrombin content of the mixture.
The average concentration of prothrombin in two bovine plasma pools 
estimated by this method is 92.6 per cent of the human control 
plasma prothrombin content.
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Conclusions
The bovine plasma prothrombin content is at least equal to the 
human plasma prothrombin content. One-stage methods are unsuitable 
for its estimation. The globulin fraction method of Douglas and 
Biggs (1953) is believed to be the most suited method for its 
measurement.
EFFICIENCY OF THE BOVINE EXTRINSIC THROMBOPLASTIN SYSTEM
All the factors concerned in the extrinsic system of prothrombin 
activation seem to be present in the bovine plasma in optimum amounts 
when measured by specific assays.
In vitro tests also show that extrinsic prothrombin conversion 
can be brought about in bovine plasma as quickly and efficiently as 
in human plasma, either by the use of the homologous brain extract, 
or of Russell's viper venom (Table 50).
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BOVINE__INTRINSIC THROMBOPLASTIN SYSTEM
Bovine whole blood clotted in ordinary glass tubes in 6» 41" 
while in siliconed glass tubes it clotted in 13' 15" (Table 52). 
This rapid clotting in ordinary glass tubes is within the normal 
limits for human whole blood clotting times, and indicates the 
efficient generation of intrinsic thromboplastin in bovine whole 
blood, a fact which is also substantiated by the finding of an 
average clotting time of the recalcified bovine citrated plasma of 
145 seconds (Table 53) which again is within the normal limits for 
human plasma recalcified clotting time.
The delayed clotting of bovine whole blood in siliconed tubes 
suggests the presence of the contact factors in bovine blood whose 
action is interfered with by the use of the siliconed ware. 
Conclusions
The whole blood clotting time and the recalcification time of 
bovine reagents are within the normal range obtained with human 
reagents.
BOVINE CONTACT FACTORS 
The activity of the bovine contact factors was measured by the 
method of Ratnoff and Rosenblum (1958). The glass activated bovine
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preparation behaved in a virtually identical manner as the human 
preparation, clotting the intact platelet—deficient human substrate 
plasma in 15 minutes after recalcification (Table 54).
Discussion
The similar activities of bovine and human plasma preparations 
suggest that bovine plasma contains both Hageman factor and P.T.A. 
in a concentration sufficient for the proper production of intrinsic 
thromboplastin. This is substantiated by the normal behaviour of 
bovine reagents in the thromboplastin generation mixtures as shall 
be shown later. Wartelle (1957b) by correction of congenitally 
deficient plasma with bovine plasma in a recalcified clotting time 
technique reported that bovine plasma had 20-30 per cent of the 
human plasma Hageman factor activity, while its content of P.T.A. 
was much higher than that of human plasma.
Conclusions
Bovine plasma contains both the contact factors in a concentration 
sufficient for the production of normal amounts of intrinsic 
prothrombin activator. They are active in a human system and 
therefore are not species specific.
BOVINE PLASMA ANTIHAEMQPHILIC GLOBULIN ACTIVITY
The thromboplastic activity of bovine adsorbed plasma when 
incubated with human serum in tne thromboplastin generation test 
of Biggs and Douglas (1953b) using human platelets was found to be 
very similar to that of human adsorbed plasma (Figure 26, A, curves 
a and b). However, active thromboplastin was rapidly formed in 
appreciable amounts within the first minute of incubation in the 
case of the bovine adsorbed plasma (curve b). This is believed 
to be due to the higher factor V content of the bovine plasma. 
Essentially similar results were obtained when bovine platelets 
were used instead of the human platelets (Figure 26, B).
The ability of bovine adsorbed plasma to correct the deficiency 
in haemophilic adsorbed plasma was tested in a similar thromboplastin 
generation technique. Various dilutions of the adsorbed bovine 
plasma in the adsorbed haemophilic plasma were tested as compared 
to dilutions of human adsorbed plasma in the haemophilic adsorbed 
plasma. All other reagents in the incubation mixture were constant 
and of human origin. Figure 27 shows the activity produced by the 
human plasma dilutions (Graph A) together with that produced by the 
bovine plasma dilutions (Graph B) • The latter were found to possess 
much higher A.H.G. activity, about five times the human plasma A.H.G. 
activity.
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A.H.G. measurement in bovine plasma by the method of Pitney 
(1956) gave A.H.G. values ranging from 590 to 1107 per cent of the 
human control plasma A.H.G. content, with an average of 816 per cent 
(Table 57). Figure 28 illustrates how the A.H.G. content of each 
plasma pool was calculated from the human plasma dilution curve. 
Discussion
The high A.H.G. content of bovine plasma has been reported by 
several groups of investigators. Maefarlane, Biggs, and Bidwell 
(1954) found it to be 16 times the content of human plasma, as tested 
in a modified thromboplastin generation test. Biggs, Eveling, and 
Richards (1955) using perhaps the most accurate method as yet devised 
for the measurement of A.H.G. found that bovine plasma had an average 
of 3.5 units per ml, while human plasma contained an average of 
0.28 units per ml, when both plasmas were compared to the activity 
of a standard preparation of purified bovine A.H.G. in a modified 
thromboplastin generation test. In other words, the bovine plasma 
A.H.G. activity was about 12.8 times that of the human plasma. 
Wartelle (1957b) reported a value of 15 to 20 times the content of 
human plasma, when correcting the recalcification time of haemophilic 
plasma in a one—stage technique that could have been easily affected 
by the higher bovine plasma factor V content. Didisheim et al (1959) 
also found very high values of A.H.G. in bovine plasma, while Hawkey 
(1960) reported complete correction of haemophilic plasma in the
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thromboplastin generation test by 1 in 10 dilution of bovine plasma.
The variation in A.H.G. concentrations reported is by no means 
strange in view of the different methods used, the different standards 
of comparison assumed, especially if human plasma was chosen as the 
standard since its A.H.G. concentration normally varies from 50-200 
per cent (Pitney, 1958) or 30-200 per cent (Biggs, Eveling, and 
Richards, 1955). Also because of the differences in methods of 
obtaining the blood samples, as well as the differences in methods 
used to kill the animals from one slaughter-house to another, which 
as Bidwell (1958) suggested would account for much of the variation 
in results on plasmas not obtained by venipuncture. Finally, 
because A.H.G. levels in the bovine plasma are expected to vary at 
least to a certain extent if not as much as human levels do.
The variation between the values obtained for bovine plasma 
observed in the six experiments conducted (Table 57) was only of 
twofolds magnitude. This may be due to the use of pooled plasma 
for each experiment which would greatly minimise the effect of 
individual differences. If the average value obtained for bovine 
plasma is corrected for the actual A.H.G. concentration of the human 
plasma used as standard which is 150 per cent of the A.H.G. activity 
of plasma pooled from ten normal individuals (Table i) it would read 
12 times the content of average normal human plasma.
Spaet and Kinsell (1953) observed that bovine plasma showed no
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loss of A.H.G. activity on storage for 24 hours at both 4°C. and 
20°C., while human plasma showed significant deterioration within 
4 hours at 20°C. Such increased stability of the bovine A.H.G. 
activity was also confirmed by Wartelle (1957b) both in citrated 
and oxalated bovine plasma.
Conclusions
The antihaemophilic globulin concentration in bovine plasma 
is at least eight times that of the control human plasma. Bovine 
antihaemophilic globulin is not species specific.
BOVINE SERUM CHRISTMAS FACTOR ACTIVITY 
The activity of bovine serum in the thromboplastin generation 
test using human platelets and human adsorbed plasma to supply the 
other factors was found to be initially higher than the activity 
of human serum but the final yield of active thromboplastin was 
slightly lower (Figure 29, A). Similar findings were obtained 
with bovine platelets (Figure 29, B). The initial increased 
activity is believed to be due to the high content of factor V in 
the bovine serum which is said to be 200 per cent of the human 
plasma factor V content (Bergna, I960). Correction of Christmas 
serum by bovine serum in a thromboplastin generation mixture 
revealed that bovine serum has about one quarter of the corrective
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ability of the human control serum (Figure 30, A and B). This was 
confirmed by the exact measurement of Christmas factor in bovine 
serum by a modified method based on that of Pitney (1958) depending 
on its ability to correct the defect of Christmas disease serum in 
a thromboplastin generation mixture. The concentration of 
Christmas factor in bovine serum ranged from 10.5 to 33.5 per cent 
of the human control serum content (Table 58). The average of the 
six experiments was 20.8 per cent of human serum Christmas factor 
activity. Figure 31 illustrates experiment 4 and the method of 
calculating the Christmas factor values for each dilution of serum 
tested as read from the human serum dilution curve.
Discussion
In view of the high Christmas factor content of the standard 
human serum used in the above assays which is about 200 per cent 
of the average normal human (Table i) it can be assumed that the 
bovine serum contained 40 per cent of the average human serum 
Christmas factor concentration. Wartelle (1957b) using the cephalin 
recalcification clotting time method of Soulier and Larrieu (1953b) 
found that bovine plasma contained 40—80 per cent of the human 
plasma Christmas factor, by correction of Christmas disease plasma. 
Didisheim et al (1959) reported uniform levels of Christmas factor 
in all mammals, while Hawkey (i960) found that a 1 in 10 dilution 
of bovine plasma or serum caused complete correction of Christmas
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serum in the thromboplastin generation test. Again this variation 
in the reported levels can be ascribed to the different methods and 
different standards used.
C onclusions
Bovine serum contains Christmas factor in a concentration about 
20 per cent of the human control serum used. Bovine Christmas 
factor is not species specific.
THROMBOFLASTIC ACTIVITY OF BOVINE PLATELETS 
Bovine whole blood contains an average of 312,350 platelets 
per cubic millimetre (Table 51) which is similar to the average 
number present in normal human blood. Bovine platelets are also 
morphologically similar to human platelets. However, it is much 
more difficult to separate the bovine platelets adequately from 
bovine blood for the preparation of platelet suspensions for use 
in the thromboplastin generation test. This is due to the very 
low sedimentation rate of bovine blood (0*5 mm per hour), therefore 
comparatively high centrifugation speeds have to be used to effect 
adequate separation of the bovine blood cells from the plasma, 
speeds which result also in the sedimentation of most of the platelets 
present. The lack of platelets in the supernatant plasma separated 
by the conventional one time centrifugation of blood perhaps accounts
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for the poor platelet suspensions obtained by Bidisheim et al (1959) 
which resulted in poor homologous thromboplastin generation. This 
difficulty was circumvented by the separation of the bovine plasma 
in stages after centrifugation for 5 minutes* intervals at increasing 
speeds, each time pipetting off the uppermost layer of relatively 
clear plasma which usually amounted to not more than 0.5 ml each 
time. The method is described in detail in appendix III, 1, ii 
and appendix III, 15, C. Such prepared plasma yielded an appreciable 
amount of platelet sediment on centrifugation at 15,000 r.p.m.
The thromboplastic activity of bovine platelets was compared 
to that of human platelets in the thromboplastin generation test 
of Biggs and Douglas (1953b) using identical incubation mixtures as 
far as the other factors are concerned. The bovine platelets had 
a weaker activity than that of the human platelet suspension, 
whether the incubation mixture contained homologous bovine or human 
reagents, (Figure 32, A and B). This cannot be due to any species 
specificity, but is believed to be due to the fewer number of 
platelets p©r unit volume in the bovine preparation. In fact, 
stronger preparations could have been made, but the comparison 
would not have been valid since bovine and human platelet suspensions 
are not prepared in an identical manner anyway. The main feature 
is that bovine platelets are active in the thromboplastin generation 
test even when using human adsorbed plasma and serum, yielding over
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90 per cent active thromboplastin after 6 minutes of incubation 
(Figure 32, B, curve b). Their less obvious activity when using 
bovine adsorbed plasma and bovine serum (Figure 32, A, curve b) is 
due to the Christmas defect in the bovine serum; the use of bovine 
adsorbed plasma with human normal serum yielded 103 per cent active 
thromboplastin (Table 56, mixture 106; and Figure 26, B, curve b). 
Conclusion
Bovine platelets possess similar thromboplastic activity to 
human platelets in the thromboplastin generation test.
BOVINE PLASMA SUBSTRATE REACTIVITY IN THE T.G.T.
The use of bovine high-spun plasma as the substrate in the 
thromboplastin generation test instead of the human high-spun plasma 
resulted in a consistent prolongation of the clotting times obtained, 
irrespective of the incubation mixture reagents being homologous or 
heterologous or combinations therefrom (Figures 33,A and B, and 34,
A and B, constructed from Tables 55, 56, 59, and 60).
This delayed reactivity of bovine plasma is reminiscent of its 
delayed thrombin—fibrinogen reaction and may perhaps be also due to 
its higher content of fibrinogen.
Conclusion
Bovine plasma is less reactive than human plasma to active
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thromboplastin, whether homologous or heterologous.
H^^L^OUS__BOVIj^_^NTRINSIC THROMBOPLASTIN GENERATION 
The production of homologous bovine active thromboplastin by 
the incubation of bovine adsorbed plasma, bovine serum, and bovine 
platelets, and subsampling onto human high—spun plasma resulted in 
an activity of 60-70 per cent of thromboplastin (Figure 34, B, curve 
a), while subsampling onto bovine high-spun plasma greatly diminished 
it to about 30 per cent (Figure 34, B, curve b). In other words, 
in a completely homologous bovine system the production of active 
intrinsic thromboplastin was much weaker than in a homologous human 
system. This is partly due to the Christmas factor deficiency in 
the bovine serum and partly due to the delayed reactivity of the 
bovine substrate plasma.
EFFICIENCY OF BOVINE INTRINSIC THROMBOHiASTIN^SYS^M 
All the factors concerned in the intrinsic thromboplastin system 
for prothrombin activation are present in bovine plasma and serum in 
amounts adequate for effective haemostasis, with the exception of 
Christmas factor which is moderately deficient in bovine serum and 
is therefore also assumed to be moderately deficient in bovine plasma,
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though this may not be the case. However, since normal clotting 
times were obtained for whole bovine blood and for the recalcified 
citrated plasma, and since the bovine blood had a prothrombin 
consumption index of 15-39 per cent (Table 49), it seems that the 
amount of Christmas factor present is sufficient for the production 
of physiologically effective concentrations of intrinsic active 
thromboplastin. This is further substantiated by the fact that 
a concentration of 50 per cent of Christmas factor is sufficient 
for effective haemostasis in the human (Biggs, 1955), and also by 
the findings of Johnson et al (1957) and Seegers (1962) that low 
concentrations of Christmas factor have been frequently observed 
in sera of perfectly normal individuals.
It should be remembered that the formation of active 
thromboplastin in the thromboplastin generation test occurs in an 
artificial system and though it reflects the general fundamental 
steps of reaction, the physiological formation of intrinsic active 
thromboplastin in vivo may not necessarily proceed in the same 
speed. Therefore, in spite of the delayed reactivity of bovine 
plasma in the thromboplastin generation test to a homologous 
incubation mixture, which is only delayed several seconds, it is 
believed that the bovine species have an efficient intrinsic 
thromboplastin system.
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SUMMARY OF BOVINE BLOOD COAGULATION MECHANISM 
Bovine blood contains all coagulation factors known to take 
part in human blood coagulation. Compared to the human control 
plasma the bovine fibrinogen measured approximately 200 per cent, 
factor V about 300 per cent, and factor VIII about 800 per cent. 
Prothrombin, factor X, factor XI, and factor XII occured in 
comparable amounts to the human reagents. Factor VII was present 
in sufficient amount for normal haemostasis, while factor IX was 
about 20 per cent of the human. Bovine platelets and tissue 
extracts were as active as their human analogues.
The bovine plasma exhibited a delayed reactivity to thrombin, 
most probably due to its higher content of fibrinogen.
Species specificity was not observed except for factors VII 
«.r>d X when tested for in the presence of brain extracts; their 
specificity, however, was not absolute.
Both the extrinsic and the intrinsic systems of prothrombin 
activation were found to be efficient.
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P A R T  IV
HGBSR BLOOD COAGULATION MECHANISM
-  190 -
HORSE BLOOD COAGULATION MECHANISM 
Data presented in this section were based on the results of 
experiments conducted on blood samples obtained from horses, mainly 
English Thoroughbred racing horses and Clydesdale farm working 
horses. None of the animals suffered from any known haemorrhagic 
condition and were under the care of the staff of Glasgow University 
Veterinary Hospital for minor surgical conditions.
HORSE PLASMA FIBRINOGEN 
The fibrinogen in horse plasma was estimated by the modified 
Greenberg method described in appendix IV, 2, II. The average of
four experiments was 436.5 mg of fibrinogen per 100 mis of plasma, 
with a range of 325-567 (Table 61).
Discussion
The observed horse plasma fibrinogen level approximates a high 
normal human plasma fibrinogen content. Stormorken (1957b) using 
the Kjeldahl method obtained the value of 300 mg per 100 mis of 
horse plasma. Also Fantl and Marr (1958) using the same method 
reported it to be 200—350 mg per 100 mis of oxalated horse plasma, 
though they used a conversion factor of 5*92 instead of the usual 
factor of 6.25 for fibrinogen calculation.
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Conclusion
Horse plasma fibrinogen is about equal to a high normal human 
fibrinogen content, with an average of 436.5 mg per 100 mis of plasma.
THROMBIN - FIBRINOGEN REACTION OF HORSE PLASMA
Horse citrated plasma gave prolonged clotting times when clotted 
with various concentrations of bovine thrombin, nearly twice the 
clotting times obtained with the control human citrated plasma 
(Table 62, and Figure 35). The addition of a 1 per cent of 
pyrocatechol solution (final concentration in the clotting mixture 
was 0*3 per cent) greatly shortened the clotting times of horse 
plasma which were still slightly longer than those obtained for 
human plasma similarly treated (Figure 35, curves and a,^).
The addition of 1 per cent of pyrocatechol solution together with 
calcium chloride solution further reduced the clotting times of 
both horse and human plasmas, but the former still gave slightly 
longer clotting times, the difference being more obvious with the 
low thrombin concentrations (curves b^ and a^ respectively). 
Discussion
The longer clotting times observed with horse plasma seem to 
be mainly due to the property of horse fibrinogen which has a 
delayed reaction when clotted with various types of thrombin as
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shall be shown shortly in a purified system. The delay may also 
be partly due to the high antithrombin content of horse plasma which 
was found to be about 150 per cent of the human plasma antithrombin 
content.
The delayed thrombin-fibrinogen reaction of horse plasma has 
been previously demonstrated by various workers. Wartelle (1957b) 
observed that horse thrombin clotted horse plasma in a longer time 
than it did human plasma. Stormorken (1957b) has shown that the 
horse plasma had 65 per cent of the reactivity of human plasma when 
clotted with bovine thrombin, and that the addition of calcium 
chloride solution which cancels the influence of changes in the pH 
did not alter the proportional differences previously reported.
He further observed that the same pattern of reactivity holds true 
for purified fibrinogens, and that horse thrombin was less reactive 
than either ox or human thrombins. Such findings were again 
confirmed by Fantl and Marr (1958) who obtained prolonged clotting 
times of horse plasma when clotted with horse, bovine, and human 
thrombins. They attributed this phenomenon to the characteristic 
structure of the horse fibrinogen. Astrup and Darling (1942c) 
believed that horse fibrinogen is chemically different from other 
fibrinogens since it was maximally precipitated by 25 per cent 
saturation with ammonium sulphate as compared to 30 per cent and 
35-40 per cent for ox and chicken fibrinogens respectively.
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Astrup (1950) has also shown that the optimum pH for horse fibrinogen 
when clotted with bovine thrombin in phosphate buffer of 0.2 ionic 
strength was 7 as compared to 7.5 for human fibrinogen.
Species specificity of the horse thrombin-fibrinogen reaction
The horse thrombin-fibrinogen reaction was investigated in a 
purified system using thrombin and fibrinogen reagents prepared free 
from anti thrombin as described in appendix III, 7, A and B, and 
appendix III, 6, A respectively. When 0.4 ml amounts of horse and 
human fibrinogen solutions were clotted with 0.1 ml amounts of human, 
bovine, and horse thrombins, it was observed that the horse 
fibrinogen gave consistently longer clotting times than the human 
fibrinogen (Table 63). Also, horse thrombin exhibited a weaker 
action than human thrombin, both on human and horse fibrinogen 
substrate solutions. The addition of 0.1 ml of 1 per cent 
pyrocatechol solution to the fibrinogen substrates shortened their 
clotting times appreciably regardless of the type of thrombin used, 
though horse fibrinogen still had longer clotting times than human 
fibrinogen.
Conclusions
Horse plasma thrombin-fibrinogen reaction is more prolonged 
than that of human plasma. The same delay was also observed with 
purified thrombin and fibrinogen solutions. This is due to the 
inherent property of horse fibrinogen. In the plasma the delay
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may also be partly due to the high antithrombin content of the 
horse plasma. Horse fibrinogen is not species specific since 
it is more actively clotted with human and bovine thrombins.
HORSE PLASMA ANTITHROMBIN ASSAY
Horse plasma antithrombin content when estimated by the method 
of Douglas and Biggs (1953) was found to be about 134 per cent 
that of human plasma anti thrombin content (Table 64, and Figure 36).
Its estimation by the modified method of Astrup and Darling 
(I942d) gave values of 131-167 per cent of human plasma anti thrombin 
content with an average of 150.7 per cent (Table 65, and Figure 37). 
Conclusion
Horse plasma antithrombin content is about 150 per cent that 
of human plasma. It may therefore be responsible for some of the 
delay observed in the horse thrombin-fibrinogen reaction of the 
plasma, especially with the high dilutions of thrombin.
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j^ g § E _ ^ ^ IN S IC  THROMBOPLASTIN SYSTEM
Using Quick’s one-stage prothrombin time test, horse plasma was 
found to clot in the shortest time with horse brain extract, namely 
13 seconds, while with human brain extract it clotted in 18 seconds 
(Table 66). Similarly, human plasma gave much longer clotting times 
with the horse brain extract. Mixtures of equal amounts of horse 
and human plasma gave similar clotting times with both horse and 
human brain extracts, suggesting the absence of demonstrable 
inhibitory activity in either plasma against the heterologous brain 
thromboplastin.
Discussion
The above findings suggest that there is a certain degree of 
species specificity in the reaction between horse brain extract and 
the horse plasma. Similar findings have been reported by Trevan 
and Macfarlane (1936), Storraorken (1957d), Barkhan, Tomlin, and 
Archer (1957), and Fantl and Marr (1958). The latter authors 
further observed that this species specificity can be abolished by 
the previous addition of the homologous serum to the brain extract. 
Conclusions
Horse brain extract is species specific towards horse plasma.
A homologous horse extrinsic system clots in as short a time as a 
homologous human system. The horse extrinsic thromboplastin system
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is therefore assumed to be haemostatic ally as efficient as the 
human system.
HORSE PLASMA. FACTOR V ASSAY 
Horse plasma factor V content was measured by the degree of 
correction of human stored plasma, using human brain extract, as 
described in appendix IV, 14. The results obtained from three 
experiments ranged between 397 and 864 per cent of the factor V 
activity of human plasma, with an average of 643 per cent (Table 
67, and Figure 38). In one experiment factor V was also estimated 
in horse serum and was found to be 100 per cent of the human plasma 
factor V activity (Table 67, experiment 2).
Using the same method Stormorken (1957a) found that horse plasma 
had 300 per cent of human plasma factor V activity, and noted that 
horse proaccelerin was easily adsorbed onto barium sulphate.
Wartelle (1957b) found factor V to be five times as much as human 
plasma factor V; Fantl and Marr (1958) reported a twofolds increase; 
while Hawkey (I960) found it to be more than three times in horse 
plasma that horse serum had about the same activity as present 
in normal b«ma.n plasma. These differences can be explained by the 
different human control plasmas used by each investigator.
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Conclusions
The factor V concentration in horse plasma is much higher than 
in human plasma, with an average of sixfolds increase.
Horse serum contains factor V in a concentration equal to that 
present in human normal plasma.
S F ^ ^ FECIFICITY OF HORSE SERUM FACTORS
A purified preparation containing factors VII and X (appendix 
III, 10) was incubated with the brain extract and calcium chloride 
solution and samples were removed at minute intervals and pipetted 
onto fresh human plasma, fresn horse plasma, or onto phenindione 
human plasma simultaneously with an aliquot of calcium chloride 
solution. The clotting times of the substrates were recorded and 
are indicative of the thromboplastic activity produced in the 
incubation mixture which is dependent on the proper interaction of 
the reagents concerned. The method is described in detail in 
appendix IV, 17.
The horse brain extract when incubated with the horse purified 
serum factors gave uniformly shorter clotting times of the substrates 
than when incubated with the human purified serum factors, indicating 
their species specificity (Table 68). Similarly, the human brain 
extract gave the shortest clotting times when incubated with human
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serum factors, again indicating their species specificity. It 
should be noted however that the serum factors prepared from the 
horse and human sera were not completely species specific, since 
the heterologous mixtures gave substrate clotting times shorter 
than when the brain extracts were incubated with saline.
Conclusion
Human and horse serum factors axe species specific towards the 
homologous brain extracts.
HORSE PLASMA FACTOR VII ASSAY 
The ability of horse plasma to correct Seitz-filtered bovine 
plasma - deficient in factors VII and X - when clotted with various 
brain extracts was taken as indicative of its factor VII content 
(method of Koller et al, 1951). Since the factor X content of 
the horse plasma has been found to average 85 per cent of the human 
plasma factor X (see later), the differences observed in the factor 
VII assays to be discussed may be assumed to be largely due to 
changes in factor VII, though it should be borne in mind that the 
species specificity of factor X towards the brain extract in use may 
affect the clotting times. Using human brain extract, the horse 
plasma was found to contain about 71 per cent of the human plasma 
factor VII activity, with a range of 63.3 to 80 per cent; while
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with the horse brain extract the human plasma had about 6 per cent 
of the horse plasma factor VII activity (Table 69, and Figure 39). 
Discussion
The above observed discrepancy in the factor VII content of 
horse plasma as compared to human plasma is explained by the species 
specificity of the reaction between the brain extracts and the serum 
factors. The fact that horse plasma has a short one-stage clotting 
time, that it was found to contain about 70 per cent of factor VII 
when human brain was used, and even a much higher content when horse 
brain was used would suggest that horse plasma contains ample amounts 
of factor VII sufficient to maintain normal haemostasis.
Stormorken (I957d) stressed that quantitative comparison of the 
horse factor VII with other species cannot be done due to its species 
specificity. Fantl and Marr (1958) observed that horse serum is as 
active as human serum when acting in a homologous system. Hawkey 
(1960) estimated horse plasma factor VII activity by its corrective 
ability on human plasma from a patient with congenital factor VII 
deficiency, clotting the mixture with human brain extract and calcium 
chloride solution. She reported the value of 86 per cent for the 
horse plasma factor VII and 100 per cent for the horse serum factor 
VII as compared to human normal plasma factor VII content. Her 
results for the horse plasma agree fairly well with those reported 
in this study.
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Conclusions
No valid quantitative comparison of horse plasma factor VII 
could be made with present day methods with any degree of precision. 
Horse plasma, however, contains sufficient factor VII to give a 
normal one-stage prothrombin time in a homologous system, and about 
70 per cent of human plasma factor VII content in a human system.
HORSE PLASMA FACTOR X ASSAY
The horse plasma factor X content was estimated by the method 
of Bachmann et al (1958) which measures the degree of correction of 
Seitz-filtered bovine plasma when clotted with Russell’s viper venom 
and cephalin in the presence of calcium chloride solution.
The horse plasma was found to contain 64.7-106 per cent of the 
human plasma factor X activity, with an average of 85.5 per cent 
(Table 70). No species specificity towards the R.V.V.-cephalin 
reagent was observed. Wartelle (1957b) found that the R.V.V.- 
cephalin clotting time of horse plasma was somewhat longer than 
that of human plasma, and inferred that horse factor X was slightly 
inferior to human factor X. Hawkey (1960) who used the method of 
Bachmann et al (1958) reported that horse plasma contained 85 per 
cent of human plasma factor X, while horse serum contained 94 per 
cent that in human plasma.
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Conclusion
Horse plasma contains an average of about 85 per cent of the 
human plasma factor X activity.
HORSE PLASMA PROTHROMBIN ASSAY 
Due to the species specificity between factor VII and brain 
extracts, attempts to measure the horse plasma prothrombin were 
made utilizing two-stage methods which are much less affected by 
the available factor VII content in the reacting mixture.
The first method used was the two-stage area method of Biggs 
and Douglas (1953a) by which the horse plasma prothrombin values 
when estimated using human brain ranged between 117*4 and 193 per 
cent of the human plasma prothrombin content, with an average of 
160 per cent (Table 71, and Figure 40). The use of horse brain 
gave slightly higher values ranging between 124.8 and 247.8 per 
cent, with an average of 180 per cent of the human plasma prothrombin.
The second method measures the amount of prothrombin in the 
globulin fraction obtained from the plasma by acid precipitation 
as described by Douglas and Biggs (1953). Vith this method the 
prothrombin was found to be much less in the horse plasma globulin 
fraction than in the human fraction, namely 32.8 and 29.2 per cent 
of the human prothrombin with human and horse brain respectively 
(Table 72).
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Discussion
The results obtained with the two-stage area method seem to 
reflect the true levels of the horse plasma prothrombin content, 
since the use of both human and horse brain extracts gave roughly 
similar values. For example in experiment 2C (Table 71, and 
Figure 40, curve C) the human plasma prothrombin estimated with 
horse brain was 106.3 per cent that estimated with human brain 
(curve A). Similarly, experiments 1C and 3C gave values of 88.6 
and 116.2 per cent respectively when each human plasma sample was 
tested with horse brain extract instead of the human brain extract, 
with an average variation of 11.3 per cent, a variation that is 
acceptable for such biological assays. It should be stressed, 
however, that in spite of the above correlation between results 
obtained with the two different brain extracts, quantitative 
comparisons were only made between plasma sasples tested with the 
same brain extract.
Since this method is affected by the antithrombin content of 
the plasma tested as compared to that of the standard plasma, and 
since horse plasma was found to contain about 150 per cent of the 
human antithrombin, it is probable that the horse plasma contains 
even higher prothrombin concentrations than those reported here.
Stormorken (1957c) estimated horse plasma prothrombin activity 
as 99 per cent that of human plasma, in a modified two-stage method
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using homologous reagents except for factor V and fibrinogen which 
were of bovine origin. While Barkhan, Tomlin, and Archer (1957) 
did not attempt quantitative assays because of the species specificity 
of the brain thromboplastins, thay noted that in a homologous system 
horse reagents were more active than human reagents, and inferred 
that horse plasma therefore contained a normal amount of prothrombin. 
Fantl and Marr (1958) reported that the prothrombin activity of the 
horse plasma was in the same range as has been observed previously 
for human plasma by Fantl (1954). They used the pyrocatechol two- 
-stage method of Fantl (1954) which measures the amount of thrombin 
formed in a mixture containing the diluted horse plasma, pyrocatechol, 
brain extract, and calcium chloride solution. At intervals aliquots 
are delivered onto barium sulphate adsorbed human plasma which served 
as the source of fibrinogen. They noted that similar results were 
obtained with either human or horse brain extract.
It is difficult to explain the low results obtained with the 
globulin fraction method, especially that this system is free from 
antithrombin and should have given perhaps truer values for the 
horse plasma prothrombin. This finding calls for further 
investigation as regards the precipitation characteristics of the 
horse prothrombin and its activation in the absence of accelerator 
factors.
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Conclusions
Horse plasma prothrombin concentration was found to be at least 
160 per cent of the human plasma prothrombin, as estimated by the 
two-stage area method. One-stage methods are unsuitable for the 
estimation of prothrombin in horse plasma because of the species 
specificity of the brain extract - factor VII reaction.
EFFICIENCY OF THE HORSE EXTRINSIC THROMBOPLASTIN SYSTEM
Horse plasma contains all the blood coagulation factors required 
for the extrinsic thromboplastin system of prothrombin activation 
in sufficient concentrations that would ensure effective normal 
haemostasis.
In vitro tests proved that the extrinsic prothrombin conversion 
can be brought about in horse plasma as quickly and efficiently as 
in human plasma, by the use of the homologous brain extract.
The delayed thrombin-fibrinogen reaction of horse plasma could 
hardly be said to hamper the efficiency of the extrinsic system, 
since the delay only amounts to fractions of a minute, a finding 
more of an academic importance rather than of any practical 
consequence.
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HORSE INTRINSIC THROMBOPLASTIN SYSTEM
Horse blood clotted in ordinary glass tubes in 7* 55”, while 
in siliconed glass tubes it clotted in 15* 29” (Table 75). The 
rapid clotting in ordinary glass tubes indicates the efficient 
generation of intrinsic thromboplastin in horse blood. Fantl and 
Marr (1958) reported whole blood clotting times for horse blood to 
be 13-19 minutes as compared with 14-19 minutes for the human control. 
They, however, demonstrated a delayed thrombin generation and 
ascribed it to the increased stability of the horse platelets, since 
they found the delay to be readily corrected by the addition of 
phospholipids, a finding previously reported by Sjolin (1957).
This may be the explanation for the longer recalcified clotting 
times of horse plasma as compared to those of human plasma, namely 
368 and 147 seconds respectively (Table 76). The preliminary 
separation of the plasma by centrifugation may have rendered the 
horse plasma relatively less platelet-rich than the human plasma, 
especially if we take into consideration the originally lower 
platelet content of horse blood which averages 117,000 platelets
per cubic millimetre (Table 74).
The prolongation of the clotting time of horse whole blood in 
siliconed ware suggests the presence of some contact factor in the 
horse blood whose action is interfered with by the use of the
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siliconed glass tubes.
Conclusion
Horse whole blood clots in ordinary glass tubes in as short a 
time as human whole blood.
HORSE PLASMA HAGEMAN FACTOR ACTIVITY
The activity of Hageman factor in horse plasma was measured by 
the latter’s ability to correct the prolonged recalcification time 
of plasma obtained from a patient with congenital Hageman factor 
deficiency. Both horse and human control plasmas were maximally 
glass-activated before being tested. The method is described in 
full in appendix IV, 24, II. Due to the scarcity of the Hageman 
deficient plasma only one experiment was made, testing two dilutions 
of horse plasma. The average Hageman factor activity in horse 
plasma was found to be 118.5 per cent that in the control human 
plasma (Table 77, and Figure 41). Wartelle (1957b) using a similar 
technique reported similar levels of Hageman factor in horse and 
human plasmas.
Conclusion
Horse plasma contains Hageman factor in comparable amount to 
that present in human plasma. Horse Hageman factor is not species 
specific.
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HORSE PLASMA THROMBOPLASTIN ANTECEDENT ACTIVITY
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Because of the unavailability plasma thromboplastin antecedent 
congenitally deficient plasma no specific assay for this factor 
was made. But in view of the shorter clotting time of horse whole 
blood in ordinary glass tubes than that in siliconed tubes, and 
since Hageman factor alone could not bring about such shortening 
in the clotting times, it is presumed that plasma thromboplastin 
antecedent is present in horse plasma in sufficient concentration 
to allow normal active intrinsic thromboplastin formation.
HORSE PLASMA ANTIHAEMOPHILIC GLOBULIN ACTIVITY
The antihaemophilic globulin activity of horse plasma was 
measured by the method of Pitney (1956). It was found to range 
from 137 to 310 per cent with an average of 209 per cent of the 
human plasma A.H.G. activity (Table 80, and Figure 43).
Discussion
The presence of A.H.G. activity in horse plasma has been the 
main controversial subject in the literature on horse blood 
coagulation. Bell, Archer, and Tomlin (1955) first reported 
that horses suffer from A.H.G. deficiency which occurs in both 
sexes, end can be corrected by normal human plasma. In 1957
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Bar khan, Tomlin, and Archer again observed a defect in the 
thromboplastin activity of horse alumina treated plasma which they 
attributed to be most likely due to deficiency of A.H.G. or P.T.A. 
factors. Wartelle (1957b) also observed that horse plasma gave 
longer clotting times in a thromboplastin generation test system 
than those obtained with human plasma, while horse and human plasma 
mixtures gave even longer clotting times of the substrate. She 
thought that perhaps a deficiency of factor V may be a contributing 
factor since horse factor V is easily adsorbed on barium sulphate 
from the oxalated plasma. She later ruled out this contention as 
a possible cause since she found that in a one-stage recalcification 
time test a human-horse plasma mixture had less corrective ability 
on the clotting time of haemophilic plasma than a corresponding 
human—saline mixture. She attributed her results to the presence 
of an inhibitor in horse plasma identical with that responsible for 
the delayed thrombin clotting time of human—horse plasma mixtures.
Fantl and Marr (1958) reported that horse oxalated barium 
sulphate adsorbed plasma had a similar A.H.G. activity to human 
plasma by correction of haemophilic plasma in a thromboplastin 
generation mixture using cephalin instead of the platelets. They 
further observed that thromboplastin formation oceured at the same 
rate as it did in the human system.
In this investigation, it was also observed that horse alumina
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adsorbed plasma had about half the thromboplastic activity of the 
human plasma when tested with human serum in the thromboplastin 
generation test using human platelets (Table 78, mixtures 118 and
116 respectively, and Figure 42, A, curves b and a). This does 
not represent a deficiency but is due to the inhibitory activity 
of horse plasma as shall be discussed in detail later. Such 
inhibitory activity was not apparent in the A.H.G. assays made by 
Pitney's method because of the use of higher plasma dilutions than 
those normally present in an ordinary thromboplastin generation test. 
Values obtained by Pitney's method are therefore a true estimate of 
the horse plasma A.H.G. content, which however may not correspond 
with the actual horse plasma A.H.G. activity in the circulating blood. 
Conclusions
The concentration of antihaemophilic globulin in horse plasma 
is about twice that in human plasma, with a range of 137 to 310 per 
cent. Horse antihaemophilic globulin is not species specific.
HORSE SERUM CHRISTMAS FACTOR ACTIVITY 
The thromboplastic activity of horse serum in the ordinary 
thromboplastin generation test when incubated with human adsorbed 
plasma was similar to the activity of human serum (Table 78, mixtures
117 and 116, and Figure 44, A, curves b and a).
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Specific measurement of Christmas factor in horse serum by the 
latter's ability to correct Christmas disease serum in a modified 
thromboplastin generation technique based on Pitney*s method (as 
described in detail in appendix IV, 22) gave values ranging from 
168 to 240 per cent of the human serum Christmas factor concentration. 
The average of the four experiments was 203 per cent (Table 81, and 
Figure 45).
Discussion
In 1956 Sjolin reported that horse plasma has an abnormal 
(delayed) thrombin generation test which was not corrected by 
Christmas disease plasma or adsorbed normal plasma, but was 
corrected by haemophilic plasma, normal plasma, and by purified 
Christmas factor. He concluded that horse blood lacks Christmas 
factor. However, in 1957 he revised this conclusion in view of 
his later findings that the delayed thrombin generation of horse 
plasma could also be corrected by several other ways, namely by 
the addition of adsorbed normal human serum previously heated at 
56°C. for 30 minutes, by the addition of washed human or horse 
platelets, and by freezing and thawing the horse plasma with its 
normal content of platelets. He therefore concluded that the 
clotting defect of horse plasma was caused by the lack of a factor 
similar to Hageman factor. Also, Barkhan, Tomlin, and Archer (1957) 
have found that the delayed thrombin generation of horse plasma
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was corrected by the addition of Christmas disease serum, and that 
horse serum was as active as human serum in the thromboplastin 
generation test. Fantl and Marr (1958) and Hawkey (1960) found 
that horse serum completely corrected Christmas disease serum in 
the thromboplastin generation test, having a similar activity to 
human serum. Wartelle (1957b) was not able to conclude if there 
existed any Christmas factor deficiency in horse plasma by the 
recalcification clotting time of horse plasma and Christmas disease 
plasma mixtures, again because of the inhibitory activity present 
in the horse plasma.
Conclusions
Horse serum contains Christmas factor activity in at least a 
similar concentration if not more to that present in human serum* 
Horse Christmas factor is not species specific.
HORSE PLATELETS 
Horse whole blood contains an average of 117,000 platelets per 
cubic millimetre (Table 74) which is about half the average platelet 
count of human whole blood. Horse platelets are morphologically
similar to human platelets. Barkhan, Tomlin, and Archer (1957)
reported platelet counts of 114,000—160,000/c.mm. whole blood of 
Thoroughbred horses, and of 184,000-312,000/c.mm. for blood from
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Shetland ponies. Fantl and Marr (1958) also observed the lower 
horse platelet count (60,000—100,000/c.mm.) and believed them to 
be more stable than human platelets.
The thromboplastic activity of horse platelets was investigated 
by substituting them instead of the human platelets in the 
thromboplastin generation test and comparing the results. Horse 
platelet suspension had very slightly less activity than the human 
platelet preparation when mixed with human adsorbed plasma and 
human serum (Table 78, mixture 116 compared with mixture 120 in 
Table 79, as illustrated in Figure 46, curves a and b). Their 
lower activity was also manifest in all the other mixtures (Tables 
78 and 79, and Figure 46). It should be remembered, however, 
that because of the initially lower number of horse platelets in 
whole blood and since platelet suspensions were prepared from 
identical volumes of human and horse blood to make up similar 
volumes of platelet preparations, the horse platelet suspension 
must have contained about half the platelet concentration present 
in the human suspension. This may possibly explain the weaker 
action of the horse platelet suspensions. Barkhan, Tomlin, and
Archer (1957) using platelet concentrations of 400,000-550,000/c.mm. 
in the thromboplastin generation mixture still observed that human 
platelets were more active than the horse platelets, while horse 
cephalin was as active as human cephalin. They further found that
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horse platelets yielded more active thromboplastin than the human 
platelets when horse serum was used instead of the human serum.
I was not able to confirm this observation, possibly because of 
the low concentration of my platelet preparations. But it could 
very well be explained by the Higher Christmas factor content of 
horse serum as well as to the presence of factor V in horse serum, 
and not necessarily to species predilection between horse serum 
and horse platelets.
The activity of the platelets can also be judged by the degree 
of clot retraction of whole blood. Horse whole blood, while 
containing similar fibrinogen concentration and with a haematocrit 
value similar to human whole blood, had an average of 37.6 per cent 
of clot retraction in one hour (Table 82). This poor clot retraction 
of horse whole blood was also the experience of Bell, Archer, and 
Tomlin (1955). Again, it can be explained by the lower platelet 
count in horse blood.
Conclusions
Horse blood has a total platelet count about half that present 
in blood. The thromboplastic activity of horse platelets
in the thromboplastin generation test was slightly weaker than the 
activity of similarly prepared human platelets. Clot retraction 
of horse blood is poor.
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HORSE PLASMA SUBSTRATE REACTIVITY IN THE T.G.T.
The use of horse high-spun plasma as the substrate in the 
thromboplastin generation test instead of the human high-spun 
plasma resulted in a consistent prolongation of the clotting times 
obtained, which in terms of active thromboplastin production 
depressed the latter to about half the values obtained with the 
human substrate plasma. This phenomenon was demonstrable with 
all the incubation mixtures tested (Tables 78, 79, 83, and 84, and 
illustrated in Figures 47 and 48).
This delayed reactivity of the horse plasma in the thromboplastin 
generation test is due to the delayed throrabin-fibrinogen reaction 
of horse plasma as demonstrated previously, and most probably 
caused by the inherent property of horse fibrinogen; also partly 
contributed to by the higher antithrombin content of horse plasma. 
Conclusion
Horse plasma is less reactive than the human plasma to active 
thromboplastin, whether homologous or heterologous.
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INHIBITORS AGAINST HUMAN THROMBOPLASTIN IN HORSE BLOOD
The presence of inhibitors in horse plasma or serum against 
human intrinsic thromboplastin formation was investigated by the 
method of Biggs and Mac far lane (1957) described in appendix IV, 23.
The addition of adsorbed horse plasma to a human thromboplastin 
generation mixture had an immediate inhibitory activity on the 
latter (Table 85, A, mixtures 132, and 133; and Figure 49, A, 
curves a and b). This cannot be simply attributed to dilution 
effect since the horse adsorbed plasma has been shown to contain 
all the necessary clotting factors in more than the optimum amounts, 
except perhaps the plasma thromboplastin antecedent which Wartelle 
(1957b) believed to be present in a low concentration as tested for 
in one—stage recalcification time tests that are easily affected 
by inhibitory substances. Heating the adsorbed horse plasma for 
15 minutes at 56°C. before its addition to the incubation mixture 
nearly completely removed the inhibitory activity (Table 85, A, 
mixture 135, and Figure 49, A, curve c). Incubation of all the 
above mixtures for two hours at 37°C. before testing gave a similar 
pattern. The inhibition produced by the adsorbed horse plasma 
did not increase but was still apparent, while the heated horse 
adsorbed plasma mixed with the human adsorbed plasma produced less 
activity than before incubation presumably because of the lower
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content of plasma coagulation factors (Table 85, B, mixtures 136,
137, and 138; and Figure 49, B).
The addition of horse serum did not produce any appreciable 
inhibitory effect, neither immediate nor after incubation (Figure 
50, A and B).
Discussion
The removal of the inhibitory effect of horse adsorbed plasma 
on human intrinsic thromboplastin generation by heating the adsorbed 
plasma for 15 minutes at 56°C. suggests that the main factor 
responsible for such activity is the horse fibrinogen. It may 
also be due to the high antithrombin concentration in horse plasma, 
since anti thrombin is known to be destroyed by heating at 56°C.
(Biggs and Macfarlane, 1957). However, this is unlikely since 
horse serum which presumably contained the same amount of antithrombin 
did not have an inhibitory effect. The presence of antithromboplastin 
as such in the horse adsorbed plasma is doubtful. Though 
antithromboplastin withstands heating to 60 C. (Niewiarowski et al, 
1959), the heated adsorbed horse plasma had no immediate inhibitory 
effect, while the low production of active thromboplastin obtained 
after its incubation with human plasma may have been due to the 
decay of plasma coagulation factors similar to that observed in the 
in the homologous human system, especially that heating totally 
destroys the A.H.G. and factor V otherwise supplied by the horse
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adsorbed plasma.
Conclusions
The horse adsorbed plasma has an inhibitory effect when added 
to a human thromboplastin generation mixture, an effect that can 
be removed by heating the adsorbed plasma to precipitate the 
fibrinogen which is believed to be the main agent responsible for 
such inhibitory activity against human intrinsic thromboplastin 
formation. The horse serum does not possess any inhibitory 
activity against human intrinsic thromboplastin.
HOMOLOGOUS HORSE INTRINSIC THROMBOPLASTIN GENERATION
The generation of homologous active horse thromboplastin by 
the incubation of horse adsorbed plasma, horse serum, and horse 
platelets, but subsampling onto human high-spun plasma resulted in 
an activity amounting to 23.5 per cent of active thromboplastin 
(Figure 48, B, curve a); while subsampling onto horse high-spun 
plasma further diminished it to 12 per cent (Figure 48, B, curve b).
Therefore, in a completely homologous horse system the 
production of active intrinsic thromboplastin is much weaker than 
in a homologous human system. In the incubation mixture itself 
this is contributed to by the weaker action of the horse platelets 
as well as by the inhibitory effect of adsorbed horse plasma on
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the thromboplastin generation. While with the use of horse plasma 
as substrate, the high antithrombin content and the delayed reaction 
of horse fibrinogen render the apparently deficient horse intrinsic 
thromboplastin generation more obvious.
EFFICIENCY OF HORSE INTRINSIC THROMBOPLASTIN SYSTEM 
All the coagulation factors cencerned in the intrinsic 
thromboplastin system for prothrombin activation are present in 
horse plasma and serum in amounts adequate for effective normal 
haemostasis. In spite of the poor homologous horse thromboplastin 
generation demonstrated in vitro, the normal clotting times 
obtained for whole blood together with the virtually complete 
prothrombin utilisation during clotting of horse blood (judged 
from the very low prothrombin consumption indices obtained by 
either of the two methods used for its estimation, irrespective 
of the species of brain extract utilised, Table 73) would suggest 
that the formation of thrombin in ample amounts can easily be 
brought about by means of the intrinsic thromboplastin system in 
horse blood, indicating the likelihood of evolution of sufficient 
active intrinsic thromboplastin that maintains normal haemostasis 
in vivo.
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SUMMARY OF HORSE BLOOD COAGULATION MECHANISM
Horse blood con ta in s a l l  the  coagu la tion  fa c to rs  known to  take 
p a r t  in  th e  human blood co agu la tion . Compared to  th e  human, th e  
h o rse  blood con tained  an equal co n cen tra tio n  of f ib rin o g en , fa c to r  
IX, and f a c to r  X II, w hile prothrom bin was a t  l e a s t  160 per cen t, 
f a c to r  V about 643 per cen t, f a c to r  VII a t  le a s t  70 per cen t, 
f a c to r  V III about 209 per cen t, f a c to r  X about 85 per cen t, and 
th e  p l a t e l e t s  about h a l f  as much as in  th e  human blood.
The horse  blood had normal whole blood c lo t t in g  tim es, normal 
prothrom bin consumption in d ic e s , bu t the  c lo t  r e t r a c t io n  was 
somewhat poor.
The horse  plasma ex h ib ited  a delayed r e a c t iv i ty  to  thrombin, 
most probab ly  due to  th e  p ro p erty  of the  horse fib rin o g en  and 
p a r t ly  due to  th e  h igh  antith rom bin  con ten t o f th e  horse plasma.
Species s p e c i f i c i ty  was only observed in  th e  re a c tio n  of 
f a c to r s  VII and X w ith  th e  b ra in  t i s s u e  e x tra c ts .
Both e x tr in s ic  and in t r in s ic  throm boplastin  systems of 
prothrom bin a c t iv a t io n  in  horse blood are  b e lieved  to  be e f f ic ie n t .
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P A R T  Y
RABBIT BLOOD COAGULATION MECHANISM
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RABBIT BLOOD COAGULATION MECHANISM 
The d a ta  p resen ted  in  th i s  s e c tio n  a re  based on th e  r e s u l t s  of 
experim ents made on blood samples obta ined  from a d u lt domestic 
r a b b i t s  o f th e  C a lifo rn ia n  s t r a in  kep t on o rd inary  p e l l e t  d ie t  
supplem ented w ith  f re s h  green v eg e tab le s.
A ll th e  anim als were h ea lth y , none o f them su ffe red  from any 
b leed in g  tendency.
RABBIT PLASMA FIBRINOGEN 
The fib rin o g en  in  r a b b i t  plasma was estim ated  by th e  m odified 
method o f Greenberg as described  in  appendix IV, 2 , I I .  The values 
o b ta ined  from seven experim ents ranged from 190 to  281 mg of 
f ib r in o g e n  p er 100 m is. of plasma, w ith  an average o f 228 mg.
This compares w ith  a low normal human plasma fib rin o g en  le v e l .
Spaet and C in tron  (1960b) have found ra b b it  plasma to  con ta in  
about 240 mg o f f ib rin o g en  per 100 mis o f plasma.
Conclusion
R abbit plasma f ib rin o g en  i s  about equal to  a low normal human 
fib rin o g e n  co n ten t, w ith  an average o f 228 mg p er 100 mis o f plasm a.
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RABBIT THROMBIN-FIBRINOGEN REACTION 
Throm bin-fibrinogen re a c tio n  o f th e  plasma
R abbit c i t r a te d  plasma gave s im ila r  c lo t t in g  tim es as th e  
human c i t r a te d  plasma when c lo tte d  w ith  various concen tra tions of 
bovine throm bin. A lso, the  a d d itio n  o f a 1 per cen t so lu tio n  of 
py rocatecho l to  th e  plasma had th e  same shorten ing  e f f e c t  on the  
c lo t t in g  tim es o f both r a b b it  and human plasmas (Table 87, and 
F igu re  51).
Species s p e c i f i c i ty  o f th e  th rom bin-fib rinogen  re a c tio n
The th rom bin -fib rinogen  re a c tio n  was fu r th e r  in v e s tig a te d  in  
a  p u r if ie d  system using  fib rin o g en  and throm bin so lu tio n s  prepared 
f r e e  from a n t i  throm bin as described  in  appendix I I I ,  6, A, and 
appendix I I I ,  7 , A and B. I t  was observed th a t  th e  ra b b it  
fib rin o g e n  gave s l ig h t ly  longer c lo t t in g  tim es than  th e  human 
fib rin o g e n  when c lo t te d  w ith  human or bovine throm bin, w hile when 
c lo t te d  w ith  ra b b it  throm bin i t  gave a sh o r te r  c lo t t in g  tim e than  
th e  human fib rin o g en  so lu tio n , (Table 88). I t  should be noted 
th a t  th e  human f ib rin o g en  so lu tio n  contained about double th e  
co n ce n tra tio n  o f f ib rin o g en  p resen t in  th e  ra b b it  p rep a ra tio n .
The use o f human fib rin o g en  so lu tio n  d ilu te d  1 in  2 w ith  s a lin e  
as to  be comparable w ith  th e  ra b b it  p rep a ra tio n  made th e  d iffe re n c e  
more obvious when c lo t t in g  w ith  human throm bin. The human
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s o lu tio n  c lo t te d  in  9 seconds compared to  11-^ r seconds obta ined  fo r  
th e  r a b b i t  f ib rin o g en  con ta in ing  th e  same fib rin o g en  co n cen tra tio n . 
The a d d itio n  o f pyrocatecho l so lu tio n  shortened th e  c lo t t in g  tim es 
o f bo th  f ib rin o g e n  so lu tio n s , w hile the  d iffe re n c e s  observed w ith  
human throm bin were n e a r ly  suppressed, those obta ined  w ith  ra b b it  
throm bin were s t i l l  apparen t, th e  r a b b i t  f ib rin o g en  being more 
r a p id ly  c lo t te d  than  th e  human p re p a ra tio n .
D iscussion
Seegers and Smith (1942) found th a t  1 ml of human oxalated  
plasma re q u ire d  2 .0  u n i ts  o f p u r if ie d  bovine throm bin to  c lo t  in  
15 seconds a t  28°C ., w hile 1 ml o f r a b b it  oxala ted  plasma requ ired  
2 .2  u n i ts  o f th e  same throm bin so lu tio n . F an tl and Ebbels (1953) 
a lso  re p o rte d  th a t  r a b b i t  plasma had a  delayed thrombin c lo t t in g  
tim e compared to  th e  normal human plasm a. They be lieved  th a t  th e  
d if fe re n c e  was n o t due to  species s p e c if ic i ty  or to  antithrom bin , 
b u t to  th e  s p e c if ic  c o n fig u ra tio n  of th e  n a tiv e  fib rin o g en .
Though my r e s u l t s  fo r  th e  th rom bin-fib rinogen  re a c tio n  o f 
c i t r a t e d  plasmas do no t agree w ith  th e  above c i te d  f in d in g s , those 
ob ta in ed  in  th e  p u r if ie d  system have some agreement and show th a t  
each f ib rin o g e n  so lu tio n  c lo ts  f a s te r  w ith  th e  homologous thrombin 
p re p a ra tio n , w hile bovine throm bin was more a c tiv e  on human 
fib rin o g e n  th an  on ra b b it  fib rin o g en . Why such d iffe re n c e s  were 
n o t observed when c lo t t in g  c i t r a te d  plasmas i s  d i f f i c u l t  to  ex p la in .
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However, i t  should be remembered th a t  the  l a t t e r  system i s  
com plicated by th e  presence o f a l l  th e  o the r coagu la tion  fa c to rs  
and in h ib i to r s ,  o th e r than  th e  ro le  p layed by th e  ph y sica l 
c h a ra c te rs  o f each plasma th a t  may w ell be d i f f e r e n t .  The f a c t  
th a t  th e  py rocatecho l shortened  th e  c lo t t in g  tim es in  th e  p u r if ie d  
th rom bin -fib rin o g en  system which i s  presumably f re e  from 
an tith ro m b in  suggests i t s  d i r e c t  a c tio n  on the  fib rin o g en  ra th e r  
th an  i t s  having an an ti-a n tith ro m b in  a c tio n . Kenton (1933) found 
th a t  an tib o d ie s  produced ag a in s t sheep or bovine fib rinogens did  
n o t r e a c t  w ith  r a b b i t  f ib rin o g en  as concluded from th e  la ck  of 
an ap h y lac tic  shock which should have occured in  case an in  vivo 
an tib o d y -an tig en  r e a c tio n  has taken  p la c e .
C onclusions
The th rom bin -fib rinogen  re a c tio n  o f r a b b it  c i t r a te d  plasma 
occurs w ith  th e  same r a te  as th e  human re a c tio n . P u r if ie d  
f ib r in o g e n  so lu tio n s  from ra b b it  and human plasma, however, were 
more a c t iv e ly  c lo t te d  w ith  th e  homologous thrombin so lu tio n , 
suggesting  a  c e r ta in  degree of spec ies s p e c if ic i ty .
The delayed  c lo t t in g  tim e o f r a b b i t  fib rin o g en  w ith  bovine 
throm bin suggests i t s  d iffe re n c e  from human fib rin o g en , a t  le a s t  
as reg a rd s  i t s  r e a c t iv i ty  to  bovine throm bin.
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RABBIT PLASMA. ANTITHROMBIN ASSAY 
The an tith rom bin  con ten t of r a b b i t  plasma was estim ated  by the  
method o f Douglas and Biggs (1953) and found to  be about 92 per cen t 
t h a t  o f th e  human plasma an tith rom bin  con ten t (Table 89, and F igure 
52 ). I t s  e s tim a tio n  by th e  m odified method of A strup and D arling  
(I942d) gave values o f 100-117.4 per cen t of th e  human plasma 
an tith ro m b in  co n ten t, w ith  an average fo r  the  th re e  experiments of 
105.8 p e r  cen t (Table 90, and F igure 53).
A strup and D arling  (I942d) rep o rted  th a t  ra b b it  c i t r a te d  plasma 
con ta in ed  148 an tith rom bin  u n its  per ml. ,  bu t d id  no t make a d ir e c t  
comparison w ith  human plasm a. Their r e s u l t  cannot p o ssib ly  be 
compared w ith  th e  average value ob ta ined  using  th e i r  method, namely 
301.7 a n t i  throm bin u n i ts  per m l., because of th e  d iffe re n c e  in  the  
o r ig in a l  throm bin u n i t  term inology. The A strup and D arling  u n i t  
i s  th e  amount o f throm bin req u ire d  to  c lo t  1 ml o f ice-coo led  
o x a la ted  plasma —im m ediately tr a n s fe r re d  to  37 C .— in  30 seconds
(A strup and D arlin g , 1941).
Spaet and C in tron  (1960a) during  an in v e s tig a tio n  on blood 
th rom bop lastin  s p e c i f i c i ty  c a su a lly  commented th a t  co n tro l r a b b i t s ' 
s e ra  had h igh  a n t i  throm bin a c t iv i t y  w ithout a c tu a l c i t a t io n  o f th e  
le v e ls  in  term s of co n cen tra tio n  o r percen tages.
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Conclusion
The r a b b i t  plasma an tith rom bin  con ten t i s  about equal to  th a t  
o f human plasm a.
RABBIT EXTRINSIC THROMBOPLASTIN SYSTEM
Using Q uick 's one-stage prothrom bin tim e t e s t ,  r a b b i t  plasma 
was found to  c lo t  in  s h o r te r  tim es than  th e  co n tro l human plasma, 
w ith  bo th  human and r a b b it  b ra in  e x tra c ts  (Table 91 ). The human 
b ra in  p re p a ra tio n s  used seemed to  be somewhat more a c tiv e  than  th e  
r a b b i t  ones. The c lo t t in g  tim e of human plasma w ith  ra b b it  b ra in  
was a p p rec iab ly  longer (28 seconds) than  th a t  w ith  human b ra in  (17 
seconds) .  M ixtures o f equal amounts o f ra b b it  and human plasma 
gave s h o r te r  c lo t t in g  tim es th an  th e  s a lin e  co n tro ls  when c lo tte d  
w ith  e i th e r  type of b ra in  e x tra c t ,  suggesting  th e  absence of any 
in h ib i to r y  a c t iv i t y  in  e i th e r  plasma ag a in s t th e  heterologous b ra in  
th rom bop lastin .
D iscussion
The p rev ious f in d in g s  suggest th e  absence o f any species 
s p e c i f i c i t y  in  th e  re a c tio n  between ra b b i t  and human reagen ts  in  
th e  one—stag e  e x tr in s ic  system . The s h o r te r  c lo t t in g  tim es of 
th e  r a b b i t  plasma a re  b e liev ed  to  be due to  i t s  h ig h e r con ten t of 
f a c to r  V as s h a l l  be shown l a t e r .  Quick (1935) found no
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a p p rec iab le  d iffe re n c e  between th e  throm boplastic a c t iv i ty  of 
b ra in ,  thymus, or lung of th e  r a b b i t .  Copley (1942) observed 
th a t  th e  age of ra b b its  up to  s ix  weeks had a s l ig h t  in fluence 
upon th e  th rom boplastic  a c t iv i ty  of th e i r  b ra in s  upon human plasma, 
w hile  over th re e  months th e  age had no s ig n if ic a n t  e f f e c t .
D idisheim  e t  a l  (1959) rep o rte d  th a t  most plasmas c lo tte d  f a s te s t  
w ith  r a b b i t  b ra in  e x tra c t .  A lso, Quick e t  a l  (1961) repo rted
th a t  r a b b i t  b ra in  was h ig h ly  a c tiv e  on human, dog, r a b b it ,  and c a t 
plasm as, and th a t  i t  was more a c tiv e  than  the  human b ra in  e x tra c t.  
They used acetone-dehydrated  b ra in  e x tra c ts .  In  th i s  work, both 
th e  human and ra b b it  b ra in s  were ex tra c ted  w ith s a l in e .  A volume 
o f s a l in e  in  m i l l i l i t r e s  equal to  th e  wet w eight of th e  b ra in  in  
grams was found to  g ive th e  sh o r te s t  c lo tt in g  tim es fo r  both human 
and r a b b it  p re p a ra tio n s . From th e  sh o rte r  c lo tt in g  tim es obtained 
w ith  th e  human b ra in  e x tra c t thus prepared as compared to  those 
ob ta ined  w ith  th e  r a b b it  b ra in , i t  can be in fe rre d  th a t  i t  i s  more 
a c t iv e  th an  th e  s im ila r ly  prepared ra b b it  b ra in  e x tra c t .
Conclusions
The r a b b i t  b ra in  e x tra c t does no t e x h ib it any species s p e c if ic i ty  
in  th e  one—stag e  prothrom bin time t e s t .  Rabbit plasma responds 
to  human b ra in  e x tra c t  in  a  s im ila r  tim e to  human plasma.
The homologous ra b b it  e x tr in s ic  th rom boplastin  system i s  as 
e f f i c i e n t  as th e  human co u n te rp a rt.
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SPECIES SPECIFICITY OF RABBIT FACTOR V
No d iffe re n c e s  were observed in  the  c lo tt in g  tim es o f s u b s tra te  
plasm as when ra b b it  or human p u r if ie d  fa c to r  V p rep a ra tio n s  were 
incubated  w ith  e i th e r  ra b b it  or human b ra in  e x tra c ts  (Table 92), 
in d ic a tin g  th a t  r a b b i t  f a c to r  V i s  no t species  s p e c if ic .  Due to  
th e  very  h igh  co n cen tra tio n  o f f a c to r  V in  ra b b it  plasma (as w ill  
be d iscu ssed  sh o r tly )  th e  p u r if ie d  ra b b it  fa c to r  V p rep a ra tio n  i s  
a lso  presumed to  co n ta in  much more fa c to r  V than  i s  p resen t in  th e  
human p re p a ra tio n . Such a h igh  fa c to r  V concen tra tio n  may have 
masked a s l ig h t  degree o f species  s p e c if ic i ty ,  though th i s  i s  very  
u n lik e ly  s in ce  ra b b it  plasma d ilu te d  1 in  1000 to  con ta in  an 
eq u iv a len t co n cen tra tio n  of fa c to r  V as p resen t in  human plasma 
d i lu te d  1 in  10 s t i l l  had as much c o rre c tiv e  a b i l i t y  on s to red  
human plasma ( fa c to r  V d e f ic ie n t)  when c lo tte d  w ith  human b ra in  
as t h a t  o f human plasm a. During f a c to r  V assays, W artelle  (1957b) 
no ted  th a t  th e  use o f e i th e r  human or ra b b it  b ra in  e x tra c ts  gave 
s im ila r  r e s u l t s .
C onclusion
The r a b b i t  f a c to r  V i s  no t spec ies  s p e c if ic .
ASSAY OF RABBIT PLASMA FACTOR V
The ra b b it  plasma fa c to r  V con ten t was measured by th e  degree 
o f c o r re c tio n  of human s to red  plasma using human b ra in  e x tra c t  as 
d esc rib e d  in  appendix IV, 14. I t  was found to  co n ta in  f a c to r  V 
in  a  co n ce n tra tio n  rang ing  from 9696—11975 per cen t th a t  in  human 
plasm a w ith  an average o f 10558 p e r cen t, i . e .  approxim ately one 
h u n d red fo ld 's  in c re a se  (Table 93, and F igure 54).
D iscussion
The h igh  co n cen tra tio n  of f a c to r  V in  ra b b it  plasma was 
g e n e ra lly  recognised  by v arious w orkers. Murphy and Seegers (1948) 
u t i l i s i n g  a  tw o-stage technique found ra b b it  f a c to r  V to  be about 
12-20 tim es more th an  th e  human. Quick and S te fa n in i (1948) 
u s in g  t h e i r  one-stage method rep o rte d  a value o f 50 tim es fo r  
r a b b i t  f a c to r  V. L a te r in v e s tig a tio n s  by th e  same group confirmed 
t h e i r  p rev ious r e s u l t  (Quick, 1960; and Quick e t  a l ,  1961). 
W arte lle  (1957c) ob ta ined  th e  value o f 40 tim es fo r  ra b b it  f a c to r  
V as compared to  th e  human f a c to r  V. The v a r ia t io n  o f th e  l a t t e r  
r e s u l t s  from those  rep o rte d  in  th i s  work i s  no t so g re a t as might 
be though t a t  f i r s t  s ig h t ,  s in ce  th e  measurement of so high a 
c o n c e n tra tio n  e n ta i l s  extrem ely high  d ilu tio n s  which magnify the  
s l ig h t e s t  e r ro r .  Furtherm ore, th e  c o n tro l samples used may no t 
n e c e s s a r i ly  have had th e  same con ten t of fa c to r  V.
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C onclusion
The r a b b it  plasma con ta in s fa c to r  V in  g re a t excess. I t s  
f a c to r  V co n cen tra tio n  was about one hundred tim es th a t  in  th e  
c o n tro l human plasma.
S ^ C IE S ^ SFECIFICITY OF RABBIT SERUM FACTORS
The sp ec ies  s p e c i f i c i ty  of th e  ra b b it  fa c to rs  VII and X was 
in v e s t ig a te d  by th e  tw o-stage e x tr in s ic  system described  in  
appendix IV, 17.
The p re in cu b a tio n  o f e i th e r  th e  ra b b it  o r th e  human p u r if ie d  
serum fa c to r s  w ith  r a b b i t  b ra in  e x tra c t  r e s u lte d  in  the  same 
c lo t t in g  tim es o f th e  s u b s tra te  plasmas whether normal human or 
ra b b i t  plasma o r phenindione human plasma (Table 94). Also, 
s im ila r  a c t i v i t i e s  were observed when human b ra in  e x tra c t  was used 
in s te a d  o f th e  r a b b i t  b ra in . This s ig n if ie s  th a t  th e  ra b b it  
fa c to r s  VII and X a re  no t spec ies  s p e c if ic  bu t a re  in terchangeab le  
w ith  th e  human fa c to rs  in  e x tr in s ic  throm boplastin  systems 
co n ta in in g  human o r r a b b i t  b ra in  e x tra c ts .  I t  i s  in te re s t in g  to  
no te  th a t  th e  a c t i v i t i e s  o f both human and ra b b it  serum fa c to rs  
in  th e  prev ious t e s t  were very  much th e  same. Since they  have 
been prepared  in  p a r a l le l  from th e  same amounts of s e ra , and in  
view o f th e  l a t e r  f in d in g s  th a t  r a b b i t  f a c to r  VII i s  about 90 per
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cen t o f th e  human, w hile ra b b it  f a c to r  X i s  about fou r tim es th e  
human f a c to r  X co n ce n tra tio n , i t  may w ell be th a t  such a high 
c o n c e n tra tio n  o f f a c to r  X has to  some ex ten t masked th e  e f f e c t  of 
a  s l ig h t  degree of spec ies  s p e c i f ic i ty .  This i s  u n lik e ly  because 
f a c to r  X i s  p re se n t in  th e  m ixture in  optimum co n cen tra tio n , and 
were a h igher co n cen tra tio n  e f fe c t iv e  i t s  e f fe c t  would have been 
obvious in  th e  m ixture con ta in ing  ra b b it  b ra in  and ra b b it  serum 
f a c to r s ,  being then  more a c tiv e  than  the  m ixture con ta in ing  th e  
human serum f a c to r s .  The long incu b a tio n  p e rio d  seems to  cancel 
any in te r f e r r in g  e f f e c ts  due to  varying co n cen tra tions o f th e  
serum fa c to r s  s in ce  i t  allow s ample tim e fo r  th e  form ation of 
maximum a c t iv i t y  which was observed to  occur w ith in  th e  f i r s t  two 
m inutes o f in c u b a tio n . However, th e  is su e  i s  fu r th e r  com plicated 
by th e  co n cen tra tio n  o f th e  b ra in  e x tra c t  i t s e l f  which i s  known 
to  behave as a s u b s tra te  (S traub and Duckert, 1961) and may have 
been a  l im it in g  f a c to r  to  th e  fu r th e r  form ation of a c tiv e  e x tr in s ic  
th ro m bop lastin . I t  i s  my fe e lin g  th a t  b ra in  p recu rso r substance 
was p re se n t in  th e  incu b a tio n  m ixture in  excess in  view of th e  very  
sh o r t c lo t t in g  tim es ob ta ined . Mann and Hurn (1952) b e lieved  
r a b b i t  b ra in  th rom bop lastin  to  be sp ec ies  s p e c if ic  and th a t  such 
s p e c i f i c i t y  could la rg e ly  be e lim inated  by th e  b r ie f  trea tm en t of 
th e  th rom bop lastin  w ith  th e  d i lu te  homologous serum. F an tl and 
Marr (1957) rep o rte d  th a t  r a b b i t  f a c to r  VII was species s p e c if ic ,
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though l a t e r  F an tl and Osborn (1962) observed th a t  th e  com bination 
o f p u r i f ie d  r a b b it  or human fa c to rs  VII and X w ith  th e  b ra in  
p re c u rso r  showed no ab so lu te  spec ies  s p e c if ic i ty ,  b u t noted a 
h ig h e r a c t i v i t y  in  th e  homologous system s, concluding th a t  a h igher 
c o n c e n tra tio n  o f th e se  fa c to rs  i s  req u ired  fo r  th e  prothrom bin 
conversion  in  a hetero logous re a c tio n  m ixture.
Conclusion
Human and r a b b i t  serum fa c to rs  reac ted  s im ila r ly  w ith  human 
and r a b b i t  b ra in  e x tra c ts  and a re  th e re fo re  no t spec ies  s p e c if ic .
RABBIT PLASMA. FACTOR VII ASSAY
The c o n ce n tra tio n  o f f a c to r  VII in  ra b b it  plasma was f i r s t  
es tim ated  by th e  degree o f c o rre c tio n  of human phenindione plasma. 
Thus i t  was c a lc u la te d  to  be 820 p er cen t o f th e  human plasma fa c to r  
VII a c t i v i t y  (Table 95, experiment 1 ) . Such a high concen tra tion  
i s  b e liev ed  to  be n o t t r u e ,  th e  r e s u l t  being in f la te d  by th e  very  
high  co n ce n tra tio n  of fa c to r  V in  ra b b it  plasma, a f a c t  th a t  renders 
comparison between th e  human and r a b b i t  plasma d i lu tio n s  f a l l i b l e .
The method of R o lle r  e t  a l  (1951) was th e re fo re  t r i e d .  I t  
measures th e  degree of c o rre c tio n  o f S e itz —f i l t e r e d  bovine plasma 
which co n ta in s  f a c to r  V in  excess thus minimising th e  e f f e c t  of 
v a r ia t io n  o f fa c to r  V co n cen tra tio n  in  th e  t e s t  plasm as. With
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t h i s  method, th e  c o r re c tiv e  a b i l i t y  of r a b b it  plasma was found to  
v a ry  from 86.6 to  94 per cen t, w ith  an average o f 89.2 p e r  cen t 
o f  th e  human plasma fa c to r  VII co n cen tra tio n  (Table 95, experim ents 
2 , 3 , and 4 , and F igure 55). I t  should be noted th a t  th e  s u b s tra te  
plasm a i s  a lso  d e f ic ie n t  in  fa c to r  X which i s  com pletely re ta in e d  
by th e  asbesto s  f i l t e r s ,  and th a t  th e  c o rre c tiv e  a b i l i t y  measured 
i s  th e re fo re  a  measure o f th e  combined a c t iv i t i e s  o f f a c to rs  VII 
and X in  th e  case o f bo th  t e s t  and c o n tro l plasm as. But s in ce  
r a b b i t  plasma was found to  con ta in  about fo u r tim es th e  concen tra tio n  
o f f a c to r  X (as w il l  be d iscussed  sh o r tly )  we can exclude th e  f a c t  
o f  i t s  having any lim it in g  e f f e c t  on th e  t e s t ,  s in ce  even in  th e  
1 i n  40 d i lu t io n s  o f  th e  t e s t  r a b b i t  plasma th e  co n cen tra tio n  o f 
f a c to r  X would be eq u iv a len t to  th a t  p re se n t in  th e  100 per cent 
p re p a ra t io n  o f th e  c o n tro l human plasma.
Conclusion
R abb it plasma co n ta in s  f a c to r  VII in  a  co n cen tra tio n  n e a r ly  
equal to  th a t  p re se n t in  th e  human plasm a.
RABEITFLASMA pactor__x _ assay
The a c t iv i t y  o f  f a c to r  X in  r a b b i t  plasma was measured by th e  
a b i l i t y  to  c o r re c t S e i t z - f i l t e r e d  bovine plasma when c lo t te d  w ith  
R u s s e l l 's  v ip e r  venom and cepha lin  in  th e  presence o f calcium
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c h lo rid e  s o lu tio n  (method of Bachmann, D uckert, and K o lle r, 1958).
The r a b b it  plasma was found to  co n ta in  388-479 p er cen t of th e  
human plasm a fa c to r  X co n cen tra tio n , w ith  an average of 436.5 per 
cen t (Table 96 ). No species  s p e c i f ic i ty  towards th e  R .V .V .-cephalin  
reag e n t was observed. Again, th e  high co n cen tra tio n  o f f a c to r  V 
in  th e  s u b s tra te  plasma rendered in s ig n if ic a n t  any v a r ia t io n  o f th e  
f a c to r  V co n ce n tra tio n  in  th e  t e s t  or co n tro l plasma samples.
Though no p rev ious q u a n ti ta t iv e  assays of ra b b it  f a c to r  X were 
made, W arte lle  (1957b) observed th a t  both th e  stypven tim e and th e  
s ty pven -cephalin  tim e o f ra b b it  plasma were s h o r te r  than  those  o f 
human plasm a, and in fe r re d  th a t  ra b b it  f a c to r  X occurs in  a  h igher 
c o n c e n tra tio n  th an  th e  human fa c to r  X, though she was aware th a t  
f a c to r  V was p re se n t in  ra b b it  plasma in  very  high concen tra tions 
which must have co n trib u ted  to  th e  sho rten ing  of th e  stypven c lo t t in g  
tim e s .
Conclusions
F ac to r X i s  p re se n t in  ra b b it  plasma in  a concen tra tio n  about 
fo u r tim es more th an  th a t  in  th e  human plasm a. I t  i s  no t species 
s p e c if ic  tow ards th e  R u s s e ll 's  v ip e r  venom -cephalin reag en t.
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RABBIT PLASMA PROTHROMBIN ASSAY
The ra b b it  plasma prothrom bin con ten t was estim ated  by th e  
tw o-stage a rea  method of Biggs and Douglas (1953a). With human 
b ra in  th rom bop lastin  th e  ra b b i t  plasma prothrom bin was found to  
average 67.5 per cen t th e  human plasma prothrom bin co n ten t, w ith  
a  range o f 66 .9 -68 .6  p e r  cen t. With ra b b i t  b ra in  e x tra c t th e  
corresponding values were an average of 72 p er cen t and a range 
o f 63.7-85 per cen t o f th e  human plasma prothrom bin estim ated  
s im ila r ly .  The r e s u l t s  a re  p resen ted  in  Table 97 and experiment 
number one i l l u s t r a t e d  in  F igure 56.
E stim ation  o f th e  r a b b i t  plasma prothrom bin by th e  g lo b u lin  
f r a c t io n  technique of Douglas and Biggs (1953) y ie ld ed  q u ite  
d i f f e r e n t  v a lu es . With human b ra in  e x tra c t  th e  r a b b i t  prothrom bin 
was 30 .7  p er cen t of th e  human prothrom bin co n cen tra tio n , w hile 
w ith  r a b b i t  b ra in  e x tra c t  i t  was 29.6 per cen t (Table 98). 
D iscussion
The r e s u l t s  ob ta ined  fo r  r a b b it  plasma prothrom bin by th e  
two—sta g e  a rea  method seem to  r e f l e c t  th e  tru e  co n cen tra tio n  of 
th e  prothrom bin r e la t iv e  to  th e  human plasma prothrom bin, in  view 
o f  th e  s im ila r  f in d in g s  obta ined  w ith  eo ther human or ra b b it  b ra in  
e x t r a c ts .  I t  i s  in te r e s t in g  to  no te th a t  th e  use o f ra b b it  b ra in  
e x tra c t  re s u lte d  in  lower values fo r  a l l  th e  plasma samples than
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when th e  l a t t e r  were estim ated  w ith  th e  human b ra in  e x t r a c t ,  except 
in  experim ent 3 (Table 97) in  which th e  ra b b i t  b ra in  was used and 
gave h ig h e r  values fo r  both  plasm as. This f in d in g , however, does 
n o t in v a l id a te  th e  r e s u l t s  s in ce  comparisons were only  made between 
samples te s t e d  w ith  th e  same species  o f b ra in  e x tra c t .
Murphy and Seegers (1948) using  a  tw o-stage procedure rep o rte d  
rabbit plasma to  co n ta in  prothrom bin in  a co n cen tra tio n  very  
slightly l e s s  th a n  th a t  in  normal human plasm a, namely 220-250 and 
290 prothrom bin u n i ts  per cubic cen tim etre  of plasma re sp e c tiv e ly . 
Fantl (1954) u t i l i s i n g  h is  pyrocatecho l tw o-stage method rep o rted  
n e a r ly  s im ila r  values fo r  both  human and ra b b it  prothrom bin 
c o n c e n tra tio n s , namely 470-720 Pyrocatechol Thrombin U nits per 
m i l l i l i t r e  o f human plasm a and 450-670 P.T.U . p e r m i l l i l i t r e  of 
rabbit plasm a. Quick e t  a l  (1961) found th a t  r a b b i t  plasma 
co n ta in ed  th e  same co n ce n tra tio n  o f  prothrom bin as p re sen t in  th e  
human plasm a in  a  tw o-stage assay  system , w hile observing th a t  
results ob ta in ed  w ith  one—stag e  t e s t s  v a rie d  g r e a t ly  according to  
th e  type o f th ro m bop lastin , exposure to  fo re ig n  su rfa c e s , and to  
th e  serum f a c to r s .
As was p re v io u s ly  encountered during  th e  prothrom bin assays 
o f  h o rse  plasm a by th e  g lo b u lin  f r a c t io n  techn ique o f  Douglas and 
Biggs (1953), t h i s  method gave much lower va lues fo r  th e  same plasma 
samples th a n  tho se  es tim ated  by th e  a rea  method, though u t i l i s i n g
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th e  same b ra in  e x t ra c ts ,  both  experim ents having been conducted 
on th e  same day. The p r e c ip i ta t io n  c h a ra c te r i s t ic s  o f human and 
r a b b i t  prothrom bins from plasma samples a t  d i f f e re n t  pH values 
rang ing  from 4 .2  to  6 .4  was in v e s tig a te d . Maximal p r e c ip i ta t io n  
o f  human prothrom bin occured a t  pH 5 .2 , w hile ra b b it  prothrom bin 
was maximally p re c ip i ta te d  a t  pH 5 .6 . This d iffe re n c e  has a 
n e g l ig ib le  e f f e c t  on th e  r e s u l t s  s in ce  on comparing the  maximal 
y ie ld s  th e  r a b b i t  prothrom bin s t i l l  measured 33 p e r cent of th e  
human prothrom bin. Since th i s  method e n ta i ls  th e  a c t iv a t io n  of 
th e  prothrom bin in  th e  absence of th e  a c c e le ra to r  fa c to rs  over a 
prolonged in cu b a tio n  p e rio d , i t  may w ell be th a t  r a b b i t  prothrom bin 
under such co n d itio n s  i s  le s s  prone to  a c t iv a t io n  or in  o the r words 
more s ta b le .  Indeed, i t  was n o ticed  th a t  during th e  p rep a ra tio n  
o f r a b b i t  throm bin from an eug lobu lin  f r a c t io n  o f ra b b it  plasma, 
r e c a lc i f i c a t io n  o f th e  l a t t e r  re s u lte d  in  th e  c lo t t in g  of th e  
so lu tio n  a f t e r  a much longer perio d  th an  i s  u su a lly  th e  experience 
w ith  a  s im ila r  human p re p a ra tio n .
C onclusion
R abbit plasma co n ta in s  prothrom bin in  a somewhat le s s  
c o n ce n tra tio n  th an  th a t  o f human plasm a, when estim ated  by the  
tw o-stage a rea  method, namely about 67 p e r cen t of th e  human plasma 
prothrom bin co n ce n tra tio n .
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EFFICIENCY OF RABBIT EXTRINSIC THROMBOPLASTIN SYSTEM 
The r a b b it  plasma was found to  con ta in  a l l  th e  coagu la tion  
f a c to r s  re q u ire d  fo r  th e  e x tr in s ic  throm boplastin  system of 
prothrom bin a c t iv a t io n .
E x tr in s ic  prothrom bin a c tiv a t io n  was brought about in  ra b b it  
plasm a as q u ick ly  and e f f ic ie n t ly  as in  human plasma, both  w ith  
r a b b i t  and w ith  human b ra in  th rom bop lastins.
RABBIT INTRINSIC THROMBOPLASTIN SYSTEM 
The r a b b it  whole blood c lo tte d  in  o rd inary  g la ss  tubes in  
6 ’ 6” w hile  in  s il ic o n e d  tubes i t  c lo tte d  in  12* 51H (Table 101). 
The r e c a lc i f ie d  c lo t t in g  time of ra b b it  plasma was a lso  found to  
be s l ig h t ly  s h o r te r  th an  th a t  o f human plasma, namely 114 and 148 
seconds re s p e c tiv e ly  (Table 102). These r e s u l t s  in d ic a te  the  
e f f i c i e n t  and ra p id  g en era tio n  o f in t r in s i c  a c tiv e  throm boplastin  
in  r a b b i t  blood and plasma as w ell as th e  presence of th e  con tac t
f a c to r s .
Salzman (1962) ob ta ined  whole blood c lo t t in g  tim es o f 2 ' 30” 
to  5 ' 15*', and b leed ing  tim es of 1 ' 0H to  6 ' 15". The l a t t e r  
were ob ta ined  by making an in c is io n  3-4 m illim e tres  long in  the  
dorsum o f th e  ra b b it  ear w ith  a  razo r b lade tra v e rs in g  a v is ib le
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v e s s e l .
The r a b b i t  blood p la te l e t s  occur in  about th e  same number as 
th e  human p la t e l e t s ,  having an average o f 311,000 p la te le t s  per 
cubic m illim e tre  o f whole blood (Table 100).
C onclusions
The r a b b it  has normal whole blood c lo t t in g  tim es, normal 
r e c a lc i f i e d  c lo t t in g  tim e of plasm a, and normal p l a t e l e t  concen tra tio n  
as compared to  th e  normal human corresponding v a lu es .
RABBIT PLASMA HAGEMAN FACTOR ACTIVITY
The a c t iv i t y  o f Hageman fa c to r  in  ra b b it  plasma was measured 
on two occasions by th e  l a t t e r  *s a b i l i t y  to  c o rre c t th e  prolonged 
r e c a lc i f i c a t io n  c lo t t in g  tim e of plasma obtained  from a p a t ie n t  
w ith  co n g en ita l Hageman fa c to r  d e fic ien cy . Both ra b b it  and human 
plasmas were maximally g la s s -a c t iv a te d  befo re  being te s te d .  The 
method i s  d escribed  in  f u l l  in  appendix IV, 24, I I .
The average Hageman fa c to r  a c t iv i t y  of ra b b it  plasma was 1025 
per cen t th a t  in  human plasma, w ith  a range of 910-1140 per cent 
(Table 103, and F igure 57). In  o th e r words, r a b b it  plasma contained 
about te n  tim es as much Hageman fa c to r  a c t iv i ty  as i s  p resen t in  
human plasm a. I t  i s  my im pression th a t  such high  values are  
exaggerated  due to  th e  presence of f a c to r  V in  very  high concen tra tions
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in  th e  ra b b i t  plasma d i lu t io n  m ixtures as compared to  i t s  
co n ce n tra tio n  in  th e  corresponding human plasma d i lu t io n  m ix tures. 
This i s  rem in iscen t of th e  in te r f e r r in g  e f f e c t  of th e  high  fa c to r  
V c o n ce n tra tio n  during  th e  assay  o f ra b b it  plasma fa c to r  VII in  
th e  o n e-stage  t e s t  r e s u l t in g  in  th e  in f l a t io n  of th e  f in a l  r e s u l t .
A ttem pts to  measure and compare th e  a c t iv i t i e s  of p u r if ie d  
ra b b it  and human Hageman fa c to r  p rep a ra tio n s  in  a s im ila r  system 
have f a i l e d .
W arte lle  (1957b) estim ated  th e  Hageman fa c to r  a c t iv i t y  of th e  
r a b b i t  plasma as 50 per cen t of th e  human plasma a b i l i t y  to  c o rre c t 
a  c o n g e n ita lly  d e f ic ie n t  human plasm a.
Conclusion
R abbit plasma con ta in s Hageman fa c to r  in  h ig h e r concen tra tions 
th an  th o se  p re se n t in  human plasm a. The ra b b it  Hageman fa c to r  i s  
n o t sp ec ie s  s p e c if ic .
RABBIT PLASMA THROMBOPLASTIN ANTECEDENT ACTIVITY
Exact measurement of th e  plasma throm boplastin  antecedent 
a c t i v i t y  o f r a b b i t  plasma was no t made because o f th e  u n a v a i la b i l i ty  
o f P .T .A . c o n g e n ita lly  d e f ic ie n t  plasm a. But in  view o f th e  longer 
c lo t t in g  tim es o f whole blood ob ta ined  when u sing  s ilic o n e d  tubes 
in s te a d  o f o rd in ary  g la ss  tu b e s , and s in ce  Hageman fa c to r  alone
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cannot cause such a d if fe re n c e , i t  i s  reasonab le to  assume th a t  
th e  r a b b i t  plasma con ta in s  P . T . A .  in  a co n cen tra tio n  th a t  i s  
s u f f ic ie n t  fo r  th e  normal g en era tio n  of a c tiv e  in t r in s ic  thrombo­
p la s t in .  W arte lle  (1957b) found th a t  ra b b it  plasma P.T.A . was 
250 p e r cen t th a t  p re se n t in  human plasma when te s te d  in  a  one- 
—stag e  r e c a lc i f i c a t io n  c lo t t in g  time procedure by c o rre c tio n  of 
P.T .A . c o n g e n ita lly  d e f ic ie n t  plasma.
RABBIT PLASMA ANTIHAEMOPHILIC GLOBULIN A C TIV ITY  
The A .H .G r. con ten t of r a b b it  plasma was measured by th e  method 
of P itn e y  (1956). I t  ranged from 246.6 to  324 p er cen t, w ith  an 
average o f 288.5 p e r cen t o f th e  human plasma A .H .G r. a c t iv i ty  
(Table 106, and F igure 59).
D iscussion
The observed high A .H .G r. con ten t of ra b b it  plasma was a lso  
ev iden t in  th e  l e t t e r ' s  g re a te r  a c t iv i t y  than  human plasma in  the  
o rd in ary  th rom bop lastin  g en era tio n  t e s t  when incubated  w ith  human 
serum and te s te d  w ith  e i th e r  human or ra b b it  p la te le t s  (F igure 58), 
though th i s  may have a lso  been p a r t ly  due to  th e  high fa c to r  V 
co n ce n tra tio n  in  th e  adsorbed ra b b it  plasma. In  th e  A .H .G r. assays 
by P i tn e y 's  method th e  use o f adsorbed haem ophilic plasma co n trib u te s  
s u f f ic ie n t  f a c to r  V , w hile th e  h igh  d ilu t io n s  of ra b b i t  plasma used
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rendered  th e  l e t t e r ' s  h igh  fa c to r  V con ten t w ithou t s ig n if ic a n t  
untoward e f f e c t  on th e  accuracy of th e  measurement.
F a n tl and Marr (1957) rep o rted  a s im ila r  range of A.H.G. in  
r a b b i t  and human plasm as. Hawkey (I960) found th a t  a 1 in  10 
d i lu t io n  o f ra b b i t  adsorbed plasma caused complete c o rre c tio n  o f 
haem ophilic plasma in  th e  th rom boplastin  g enera tion  t e s t .
W arte lle  (1957b) made a q u a n ti ta t iv e  estim ate  of ra b b it  plasma 
A.H.G. co n ten t by c o rre c tio n  of haem ophilic plasma in  a one-stage 
r e c a lc i f i c a t io n  tim e t e s t  and found th a t  ra b b it  plasma contained 
3-4 tim es as much A.H.G. as human plasm a.
Conclusions
R abbit plasma con ta in s  an tihaem ophilic  g lo b u lin  in  a 
c o n ce n tra tio n  about two and a h a l f  to  th re e  tim es th a t  p re sen t in  
human plasm a. The r a b b it  an tihaem ophilic  g lo b u lin  i s  n o t spec ies 
s p e c if ic .
RABBIT SERUM CHRISTMAS FACTOR ACTIVITY
The th rom bop lastic  a c t iv i t y  o f r a b b i t  serum in  an o rd inary  
th rom bop lastin  g en era tio n  t e s t  when incubated  w ith  human adsorbed 
plasma was found to  be weaker than  th a t  o f human serum whether 
human or r a b b i t  p la t e l e t s  were used (Table 104, 105, and F igure 60). 
When incubated  w ith  ra b b it  adsorbed plasma th e  d iffe re n c e  was le s s
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marked, and n e a r ly  com pletely elim inated when ra b b it  p la te le ts  were 
used  in  p la c e  o f th e  human p la te le ts  (Table 105, m ixtures 146 and 
147).
S p e c if ic  measurement of Christmas fa c to r  a c t iv i ty  o f ra b b it  
serum by a m odified method based on P itn e y 's  method (1956) revea led  
th e  p resence  o f Christm as fa c to r  in  low amounts compared to  human 
s ta n d a rd s , th e  average o f th re e  estim ations was 29.3 per cen t, w ith  
a  range o f 20 .4  to  40 per cent of the human serum Christmas fa c to r  
a c t i v i t y  (Table 107, and F igure 61).
D iscussion
S ince r a b b it  plasma was found to  con tain  more than  adequate 
amounts o f f a c to r  X which i s  no t consumed during in t r in s ic  prothrom bin 
conversion , i t  i s  assumed th a t  ra b b it  serum a lso  contained equ ivalen t 
amounts o f f a c to r  X. I t s  weaker throm boplastic a c t iv i ty  in  th e  
th ro m b o p lastin  g en era tio n  t e s t  can th e re fo re  be ascribed  to  i t s  
lower Christm as f a c to r  conten t as corroborated by the  sp e c if ic  
a ssa y s . The masking of th i s  weaker a c t iv i ty  on incubation  w ith  
adsorbed r a b b it  plasma and ra b b it  p la te le ts  i s  be lieved  to  be due 
to  th e  overwhelming high  conten t of o ther c lo tt in g  fa c to rs  in  th e  
l a t t e r  reag en ts  r a th e r  than  to  species s p e c if ic i ty  between ra b b it
serum and plasm a c lo t t in g  fa c to rs .
D idisheim  e t  a l  (1959) and Hawkey (i960) repo rted  th a t  ra b b it  
serum had a s im ila r  a c t iv i t y  to  human serum in  th e  throm boplastin
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g e n e ra tio n  t e s t .  The l a t t e r  au thor concluded complete c o rre c tio n  
o f Christm as d ise a se  serum in  th e  th rom boplastin  g en era tio n  t e s t  
w ith  1 in  10 d i lu t io n  o f r a b b i t  plasma or serum, though h er a c tu a l 
f in d in g s  were as fo llow s
Human serum — — — 10 9 10
R abbit serum — 120 60 27 13 11
The weaker a c t iv i t y  of th e  r a b b i t  serum in  c o rre c tin g  Christmas 
d ise a se  serum i s  apparen t, and would have been more obvious i f  
th e se  va lu es  were expressed in  term s of percentage o f a c tiv e  
th rom bop lastin .
F a n tl and Marr (1957) and W artelle  (1957b) a lso  m ain tain  th a t  
Christm as fa c to r  i s  p re sen t in  ra b b it  plasma in  th e  same concen tra tion  
as in  human plasma, by c o rre c tio n  o f Christm as d isease  plasma in  
a  one-stage  r e c a lc i f ic a t io n  tim e t e s t  whose r e s u l t s  can be e a s i ly  
v i t i a t e d  by th e  very  high  co n cen tra tio n  o f o th e r c lo t t in g  fa c to rs  
in  th e  ra b b it  plasma ( fa c to rs  V, VTII, and X) as compared to  th e i r  
co n ce n tra tio n  in  th e  human co n tro l m ix ture, e s p e c ia lly  th a t  they  
only  te s te d  low d i lu tio n s  of r a b b it  plasma, namely 1 in  20.
W arte lle  (1957b), however, observed th a t  in  th e  th rom boplastin  
g en era tio n  t e s t  th e  r a b b i t  serum was s l ig h t ly  in f e r io r  to  th e  human 
serum, and from her r e s u l t s  i t  i s  obvious th a t  even a m ixture of 
equal volumes o f human and ra b b it  s e ra  d id  no t genera te  a c tiv e  
th rom bop lastin  in  a comparable co n cen tra tio n  to  th a t  a t ta in e d  by
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human serum alone .
C onclusion
R abbit serum co n ta in s  about one th i r d  th e  co n cen tra tio n  o f 
C hristm as f a c to r  p re se n t in  human serum. The r a b b i t  Christm as 
f a c to r  i s  n o t sp ec ie s  s p e c if ic .
RABBIT BLOOD PLATELETS
R abbit whole b lood co n ta in s  an average of 311,000 p la t e l e t s  
p e r cubic m illim e tre  (Table 100) which i s  s im ila r  to  a normal human 
p l a t e l e t  coun t. R abbit p la te le t s  a re  m orphologically  s im ila r  to  
th e  human p l a t e l e t s .  Casey e t  a l  (1936) rep o rted  p l a t e l e t  counts 
o f 388,000-798,000/c.ram. o f whole r a b b i t  blood, from 180 estim ations 
on 15 breeds (no t in c lu d in g  th e  C a lifo rn ia n  breed in v e s t ig a te d  in  
t h i s  work). They observed th a t  in  th e  b igger breeds th e  counts 
were u s u a lly  h ig h e r.
The th rom bop lastic  a c t iv i t y  of th e  r a b b i t  p la te le t s  was 
in v e s tig a te d  by s u b s t i tu t in g  them in  p lace  of th e  human p la te le ts  
i n  th e  th rom bop lastin  g en era tio n  t e s t  and comparing th e  r e s u l t s .
The r a b b i t  p l a t e l e t  p re p a ra tio n  had le s s  a c t iv i t y  than  th e  human 
p re p a ra tio n  when mixed w ith  human adsorbed plasma and human serum 
(Table 105, m ixture 144 compared w ith  m ixture 140 in  Table 104; and 
i l l u s t r a t e d  in  F igure 62, A, curves b and a re s p e c t iv e ly ) .
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But w ith  r a b b i t  adsorbed plasma and r a b b i t  serum, the rabbit 
p l a t e l e t s  ex h ib ited  more activity than th e  human, p la t e l e t s  (Table 
105, m ix ture 146 compared to m ixture 142 in Table 104; i l l u s t r a t e d  
in  F ig u re  62, B, curves b and a respectively). This phenomenon 
may be due to  sp ec ie s  s p e c i f i c i t y  between th e  r a b b i t  p la t e l e t s  and 
th e  r a b b i t  blood co ag u la tio n  f a c to r s ,  or to  an excess o f c lo t t in g  
f a c to r s  being  adsorbed on th e  r a b b i t  p la te le t s  which to g e th e r  w ith  
th e  a lre a d y  h igh  r a b b i t  plasma coagu la tion  fac to rs*  co n cen tra tio n  
in  th e  in cu b a tio n  m ixture render th e  f in a l  co n cen tra tio n  o f th e se  
c lo t t in g  fa c to r s  in  th e  m ixture abnorm ally h igh , a co n d itio n  th a t  
may mask th e  weaker a c t iv i t y  of th e  r a b b i t  p l a t e l e t s .
E g li and K esse ler (1955) noted s im ila r  a c t i v i t i e s  fo r  r a b b i t  
and human p la te l e t s  in  th e  th rom bop lastin  g en e ra tio n  t e s t .
Humphrey and Jaques (1954) found th a t  r a b b i t  p la t e l e t s  co n ta in  
much g re a te r  amounts o f h istam ine and se ro to n in  than  th o se  p re sen t 
i n  human p l a t e l e t s ,  namely 30-60 tim es as much. Kjaerheim and 
Hovig (1962) observed th a t  th e  u l t r a s t r u c tu r e  of is o la te d  r a b b it  
p l a t e l e t s  was in  good agreement w ith  th a t  of th e  human p la t e l e t s .
The a b i l i t y  o f r a b b i t  p la t e l e t s  to  b rin g  about c lo t  r e t r a c t io n  
was found to  be s im ila r  to  th a t  of human p la t e l e t s .  B abbit whole 
blood having s im ila r  f ib rin o g en  and haem atocrit values to  human 
whole blood had an average of 54.6 p e r cen t o f c lo t  r e t r a c t io n  in
one hour (Table 108).
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Conclusions
R abbit blood con ta in s a s im ila r  number of p l a te le t s  as p re sen t 
in  human blood. The throm boplastic  a c t iv i ty  o f ra b b it  p la te le ts  
in  th e  th rom boplastin  g enera tion  t e s t  was weaker than  th a t  of human 
p la te l e t s  when used in  a human system, w hile i t  was s tro n g e r when 
th ey  were used in  a ra b b it  system. Rabbit c lo t  r e t r a c t io n  i s  
normal by human s tan d ard s .
RABBIT PLASMA SUBSTRATE REACTIVITY IN THE T.G.T.
The use of ra b b it  high-spun plasma as th e  s u b s tra te  in  th e  
th rom bop lastin  g enera tion  t e s t  in s te a d  of th e  human high-spun plasma 
re s u lte d  in  c o n s is te n t shorten ing  of th e  c lo t t in g  tim es ob ta ined , 
which in  term s o f percen tage a c tiv e  throm boplastin  would give 
h igher values than  those  obtained w ith human high-spun plasma.
This phenomenon was dem onstrable w ith  a l l  th e  in cu b a tio n  m ixtures 
te s te d  (F igures 63 and 64 construc ted  from Tables 104, 105, 109, 
and 110). Such enhanced r e a c t iv i ty  o f r a b b it  plasma may be due 
to  th e  h igh  concen tra tion  o f a c c e le ra to r  fa c to rs  V and X p re se n t.
As shown p rev io u s ly , both  th e  th rom bin -fib rinogen  re a c tio n  and th e  
an tith rom bin  con ten t o f ra b b it  plasma were s im ila r  to  human plasm a. 
Conclusion
R abbit high-spun plasma i s  more re a c tiv e  th an  human high-spun
-  248 -
plasma to  a c tiv e  in t r in s ic  throm boplastin , whether homologous or 
h e tero lo g o u s.
INHIBITORS AGAINST HUMAN THROMBOPLASTIN IN RABBIT BLOOD
No in h ib i to r s  were observed in  ra b b it  adsorbed plasm a or in  
r a b b i t  serum ag a in s t human in t r in s i c  throm boplastin  form ation when 
in v e s tig a te d  by th e  method of Biggs and M acfarlane (1957) as c i te d  
i n  appendix IV, 23.
The r e s u l t s  ob tained  are  p resen ted  in  Table 111 and i l l u s t r a t e d  
in  F igures 65 and 66. I t  w il l  be seen th a t  m ixture number 158 had 
le s s  a c t iv i t y  because o f th e  d e fic ien cy  of th e  Christm as fa c to r  in  
th e  r a b b i t  serum, bu t th e  same a c t iv i ty  was p re sen t a f te r  two hours 
o f in cu b a tio n  a t  37°C. (m ixture 161) thus ru lin g  out th e  p o s s ib i l i ty  
o f th e  presence o f any in h ib ito ry  e f f e c t  in  r a b b i t  serum.
Conclusion
R abbit adsorbed plasma and ra b b it  serum do no t possess any 
in h ib i to ry  a c t iv i t y  a g a in s t human in t r in s ic  a c tiv e  th rom boplastin  
form ation  in  a  th rom boplastin  gen era tio n  system.
HOMOLOGOUS RABBIT INTRINSIC THROMBOPLASTIN GENERATION
The g en era tio n  o f ra b b it  homologous a c tiv e  in t r in s ic  thrombo­
p la s t in  by th e  incu b a tio n  of ra b b it  adsorbed plasma and ra b b it  
serum w ith  ra b b it  p l a t e l e t  suspension, w ith  subsampling onto 
r a b b i t  high—spun plasm a, occured a t  a f a s te r  r a te  and in  a g re a te r  
degree than  th a t  of a comparable human homologous system (Table 110, 
m ixture 154 compared to  m ixture 140 in  Table 104). The use of 
human s u b s tra te  high-spun plasma s t i l l  gave much h igher values fo r  
th e  r a b b i t  homologous in cubation  m ixture than  those  obtained  w ith  
a human homologous system (Figure 64, B, curves b and a  re s p e c t iv e ly ) .
These fin d in g s are  to  be expected from th e  p rev io u s ly  dem onstrated 
h igh  co n cen tra tio n s  of most of th e  blood c lo t t in g  fa c to rs  p re sen t 
in  r a b b i t  plasma, combined w ith  th e  absence of in h ib ito ry  a c t iv i ty  
and a normal an tithrom bin  le v e l .
E g li and K esseler (1955), W arte lle  (1957b), and Didisheim e t  
a l  (1959) found th a t  r a b b it  th rom boplastin  g en era tio n  was s im ila r  
to  th a t  of man. W arte lle  (1957b) a t t r ib u te d  th e  i n i t i a l  
h y p e ra c tiv i ty  in  ra b b it  m ixtures to  th e  presence o f preformed 
th rom boplastin  a c t iv i t y  in  ra b b it  reag e n ts .
EFFICIENCY OF RABBIT INTRINSIC THROMBOPLASTIN SYSTEM
A ll th e  coagu la tion  fa c to rs  concerned in  th e  in t r in s ic  
th rom bop lastin  system of prothrom bin a c t iv a t io n  a re  p re sen t in  
r a b b i t  plasma and serum in  amounts adequate fo r  e f fe c t iv e  normal 
haem ostasis, w ith  th e  exception  of Christmas f a c to r  which i s  s l ig h t ly  
d e f ic ie n t  in  th e  ra b b it  serum. In  s p i te  of th i s  s in g le  d e fic ien cy , 
normal whole blood c lo t t in g  tim es and normal plasma r e c a lc i f ic a t io n  
c lo t t in g  tim es were ob ta ined . A lso, g re a t amounts of a c t iv e  
i n t r in s ic  throm boplastin  were formed in  a homologous ra b b it  
th rom bop lastin  gen era tio n  m ixture.
Moreover, a  prothrom bin consumption index fo r  r a b b i t  blood of 
about 25 p e r cen t (Table 99) in d ic a te s  th e  e f f ic ie n t  in t r in s ic  
prothrom bin conversion in to  throm bin, s u f f ic ie n t  to  e f f e c t  normal 
haem ostasis.
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SUMMARY OF RABBIT BLOOD COAGULATION MECHANISM 
R abbit blood con ta in s a l l  th e  coagu la tion  fa c to rs  known to  
take  p a r t  in  th e  human blood coagu la tion  mechanism. Compared to  
th e  human, th e  ra b b it  blood contained  s im ila r  co ncen tra tions  of 
f ib rin o g en , p la t e l e t s ,  f a c to r  "VII, and an tith rom bin ; w hile th e  
prothrom bin was 67 per cen t, and th e  Christmas fa c to r  about one 
th i r d  th a t  of th e  human serum. R abbit plasma contained  much 
h ig h er values fo r  th e  o th e r coagu la tion  f a c to r s ,  namely 100 tim es 
o f fa c to r  V, 4 tim es o f fa c to r  X, 3 tim es o f A.H.G., and about 10 
tim es o f Hageman fa c to r .
No species  s p e c i f ic i ty  was observed fo r  any o f th e  c lo t t in g  
fa c to r s ,  except th a t  th e  p u r if ie d  ra b b it  fib rin o g en  seemed to  be 
more a c t iv e ly  c lo tte d  w ith  p u r if ie d  ra b b it  throm bin.
The ra b b it  blood had normal whole blood c lo t t in g  tim es, normal 
plasma r e c a lc i f ic a t io n  c lo t t in g  tim e, normal c lo t  r e t r a c t io n ,  and 
a normal prothrom bin consumption index .
Both th e  e x tr in s ic  and th e  i n t r in s ic  systems o f prothrom bin 
a c t iv a t io n  in  ra b b i t  blood a re  be liev ed  to  be e f f ic ie n t .
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P A R T  VI
LOBSTER BLOOD COAGULATION MECHANISM
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LOBSTER BLOOD COAGULATION MECHANISM 
The data presented in this part are based on the results of 
experiments conducted on blood samples obtained from lobsters of 
the genus Nephrops norvegicus taken as representative of the 
crustacean class of Arthropoda.
The blood samples were taken from fresh live healthy animals 
obtained at frequent intervals from Millport Marine Station, Isle 
of Cumbrae, Scotland. The animals were kept in fresh sea water 
in a large tank with constant aeration, the temperature was kept 
at about 10-15°C. by a continuous flow of cold water in a jacket 
around the tank. None of the animals used were kept for more 
than two days in the tank. They were fed on fresh mussels.
Arthropods have an open vascular system which bathes the tissues 
directly. The lobster has a short tubular muscular heart which 
pumps the blood into a short aorta that soon breaks into several 
smaller arteries. From the latter the blood flows into open 
spaces or sinuses between the tissues from where it is collected 
in a sternal sinus then passes to the gills. The blood returns 
through a pericardial sinus and three pairs of ostia into the heart.
Because of the resemblance between this open system without 
veins to the lymphatic system of vertebrates, arthropod blood is 
called ,themolymph,,. The hemolymph can be easily obtained from
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any of the limb joints by puncturing their membrane with a needle 
and withdrawing the requisite volume of blood by a syringe.
Since the coagulation of crustacean blood has unique features 
very different from those of human blood coagulation, it is my 
intention to review the literature on this subject and present the 
already known facts before discussing them in the light of my 
findings. I should perhaps note that the terminology will be 
that of the authors whose work is reviewed, quotation marks being 
used in cases where confusion with similarly named but different 
substances from vertebrate blood coagulation might otherwise occur.
HISTORICAL REVIEW OF CRUSTACEAN BLOOD COAGULATION 
Blood coagulation was first described in Crustacea by Hewson 
in 1777 who noted that lobster blood clots are less firm than those 
of higher animals. He further observed that lobster clots contain 
white threads which under the microscope appear to consist 
essentially of cells. Carpenter (1843) was the first to maintain 
that fibrin is also formed in the clotting of invertebrate blood.
In 1846 Wharton Jones described two kinds of cells to occur in the 
blood of lobsters and crabs, one granulated and the other nucleated 
and by far the commonest. He noted that lobster blood formed a 
more complete clot than crabs' blood in which the blood corpuscles
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form aggregates that do not show any tendency to coagulate and form 
a true clot. Pouchet (1882), however, reported that no fibrin was 
formed in crayfish blood. Geddes (1879-1880) thought that the 
compact clot of lobster blood consisted exclusively of cells 
connected with each other by pseudopodia without the cooperation of 
fibrin. He termed the syncytium formed the "plasmodium".
Fredericq (1879) from microscopic studies believed that the 
coagulation of lobster blood starts from the blood cells. He 
differentiated the coagulation process into two phases, the first 
is that of cell agglutination, a phase that cannot be prevented 
even by saturated salt solutions. The second phase of coagulation 
which he called "plasma coagulation" occurs after the plasma has 
been released from the clumps formed by the first coagulation.
This plasma he maintains can coagulate again, resembling more a 
fibrinogen coagulation, and can be prevented by the addition of 
certain salt solutions, and by temperatures above 50°C.
Schafer (1883) presented evidence that in the case of the 
sea-urchin blood the cells were capable of exuding a coagulable 
material.
Halliburton (1885) made some detailed investigations on the 
blood coagulation of Nephrops norvegicus. He believed that the 
spontaneous coagulation of crustacean blood is similar in nearly 
all respects to that of vertebrate blood. Namely, that it does
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not occur in the living vessels but only takes place after the
blood is shed, that it can be prevented by the admixture with the
blood of certain salts e.g. four parts of a saturated solution of
magnesium sulphate to one part of blood, and that it can be hindered
by cold (temperature of melting ice). He also noted that the clot
consisted of fibrin which entangled the cells. The formation of
the fibrin was due to the solidification of a proteid of the globulin
class or fibrinogen which existed in solution in the plasm. This
change he attributed to the action of a ferment yielded by the
amoeboid corpuscles of the blood. He prepared this ferment from
blood or serum by the alcohol precipitation method of Schmidt (1892)
and found that the dry powder thus obtained from mammalian or from
crustacean blood when added to the dilute lobster plasm (obtained
over saturated magnesium sulphate and the precipitate filtered off)
caused coagulation in five minutes; just as he found that the
"thrombin" produced from the blood of crayfish, crabs, and lobsters
could coagulate salted cat plasm. However, he was able to obtain
a purified preparation of lobster fibrinogen by salting it out from
the blood by a saturated solution of sodium chloride. He observed
that lobster fibrinogen is different from human fibrinogen with
respect to solubility, also that the former coagulates at 65°C.
o
while the human fibrinogen coagulates at 56 C.
Haycraft and Carlier (1888) found that the blood of the crab
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Carcinus maenas failed to clot when carefully removed with an oiled 
pipette and kept surrounded by oil. Contact of the fluid with any 
part of the glass vessel wall was sufficient to cause clotting.
They observed that while the blood remained fluid the corpuscles 
underwent no deformation, their disintegration following contact 
with a non-oily substance.
Cuenot (1891) stressed the differences between the various 
species of Crustacea first observed by Wharton Jones. He found 
that Arthropods possess true blood coagulation, some have very 
insignificant clots and some have very compact clots; while 
molluscs and worms had no coagulation at all. Cuenot seemed to 
join Halliburton's interpretation that Fredericq's first and second 
phases of coagulation are one and the same process* He further 
observed that the blood of Crustacea kept in captivity lost the 
power of coagulation, assuming that they used up the fibrinogen as 
a reserve nutrient.
Though several authors were aware of the presence of more than 
one kind of cells in crustacean blood (Heitzmann, 1873; Geddes, 
1879-1880; Frommann, 1884; and Lowit, 1889) it was Hardy (1892) 
who differentiated between their respective functions. Hardy 
examined fresh hanging-drop preparations and osmic acid fixed and 
iodine stained preparations of the blood of the crayfish Astacus.
He identified three types of cells. The first which he called
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the "explosive cells" are pale oval cells notorious for their great 
irregularity in shape and their extreme sensitivity to contact with 
foreign bodies, then undergoing an explosive disruption of the 
protoplasm. They appeared in preparations of few seconds as large 
distinct rounded nuclei which floated freely in the plasma. They 
were of about 25-30 |i by 10-11 (jl in size, the nucleus being 13-14 p. 
by 8-10 ji. When stained with eosin after fixation with osmic acid 
they remained uncoloured and because of the general colouration of 
the plasma they became obscured as though they have vanished; while 
the second type of cells "the eosinophilic cells" acquired a deep 
opaque red colour. These latter cells are actively amoeboid in 
fresh preparations and contain large refractile granules or rather 
spherules. These cells are stable for hours, and are about 18 by 
27 p. in size. The explosive cells were more abundant, occuring 
in the ratio of 1 .2 -5 to each eosinophilic cell, with an average 
of 3 to 1. The third type of cell, which is also the rarist, is 
the basophil. This is a larger cell with irregular shape and has 
no amoeboid movement, the granules are less refractive and colourless 
with great diversity in size, but stain deeply with methylene blue 
within few minutes without the cell generally undergoing any change. 
They occur more frequently in poisoned animals. Hardy noted a 
marked correspondence in time between the solution of the explosive 
cells and the solidification of the plasma, while the only other
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cellular elements normally present, the eosinophils, remained 
unchanged and alive for a considerable time after the blood has 
clotted. He therefore deduced that the ferment responsible for 
blood clotting must originate from the explosive cells, being a 
product of their activity and the result of the solution of the 
cell granules. He also observed that iodine solution (0*25 per 
cent) delays the clotting time, which coincides with the delay in 
the solution of the granules, maintaining that iodine prevents 
indefinitely the explosion of the corpuscles, but not the solution 
of the granules; while it fixes completely the granules and cell 
substance of the eosinophilic cells. He stated the causes that 
determine the explosion of the explosive cells and the clotting of 
plasma to be the contact with foreign solid bodies and the presence 
in the plasma of the products of disintegration of other explosive 
cells. He ably described the process as follows "Corpuscles in 
contact with the glass explode practically at once, while in the 
hanging drop one sees a larger and larger number of intact corpuscles 
(as one focuses further) which in their turn explode".
Heim in his thesis (1892) considered the first coagulation to 
form a clot composed of cellular aggregates without true fibrin, 
nnA the second coagulation to form a clot which is chemically 
different, being composed of fibrin. Calcium salts were essential 
for the second coagulation but not for the first. He, however,
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stated that lobster and mammalian purified "thrombin" could 
interchangeably clot lobster and mammalian blood. He prepared 
the "thrombin ferment" from lobster muscle, and the purified 
lobster fibrinogen by precipitation with saturated solutions of 
magnesium sulphate. He further extended Wharton Jones' observations 
on the differences between the various species of Crustacea, 
dividing them into two categories.
Bottazzi (1902) confirmed many of Halliburton's results and 
was of the opinion that crustacean blood clotting occured in two 
successive phases of the same process, observing that oxalates 
prevented the second but not the first coagulation. He prepared 
the fibrinogen solution by precipitation with ammonium sulphate 
solution which he found caused the fastest salting out action.
Loeb in 1903 started extensive investigations on the blood 
coagulation of Crustacea and can rightly be said to have contributed 
the most fundamental findings towards the proper understanding of 
crustacean coagulation. Only his most important findings shall be 
reviewed here. While acknowledging the presence of two different 
processes, he believed that coagulation occured in one phase.
The first process of cell agglutination could be prevented by small 
amounts of oxalate or citrate, while the second process of true 
coagulation was prevented only by saturated salt solutions. He 
attributed cell agglutination to certain changes in the cytoplasmic
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layers of the cells whereby they become sticky, stick together 
into a gelatinous mass, a pseudo—clot, which resembles a common 
fibrin clot and which in the course of a short time retracts.
He designated the fibrin-like network the "cell fibrin". It 
should be noted that this clot, however, does not contain fibrinogen 
since his early experiments were conducted on the King crab Limulus 
polyphemus which has no true blood coagulation, possessing only 
the first process of cell agglutination. In fact, today the Limulus 
is classified as not belonging to the Crustacea. He was aware 
that this animal had only the coagulation phase identical to the 
lobster's first coagulation (Loeb, 1904c and 1905). In the lobster 
he observed that the first coagulum was usually relatively small, 
and in the course of twenty minutes to one hour the surrounding 
fluid would coagulate as a solid gelatinous mass which in the next 
twenty four hours retracted but little (Loeb, 1903b). In order to 
differentiate between the two phases he resorted to ice-cooling of 
the blood followed by filtration, the plasma was then stabilised by 
heating for 30 minutes at 56°C. to destroy the fibrin ferment (Loeb, 
1904b). He made two different preparations of the coagulation 
ferment by extraction of either the lobster muscle or the cell fibrin 
with water. He thought that the enzyme occuring in the muscle was 
different from that present in the cells, designating them as the 
"tissue coagulin" and the "blood coagulin" respectively (Loeb, 1906).
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Loeb (1906) believed that coagulation could occur in one of two 
ways. Firstly the fibrinogen is acted upon directly by the "blood 
coagulin" which occurs as such in the blood cells, in which reaction 
calcium is not needed. Secondly, the fibrinogen can be acted upon 
directly by the "tissue coagulin" and here calcium is required.
He thus concluded that coagulation in lobsters occurs in one phase, 
since stabilised plasma coagulated as rapidly by the addition of 
muscle extract as genuine plasma did, and because no increase in 
activity was observed when the lobster muscle extract was previously 
mixed with lobster serum. He further observed that the differences 
between the two enzymes acting in the lobster blood coagulation are 
of a quantitative nature as well as of a qualitative one. The muscle 
extract, other than requiring the presence of calcium ions, is more 
heat stable and more specifically adapted than the blood cells' 
extract (Loeb, 1903c and 1906). Also he found that no enzyme active 
in vertebrate coagulation had any effect on lobster blood, and vice 
versa (Loeb, 1904b) which reflects his more precise observations 
than those previously reported by Halliburton and Heim. Similar 
to mammalian thromboplastin, he found that some dilution of the 
muscle extract was necessary for optimal activity, and that when 
dialyzed muscle extract was used an inverse ratio was obtained 
between the concentration of the extract and the clotting time, 
concluding that lobster muscle extract contained an inhibitory
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factor (Loeb, 1905 and 1907). Later in 1910, Loeb and Fleisher 
investigated the species specificity aspect of lobster blood 
coagulation in greater detail. Using pieces of muscle from the 
various crabs and other Crustacea in clotting lobster plasma, they 
found a certain degree of species specificity to occur similar to 
what was known of mamnalian species. Lobster muscle had the 
strongest effect on lobster plasma, while only three out of the 
five crab species studied had any effect on lobster plasma. The 
muscle of Limulus and of different invertebrates not belonging to 
the Crustacea as well as that of vertebrates had no effect. Also, 
when cell fibrin was used instead of the muscle extracts, the 
preparations from all Crustacea were active, those from other 
animals were inactive, while extracts of the sea-urchin eggs had 
a weak effect. Loeb's final contribution on the subject was a 
study of the blood cells of the King crab Limulus in which he stated 
that the Limulus possesses only one kind of cells which combine the 
characters of leucocytes as well as blood platelets of mammals, 
being nucleated, motile, and producing substances initiating or 
accelerating the coagulation (Loeb, 1920). He was able to isolate 
these blood cells by drawing the blood with an oiled canula into an 
open dish stood on melting ice, allowing the cells to sediment 
forming "an even opaque layer of tissue consisting of several rows 
of agglutinated cells". The supernatant blue-coloured fluid was
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removed and replaced by any desired test solution. He confirmed 
that in Limulus haemostasis was achieved by the agglutination of 
the amoebocytes, being wholly a cellular process which was not 
dependent on the formation of fibrin that was lacking in this 
animal. He similarly prepared the "cell-fibrin tissue" from 
certain other Crustacea (not specifically cited) from which he was 
able to extract the "blood coagulin", noting that agglutination of 
the cells preceded the diffusion of the coagulin into the 
surrounding fluid. However, no mention was made of its potency 
in terms of clotting times, in fact no details of his procedure 
were mentioned at all.
Alsberg and Clark (1908-1909) presented evidence that the 
essential protein which constitutes Limulus "cell fibrin" is 
physico-chemically different from fibrin, more resembling an 
elasto-gelatin.
Nolf (1909b) believed that clotting of crustacean blood was 
due to the action of a substance in the blood or muscle cells 
(A-Fibrinogen) directly on a substance in the plasma (B-Fibrinogen). 
Thus he differed from Loeb in that Crustacea have only one 
coagulation enzyme occuring in both muscle and blood cells, and 
explained Loeb's contention of their difference as due to the 
difference in the content of inhibitory substances in each. He 
also observed that muscle extracts very quickly lost their activity,
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had no effect on mammalian fibrinogen, and that strong thrombin 
solutions had no effect on crustacean plasma.
Tait and Gunn (1918) made experiments on the blood of Astacus 
fluviatilis, a sea-crayfish, and verified the presence in its blood 
of three types of cells among which, however, two types were 
concerned with coagulation. A first coagulation occured due to 
the liberation of a soluble product from the lysed "explosive cells'* 
of Hardy, and a second coagulation which occured after after a 
certain interval of time due to the cytolysis of the "thigmocytes", 
cells that are characterised by their ability to adhere to and 
spread upon glass until they are reduced to a thin vacuolated sheet. 
They further noted that the "thrombin material" liberated by one 
explosive corpuscle or one thigmocyte was capable of coagulating 
only a limited amount of the surrounding plasma. They also stressed 
that there was no sharp distinction between the cells, entertaining 
the possibility that the explosive cells may develop into thigmocytes 
within the blood stream, and by the acquisition of granules may 
further be transformed into amoebocytes. They classified the 
coagulation mechanisms in Crustacea into three typess- 
Type A s agglutination of cells alone, no gelation of plasma,
(Cancer pagurus, Maia squinado, Inachus dorynchus, etc..). 
Type B : agglutination of cells with the subsequent gelation of
plasma, (Carcinus maenas, Palemon serratus, Portunus
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puber, and Homarus vulgaris, in increasing order of 
solidness of the clot).
Type C : same as type B, but the agglutination of the cells is
insignificant and restricted to the immediate surroundings 
of the explosive cells, after which gelation spreads to 
the whole plasma, (Falinurus vulgaris, and Astacus 
fluviatilis).
Among the species investigated they found no correlation between 
the type of coagulation and the distribution of other physiological 
or zoological classification.
Howell (1914a and 1916) found that vertebrate fibrin as studied 
under the microscope precipitated in the form of long needles 
forming a network, while invertebrate (crab) fibrin precipitated 
as a structureless gel, the clots were soft, transparent, broke 
easily into pieces which easily flowed together again, and with no 
tendency to retract. The addition of alkali to human fibrinogen 
produced essentially the same picture of a structureless gel. Pig 
thrombin did not clot crab blood. This was confirmed again by 
7.nw<y. (1 9 3 3) who demonstrated that lobster plasma was clotted by 
lobster muscle extract but not by vertebrate thrombin or even by 
fish thrombin. This specific adaptation between crustacean blood 
and tissue coagulains and crustacean blood or fibrinogen was also 
confirmed by Moore et al (1935), Silberberg (1938), Glavind (1948),
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George and Nichols (1948), and Duchateau and Florkin (1954).
Glavind in 1948 published a monograph on the coagulation of 
crustacean blood containing a most detailed study of the subject.
His findings shall be discussed later in the text when relevant. 
Generally, he found that crustacean blood clotting occured in one 
phase only, due to the action of one enzyme occuring in the muscles 
and the blood cells which required the presence of calcium ions, 
thus resembling vertebrate thromboplastin, but this enzyme also 
resembled thrombin in physico-chemical properties and in its ability 
to clot purified fibrinogen. No enzyme active in a crustacean 
system was active in a mammalian system and vice versa, but the 
crustacean "coagulin" was active against fibrinogen from other 
crustacean species. He observed that clotting of crustacean blood 
was inhibited by heparin and hirudin, though large concentrations 
were required. He also noted the difficulty of keeping lobsters 
alive in captivity, and that great fluctuations occured in the 
quality of their blood in which the cell volume sometimes dropped 
to ten per cent of the original, while the fibrinogen level 
decreased so much that the blood could not be made to clot. He 
mentioned that half of the animals gave blood samples unsuitable 
for clotting experiments and therefore mainly experimented on newly 
caught animals.
George and Nichols (1948) from a detailed study of the marine
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blue crab Callinectes sapidus and of the fresh—water crayfish 
Cambarus bartoni, classified their blood cells into four types, 
the lymphoid cells, the semi-hyaline thigmotactic amoebocytes 
equivalent to Hardy's explosive cells or to Tait and Gunn's 
explosive cells and thigmocytes, the granular eosinophlic cells, 
and finally cells with refractile granules that are intermediate 
between the second and third types. They also supported Tait and 
Gunn's theory of the differentiation of the cells in the blood 
channels, but suggested that the lymphoid cells may differentiate 
along two or more lines. They did not recognize any difference 
between the explosive cells and the thigmocytes, and believed that 
"thrombin" may be liberated from the eosinophils as well as from 
the finely granular thigmotactic amoebocytes. Again, they observed 
that in crabs whose blood clotted instantly after extravasation the 
cells disintegrated correspondingly rapidly, while a weak clotting 
reaction was associated with stability of the blood cells.
A comparison of the efficiency of the haemostatic mechanisms 
in various Crustacea in relation to their anatomical and physiological 
characters was made by Morrison and Morrison (1952) who studied 
twelve crustacean species. They found there was a degree of 
compensation whereby animals lacking one or more mechanisms were 
particularly strong in others. For example, the spider crab Libinia 
has no fibrinogen nor the power of autotomy but is very strongly
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protected by its shell, while the Gecarcinus species have no shell 
nor fibrinogen but have a highly developed power of autotomy.
The spiny lobster Panulirus argus with little capacity for autotomy 
and not too heavy a shell in relation to its large size possesses 
a high concentration of fibrinogen. The King crab Limilng ha.« no 
shell nor fibrinogen but shows a copious cellular agglutination. 
Other crabs (Callinectes, Carcinides, and Grapsus) were found to 
utilize all of the mechanisms, each in moderate extent. Finally, 
they observed that in animals previously considered to possess only 
an initial cellular phase of coagulation (cell agglutination) the 
weight of the blood coagulum (deposit obtained on filtering the 
clotted blood, washed and dried several times) was 3-8 times greater 
than was expected from an estimate of the maximal cellular 
contribution, and therefore concluded that plasma components must 
be of importance in these species.
Duchateau and Florkin in 1954 developed a method for the 
preparation of lobster fibrinogen by ammonium sulphate precipitation 
in which the third precipitation yielded an electrophoretically 
homogeneous fibrinogen preparation clottable in the presence of 
lobster muscle extract and calcium chloride solution in six minutes 
producing a firm gel, but in the ultracentrifuge the preparation 
showed two components of nearly equal proportion, the rapidly 
sedimented first component had an S20w value similar to haemocyanin.
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Because of the difficulty of isolating the coagulin of the 
explosive cells in vitro, they worked with the muscle extract as 
prepared by the method of Loeb (1905) and further enriching it by 
centrifugation at 48,000 r.p.m. for 30 minutes, using the supernatant 
as the coagulant material. This purified muscle coagulin showed 
three constituents on electrophoresis. Further isolation and 
identification of the active coagulant could not be made because 
of the instability of the preparation.
Gregoire in 1951 started a series of investigations by the 
phase contrast microscope on the blood cells of Arthropoda, mainly 
on insects but later also included some Crustacea, namely Limulus 
polyphemus and Homarus americanus. She observed that in Crustacea 
the coagulation mechanism was similar to her pattern I of insect 
blood coagulation, namely the formation of islands of coagulation 
around Hardy's explosive cells, while the other categories of cells 
did not take part but were passively entrapped in the coagulum.
The process of local jollification then extended to the whole plasma. 
Against Loeb's and Howell's conceptions, the development of "cell 
fibrin" by the general cell disintegration and fusion of their 
cytoplasm was not observed (Gregoire, 1952 and 1955).
Jitaniu and Dimitriu in 1961 presented evidence of the absence 
of fibrinogen in the hemolymph of the fresh-water crab Astacus 
fluviatilis and the marine-water crabs Carcinus maenas and
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Pachigrapsus marmoratus. They explained the transformation of 
the hemo lymph of these animals from the state of sol into that of 
gel by the ionic increase in lipidic and macroergic molecules 
provoked by the destruction of the hemolymph cells whose behaviour 
simulated the viscous metamorphosis of mammalian thrombocytes.
The formed gel which did not retract was found to liquefy on 
agitation or handling with a glass rod, but gelled again on being 
stood undisturbed. Incomplete gelling or a prolonged gelling time 
of the hemolymph were observed during the months November and 
December during which the animals were in hibernation, and in 
animals kept for a long time in captivity, coinciding with a 
decrease in the number of the cells and a decrease in the protein 
and electrolyte concentration of the hemolymph.
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THE EXTRINSIC THROMBOPLASTIN SYSTEM OF THE LOBSTER
THE ACTIVITY OF LOBSTER TISSUE EXTRACT 
The activity of the lobster tissue extract prepared from lobster 
muscle tissue was tested in a one-stage procedure by clotting the 
lobster oxalated plasma in the presence of calcium chloride solution. 
Several batches of lobster muscle extract prepared by the method of 
Loeb (1905) as described in appendix III, 13, IIA failed completely 
to cause the clotting of the lobster plasma. But extracts prepared 
by the method of Owren (1949) as described in appendix III, 13, IIB 
clotted the lobster plasma in the presence of 3 per cent calcium 
chloride solution in about 3—5 minutes (Table 112). In the absence 
of the tissue extract the recalcification time of the lobster plasma 
was more than 10 minutes, in fact the plasma did not clot at all. 
That this plasma was suitable for clotting experiments was evident 
from the very short clotting times obtained with the lobster cell 
extract to be discussed later which was about 6 seconds.
The lobster muscle extract was also found to clot solutions of 
purified lobster fibrinogen in the presence of calcium chloride 
solution in less than two minutes. The potency of the muscle 
extract was found to deteriorate easily since its storage in the 
frozen condition at -20°C. for 72 hours resulted in the complete
-  273 -
dissappearance of its clotting activity (Table 112, experiment 3). 
Such great storage lability may explain the lack of activity in the 
extracts prepared by the method of Loeb (1905) which entails 
standing the preparation overnight in the refrigerator at one stage. 
Species specificity of the lobster muscle extract
The lobster plasma was found to be specifically clotted by the 
lobster muscle extract but not affected at all by the human brain 
extract (Table 113). Also, the lobster muscle extract was without 
effect on human plasma which clotted within few minutes similar to 
its recalcified clotting time in the absence of any tissue extract. 
Discussion
The lobster muscle extract obviously acts in a different way 
to human tissue extracts since it also clots solutions of purified 
lobster fibrinogen, suggesting the presence of preformed coagulant 
activity in the extract and only requiring the presence of calcium 
chloride solution. Thus in one aspect it resembled mammalian 
thrombin while in the other it resembled mammalian tissue 
thromboplastin. This confirms the previous findings of Loeb (1906), 
Nolf (1909a), Grlavind (1948), and Duchateau and Florkin (1954).
Nolf (1909a) suggested that prothrombin and fibrinogen from the 
lobster blood may have the same precipitation characters, inferring 
the contamination of lobster purified fibrinogen preparations with 
prothrombin. But prothrombin has never been demonstrated in any
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invertebrate animal, also adsorbed lobster plasma is clotted with 
the tissue extract as fast as unadsorbed lobster plasma (Glavind, 
1948), while the purified lobster fibrinogen which is 
electrophoretically homogeneous has been shown by ultracentrifugation 
studies to contain only two components, hemocy&nin and fibrinogen 
(Duchateau and Florkin, 1954). It is therefore reasonable to 
conclude that the lobster muscle extract acts directly on the 
lobster fibrinogen in the presence of calcium chloride solution.
This is also corroborated by the lack of accelerator factors in the 
lobster plasma and serum as shall be discussed later.
The increased lability of the lobster muscle extracts on storage 
has been pointed out by Nolf (1909b), Moore et al (1935), Glavind 
(1948), and Duchateau and Florkin (1954). Glavind (1948) found 
that lobster muscle extract loses all its activity within few hours 
if kept at room temperature, within 48 hours at 10°C., within 3-7 
days at -15°C., and within 12 days at -70°C. He also noted that 
the dried preparation was not stable at room temperature. A fresh 
preparation, therefore, has to be made for each experiment.
That lobster muscle extracts and lobster plasma possess an 
absolute degree of species specificity as opposed to vertebrate 
reagents, while having a certain degree of inter-species specificity 
niaftng Crustacea seems to be unequivocal as demonstrated by various 
workers (Loeb, 1903b, 1903c, 1904b, and 1906; Nolf, 1909b; Loeb
- 275 -
and Fleisher, 1910; Howell, 1916; Zunz, 1933; Moore et al, 1935; 
Silberberg, 1938; Glavind, 1948; George and Nichols, 1948; and 
Duchateau and Florkin, 1954).
Various attempts to purify the coagulant substance of the 
lobster muscle extracts have failed. Glavind (1948) found that 
the "coagulin" cannot be precipitated from the muscle extract at 
any pH value, being consistently present in the supernatant; also 
that it cannot be adsorbed by magnesium hydroxide, aluminium 
hydroxide, or charcoal. Duchateau and Florkin (1954) enriched 
Loeb’s muscle extract by centrifugation at 48,000 r.p.m. for 30 
minutes, then discarding the precipitate. They found this purified 
"coagulin" to be a substance of a low molecular weight, containing 
a negligible amount of nitrogen, and had three constituents on 
electrophoresis. But further isolation and identification of the 
coagulant substance was hindered by the instability of the preparation. 
Conclusions
The lobster muscle extract clots the lobster plasma as well as 
the lobster purified fibrinogen solution in about the same time in 
the presence of calcium chloride solution, suggesting a direct 
action on the fibrinogen. Lobster muscle extract is very unstable 
compared to human tissue extracts. Lobster plasma and tissue 
extracts are completely species specific and are not interchangeable 
with vertebrate reagents.
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THE ACTIVITY OF ACCELERATOR FACTQRS IN LOBSTER BLOOD
In specific assays measuring the degree of correction of various 
artificially induced coagulation factor deficiencies the lobster 
plasma was found to lack completely any factor V or factor X 
activity, while the lobster serum lacked completely factor VII 
activity (Tables 114, 116, and 115 respectively). The concept 
that these factors may be present in lobster blood but are species 
specific is hard to substantiate in view of the ability of the 
lobster muscle extract to clot the lobster purified fibrinogen in 
as short a time as it clots whole lobster plasma. Indeed, their 
presence would have been of no avail since lobster plasma does not 
contain prothrombin as previously discussed, and further confirmed 
by the inability of Russell's viper venom-cephalin reagent to clot 
the lobster plasma (Table 117), though this finding is difficult 
to interpret due to the interference of species specificity if this 
existed between the R.V.V. and the lobster plasma.
Conclusions
The lobster blood lacks completely any factor V, VII, or X 
activities in human assay systems. Results of the lobster 
homologous clotting mixtures also suggest their absence from the 
lobster blood.
ANTITHROMBIN ASSAY IN LOBSTER PLASMA
During assays on the lobster plasma and serum for the extrinsic 
accelerator factors V, VII, and X, prolonged clotting times were 
observed for the mixtures containing lobster plasma or serum, 
suggesting the presence in them of some inhibitory activity which 
was eliminated by the further dilution of the lobster reagents in 
saline. Also, since the lobster plasma was not clotted at all by 
bovine thrombin (Table 118) presumably due to its species specificity, 
the presence of antithrombin may have been a contributing factor.
Antithrombin assay by the method of Astrup and Darling (I942d) 
conclusively demonstrated the complete lack of antithrombin from 
lobster plasma (Table 119). The inhibitory activity previously 
observed in mixtures containing lobster plasma or serum is therefore 
though to be due to the difference in ionic strength and colloidal 
composition of the lobster plasma and serum as compared to the saline 
or human plasma used as the control.
Conclusion
Lobster blood does not contain any antithrombin activity.
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SUMMARY OF TEDS LOBSTER EXTRINSIC SYSTEM 
The lobster blood does not possess an extrinsic thromboplastin 
system as exists for vertebrates. It lacks all the factors 
concerned in the reaction, except of course the fibrinogen and a 
coagulant substance present in the muscle extract. The latter, 
however, differs from vertebrate tissue thromboplastin in clotting 
lobster purified fibrinogen directly in the presence of calcium 
chloride solution. Thus, the lobster muscle extract resembles 
more vertebrate thrombin rather than vertebrate tissue thromboplastin.
No data are available on the exact role played by the lobster 
tissue "coagulin" in physiological haemostasis.
LOBSTER INTRINSIC THROMBOPLASTIN SYSTEM
LOBSTER WHOLE BLOOD CLOTTING TIMES 
Lobster whole blood was found to clot in 15-20 minutes at 37°C. 
and in 3-5 minutes at 15°C. (Table 120). In siliconed tubes more 
prolonged clotting times were obtained in either case. In the 
above quoted clotting times the recorded end point was the formation 
of an invertible clot. In actual fact, cellular agglutination and 
flocculation occured almost immediately after withdrawal of the
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blood and its delivery in the clotting tubes, ordinary or siliconed, 
at 37°C. or at 15°C. With the use of siliconed tubes, however, the 
cellular agglutination though rapid in onset was not of the same 
magnitude as occured in the ordinary glass tubes.
It was observed that animals kept in captivity until they were 
devitalised as judged by their sluggish movements, lack of fight on 
handling, and dehydrated collapsed joint spaces, had much longer 
whole blood clotting times than those obtained when the animals were 
in the fresh condition (Table 120).
o
The prolonged clotting times obtained at 37 C. suggest that this 
temperature somehow delays the process by which the final coagulant 
material is produced. This is not strange in view that the natural 
environment of Crustacea has a temperature about 10-15°C. which also 
seems to be most suitable for the evolution of the intrinsic 
coagulant material from the "explosive cells".
Conclusions
The lobster whole blood clots faster in ordinary glass tubes 
and at 15°C. The lobster whole blood clotting mechanism is well 
adapted to the temperature of its normal environment. Foreign
surfaces enhance the clotting of lobster blood.
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HAGEMAN FACTOR AND P.T.A. ACTIVITIES IN LOBSTER PLASMA
Assays for the Hageman factor and the plasma thromboplastin 
antecedent in the lobster plasma by the degree of shortening of the 
clotting times of human intact plasma and by the correction of human 
plasma congenitally deficient in Hageman factor shoved that the 
lobster plasma did not possess either activity (Tables 121 and 122), 
or if it did they were species specific. It is more probable, 
however, that the contact factor or factors in lobster blood reside 
in the blood cells themselves, particularly in the explosive cells 
of Hardy which were observed to explode immediately on contact with 
foreign surfaces (Haycraft and Carlier, 1888; and Hardy, 1892).
This was also confirmed by phase contrast microscopy observations 
of the lobster cells as shall be described later.
Conclusions
The lobster plasma lacks Hageman factor and plasma thromboplastin 
antecedent activities in human assay systems. These contact factors 
may be present in the lobster plasma but are species specific, though 
it is more probable that such activities reside in the lobster blood 
cells themselves, in particular in the explosive cells.
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LOBSTER BLOOD CELLS
Lobster blood contains only nucleated cells similar to the 
vertebrate leucocytes. There are no red blood corpuscles, but the 
oxygen-carrying pigment, haemocyanin, is present in the blood as a 
freely soluble protein, giving the blood its blue colour when well 
oxygenated.
The role played by any of the lobster blood cells in the 
coagulation of the lobster blood was investigated by observing 
freshly prepared blood smears under the microscope by phase contrast 
which allows easy and immediate identification of any change in the 
consistency and physical characters of the blood, as from sol to gel, 
in the form of areas of increased density and granularity. Such 
differences are not at all discernible if examined under the ordinary 
light microscope. As it was the experience of previous workers that 
lobster blood cells agglutinate and some of them explode or disintegrate 
immediately on extravasation, it was therefore imperative that blood 
smears are examined as soon as possible. This was achieved by first 
setting up the microscope and lighting by the use of a dummy slide.
Then the lobster under test was brought in a small water tank and as 
soon as the blood sample was withdrawn by a siliconed needle and 
syringe, a drop was placed on a previously prepared glass slide, 
immediately covered very gently by a cover slip, put on the microscope
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stage and examined. The whole procedure from puncturing the joint 
space to obtain the sample till the start of actual observation 
should not take more than one minute, otherwise the very first 
changes will be missed. In such unstained preparations the exact 
differentiation of the cells as in stained smears was of course not 
possible, but generally three types of cells were recognizable.
The first and by far the most important and only type of cells 
concerned with coagulation were the explosive cells of Hardy.
They appeared as large rounded nuclei surrounded by a pale hyaline 
cytoplasmic area that is not sharply defined. Vi thin few seconds 
clear rounded vesicles or vacuoles of various sizes were formed in 
a rossette shape around the nucleus (Figure 67) and again very 
rapidly dissapeared as if they have exploded; during which process 
the surrounding plasma became progressively denser (Figure 6 8) until 
the whole preparation looked granulated signifying the complete 
solidification of the plasma. Figure 69 illustrates the picture 
seen after complete plasma solidification has occured, shoving two 
well-developed coagulation islands around two explosive cells, while 
the remainder types of cells were found passively embedded within 
the clotted plasma. The explosive cells did not show any amoeboid 
movements and did not agglutinate together. They appeared to be 
fixed to the glass slide, while the shape of veils formed by the 
coagulation process seemed to be governed by the direction of current
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flow in the preparation. The size and density of the coagulation 
islands formed varied greatly from cell to cell.
The second type of cells observed was very large cells of 
irregular shape containing large highly refractile granules, almost 
obscuring a relatively small nucleus. These were the only type of 
cells still evidently seen as luminous bodies when the condenser 
was racked from the phase contrast position to the dark-field position. 
They corresponded to Hardy's "eosinophilic cells" (1892), Tait and 
Gunn's "amoebocytes" (1918), and to the "granular cells" described 
by George and Nichols (1948). They showed some amoeboid movements, 
but seemed to have no role in the process of plasma solidification.
The third type of cells observed was of intermediate size between 
the explosive cells and the eosinophilic cells, with abundant 
well-defined cytoplasm that tended to spread on the glass slide 
forming thin large sheets around a globular nucleus. This last 
type seems to correspond to the "thigmocytes" described by Tait and 
Gunn (1918) as highly phagocytic cells whose cytolysis contributed 
to the process of plasma coagulation. However, in phase contrast 
preparations, they were never seen to disintegrate, nor to produce 
any clotting of their surrounding plasma, but were scattered adherent 
to the glass.
All the above findings are very similar to those previously 
reported by Gregoire (1951, 1952, and 1955) to occur in insects'
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blood, as veil as in the blood of the giant lobster Homarus 
americanus.
The total cell counts in lobster blood varied from 13,200 to 
56,000 cells/c.mm. of whole blood, with an average of 25,910 (Table 
123). The higher counts were observed to occur in the larger 
lobster specimens, while on one occasion the re-counting of the 
cells in the blood of a dying lobster shoved great diminution in 
their number compared to that obtained when the animal was in the 
fresh and healthy condition (Table 123, experiment 6 ).
The differential count of the explosive cells was made as 
described in appendix IV, 1, C. They were found to constitute 
about 20 per cent of the total cell count (Table 123), thus their 
absolute number averaged about 5 ,2 0 0 cells/c.nm. of whole blood.
In the blood of the crayfish Astacus fluviatilis, Hardy (1892) found 
a total cell count of 250-400 cells/c.mm., with an explosive cell- 
eosinophil cell ratio of about 3 to 1; while Tait and Gunn (1918) 
reported an explosive cell ratio of 40-50 per cent of the total cell 
count in the same species of crayfish. Yeager and Tauber (1935) 
made total counts on 13 crustacean species and reported an average 
of 18,700 A 6,500 cells/c.mm. of whole blood.
Conclusions
The lobster blood contains a type of cells, the "explosive cells" 
of Hardy, which are very fragile and whose cytoplasm disintegrates
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on contact with foreign surfaces releasing a substance which either 
by itself coagulates or there induces coagulation in the surrounding 
plasma. In the lobster Nephrops norvegicus these cells constitute 
about twenty per cent of the total blood cells' count.
LOBSTER FIBRINOGEN
1. Identification
Fibrinogen is known to normally occur in all vertebrate plasmas. 
It was also demonstrated in plasma of cold-blooded vertebrates, 
namely the reptiles, amphibians, and fish (Zunz, 1933; and Fantl, 
1961). Among the invertebrates, Crustacea form a class which is a 
large division of the animal kingdom comprising crabs, lobsters, 
crayfish, prawns, shrimps, and a vast multitude of less familiar 
forms that are not distinguished by any popular names. Fibrinogen 
does not occur uniformly in the plasma of all crustacean species, a 
state which led to much controversy and confusion. Geddes (1879- 
1880) first reported that lobster blood clots consisted only of cells 
without any fibrin. Fouchet (1882) maintained that there was no 
fibrin in the blood of Nephrops norvegicus, while Halliburton (1885) 
stated that the blood clots of Nephrops norvegicus consisted of 
fibrin entangling the blood cells. Alsberg and Clark (1908-1909) 
demonstrated conclusively that the blood of the crab Limulus
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polyphemus did not contain fibrinogen. Later several species were 
reported to have no fibrinogen in their plasmas, for example Cancer 
pagurus, Maia squinado, and Xnachus dorynchus (Tait and Gunn, 1918); 
Libinia, and Gecarcinus (Morrison and Morrison, 1952); Astacus 
fluviatilis, Carcinus maenas, and Fachigrapsus marmoratus (Jitariu 
and Dimitriu, 1961).
It was therefore necessary to establish conclusively the presence 
or absence of fibrinogen in the blood of the lobster Nephrops 
norvegicus. Lobster plasma (appendix III, 3) and lobster serum 
(appendix III, 5) were electrophoresed in barbitone buffer at pH 8 .6  
for 2 hours, alongside control samples of human plasma and serum.
The strips were then stained with Ponceau S stain and their 
densitometric scannings made as described in appendix II, 7. The 
proteins in the lobster plasma were found to separate into three 
components. The fastest and most abundant was haemocyanin (h), the 
oxygen—carrying pigment of lobster blood; a second slower and less 
abundant component but with a definite peak was component f which 
is believed to represent the true lobster fibrinogen; and finally 
an even slower and smaller component (x) which is as yet unidentified 
(Figure 70). In fact component x was only encountered in one plasma 
sample, all other plasma samples failed to show this component 
(compare with Figures 71 and 73). The lobster serum while showing 
the haemocyanin component, failed to show the fibrinogen one in all
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the preparations tested (Figures 70 and 71), and was not clottable 
with the lobster blood cells* extract (Table 125, mixture 6 ).
It should be noted that the lobster fibrinogen (component f) 
had a mobility very similar to that of human albumin, a fact which 
denotes its different nature from human fibrinogen which hardly 
moves at all from the origin (Figure 72).
That this component f actually represents a clottable protein 
present in the lobster plasma was shown by its absence from the 
lobster serum obtained from spontaneously clotted lobster blood.
Also, it was absent from lobster plasma clotted with lobster blood 
cells' extract (Figure 73). This fact is further substantiated by 
the coincicence of the f peak in lobster plasma electrophoresis 
strips with that obtained by the electrophoresis of a purified 
lobster fibrinogen preparation (Figure 74, II) which proved clottable 
by the lobster blood cells' extract in six seconds.
2. Assay of fibrinogen in lobster plasma
Oxalated lobster plasma diluted 1 in 10 in saline was clotted 
with lobster blood cells' extract in the presence of calcium chloride 
solution. The formed fibrin was collected on ballotini glass beads, 
and after several washings in saline the protein content of the 
deposit was estimated by the modified Greenberg method described in 
appendix IV, II. On two occasions the fibrinogen was also estimated 
by the micro-Kjeldahl method described in appendix IV, I. The
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average fibrinogen content of lobster plasma by the Kjeldahl method 
was 251.6 mg/100 mis absolute plasma, and by the Greenberg method 
was 213.2 mg/100 mis absolute plasma (Table 124). Experiment 6  
made on the plasma of a lobster kept in captivity until it showed 
signs of devitalisation had a fibrinogen concentration of 30 mg as 
compared to the original level of 186.6 mg/1 0 0 mis of plasma.
This lowered fibrinogen content together with the diminution of the 
total cell count in devitalised lobsters as previously demonstrated 
account for the prolonged whole blood clotting times observed for 
samples obtained from devitalised specimens, and confirms the previous 
experiences of Cuenot (1891) and Glavind (1948).
Though marked variations in the fibrinogen levels occured from 
one specimen to another, this method seems to be the most accurate 
yet utilized, since the lobster cell extract used contained only 
minute amounts of protein as shown by its electrophoresis pattern 
(Figure 73) in which the main component was haemocyanin, a 
contaminant which is soluble and easily removed in the washing stage. 
Glavind (1948) modified Gram's gravimetric method (1921) by clotting 
1 ml of the lobster plasma with 0*5 ml of muscle extract in the 
presence of 0.5 ml of 3 per cent calcium chloride solution. The 
clot was dried between filter paper, washed in distilled water for 
30 minutes then dried in alcohol and ether to remove the pigment, 
and finally weighed on a microbalance. He reported average fibrinogen
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values of 294 mg/100 mis of Homarus americanus plasma citrated 1 in 
5 (equivalent to 367 mg/1 0 0  mis of absolute plasma), and still 
higher values of 400 mg/100 mis of citrated plasma of newly captured 
animals (equivalent to 500 mg/1 0 0 mis of absolute plasma).
However, the use of undiluted plasma in addition to the presence of 
the protein-rich muscle extract in a high proportion in the mixture 
(l to 4) might lead to the entrapping of excess insoluble protein 
matter in the meshes of the clots, giving rise to inaccurate results.
3. Preparation of purified lobster fibrinogen
Several method have been used for the preparation of lobster 
fibrinogen from the plasma by precipitation with solid sodium chloride, 
saturated magnesium sulphate solution, or acidification with acetic 
acid (Halliburton, 1885; Heim, 1892; Bottazzi, 1902; Loeb, 1905; 
and Glavind, 1948). The best devised method, however, was that of 
Duchateau and Florkin (1954) which mainly relies on the precipitation 
of the fibrinogen with saturated magnesium sulphate solution in 
three stages. Their first precipitate obtained from plasma of the 
giant lobster Homarus americanus by 25 per cent saturation with 
magnesium sulphate contained three electrophoretic components, 
haemocyanin, fibrinogen, and an unidentified protein. The fibrinogen 
was greatly increased in proportion to the haemocyanin on comparison 
with the original plasma. The second precipitate obtained with 
31 per cent saturation of magnesium sulphate contained fibrinogen
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and the unidentified protein; while the third precipitate obtained
with 45 per cent saturation with the magnesium sulphate consisted
of an electrophoretically homogeneous fibrinogen preparation that
was clottable with lobster tissue extract and calcium chloride
solution in six minutes producing a firm gel. However, in the
ultracentrifuge, this preparation showed two components of equal
proportion, of which the slower sedimenting one with a Svedberg
sedimentation constant in water at 20°C. (S__ ) of 16.9 was identified20w
as the fibrinogen. The faster sedimenting component was haemocyanin 
(S>20w = 21). This was the method used in this work to prepare 
purified fibrinogen from the plasma of the lobster Nephrops norvegicus, 
with the slight modification of dissolving the various precipitates 
obtained in saline solution instead of distilled water, and dialysing 
them immediately against saline in the cold overnight to get rid of 
the excess magnesium sulphate ions. The method is described in 
detail in appendix III, 6 , B. In my hands, the solution of precipitate 
1 contained nearly equal amounts of fibrinogen and haemocyanin on 
electrophoresis (Figure 74, I) and was clotted with the lobster 
blood cells' extract and 3 per cent calcium chloride solution in
7.5 seconds (Table 125, mixture 9). Solution of precipitate 2 was 
the most pure preparation, consisting mainly of fibrinogen and only 
a trace of haemocyanin (Figure 74, II). It was clotted with lobster 
blood cells' extract and 3 per cent calcium chloride solution in
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6.5 seconds (Table 125, mixture 10). Solution of precipitate 3 
contained little fibrinogen and an appreciable amount of haemocyanin 
(Figure 74, III). It was clotted in 134 seconds forming a small 
gel floating amidst the surrounding fluid (Table 125, mixture 11).
The fibrinogen bands in the first two precipitate solutions had 
the same fast mobility of the fibrinogen in the original plasma,
_5
having an electrophoretic mobility of 5.5 x 10 cm./second/volt/cm.
(Figure 74, I and II; and Figure 71).
It seems that the lobster fibrinogen is not a globulin since
Ducbateau and Florkin (1954) have separated it from the precipitates
by solution in distilled water, while globulins are not soluble in
this medium but require the presence of an electrolyte such as
sodium chloride in the solution. They also have demonstrated that
the lobster fibrinogen was more soluble than the bovine fibrinogen,
-5also that it had a very rapid electrophoretic mobility of 5.7 x 10  
compared to a mobility rate of 2 .7  x 10 for the bovine fibrinogen. 
Conclusions
The lobster plasma contains a soluble coagulable protein that 
is missing in lobster serum or lobster plasma clotted with lobster 
blood cells' extract, in a concentration averaging 213-251 rag/1 0 0 mis 
of absolute plasma. It had a fast electrophoretic mobility similar 
to that of human albumin; and was best separated from plasma by 
precipitation with 31 per cent saturation with magnesium sulphate.
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LOBSTER BLOOD CELLS' EXTRACT
Most of the earlier investigations on the clotting of crustacean 
blood have been carried out using muscle extracts as the coagulant 
material. These extracts varied greatly in potency and were 
usually of weak thromboplastic activity, giving clotting times 
ranging from several minutes to several hours, without a sharply 
defined end point. This seemed strange in view of the fact that 
the explosive ceils of the blood almost instantaneously explode on 
contact with foreign surfaces releasing a potent coagulant material 
that immediately clots the surrounding plasma.
Loeb (1903b, 1905, and 1920) made use of the thromboplastic 
activity of the lobster blood cells in his clotting experiments on 
the plasma of the giant lobster Homarus americanus. He allowed the 
carefully withdrawn blood to stand in a clean sterile dish over 
melting ice, avoiding agitation of the blood. As soon as the cells 
settled forming an opaque layer of tissue, the supernatant fluid 
was drawn off and replaced by the desired test solution. Later, 
he extracted this "cell fibrin" preparation in a volume of saline 
for 25 minutes and used the extract to clot the plasma samples under 
test. ¥ith this preparation he obtained clotting times varying 
from 5 to about 16 minutes. He noted the great temperature and 
storage lability of the cell-fibrin extracts. Glavind (1948) also
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attempted preparing similar extracts by collecting the freshly spun 
down cellular sediment whenever blood samples were available, storing 
it meanwhile in dry ice at -70°C. until a sufficient amount was 
collected, usually from 10-20 animals. The sediments were then 
ground in one part quartz and one part distilled water to which has 
been added an amount of calcium chloride calculated so as to 
compensate for the oxalate added to the plasma. The mixture was 
then stored in the ice-box overnight, and finally centrifuged.
He found that the extracts prepared in this manner were as a rule 
active but weaker than the muscle extracts similarly prepared, giving 
clotting times of 2-30 minutes. They had the same lability 
characteristics as described for the muscle extracts.
A potent lobster blood cells' extract was prepared by a very 
simple and rapid method described in detail in appendix III, 16. 
Briefly, the freshly withdrawn oxalated blood was centrifuged 
immediately for 5 minutes at 2 ,0 0 0 r.p.m. in siliconed conical 
centrifuge tubes. The supernatant plasma decanted (usable for all 
clotting experiments) and the tube washed gently with saline 
without dislodging the deposit which is then thoroughly emulsified 
in a small volume of saline and immediately centrifuged in the cold. 
The supernatant which should be as clear as saline is used without 
delay in the clotting experiments. In the presence of calcium 
chloride solution, this cell extract clotted lobster oxalated plasma
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in 5-7 seconds (Table 125, mixture l) which is the shortest clotting 
time yet recorded for crustacean blood with any extract. The cell 
extract itself did not contain any fibrinogen as judged by its 
electrophoretic pattern (Figure 73, a) as well as by its inability 
to form a clot by itself in the presence of calcium chloride 
solution (Table 125, mixture 3). The lobster blood cells' extract 
also had the ability to clot lobster adsorbed plasma and lobster 
purified fibrinogen preparations in as short a time as obtained for 
the lobster plasma (Table 125, mixtures 7, 9, and 10 respectively). 
This suggests that the extract contained a preformed active coagulant 
material that acts directly on the fibrinogen, and only requires 
the presence of calcium chloride solution. The optimal concentration 
of calcium chloride solution was 3 per cent; higher concentrations 
(11 per cent or molar solution) hardly improved the clotting times, 
while an H/40 (0 .2 7  per cent) solution gave much longer clotting 
times (Table 125).
The lobster blood cells' extract had no activity at all on 
human plasma or on human purified fibrinogen (Table 125, mixtures 
4 and 5, and 12 respectively), thus resembling the lobster muscle 
extract in its species specificity.
While the lobster blood cells' extract behaved as a thrombin­
like material by directly clotting purified fibrinogen preparations, 
it showed no esteratic activity when using TAMe an a substrate (Table
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126). This demonstrates that whatever its mode of action is, by 
which it causes the clotting of lobster fibrinogen, it almost 
certainly is not through the splitting of arginyl-glycine bonds as 
occurs when human fibrinogen is clotted with human or bovine thrombin.
Cell extracts stored frozen at -20°C. for the short period of 
three hours, when rethawed and used, were found to have lost all 
clotting activity as compared to the original fresh extract (Table
127). The same findings were observed when the extract was kept 
at ordinary room temperature on the bench for the same period.
Such great storage lability of the cell extract necessitated the 
frequent preparation of fresh aliquots, their use immediately on 
preparation, and keeping them at the temperature of melting ice 
during the period of the various experiments.
Conclusions
An extremely active lobster blood cells1 extract was made from 
the freshly sedimented blood cells by a simple and rapid method.
The extract clotted oxalated lobster plasma, adsorbed lobster 
plasma, and purified lobster fibrinogen solutions within few seconds, 
in the presence of calcium chloride solution. It seemed to act 
directly on the fibrinogen, but had no esteratic activity on TAMe 
substrate. It was very labile on storage and is highly species 
specific.
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FURTHER INVESTIGATIONS ON THE ACTIVITY 
OF THE LOBSTER BLOOD CELLS' EXTRACT 
Since the lobster blood cells' extract by directly clotting 
adsorbed lobster plasma or purified lobster fibrinogen solution 
behaved as a thrombin-like material on one hand, while on the other 
hand it required the presence of calcium chloride solution for its 
action to be manifest, resembling vertebrate thromboplastins, 
further investigations of its characters were necessary.
Effect of heparin on the activity of the lobster cells' extract
Mixtures of lobster oxalated plasma were incubated with various 
concentrations of heparin (varying from 0-500 units in each mixture) 
for three minutes before clotting them with lobster blood cells* 
extract and calcium chloride solution. Heparin was found to prolong 
the clotting times progressively as its concentration rose in each 
mixture, up to 360 seconds obtained with the mixture containing 
500 units of heparin, compared to a control clotting time of 27 
seconds (Table 128, line l). While at all the heparin concentrations 
the action of bovine thrombin (50 units/ml with a final concentration 
of 12.5 units/0.4 ml of the clotting mixture) on human plasma was 
completely antagonised resulting in an incoagulable mixture (Table 
128, line 2 ), mixtures of lobster plasma were still coagulable though 
in prolonged periods. This observation can be explained either by
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the use of a highly concentrated and active cell extract, or that 
heparin is not so much specifically antagonistic towards lobster 
blood cells’ extract as it is to bovine thrombin. The latter 
explanation seems more attractive, since the cell extract could not 
have been that strong since in fact its dilution by one-fold in 
saline immediately resulted in the prolongation of the clotting 
time of the plasma from 5 seconds to 8 seconds, suggesting there 
was no excess active coagulant material present in the extract.
The addition of toluidine blue (a heparin antagoniser) to the 
lobster clotting mixtures containing heparin resulted in a 
diminution of the previously observed delay in clotting times, more 
pronounced with the more concentrated toluidine blue solution 
containing 50 mg per cent (Table 128, lines 3 and 5). It should 
also be noted that such concentrations of toluidine blue were still 
insufficient to prevent the action of heparin in the human clotting 
mixtures (Table 128, lines 4 and 6 ).
The addition of hexadimethrine bromide, a heparin neutralizer, 
in the form of Polybrene (Abbott) to the various plasma-heparin 
mixtures resulted in the greatest diminution in clotting times.
At a concentration of 1 mg in each mixture, it was able to completely 
neutralize heparin concentrations of up to 250 units in the lobster 
mixtures, and of up to 125 units in the human mixtures (Table 128, 
lines 7 and 8 ). However, it was observed that hexadimethrine
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bromide by itself slightly retarded the clotting time of lobster 
plasma from a control reading of 27 seconds to 56 seconds; while 
50 seconds was the shortest clotting time obtainable for any lobster 
clotting mixture containing hexadimethrine bromide, whether heparin 
was present or absent.
Whatever the nature of the coagulant material present in the 
cell extract is, it again bears some resemblance to vertebrate 
thrombin in being antagonised by heparin. Haycraft (1884) who 
discovered hirudin, the coagulation-preventing substance obtained 
from the medicinal leech, observed that it was unable to prevent 
the coagulation of crustacean blood; a finding later confirmed by 
Loeb (1903c). Numanoi (1938) using very high concentrations of 
heparin and hirudin found that they inhibited the blood coagulation 
of the crustacean species Ligia exotica. He reported that the 
degree of anticoagulant action of heparin and hirudin for the blood 
of the Ligia was of the order of 1 to 400, while that for human 
blood was 1 to 1 0 0,0 0 0, again stressing the need for greater 
concentrations of heparin to retard the clotting of crustacean blood. 
Glavind (1948) confirmed that hirudin in amounts which strongly 
inhibit human coagulation was without effect on lobster blood 
clotting, though large amounts had some inhibitory action. He 
also found that the heparin concentration required to inhibit the 
clotting of the lobster plasma with the muscle extract was much
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greater (about 1000 times) than that required for vertebrate blood, 
and vas of the same magnitude as the concentration required to 
protect vertebrate platelets from agglutination and disintegration.
He further observed that the prevention of agglutination of the 
lobster blood cells was very difficult and much higher concentrations 
of heparin than those required to inhibit spontaneous lobster blood 
coagulation (3.3 gm per cent in lobster blood) were still unable to 
prevent the cellular agglutination and disintegration. Because he 
was able to inhibit the clotting of the lobster plasma - muscle 
extract mixture by using a heparin concentration of 0.9-1.25 gm per 
cent (equivalent to 0.9-1.25 mg in the mixture or 90-125 units) as 
compared to 3.3 gm per cent (equivalent to 3.3 mg in the mixture or 
330 units) required to inhibit spontaneous coagulation, he inferred 
that the native blood cells contain "coagulin" in a much larger 
concentration than present in the muscles, not being necessarily a 
different enzyme as Loeb previously suggested (1906).
The hepatopancreas of various Crustacea was found to contain a 
substance which very strongly inhibited the coagulation of both 
lobster and vertebrate bloods, its mode of action, however, is as 
yet unknown (Abelous and Billard, 1898; Nolf, 1909b; Gautier, 1913; 
and Numanoi, 1938).
Lobster blood cells1 extract—fibrinogen reaction
When lobster plasma was clotted with various dilutions of
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lobster blood cells' extract, the clotting times were found to 
increase proportionately in the first two dilutions, after which 
the lobster blood cells' extract diluted 1 in 8 in saline seemed 
to lose its activity more than was expected until with the 1 in 32 
dilution the plasma was incoagulable (Table 129).
Clotting of the lobster purified fibrinogen (solution of 
precipitate 2 ) with various dilutions of the lobster blood cells' 
extract gave progressively increasing clotting times which when 
plotted on double logarithmic paper against the concentration of 
the cell extract were found to produce a straight line, as obtained 
with a human thrombin-fibrinogen dilution curve, suggesting that 
the reaction of the cell extract with the lobster fibrinogen is also 
a first order reaction (Table 129).
Clotting progressive dilutions of the lobster fibrinogen with 
the concentrated cell extract also gave clotting times inversely 
proportional to the concentration of the fibrinogen.
The prolonged clotting times of the lobster plasma obtained with 
the 1 in 8 and the 1 in 16 dilutions of the cell extract as compared 
to the shorter clotting times of the lobster fibrinogen clotted with 
the same dilutions of the cell extract suggest the presence of some 
sort of inhibitor in the lobster plasma, but may have been due to 
the presence of oxalate ions in the plasma whose effect became 
apparent only with the higher dilutions of the cell extract,
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although excess calcium chloride solution was always added to each 
mixture.
Conclusions
The active coagulant material present in the lobster blood cells' 
extract resembled vertebrate thrombins in two other features.
Firstly, its clotting activity was antagonised by heparin whose 
action was again reversed by the addition of either toluidine blue 
or of hexadimethrine bromide. However, much higher concentrations 
of heparin were needed to completely antagonise the cell extract 
activity than was required to inhibit a potent vertebrate thrombin 
preparation.
Secondly, an inversely proportional relationship was observed 
between the concentration of the cell extract and the clotting time 
of purified lobster fibrinogen solution, similar to that observed 
in vertebrate thrombin-fibrinogen dilution curves.
The presence of antihaemophilic globulin activity in adsorbed 
lobster plasma was tested for in a thromboplastin generation test 
using human plasma as the substrate. The lobster adsorbed plasma 
was found to lack completely any antihaemophilic globulin activity, 
also it had no inhibitory effect when added to a human thromboplastin
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generation mixture (Table 130).
Similarly, the lobster serum did not show any Christmas factor 
activity in the thromboplastin generation test, did not correct 
the defect of Christmas disease serum, and did not possess any 
inhibitory activity against human thromboplastin generation mixtures 
(Table 131).
Discussion
The lack of factor VIII and factor IX activities in lobster 
blood, together with the previously demonstrated lack of factors 
II, V, VII, X, XI, and XII activities suggest that the lobster 
blood does not possess either the extrinsic or the intrinsic 
thromboplastin mechanisms. It seems more reasonable to conclude 
that these factors are actually missing from lobster blood rather 
than present but species specific, especially that it has been 
observed that the coagulation of the lobster blood is mainly 
dependent on the disintegration of the explosive cells, while an 
extract of the lobster blood cells was found to contain a coagulant 
material possessing many similarities to vertebrate thrombin. All 
these findings lead to the conclusion that lobster blood coagulation 
occurs in one phase only, namely the conversion of a soluble protein 
present in the blood (lobster fibrinogen) into an insoluble product 
resembling fibrin, by the action of a coagulant material released 
from a certain type of blood cells, the explosive cells, characterised
-  303 -
by their ability to disintegrate very rapidly on contact with 
foreign surfaces. It is only assumed that such a mechanism is 
also operative in vivo as it is in vitro, possibly substantiating 
and/or substantiated by cellular agglutination as described by 
Loeb (1903b, 1904a, and 1920); Glavind (1948), and Gregoire (1952) 
to achieve proper haemostasis.
Conclusion
The lobster blood does not contain any of the precursor 
thromboplastic factors known to take part in vertebrate blood 
coagulation.
DEMONSTRATION OP THE DEVELOIMENT OF CLOTTING ACTIVITY 
IN THE LOBSTER NATIVE BLOOD
 ...... .........................  ' -I ■ ■ ■ ! ■ ■ ■ ■ ■
Nascent clotting activity was demonstrated to develop in native 
whole lobster blood by subsampling aliquots of the latter onto 
aliquots of purified lobster fibrinogen. The clotting activity 
was maximal within one minute after the blood withdrawal, after 
which time the clotting activity became progressively weaker (Table 
132). The appearance of this clotting activity is believed to 
coincide with the disruption of the lobster explosive cells 
releasing the coagulant material. The gradual disappearance of 
the clotting activity on incubation is thought to be due to the
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consumption of the coagulant material as well as to its great 
lability, rather than to the presence of inhibitory factors similar 
to vertebrate antithrombin.
Conclusion
An active coagulant material which clots purified lobster 
fibrinogen is generated in native lobster blood within the first 
minute of its withdrawal from the animal, thereafter the clotting 
activity disappeared progressively on further incubation.
LOBSTER BLOOD CLOT RETRACTION
Clots formed from lobster whole blood were found to have very 
negligible retraction varying from 0-4 per cent within one hour, 
and only very slightly improved on further standing for 24 hours 
(Table 133). The lobster blood clots are not as firm as vertebrate 
blood clots, and are in the form of clear gels which break easily 
into gelatinous masses on handling.
Conclusion
In vitro clots of lobster blood do not possess the power of 
retraction.
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SUMMARY OP THE LOBSTER BLOOD COAGULATION MEEHANISM
The lobster blood does not contain any of the coagulation 
factors known to take part in vertebrate blood coagulation, except 
for a soluble protein, the lobster fibrinogen, present in a 
concentration of about 250 mg per 100 mis of absolute plasma, and 
has an electrophoretic mobility similar to that of human albumin.
Lobster fibrinogen is directly clotted by an active coagulant 
material present in the lobster muscle and in the explosive cells 
of the blood. The coagulant material is highly unstable on storage, 
resembles vertebrate thrombins in many aspects, but requires the 
presence of calcium chloride solution for its activity to be 
manifest. The coagulant material had no hydrolytic activity on 
arginine esters.
No enzyme active in the lobster blood coagulation was active 
•in the human blood coagulation and vice versa, indicating the 
absolute species specificity of the crustacean coagulation 
mechanism.
Lobster whole blood containing about 5,200 explosive cells per 
cubic millimetre was found to spontaneously clot in ordinary glass 
tubes within 3-5 minutes at 15°C. and in moderately longer times 
at 37°C. suggesting that the lobster coagulation mechanism is well 
adapted to function at this lower temperature of their normal
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environment. Such in vitro blood clots showed very negligible 
retraction.
The rapid occurence of lobster blood coagulation in one phase, 
together with the lobster's moderate power of autotomy as well as 
its protection by a strong shell show that the haemostatic 
mechanism of the lobster is well adapted for its survival.
0 ENEfiAL D I S C U S S  I O N
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G E N E R A L  D I S C U S S I O N  
Findings reported in this work have been already discussed 
under the headings of the separate subjects. This is now a 
discussion of general aspects not already covered, with brief 
reference to personal findings where relevant.
The process of evolution of the mammalian coagulation mechanism 
shall first be presented, followed by discussion of the differences 
and specificity of the various coagulation factors in the different 
species, and their implications.
In discussing the process of evolution of the coagulation 
mechanism, two facts should be kept in mind. Firstly, a biological 
species is defined as an evolved or evolving, genetically distinctive, 
reproductively isolated, natural population. Professor Etaerson 
stated that "Artificial populations compounded by man through 
domestication are not given species rank, even when they are 
genetically distinctive and reproductively isolated populations.
Under natural conditions such man-produced populations would seldom 
maintain their genetic distinctiveness even if they were able to 
survive" (Emerson, 1945). It follows therefore that the domestic 
cattle or fowl for example, though classified as full species, the 
separate breeds are not. Though the separate breeds investigated 
here do not represent natural species, however, it is reasonable
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though not certain, to suppose that similar findings would have 
been observed were these breeds natural species. Secondly, the 
coagulation process is not necessarily a defensive mechanism in all 
the species, it may well be part of a metabolic process (Nolf, 1908) 
or indeed wholly concerned with cellular activities as occurs in 
primordial organisms (Heilbrunn, 1937; and Robb-Smith, 1955).
The phylum Protozoa represents the simplest but by no means 
simple animals. In such unicellular organisms, for example the 
amoeba, a surface precipitation reaction has been described to occur 
in the form of changes in the cytoplasmic consistency from sol to 
gel and vice versa. This reaction, a character of the cell 
protoplasm, is necessary for the cellular activities of pseudopodial 
formation, phagocytosis, as well as division, and is thought to be 
analogous to a clotting reaction (Heilbrunn, 1961). The reaction 
occurs normally only in the presence of free calcium ions. It can 
be prevented by the removal of the free calcium ions through the 
addition of oxalates or citrates. It can also be prevented by the 
addition of heparin.
In invertebrates of more complex structure (multicellular 
organisms with a body cavity) as the Echinoderms exemplified by the 
sea-urchin and the starfish, haemostasis takes place only in the 
form of cellular agglutination, again dependent on the presence of 
calcium ions (Davidson, 1953).
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As we go up the scale of evolution, achievement of haemostasis 
by cellular agglutination seems to be the only mechanism observed 
in several phylae, namely Molluscs represented by the oyster "Ostrea 
edulis" (Takatsuki, 1934), the boring mussel "Pholas" and the 
gastropod "Buccinum" (Geddes, 1879-1880); Worms represented by the 
common earthworm (Geddes, 1879-1880); and the Arthropoda represented 
by insects and Crustacea. In insects, however, four types of 
reaction were described by Gregoire (1951). The first and most 
important is the formation of coagulation islands or granular clouds 
caused by the disintegration of the fragile hyaline cells of the 
haemolymph. The second type of reaction is the production of 
pseudopodial meshworks by the hyaline cells with the occasional 
formation of diffuse plasma veils. The third type is the first 
two combined. The fourth type showed no visible plasma coagulation 
nor any reaction in the hyaline cells. Oxalates and cocaine 
hydrochloride were found to delay or prevent the alterations in the 
hyaline cells and consequently preventing the coagulation of the 
haemolymph. Similarly, in Crustacea there is wide variation of 
the process of haemostasis. Several species rely on cellular 
agglutination alone, for example the king crab Limulus polypheraus 
(Loeb, 1903b, 1904c, and 1920), Cancer pagurus and Maia squinado 
(Tait and Gunn, 1918), as well as the species Libinia and Gecarcinus 
(Morrison and Morrison, 1952). In the latter species the power of
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autotoiqy is particularly well developed. When a limb is injured 
it is reflexly shed off at its origin from the body, a diaphragm 
extends across the breaking plane and a valve closed by the blood 
pressure from within shuts off the blood sinus when the limb is 
finally lost. In other species, cellular agglutination is 
followed by the gelation of the plasma, for example Homarus vulgaris 
(Tait and Gunn, 1918), Homarus americanus (Glavind, 1948), and 
Nephrops norvegicus as demonstrated in Part VI. These species 
possess a fibrinogen-like substance present in the plasma, coagulable 
by a thrombin-like substance released either from the blood cells 
or from muscle tissues on injury, in the presence of calcium ions.
The active coagulant material can be inhibited by heparin in large 
concentrations, which action is again neutralized by hexadimethrine 
bromide. Up to this point in evolution, the blood cells played 
the predominant role, being contact sensitive, and releasing the 
active coagulant material.
Next in the scale of evolution are the cold-blooded vertebrates, 
namely fish, amphibians, then reptiles. These were not investigated 
■in this study. However, it is reported that the blood of fish 
contains fibrinogen that can be clotted by thrombin which is evolved 
from prothrombin (Russel et al, 1962). Warner et al (1939a) found 
that dogfish blood contains eight per cent of the dog's plasma 
prothrombin level when estimated by a two-stage method utilising
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either human brain extract or dog lung extract. Hawkey (I960) 
reported that dogfish blood lacks factors VII, IX, and X in human 
assay systems; while Fantl (1961) found that trout plasma is 
clottable with Russell' s viper venom in 13 seconds and with trypsin 
in 8 seconds suggesting the presence of prothrombin and perhaps 
factors V and X in ample amounts. Fibrinogen was present in a 
concentration of 230 mg per 100 mis of plasma, and was clottable 
with bovine thrombin with a reactivity of 80 per cent that of human 
fibrinogen. Amphibians possess even greater similarity to the 
mammalian coagulation mechanism. They have an efficient extrinsic 
thromboplastin system, though most of the toad reagents were species 
specific (Hawkey, 1960; and Fantl, 1961). They also have an 
intrinsic thromboplastin system with rapid formation of active 
intrinsic thromboplastin when their plasma was incubated with human 
cephalin and calcium chloride; their serum, however, very slightly 
corrected Christmas disease serum, while their adsorbed plasma did 
not correct haemophilic adsorbed plasma in the thromboplastin 
generation test (Hawkey, 1960). Their blood contains nucleated 
thrombocytes instead of the platelets, the removal of which by 
filtration renders the plasma incoagulable (Tait and Green, 1926). 
install and Huntsman (1960) and Hawkey (1960) have demonstrated 
that the coagulation mechanism of the toads' blood is well adapted 
to function properly at the low temperatures to which this species
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is frequently subjected. The phylum of Reptiles comprises snakes, 
lizards, and tortoises. The blood of the tiger snake Notechis 
scutatus was investigated by Fantl (1961) who found that the only 
clotting factor present in it in adequate concentration was the 
fibrinogen. Prothrombin was present in very little amounts since 
the plasma was clottable with Russell's viper venom in 24 seconds 
and with trypsin in 22-49 seconds. Snake plasma did not correct 
the defect of congenitally Hageman factor deficient plasma. On 
the other hand, lizard and tortoise bloods had efficient homologous 
extrinsic thromboplastin systems, could be activated by contact with 
kaolin, but had reduced intrinsic thromboplastin formation (Fantl, 
1961).
A further step in evolution is represented by the non-mammalian 
vertebrates, namely the Avian phylum. As demonstrated in Part II 
fowl blood contains nucleated thrombocytes instead of platelets, 
but the intrinsic thromboplastin system lacks many factors (IX, X, 
XI, and XII), while factor VIII activity was only demonstrable when 
the adsorbed plasma was incubated with fowl thrombocyte suspensions.
In mammalian vertebrates represented by cattle, horses, and 
rabbits (discussed in Parts III, IV, and V respectively) we find 
that the extrinsic thromboplastin systems are very efficient while 
the species specificity of some of the factors concerned in this 
reaction starts to disappear, for example factor V of the three
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species, and factors VII and X of the rabbit. Moreover, they were 
found to possess efficient intrinsic thromboplastin systems 
containing all the factors known to take part in the human blood 
coagulation mechanism, including the Hageman fantor and the plasma 
thromboplastin antecedent. All these factors also lost their 
species specificity and were completely interchangeable in a human 
intrinsic thromboplastin system.
That the human blood coagulation mechanism as it now exists 
has undergone evolution along the broad lines described above depends 
in the first place on our acceptance of Darwin's theory of evolution. 
However, the above findings strongly confirm Heilbrunn's suggestion 
that plasma clotting in higher animals is a result of a progressive 
evolutionary extension into the extra-cellular plasma of the 
cytoplasmic sol-gel mechanism which is present in the cells of all 
living organisms (Heilbrunn, 1937 and 1956). Activities formerly 
characteristic of the cells are now detectable as free factors in 
the plasma, while all the time during evolution new factors appeared 
forming a second thromboplastin system. Because higher vertebrates 
possess two thromboplastin systems instead of one, it is believed 
that their haemostatic mechanism is more efficient, though its 
growing complexity may well be also a safeguard against undue 
clotting or thrombosis.
Great differences were observed in the levels of the different
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coagulation factors concerned in the vertebrate coagulation mechanism, 
as seen in Table 134 which because of its importance is again 
reproduced below and shows the various concentrations of the different 
factors in the species investigated, compared to normal human blood, 
in terms of percentage values except in the case of the platelets 
and the fibrinogen.
S P E C I E S
Lobster Fowl Cattle Horse Rabbit
Blood platelets 
/c.mm. whole blood 5,200* 19,650** 312,350 117,000 311,000
fibrinogen in mgms. 
per 100 mis plasma 230 264 697 436 228
Prothrombin Nil 13-23 £ 100-300 # 160 $ 70 fo
Factor V Nil Present(sp.sp.) 268 % 643 % 10558 i*
Factor VII Nil
Present
(sp.sp.)
Present
(sp.sp.)
80 fo 
(sp.sp.) 89 io
Factor VIII Nil Present(sp.sp.) 816 % 209 fo 288
Factor IX Nil Nil 20 # 203 £ 29 f*
Factor X Nil
Present
(sp.sp.)
101 % 
(sp.sp.)_
85 % 
(sp.sp.) 436 1o
Factor XI Nil Nil 100 % — —
Factor XII Nil Nil 100 % 118 fc 1025 $>
* Explosive cells.
** Thrombocytes.
(sp.sp.) as species specific.
Nhile fowl plasma lacked several of the intrinsic factors (IX, 
XI, and XII) and had little prothrombin, plasmas of the other
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vertebrates contained all the coagulation factors in ample amounts 
and in many instances in apparent great excess as compared with the 
human, with the exception of factor IX which was partially deficient 
in cattle and rabbits' sera. If we correlate such activities as 
determined by laboratory tests with a haemorrhagic condition in the 
case of deficiencies, or with thrombosis in the case of increased 
activities, as is the practice in human blood coagulation, we would 
expect these species to be greatly compromised with haemorrhages or 
thromboses, yet they appear to survive satisfactorily without 
suffering from these two diseases. Bigland and Triantdphyllopoulos 
(1960) suggested that birds perhaps bypass the plasma coagulation 
system and rely on a mechanism of vaso-constriction and rapid 
liberation of tissue thromboplastin following trauma. Fantl (1961) 
has also suggested that the relationship between the activity of a 
clotting factor as found in laboratory tests and the clinical 
symptoms observed in mammals is apparently not applicable to birds 
and snakes, and suggested that the level of fibrinogen is perhaps 
the deciding factor in haemostasis in these two species.
The role, reason, and implication of the presence of many factors 
in apparent excess as compared with the human in some vertebrate 
species is beyond the scope of this investigation. However, two 
important facts are revealed. Firstly, it is perhaps misleading 
to compare the various species on the same basis. For instance,
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if all the species investigated were compared using the rabbit plasma 
as the reference standard, they all would seem to have very deficient 
coagulation mechanisms, including man, which is not actually the case. 
Secondly, that horse serum is a rich source for Christmas factor, 
while rabbit plasma is a very rich source for factors V and XII, 
similar to the previously observed finding that bovine plasma contains 
a high concentration of factor VIII as well as of fibrinogen.
As regards the specificity of the various coagulation factors, 
it was demonstrated that those factors active in crustacean coagulation 
were absolutely species specific towards vertebrate reagents, while 
possessing some degree of specificity among the various crustacean 
species inside the class. Also, it was demonstrated that all the 
coagulation factors present in fowl blood were absolutely species 
specific. In the mammalian vertebrates, namely cattle and horses, 
the species specificity was only encountered in the case of factors 
VII and X, and in the case of cattle was only of a minor degree 
that can be eliminated by prolonged incubation of the factors concerned 
with the heterologous tissue thromboplastin extract. Such species 
specificities would naturally interfere with the proper interpretation 
of tests in which these animal reagents are used in conjunction with 
human reagents. Several authors have devised methods for the assay 
of human blood coagulation factors in which animal reagents are used, 
either as thromboplastic agents, for example bovine brain extracts
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(Owren, 1959; and Nour-Eldin, 1962), or as the deficient substrate 
to be corrected by the human test plasma, for example Seitz-filtered 
or adsorbed bovine plasma (Koller et al, 1951), chicken plasma 
(Wartelle, 1957b), and bovine serum (Bergna, 1960). Unless the 
limitations of the use of these animal reagents are well recognized, 
and until fuller and proper understanding of the effects these 
reagents have on human assay systems, particularly in one-stage 
techniques, the frequent use of these reagents requires further 
critical review.
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S U M M A R Y
Blood coagulation has been investigated in lobsters, fovl, 
cattle, horses, and rabbits. Comparison has been made with the 
human blood coagulation mechanism, on the basis of current concepts 
of that system.
Blood coagulation in the lobsters was found to occur in one 
phase, namely the conversion of lobster fibrinogen from the state 
of sol into that of gel by the action of an active thrombin-like 
material, in the presence of calcium ions. This material is 
released directly from one particular kind of blood cell, the 
explosive cell, characterised by its great sensitivity to contact 
with foreign surfaces which causes it to disintegrate almost 
instantaneously. The thrombin-like material had no hydrolytic 
activity on arginine esters, but its property of coagulating 
lobster plasma or purified lobster fibrinogen was inhibited by 
large concentrations of heparin, which action was reversed by 
hexadimethrine bromide. The lobster blood did not contain any of 
the other coagulation factors known to occur in man. The lobster 
coagulation reagents were absolutely species specific and were not 
interchangeable with human coagulation reagents.
Fowl blood lacked completely factors IX, XI, and XII activities,
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while factors V, VII, VIII, and X were present but species specific. 
Fowl thrombocytes possessed a weak thromboplastic activity even in 
homologous thromboplastin generation mixtures.
In the mammalian vertebrates, species specificity was only 
demonstrable in the case of factors VII and X in bovine and equine 
blood; all the other factors were not species specific and mostly 
present in high concentrations, especially bovine factors I, II, and 
VIII, equine factors II, V, and IX, and in the rabbit factors V and 
XII. The exception was factor IX which was partially deficient in 
both cattle and rabbit sera.
All vertebrate plasmas and the extracted fibrinogen solutions 
were coagulated most rapidly with the homologous thrombin solution, 
again revealing the species specificity of the thrombin-fibrinogen 
reaction.
Adsorbed plasmas from the fowl and horses had an inhibitory 
effect when added to human thromboplastin generation mixtures.
This inhibitory property can be removed by heating the adsorbed 
plasma prior to its addition, to precipitate the fibrinogen which 
is believed to be, or associated with, the responsible agent, since 
both fowl and horse sera had no such inhibitory activity at all.
The presented findings reveal that during the process of 
evolution, several phenomena occur. Firstly, functions which were 
the sole property of the cells become attributed to factors freely
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soluble in the extra-cellular plasma. Secondly, the coagulation 
mechanism becomes more complex due to the appearance of more 
coagulation factors; clotting then occurs after several stages of 
interactions, with the consequent differentiation of two 
thromboplastin systems, the more primitive extrinsic or tissue 
thromboplastin system, and the more intricate intrinsic or plasma 
thromboplastin system being acquired in higher animals. Thirdly, 
the mammals which are regarded as the most highly evolved species, 
have an increased concentration of the coagulation factors, thereby 
probably ensuring the efficiency of the coagulation mechanism.
Finally, factors which in lower animals were completely species 
specific gradually lose their specificity, eventually becoming 
fully interchangeable with human blood coagulation factors.
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